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Abstract	
Background	
Antimicrobial	resistance	(AMR)	is	a	global	healthcare	problem	with	significant	
negative	consequences,	particularly	in	Thailand	where	antibiotics	are	sold	without	
prescription.	Inappropriate	use	of	antimicrobial	medications	is	a	major	cause	of	AMR	
worldwide.	Antimicrobial	stewardship	(AMS)	was	initiated	in	response	to	the	
growing	problem	of	AMR	and	to	ensure	optimal	antimicrobial	use	that	minimises	
AMR.	A	multidisciplinary	approach	is	considered	best	practice	in	AMS,	however,	not	
all	AMS	programs	involve	nurses,	despite	nurses	comprising	the	largest	and	only	
group	of	healthcare	professionals	that	provide	24-hour	care	in	acute	hospital	
environments.	In	addition,	the	role	and	contribution	of	nurses	to	AMS	has	not	been	
fully	described	or	evaluated	in	the	Thai	or	international	research	literature.		
Aims	and	Methods	
This	research	program	used	a	single	institution,	case	study	approach	to	
explore	the	current	and	potential	roles	of	nursing	in	AMS,	within	the	broader	context	
of	clinical	governance	in	the	acute	healthcare	setting	in	Thailand,	and,	to	describe	
the	attitudes	and	perceptions	of	key	stakeholders	to	antimicrobial	resistance	and	
stewardship.	The	research	was	conducted	in	four	phases	using	multiple	methods:	
survey,	in-depth	interview	and	focus	groups.	Methodological	triangulation	was	used	
to	fulfil	the	aims	of	the	research.	The	case	hospital	was	a	1,000-bed	university	
healthcare	facility	in	Bangkok,	Thailand.	The	specific	aims	of	the	study	were	to:	
I. Explore	the	perceptions	and	attitudes	toward	AMS	among	clinicians	in	
acute	healthcare	in	Thailand;	
II. Identify	strengths	and	weaknesses	of	AMS	clinical	governance	structures	
and	activities	as	perceived	by	organisational	leaders	(executives	and	
clinical	leaders)	and	nurses	working	in	acute	healthcare	in	Thailand,	using	
the	CDC	recommendations	as	a	framework	for	the	analysis;	
III. Explore	current	and	potential	for	patient	participation	in	AMS	in	Thailand;	
and	
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IV. Explore	how	organisational	leaders	and	nurses	perceive	potential	future	
roles	for	nurses	in	AMS	in	Thailand	within	the	current	governance,	
educational	and	practice	context.		
Results	
The	perceptions	and	attitudes	towards	AMR	and	AMS	were	explored	in	a	
survey	of	1087	participant	clinicians	who	worked	in	acute	healthcare	in	Thailand	
(62%	response	rate),	comprising	392	doctors,	613	nurses	and	82	pharmacists.	The	
majority	of	participants	agreed	that	improving	antimicrobial	prescribing	would	
decrease	antimicrobial	resistance	(AMR)	and	should	be	a	priority	of	hospital	policy.	
Doctors	were	significantly	less	likely	to	agree	with	policies	that	limit	antimicrobial	
prescribing	(p<0.001)	compared	with	nurses	or	pharmacists,	and	doctors	were	
significantly	less	likely	than	other	clinicians	to	be	interested	in	participating	in	AMS	
education	(p<0.001).	Pharmacists	indicated	highest	agreement	with	statements	
recommending	that	a	specialist	team	provide	individualised	antimicrobial	prescribing	
advice	(P<0.01)	and	that	feedback	improves	antimicrobial	selection	(p<0.001).	
Nurses	were	less	likely	than	other	participants	to	agree	that	community	antibiotic	
use	(p<0.001)	or	patient	pressure	for	antibiotics	contributes	to	AMR	(p<0.001).	It	
was	also	noted	that	the	results	of	the	clinician	survey	identified	that	fewer	nurses	
than	doctors	and	pharmacists	had	heard	of	AMS	terminology	in	English	(10.9%	vs.	
20.4%	vs.	48.8%,	p<0.001).	
Similarly,	the	themes	emerging	from	organisational	leader	interviews	and	
focus	groups	with	nurses	were	that	AMR	was	a	substantial	problem	across	all	sectors	
of	Thailand	and	within	the	study	hospital.	The	findings	highlighted	the	potential	
barriers	and	facilitators	to	effective	implementation	of	AMS	programs	in	Thai	
hospitals.	Semi-structured	interviews	were	used	to	identify	the	strengths	and	
weaknesses	of	AMS	clinical	governance	structures	and	activities;	there	were	15	
interviews	with	organisational	leaders	and	18	nurses	in	three	focus	group	
discussions.	A	major	finding	in	relation	to	clinical	governance	was	that	although	
there	was	executive	level	endorsement	of	AMS	projects	at	the	study	hospital	and	a	
strong,	recognised	clinical	champion	who	provided	leadership	for	AMS	activities	
across	the	organisation,	the	AMS	program	had	not	been	fully	integrated	into	the	
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clinical	governance	structures	of	the	organisation.	Other	findings	highlighted	the	
limited	engagement	of	clinicians	with	the	AMS	program	resulting	in	variable	
implementation	of	the	program	in	clinical	practice.	Participant	recommendations	to	
improve	the	AMS	program	in	the	study	hospital	included:	1)	the	development	and	
use	of	formal	AMS	policies,	2)	increasing	organisational	investment	in	personnel,	3)	
development	of	information	management	systems,	4)	provision	of	staff	education,	
and,	5)	establishing	a	multidisciplinary	approach	to	AMS.	
A	total	of	205	patients	were	surveyed	and	24	nurses	participated	in	focus	
groups	or	interviews	to	explore	the	current	and	potential	for	patient	participation	in	
AMS	in	Thailand.	The	main	findings	were	that	in	the	Thai	community,	both	patients	
and	nurses	perceived	that	antibiotics	are	commonly	used,	and	that	there	was	a	
misconception	by	patients	that	antibiotics	are	useful	to	treat	viral	infections.	
Patients	also	reported	that	they	relied	on	health	professionals	for	information	about	
antibiotic	use	in	the	community	and	they	wanted	more	information	about	the	best	
way	to	use	antibiotics.	When	in	hospital,	patients	were	not	sure	if	they	needed	
antibiotics	and	they	expected	health	professionals	to	manage	their	antibiotic	use.	
However,	patients	also	wanted	to	participate	in	AMS	during	their	hospitalisation.	
There	was	limited	explicit	recognition	by	clinical	nurses	of	the	potential	to	engage	
patients	in	AMS	or	the	possibility	for	patients	to	take	an	active	role	in	the	process.	
Further	work	is	required	to	promote	patient	participation	as	an	active	process	in	
AMS	and	to	foster	decision-making	in	antibiotic	use	that	is	a	shared	process	involving	
clinicians,	patients	and	their	families.		
The	potential	future	roles	for	nurses	in	AMS	in	Thailand	within	the	current	
governance,	educational	and	practice	context	were	explored	in	interviews	with	15	
organisational	leaders	and	in	focus	groups	with	18	nurses.	Findings	were	that	nurses’	
role	in	AMS	in	acute	healthcare	is	to	support	AMS	system	processes	by	monitoring:	
patient	safety,	assessing	optimal	antibiotic	use	and	by	providing	relevant	patient	
education.	Specialty	nurses	provide	specific	advanced	and	extended	roles	in	AMS	in	
both	the	acute	and	primary	health	care	settings.	However,	the	lack	of	existing	
policies	that	formally	describe	the	scope	of	practice	and	responsibilities	of	nurses	in	
relation	to	AMS,	existing	professional	hierarchies	that	limit	the	scope	of	nurses’	role	
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within	the	context	of	a	poorly	defined	overall	role	for	nurses	in	AMS	in	the	Thai	
healthcare	system,	and	inconsistent	engagement	of	nurses	in	AMS	were	perceived	
barriers	to	the	full	involvement	of	nurses	in	the	process	of	AMS.	Moreover,	these	
factors	limited	nurses’	involvement	in	managing	AMR.	Potential	future	roles	for	
nurses	that	were	discussed	included	the	strengthening	of	existing	roles	by	
integrating	nurses	into	the	multidisciplinary	team	and	the	development	of	advanced	
and	extended	existing	roles.	
Conclusions	
The	findings	of	this	study	identify	that	organisational	support	is	needed	if	
nurses	are	to	engage	AMS	programs	consistently	in	order	to	support	hospital	quality	
and	safety	framework.	The	implications	of	a	clear	clinical	AMS	governance	structure	
and	a	policy	for	clinical	nurses,	integrating	AMS	knowledge	into	undergraduate	
nursing	curriculum,	providing	in-service	educational	programs	about	AMS	for	nurses,	
and	developing	a	leadership	role	in	AMS	for	infection	control	nurses	in	acute	care	
along	with	advanced	practice	roles	for	nurses	in	the	regional	areas	of	Thailand	are	
suggested.	Further	research	is	needed	for	a	broader	perspective	by	exploring	the	
current	and	potential	role	of	nurses	in	different	acute	care	settings	in	different	level	
hospitals	and	in	remote	or	provincial	areas	in	Thailand.	
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Chapter	1	
Introduction	
1.1	The	research	problem		
Antimicrobial	resistance	(AMR)	is	a	major	healthcare	problem	worldwide	
(WHO,	2014a).	Patients	with	antimicrobial	resistant	infections	are	more	likely	to	be	
at	risk	of	worse	clinical	outcomes,	recurrent	infection,	and	death,	than	infected	
patients	without	AMR	(Huttner	et	al.,	2013).	In	addition,	AMR	creates	a	massive	
financial	burden	to	healthcare	systems	(WHO,	2011b).	AMR	is	a	problem	in	both	
developing	and	developed	countries	(Lestari,	Severin,	&	Verbrugh,	2012).	The	South-
East	Asia	(SEA)	region	faces	unique	problems	related	to	antimicrobial	usage	(WHO,	
2010a).	In	more	than	half	of	South-East	Asian	countries	including	Thailand,	people	
have	easy	access	to	antimicrobials	without	a	doctor’s	prescription	(WHO,	2015b).	In	
Thailand,	as	many	as	90,000	patients	are	affected	by	AMR	annually	and	the	cost	of	
the	therapeutic	use	of	antibiotic	medications	is	over	$US	200	million	per	year.	The	
increase	in	AMR	has	resulted	in	approximately	3.24	million	extra	days	of	hospital	
stay	and	accounted	for	38,481	deaths	annually	in	Thailand	(Pumart	et	al.,	2012).	
Antimicrobial	stewardship	(AMS)	is	important	to	ensure	optimal	
antimicrobial	medicine	use	and	minimise	antimicrobial	resistance	(MacDougall	&	
Polk	E.,	2005).	A	multidisciplinary	approach	is	considered	best	practice	in	AMS	(Lin	et	
al.,	2013b),	however	not	all	AMS	programs	include	nurses	(Edwards,	Drumright,	
Kiernan,	&	Holmes,	2011c).	Nurses	are	the	largest	group	of	healthcare	professionals	
and	are	the	only	healthcare	professionals	with	patients	24	hours	a	day	in	acute	care	
environments	(Mensik,	2014).	Nurses	are	therefore	in	a	unique	position	to	educate	
patients	and	family	regarding	safe	use	of	antimicrobial	medicines,	ensure	evidence-
based	administration	of	antimicrobial	medicines,	monitor	the	effectiveness	of	
antimicrobial	medicines,	identify	unnecessary	antimicrobial	medicines	and	
contribute	to	multidisciplinary	plans	of	care	(Edwards	et	al.,	2011c;	Galvin	&	Fennell,	
2012;	Gillespie,	Rodrigues,	Wright,	Williams,	&	Stuart,	2013b;	Ladenheim,	
Rosembert,	Hallam,	&	Micallef,	2013b;	Lim,	2010;	Storr,	2012).		
	 Although	nurses	may	not	be	direct	prescribers	of	antibiotics,	they	have	the	
potential	to	influence	the	prescription	and	use	of	medicines	by	monitoring	
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prescription	decisions	(Castledine,	2006;	Jutel	&	Menkes,	2010b)	and	ongoing	
therapy.	In	addition,	actively	educating	patients	is	a	key	strategy	in	reducing	AMR	to	
which	nurses	can	make	a	major	contribution	(WHO,	2014b).	Despite	the	important	
role	that	nurses	may	play	in	the	safe	and	effective	use	of	antibiotics,	little	is	known	
about	nurses’	contribution	to	AMS	(Edwards,	Loveday,	Drumright,	&	Holmes,	2011e).	
In	particular,	the	current	and	potential	role	of	nurses	in	AMS	in	Thailand	needs	
further	investigation	in	order	to	understand	how	nurses	can	contribute	to	safe	use	of	
antimicrobial	medicines	and	reduction	in	AMR.	
1.2	Background	
	 Since	the	accidental	discovery	of	penicillin	by	Alexander	Fleming	in	1928,	
antimicrobials	have	been	used	widely	in	the	treatment	of	infections	(Paskovaty,	
Pflomm,	Myke,	&	Seo,	2005a);	however,	in	the	1940s	and	1950s,	clinicians	began	to	
recognise	the	emergence	of	AMR	(Owens	Jr,	2008).	In	1945,	Alexander	Fleming’s	
Nobel	Prize	interview	with	The	New	York	Times	included	a	warning	that	penicillin	
was	being	over	prescribed	and	misuse	would	lead	to	a	drug	resistance	problem	
(Paskovaty,	Pflomm,	Myke,	&	Seo,	2005b).	
1.2.1	Antimicrobial	resistance	
	 AMR	is	a	growing	public	health	problem	worldwide	and	is	considered	by	the	
World	Health	Organization	(WHO)	to	be	a	global	crisis	and	a	major	issue	in	
healthcare	(WHO,	2017a).	The	WHO	defined	antimicrobial	resistance	(AMR)	as	‘the	
ability	of	a	microorganism	(like	bacteria,	viruses,	and	some	parasites)	to	stop	an	
antimicrobial	(such	as	antibiotics,	antivirals	and	antimalarials)	from	working	against	
it.	As	a	result,	standard	treatments	become	ineffective,	infections	persist	and	may	
spread	to	others’	(WHO,	2017b).			
	 Antimicrobial	resistance	can	make	treatment	of	patients	more	difficult	or	
even	impossible,	or	reduce	the	effectiveness	of	antibacterial,	anti-parasitic,	antiviral	
and	antifungal	drugs	(WHO,	2017a).	The	incidence	and	prevalence	of	AMR	is	growing	
worldwide	and	the	consequences	are	significant.	The	European	Center	for	Disease	
Prevention	and	Control	(ECDC)	reported	that	25,000	people	in	Europe	die	every	year	
because	of	antibiotic	resistant	microorganisms	(Anguita,	2012).	The	Center	for	
Disease	Control	and	Prevention	(CDC)	in	the	United	States	of	America	(USA)	has	
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estimated	that	more	than	two	million	people	are	infected	by	antibiotic-resistant	
pathogens	resulting	in	23,000	deaths	annually	in	the	USA	(CDC,	2013).	According	to	
the	CDC,	more	than	20	bacterial	species	are	resistant	to	available	antibiotics	(CDC,	
2013).	Tuberculosis	(TB)	is	a	case	in	point.	In	2014,	WHO	reported	that	each	year	
480,000	people	develop	multi-drug	resistant	TB	worldwide.	Only	about	half	of	multi-
drug	resistant	TB	patients	were	treated	successfully,	so	around	250,000	people	die	
annually	of	resistant	TB	infections	(WHO,	2017a).	A	further	example	of	widespread	
resistance	is	related	to	infection	with	gonorrhea	where	treatment	failure	with	third	
generation	cephalosporin	has	been	identified	in	at	least	10	countries	(Australia,	
Austria,	Canada,	France,	Japan,	Norway,	Slovenia,	South	Africa,	Sweden	and	the	
United	Kingdom	of	Great	Britain	and	Northern	Ireland)	(WHO,	2017a).		
	 Inappropriate	use	of	antibiotics	not	only	leads	to	AMR	but	also	increases	the	
risks	for	serious	adverse	events	with	no	clinical	benefit.	In	US	hospitals	for	example,	
it	is	estimated	that	50%	of	antibiotics	prescribed	are	unnecessary	or	inappropriate	
(CDC,	2013)	and	a	point	prevalence	study	in	a	tertiary	hospital	in	Australia	found	that	
47%	of	antibiotic	use	was	inconsistent	with	antimicrobial	guidelines	or	patients’	
microbiological	results	(Ingram,	Seet,	Budgeon,	&	Murray,	2012).	Compounding	this	
problem	in	the	last	two	decades,	is	the	dramatic	increase	in	the	rate	of	AMR	while	
the	development	of	new	antimicrobial	drugs	has	slowed	down	(Kelkar	&	Galwankar,	
2013).	The	US	Food	and	Drug	Administration	reported	that	the	rate	of	approval	of	
new	antimicrobials	dropped	a	significant	56%	from	1983	to	2002	(MacDougall	&	Polk	
E.,	2005).	MacGowan	and	Macnaughton	(2013)	argue	that	the	tendency	for	
inappropriately	short	courses	of	antibiotics,	and	AMS	practices	of	reserving	the	use	
of	new	antimicrobials	to	prevent	AMR	have	financial	implications	for	pharmaceutical	
companies	resulting	in	a	reduction	in	antimicrobial	research	and	development	and	
manufacturing.		
1.2.1.1	Antimicrobial	resistance	in	South-East	Asia	and	Thailand	
	 Infectious	diseases	are	a	major	public	health	problem	in	the	South-East	Asia	
(SEA)	region.	Each	year,	approximately	40%	of	all	causes	of	death	are	related	to	
communicable	diseases	in	SEA	(WHO,	2010b).	In	2010,	the	WHO	reported	that	about	
3.5	million	SEA	people	currently	live	with	HIV/AIDS	while	34%	of	all	TB	patients	are	
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from	this	region;	many	of	these	people	have	multidrug-resistant	TB	requiring	high	
consumption	of	drugs	that	are	not	only	expensive	but	also	toxic.	Limited	regulatory	
environments	increase	the	potential	for	the	spread	of	AMR	in	SEA	(WHO,	2010b)	
exacerbating	the	problem	of	AMR	in	this	region.		
	 In	Thailand,	as	many	as	90,000	patients	are	affected	by	AMR	annually	and	the	
cost	of	the	therapeutic	use	of	antibiotic	medications	is	over	$US	200	million	per	year.	
The	increase	in	AMR	has	resulted	in	approximately	3.24	million	extra	days	of	hospital	
stay	and	accounted	for	38,481	deaths	annually	in	Thailand	(Pumart	et	al.,	2012)	
costing	0.6%	of	national	GDP	(WHO,	2016c).	It	is	estimated	that	an	additional	19,000	
deaths	are	caused	by	multidrug	resistant	bacteria	in	Thailand	each	year.	Mortality	
attributed	to	multidrug	resistance	(MDR)	was	highest	for	hospital-acquired	
multidrug-resistant	Acinetobacter	bacteremia	(41%)	(Lim	et	al.,	2016;	MOPH,	2012)	
	 There	are	many	factors	influencing	the	occurrence	of	AMR	in	Thailand	in	
particular.	These	factors	include	the	availability	of	antimicrobial	drugs	without	
prescription,	inappropriate	prescribing	of	antimicrobials	by	medical	practitioners	and	
inappropriate	practices	related	to	prevention	and	control	of	the	spread	of	
antimicrobial	resistance	overall	(Moongtui,	Picheansathian,	&	Senaratana,	2011).	
Antimicrobials	are	being	consumed	increasingly	in	Thailand	and,	since	2000;	
antimicrobial	medicines	have	been	the	most	produced	and	imported	drug	
(Sumpradit	et	al.,	2012b).	Over	5,200	antimicrobial	medications	are	registered	with	
the	Thai	Food	and	Drug	Administration	of	which	two	thirds	are	used	in	humans	
(Sumpradit	et	al.,	2017).	In	2010,	the	Bureau	of	Drug	Control,	Thailand	found	the	
total	value	of	antimicrobial	use	amounted	over	US$	430	million	(Thongmuang,	
2014).	The	top	three	classes	of	antibiotics	used	in	Thailand	are	penicillins,	
cephalosporins	and	carbapenems	in	that	order	(Sumpradit	et	al.,	2017).	In	Thailand,	
antibiotics	are	available	over	the	counter.	An	example	of	antibiotic	availability	
without	prescription	is	the	finding	that	84.5%	of	grocery	stores	in	Mahasarakarm	
province,	one	of	the	larger	provinces	in	Thailand,	sell	antibiotics	over	the	counter	
(Arparsrithongsagul,	2010).	A	study	of	antibiotic	use	and	AMR	in	communities	in	
Thailand	found	that	the	availability	of	antibiotics	and	their	inappropriate	use	in	the	
Thai	community	affect	the	occurrence	of	AMR	(Khamsarn	et	al.,	2016).		
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	 1.2.2	Antimicrobial	stewardship	
	 Antimicrobial	stewardship	programs	were	initiated	in	response	to	the	
growing	problem	of	AMR	worldwide.	Antimicrobial	stewardship	(AMS)	is	a	practice	
to	ensure	the	optimal	selection,	dose,	and	duration	of	antimicrobial	treatments	to	
ensure	the	best	clinical	outcomes	of	treatment	or	prevention	of	infection	while	
decreasing	toxicity	effects	to	patients	and	providing	the	lowest	risk	for	subsequent	
resistance	(Gerding,	2001).	In	essence,	these	programs	aim	to	improve	patient	care	
quality	and	safety	through	increased	infection	cure	rates,	reduced	treatment	
failures,	and	correct	prescribing	for	therapy	and	prophylaxis.	The	overall	benefits	are	
a	reduction	in	AMR,	length	of	hospital	stay	and	healthcare-related	costs	(CDC	2014).	
In	Australia	for	example,	the	Australian	Commission	on	Safety	and	Quality	in	Health	
Care	defined	AMS	as	‘an	ongoing	effort	by	a	health	care	institution	to	optimise	
antimicrobial	use	among	hospital	patients	in	order	to	improve	patient	outcomes,	
ensure	cost-effective	therapy	and	reduce	adverse	sequelae	of	antimicrobial	use	
including	antimicrobial	resistance’	(Duguid	&	Cruickshank,	2011,	p.	4).	Similarly,	the	
Society	for	Healthcare	Epidemiology	of	America	(SHEA),	the	Infectious	Diseases	
Society	of	America	(IDSA),	and	the	Pediatric	Infectious	Diseases	Society	(PIDS)	refer	
to	AMS	as	“coordinated	interventions	designed	to	improve	and	measure	the	
appropriate	use	of	antimicrobial	agents	by	promoting	the	selection	of	the	optimal	
antimicrobial	drug	regimen	including	dosing,	duration	of	therapy,	and	route	of	
administration”	(SHEA,	IDSA,	&	PIDS,	2012,	p.	323).		
	 In	the	late	1970s	and	1980s,	Hartford	Hospital	in	CT,	USA	was	among	the	first	
hospitals	to	formally	recognise	the	importance	of	AMS	and	established	a	committee	
that	included	an	infectious	diseases	physician	and	clinical	pharmacists	to	undertake	
some	of	the	first	prospective	audits	and	establish	what	is	now	referred	to	as	an	
antimicrobial	stewardship	program	(Owens	Jr,	2008).		
	 In	1995,	the	Centers	for	Disease	Control	and	Prevention	(CDC)	launched	the	
Get	Smart	campaign	to	focus	on	reducing	the	inappropriate	use	of	antimicrobials	in	
the	outpatient	setting	(Doron	&	Davidson,	2011).	In	1998,	the	World	Health	
Assembly	adopted	a	resolution	urging	Member	States	to	take	action	against	AMR	
and,	in	2001,	WHO	published	the	WHO	Global	Strategy	on	Containment	of	
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Antimicrobial	Resistance	to	empower	a	response	to	the	AMR	problem	(Leung,	Weil,	
Raviglione,	&	Nakatani,	2011).		
	 In	2004,	the	CDC	initiated	the	Get	Smart	for	Healthcare	program	to	promote	
collaboration	across	healthcare	settings	and	mobilise	national	and	local	health	
officials	in	educating	patients	(Moody	et	al.,	2012).	In	2005	the	World	Health	
Assembly	emphasised	the	importance	of	the	antimicrobial	resistance	problem	and	
called	for	the	optimal	use	of	antimicrobial	agents	by	both	healthcare	providers	and	
consumers	(Leung	et	al.,	2011).	The	Infectious	Disease	Society	of	America	(IDSA)	and	
the	Society	for	Healthcare	Epidemiology	of	America	(SHEA)	then	published	
guidelines	for	the	development	of	programs	to	enhance	AMS	in	hospital	settings	in	
2007	(Dellit	et	al.,	2007).	In	2010,	the	CDC	released	a	revised	Get	Smart	for	
Healthcare	campaign	for	improving	antibiotic	use	in	inpatient	healthcare	facilities	to	
prevent	antimicrobial	overuse	and	promote	AMS.	In	2011,	the	WHO	identified	AMR	
as	a	major	public	health	concern	for	the	global	health	agenda	and	the	No	Action	
Today,	No	Cure	Tomorrow	project	was	launched	to	prevent	the	development	and	
spread	of	AMR	worldwide	(WHO,	2011b).	
	 In	2015,	WHO	revealed	a	report	‘Worldwide	country	situation	analysis:	
Response	to	antimicrobial	resistance’	which	addressed	significant	gaps	in	controlling	
the	AMR	problem	across	the	world	(WHO,	2015b).	At	this	point,	WHO	and	the	sixty-	
eight	member	World	Health	Assembly	have	developed	a	draft	Global	Action	Plan	to	
combat	AMR.	
	 In	2016,	world	leaders	committed,	at	the	UN	General	Assembly,	to	act	on	
AMR	issue	by	addressing	the	root	causes	of	AMR	across	multiple	sectors,	particularly	
human	health,	animal	health	and	agriculture	(WHO,	2016d).	Leaders	in	this	meeting	
called	on	WHO,	the	Food	and	Agriculture	Organisation	of	the	United	Nations	(FAO)	
and	the	World	Organisation	for	Animal	Health	(OIE)	in	collaboration	with	the	World	
Bank	to	coordinate	their	planning	and	actions	to	report	back	to	the	UN	Assembly	in	
2018.	
	 Thailand	is	also	facing	the	challenge	of	treating	and	preventing	infections	
while	reducing	the	emergence	and	spread	of	future	AMR.	In	response	to	the	growing	
problem	in	Thailand,	the	National	AMR	Surveillance	of	Thailand	(NARST)	center	in	
the	Ministry	of	Public	Health	(MOPH)	was	established	in	1998	to	inform	and	evaluate	
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AMR	surveillance.	In	2005,	NARST	was	established	as	a	WHO	Collaborative	Centre	
for	Antimicrobial	Resistance	Surveillance	and	Training	(Keatyingaungsuri,	
Kadsomboon,	&	Maleewong,	2011).	In	2007,	the	MOPH	translated	its	activities	into	
the	campaign	known	as	Antibiotic	Smart	Use	initiated	to	promote	rational	antibiotic	
use	and	support	infection	control	surveillance	in	Thai	hospitals	(MOPH,	2012).	To	
encourage	Thai	hospitals	to	implement	AMS	programs,	the	National	Health	Security	
Office	also	within	MOPH	will	financially	compensate	hospitals	that	have	standards	
for	appropriate	antibiotic	prescribing	in	upper	respiratory	tract	infections,	acute	
diarrhoea,	and	simple	wounds	(Sumpradit	et	al.,	2012b).	Since	2013,	an	antibiotic	
awareness	day	has	been	held	to	promote	public	awareness	for	appropriate	antibiotic	
use	(Sumpradit	et	al.,	2017)	.		
	 Recently	in	late	2016,	the	National	Strategic	Plan	on	AMR	2017-2021	was	
launched	by	the	Royal	Thai	Government	that	included	the	WHO	Country	
Cooperation	Strategy	on	AMR,	with	the	purpose	of	establishing	goals	for	reducing	
morbidity	and	economic	effects	of	AMR	(Sumpradit	et	al.,	2017).	The	strategies	that	
have	been	established	to	achieve	the	national	plan	include:	a)	an	AMR	surveillance	
system	using	the	One	Health	approach,	b)	regulation	of	antimicrobial	distribution,	c)	
infection	prevention	and	control	and	AMS	in	humans,	d)	AMR	prevention	and	
control	and	AMS	in	agriculture	and	pets,	e)	strategies	to	increase	public	awareness	
of	AMR	and	appropriate	use	of	antimicrobials,	and	f)	governance	mechanisms	to	
implement	and	sustain	AMR	actions	(Sumpradit	et	al.,	2017).	
	 1.2.3	Antimicrobial	usage	in	the	21st	century	
1.2.3.1	Antimicrobial	usage	worldwide		
	 Antimicrobial	consumption	is	on	the	rise	worldwide.	Van	Boeckel	et	al.	(2014)	
who	studied	global	antibiotic	consumption	between	2000	and	2010	showed	that	
antibiotic	use	increased	significantly	by	36%	from	54,083,964,813	standard	units	in	
2000	to	73,620,748,816	standard	units	in	2010.	India	was	found	to	be	the	biggest	
consumer	of	antibiotics;	China	and	the	USA	were	the	second	and	third	largest	
antibiotic	users	respectively,	and	broad-spectrum	penicillins	were	the	most	
consumed	antimicrobial	in	2010	(Van	Boeckel	et	al.,	2014).	Carbapenams,	which	are	
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broad	spectrum	and	expensive	antibiotics,	are	being	used	increasingly	in	Pakistan,	
Egypt	and	India.		
	 Antimicrobial	consumption	is	a	major	driver	of	antimicrobial	resistance.	It	has	
been	shown	that	the	prevalence	of	resistance	increases	about	1.5%	following	an	
increase	in	antibiotic	use	by	one	daily	dose	per	one	thousand	people	(Albrich,	
Monnet,	&	Harbarth,	2004;	Davies	&	Verde,	2013)	(Figure	1).	A	systematic	review	by	
Morgan,	Okeke,	Laxminarayan,	Perencevich,	and	Weisenberg	(2011a)	concluded	that	
19%	to	100%	of	antimicrobial	consumption	worldwide	excluding	northern	Europe	
and	North	America,	was	not	by	prescription.	In	Nigeria	and	Palestine	for	example,	
100%	of	antimicrobials	were	sold	without	prescription	(Morgan	et	al.,	2011a).	The	
problem	with	the	use	of	non-prescription	antimicrobials	is	that	the	antimicrobials	
and	doses	are	often	inappropriate,	and	the	course	of	treatment	is	too	short	(Morgan	
et	al.,	2011a).		
 
		
Figure	1.1	Correlation	between	antibiotic	use	and	antibiotic	resistance	
(Source:	https://nanoporetech.com/resource-centre/posters/real-time-detection-antibiotic-
resistance-genes-using-oxford-nanopore)	
1.2.3.2	Antimicrobial	use	in	the	USA	
	 In	the	USA,	antibiotics	are	regularly	prescribed	in	hospitals	(Hadler	et	al.,	
2014);	and	in	2010	the	USA	was	the	third	largest	consumer	of	antibiotics	in	the	world	
(Van	Boeckel	et	al.,	2014).	A	study	of	outpatient	antibiotic	prescribing	in	the	US	from	
2000	to	2010	found	that	1.4	billion	antibiotics	were	used	over	the	study	period;	
while	antibiotic	consumption	among	children	and	adolescents	decreased	by	18	%,	it	
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increased	steadily	in	adults	and	by	30	%	in	elderly	people	(Lee	et	al.,	2014).	It	is	
estimated	that	50%	of	antibiotics	prescribed	in	US	hospitals	are	unnecessary	or	
inappropriate	(CDC,	2013;	Hadler	et	al.,	2014).	In	addition,	approximately	30%	of	
antibiotics	used	in	the	treatment	of	adult	patients	were	used	for	longer	than	
recommended	by	prescription	guidelines	(Hadler	et	al.,	2014).		
1.2.3.3	Antimicrobial	use	in	Europe		
	 High	antimicrobial	consumption	is	also	a	vital	issue	in	healthcare	systems	in	
Europe.	According	to	the	European	Centre	for	Disease	Prevention	and	Control	
(ECDC)	that	collects	information	from	all	EU	countries	(WHO,	2011a),	antibiotic	
consumption	in	Europe	varies	widely	depending	on	the	country.	Countries	in	the	
east	and	south	usually	report	much	higher	antibiotic	resistance	rates	than	in	the	
north	where	consumption	of	antibiotics	is	lower	(ECDC,	2014;	WHO,	2011a).	
Penicillins	are	the	most	frequently	consumed	antibiotics	in	Europe	overall	(ECDC,	
2014).		
	 In	the	period	between	2008	and	2012,	data	for	antimicrobial	consumption	
showed	increasing	use	of	antimicrobials	in	Belgium,	Latvia,	Norway,	Spain	and	the	
United	Kingdom	(ECDC,	2014).	However,	the	consumption	of	beta-lactamase-
sensitive	penicillins	decreased	significantly	in	11	countries:	Austria,	Belgium,	
Bulgaria,	Denmark,	Estonia,	Italy,	Latvia,	Luxembourg,	the	Netherlands,	Norway	and	
Spain.	In	2012,	Greece	was	the	highest	consumer	of	antimicrobials	for	systemic	use.	
In	contrast,	the	Netherlands	were	the	lowest	antimicrobial-consuming	country	of	
Europe	in	2012	(ECDC,	2014).		
	 In	order	to	raise	awareness	of	antibiotic	use	in	Europe,	European	countries	
have	launched	strategies	and	implemented	programs	to	control	antimicrobial	
resistance.	These	include	campaigns	to	promote	prudent	use	of	antimicrobials	in	
communities	and	providing	information	about	antimicrobial	consumption	and	
resistance.	The	WHO	in	the	European	Region	organizes	the	European	Antibiotic	
Awareness	Day	(EAAD)	on	the	18th	of	November	each	year	(WHO,	2011a).		
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1.2.3.4	Antimicrobial	use	in	Australia	
	 Australia	has	one	of	the	highest	rates	of	antimicrobial	consumption	in	the	
developed	world	(Rawlins,	McKenzie,	&	Mar,	2013).	Over	the	last	10	years,	
antimicrobial	consumption	has	increased	by	approximately	10%;	rising	to	24/1000	
population/day	(Hardy-Holbrook,	Aristidi,	Chandnani,	DeWindt,	&	Dinh,	2013).	In	
Denmark,	the	Netherlands	and	Sweden,	antimicrobial	consumption	is	less	than	
15/1000	population/day	(Rawlins	et	al.,	2013).	The	report	‘Antimicrobial	Utilization	
Surveillance	in	Australian	Hospitals,	September	2008	to	August	2012’	presented	
antibiotic	usage	in	defined	daily	dose	(Shaban,	Cruickshank,	Christiansen,	&	
Committee,	2013).	Penicillin	was	the	most	frequently	dispensed	antimicrobial	in	
Australian	hospitals	over	this	time.		
	 A	point-prevalence	study	of	antibiotic	use	at	an	Australian	tertiary	hospital	
found	that	47%	of	antibiotic	use	was	outside	Australian	guidelines	(Ingram	et	al.,	
2012).	Surveys	by	the	Australian	Group	on	Antimicrobial	Resistance	(AGAR)	reported	
the	continuing	trend	for	the	use	of	antibiotics	to	treat	upper	respiratory	tract	
infections	such	as	colds	and	acute	bronchitis	or	bronchiolitis	over	the	past	20	years	
(Hardy-Holbrook	et	al.,	2013).	Reports	of	antibiotic-resistant	bacteria	in	hospitals,	
nursing	homes	and	community	settings	are	on	the	rise.	For	example,	the	incidence	
of	Methicillin-resistant	Staphylococcus	aureus	(MRSA)	infection	in	the	community	
between	2001-2010,	increased	by	10	to	20	%	(Rawlins	et	al.,	2013).	
1.2.3.5	Antimicrobial	use	in	South-East	Asia	and	Thailand		
	 AMR	is	a	problem	in	both	developing	and	developed	countries	(Lestari	et	al.,	
2012).	The	South-East	Asia	(SEA)	region	is	a	mix	of	developed	and	developing	
countries	(www.unctad.org).	SEA	faces	unique	problems	related	to	antimicrobial	
usage;	most	prominent	is	the	availability	of	antibiotics	without	prescription.	An	
additional,	related	concern	is	the	poorly	regulated	use	of	antimicrobials	in	animals	
for	prophylaxis	and	growth	promotion	(WHO,	2010a).	
	 The	review	of	AMR	among	pathogenic	bacteria	in	South-East	Asia	from	1995	
to	2007	showed	that	the	antimicrobial	resistance	problem	has	been	increasing	
continuously	in	SEA	(Lestari	et	al.,	2012).	A	study	of	tuberculosis	(TB)	in	the	WHO	
SEA	region	in	2010	found	that	34%	of	all	TB	patients	were	resistant	to	antimicrobials	
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in	this	region	(Nair,	Wares,	&	Sahu,	2010)	while	more	than	50	%	of	Staphylococcus	
aureus	infected	patients	are	now	methicillin-resistant	(Ray,	Gautam,	&	Singh,	2011).	
In	addition,	Escherichia	coli	resistance	to	third	generation	cephalosporins	and	
fluoroquinolones	has	been	on	the	increase	and	Klebsiella	pneumonia	resistance	to	
third	generation	cephalosporins	is	increasing	and	widespread	in	SEA	(WHO,	2014a).		
	 Inappropriate	prescriptions	and	overuse	of	antimicrobials	is	a	pressing	
healthcare	problem	in	Thailand.	In	the	National	Antimicrobial	Resistance	Surveillance	
Center,	Department	of	Medical	Sciences,	Ministry	of	Public	Health	report,	
Acinetobacter	baumanni	was	identified	as	a	major	bacteria	associated	with	hospital-
acquired	infection	in	Thailand	and	Enterobacteriaceae	(such	as	Escherichia	coli),	
Staphylococcus	aureus	and	Pseudomonas	aeruginosa	were	the	organisms	most	likely	
to	be	associated	with	AMR	(MOPH,	2012).	Since	2000,	the	prevalence	of	colonisation	
and	infection	with	Carbapenam-resistant	Acinetobacter	baumanni	has	increased	
sharply	by	up	to	80	%	in	Thai	hospitals	(Apisarnthanarak,	Buppunharun,	Tiengrim,	
Sawanpanyalert,	&	Aswapokee,	2009).	Colonisation	and	infection	with	Methicillin-
resistant	Staphylococcus	aureus	(MRSA)	was	found	in	approximately	65	%	of	
intensive	care	patients	in	2009	(Mootsikapun,	Trakulsomboon,	Sawanpanyalert,	
Aswapokee,	&	Suankratay,	2009).	
	 In	2011,	in	response	to	the	AMR	problem	in	the	region,	the	Health	Ministers	
of	Member	States,	South-East	Asia	Region	initiated	a	commitment	to	combat	drug	
resistance	through	the	Jaipur	Declaration	(WHO,	2014d).	Improvement	of	public	
health	by	adopting	a	multidisciplinary	approach	to	the	problem	is	a	priority	of	the	
work	of	the	WHO	in	the	region	(WHO,	2014c).		
	 1.2.4	Significance	of	antimicrobial	resistance	and	inappropriate	use	of	
antimicrobials	
	 Antimicrobial	resistance	has	significant	severe	consequences	both	from	a	
human	and	economic	perspective	(WHO,	2014a).	Patients	with	antimicrobial	
resistant	infections	have	a	higher	risk	of	worse	clinical	outcomes,	recurrent	infection	
and	death	than	infected	patients	without	AMR	(Huttner	et	al.,	2013).	It	has	been	
estimated	that	more	than	500,000	people	worldwide	die	every	year	as	a	result	of	
AMR	(CDC,	2013).	A	recent	study	predicted	that	10	million	people	would	die	every	
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year	because	of	AMR	by	2050	if	no	proactive	global	action	to	respond	the	AMR	
problem	(de	Kraker,	Stewardson,	&	Harbarth,	2016).		
	 The	economic	implications	of	AMR	are	significant.	Less	effective	antibiotics	
require	prolonged	and	augmented	treatments,	extended	length	of	hospital	stay	and	
higher	healthcare	use.	In	2014,	WHO	estimated	that	antimicrobial	resistance	
reduced	real	gross	domestic	product	(GDP)	by	0.4%	to	1.6%	resulting	in	a	loss	of	
billions	of	dollars	worldwide	(WHO,	2014c).	For	the	USA	health	system,	this	cost	
amounts	to	about	US$21	to	$34	billion	dollars	annually	while	each	year,	drug-
resistant	bacteria	costs	Europe	€	1.5	billion,	including	loss	in	productivity	(ECDC,	
2009).	In	Thailand,	it	is	estimated	that	there	are	about	$70-$170	million	in	economic	
losses	annually	from	antimicrobial	resistance	(Pumart	et	al.,	2012).	In	addition,	in	
2013,	the	World	Economic	Forum	(WEF)	emphasised	that	AMR	represented	a	global	
risk	for	food	shortage	as	a	result	of	livestock	infection	(WEF,	2013).		
	
1.3	Chapter	summary	
	 The	incidence	and	prevalence	of	AMR	is	growing	worldwide	and	the	
consequences	are	significant.	The	overuse	and	misuse	of	antibiotics	contribute	to	
AMR	while	the	development	of	new	antimicrobial	drugs	has	slowed	down.	WHO	
emphasised	that	the	emerging	of	AMR	is	a	global	health	crisis.	In	Thailand,	the	
availability	of	antibiotics	without	prescription	and	inappropriate	use	of	antibiotics	in	
both	community	and	healthcare	settings	are	the	main	factors	influencing	the	
occurrence	of	AMR.		
	 Several	organisations	worldwide	have	reacted	to	the	AMR	health	crisis.	In	
Thailand	in	particular,	the	National	Antimicrobial	Resistance	Surveillance	center	was	
established	to	inform	and	evaluate	AMR	surveillance.	In	2007,	the	Antibiotics	Smart	
Use	(ASU)	program	was	introduced	as	a	model	for	promoting	the	rational	use	of	
medicines,	starting	with	antibiotics.	Recently	in	late	2016,	the	National	Strategic	Plan	
on	AMR	2017-2021	was	launched	with	the	goal	of	reducing	morbidity	and	the	
economic	effects	of	AMR.		
	 A	multidisciplinary	approach	is	an	important	element	for	initiating	and	
sustaining	AMS	programs.	Nurses	are	in	a	key	position	to	collaborate	within	an	AMS	
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team	although	their	role	is	not	established	or	consistent.	The	role	of	nurses	in	AMS	
within	the	unique	context	of	healthcare	and	antibiotic	availability	in	Thailand	
requires	further	in	depth	investigation.		
1.4	Aims	of	the	study	
	 The	purpose	of	this	research	program	was	to	explore	the	current	and	
potential	roles	of	nursing	in	AMS	in	acute	healthcare	in	Thailand	within	the	broader	
context	of	clinical	governance	and	attitudes	and	perceptions	of	antimicrobial	
resistance	and	stewardship	using	a	single	organisational	case	study.		
	 In	order	to	understand	the	current	and	potential	role	of	nurses	in	AMS,	the	
specific	aims	of	this	study	were	to:		
I. Explore	the	perceptions	and	attitudes	toward	AMS	among	clinicians	in	
acute	healthcare	in	Thailand;	
II. Identify	strengths	and	weaknesses	of	AMS	clinical	governance	structures	
and	activities	as	perceived	by	organisational	leaders	(executives	and	
clinical	leaders)	and	nurses	working	in	acute	healthcare	in	Thailand,	using	
the	CDC	recommendations	as	a	framework	for	the	analysis;	
III. Explore	current	and	potential	for	patient	participation	in	AMS	in	Thailand;	
and	
IV. Explore	how	organisational	leaders	and	nurses	perceive	potential	future	
roles	for	nurses	in	AMS	in	Thailand	within	the	current	governance,	
educational	and	practice	context.		
	 To	meet	these	aims,	a	multiple	methods	approach	was	used	in	a	single	
organisational	case	study	design.	Understanding	the	current	and	potential	role	of	
nurses	in	AMS	is	necessary	to	inform	nursing	education	and	professional	
development	in	relation	to	AMS,	health	service	AMS	governance,	and	strategies	to	
engage	patients	both	within	the	hospital	and	the	community	through	education	and	
health	promotion.		
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1.5	Overview	of	thesis	structure		
This	thesis	is	presented	in	eight	chapters.	In	Chapter	2,	a	review	of	the	
literature	is	presented	in	four	major	sections.	The	first	section	presents	the	general	
framework	of	AMS	programs	through	a	review	of	worldwide	guidelines	and	the	CDC	
recommendations.	In	the	second,	third	and	fourth	sections,	the	current	state	of	
knowledge	relating	to	nurses’	role	in	AMS,	clinicians’	perceptions	and	attitudes	
towards	AMS,	and	patient	participation	in	AMS	are	explored	through	a	narrative	
review	of	the	literature.	
	 The	research	program	was	conducted	in	four	phases.	In	Chapter	3,	the	design	
and	methods	used	to	address	the	aims	of	the	research	are	described	in	detail	for	
each	of	the	four	phases.	This	is	followed	by	a	discussion	of	the	ethical	considerations	
associated	with	the	conduct	of	the	research.		
	 The	findings	of	the	study	are	presented	over	four	chapters	addressing	each	of	
the	four	aims	of	the	program.	In	Chapter	4,	the	findings	related	to	the	investigation	
of	multidisciplinary	clinicians’	perceptions	and	attitudes	towards	AMS	are	described.	
The	findings	relating	to	the	current	AMS	clinical	governance	structures	and	activities	
and	perceived	strengths	and	weaknesses	of	these	governance	structures	are	
reported	and	discussed	in	Chapter	5.	In	Chapter	6,	the	integrated	findings	relating	to	
current	and	potential	patient	participation	in	AMS	are	presented	and,	in	Chapter	7,	
are	the	findings	relating	to	how	organisational	leaders	and	nurses	perceive	current	
and	potential	future	roles	for	nurses	in	AMS	in	Thailand	within	the	current	
governance,	educational	and	practice	context.		
	 Finally,	in	Chapter	8,	the	integrated	findings	are	discussed	in	terms	of	their	
contribution	to	our	understanding	of	strategies	for	sustainable	and	multidisciplinary	
AMS,	implications	for	practice,	limitations	and	strengths	of	the	study,	and	future		
research.		
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Chapter	2	`	
Literature	Review	
In	order	to	explore	the	current	and	potential	role	of	nurses	in	antimicrobial	
stewardship	(AMS)	in	acute	care	in	Thailand,	the	current	research	and	professional	
literature	was	reviewed	and	is	presented	in	four	major	sections	commensurate	with	
the	research	aim	to	understand	the	status	of	AMS	in	healthcare	in	Thailand.	In	the	
first	section,	the	general	framework	of	AMS	programs	is	described	by	reviewing	
worldwide	guidelines	for	AMS.	In	the	second,	third	and	fourth	sections	of	this	
review,	the	current	state	of	knowledge	relating	to	nurses’	role	in	AMS,	clinicians’	
perceptions	and	attitudes	towards	AMS,	and	patient	participation	in	AMS	are	
explored.	
2.1	A	framework	for	antimicrobial	stewardship	programs		
Antimicrobial	stewardship	(AMS)	has	been	defined	as	‘…an	ongoing	effort	by	
a	health-care	institution	to	optimise	antimicrobial	use	among	hospital	patients	in	
order	to	improve	patient	outcomes,	ensure	cost-effective	therapy	and	reduce	
adverse	sequelae	of	antimicrobial	use	including	antimicrobial	resistance’	(Doron	&	
Davidson,	2011,	p.	4).	Importantly,	AMS	programs	are	a	multifaceted	approach	with	
the	potential	to	prevent	and	reduce	the	emergence	of	antimicrobial	resistance	
(AMR).	Antimicrobial	stewardship	programs	aim	to	promote	the	use	of	the	right	
antibiotic,	at	the	right	dose,	at	the	right	time,	and	for	the	right	duration	during	
hospitalisation	(CDC,	2010).	The	Society	for	Healthcare	Epidemiology	of	America	
(SHEA),	the	Infectious	Diseases	Society	of	America	(IDSA),	and	the	Pediatric	
Infectious	Disease	Society	(PIDS)	refers	to	antimicrobial	stewardship	programs	as	
‘coordinated	interventions	designed	to	improve	and	measure	the	appropriate	use	of	
antimicrobial	agents	by	promoting	the	selection	of	the	optimal	antimicrobial	drug	
regimen	including	dosing,	duration	of	therapy,	and	route	of	administration’.	(SHEA	et	
al.,	2012,	p.	323)		
There	is	evidence	that	AMS	programs	help	to	improve	patient	clinical	
outcomes,	reduce	adverse	effects	of	antibiotics,	prevent	antimicrobial	resistance	
(Owens	Jr,	2008)	and	reduce	financial	costs	for	health	services	(Dellit	et	al.,	2007).		
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In	this	section	the	overall	framework	of	AMS	programs	based	on	a	review	of	
guidelines	from	organizations	including	the	Center	for	Disease	Control	and	
Prevention	(CDC,	2014),	the	Center	for	Disease	Control	and	Prevention	(CDC)	and	
Institute	for	Healthcare	Improvement	(IHI)	(CDC&IHI,	2012),	the	Infectious	Disease	
Society	of	America	and	Society	for	Healthcare	Epidemiology	of	America	(Dellit	et	al.	
2007),	Antimicrobial	Stewardship	in	Australian	Hospitals	by	Australian	Commission	
on	Safety	and	Quality	in	Healthcare	(Duguid	&	Cruickshank,	2011),	Antimicrobial	
Prescribing	Policy	and	Practice	in	Scotland	(Nathwani,	2006)	and	the	United	Kingdom	
Antimicrobial	Framework	(SACAR,	2007)	is	outlined.	
This	composite	review	has	identified	the	core	elements	of	hospital	AMS	
programs	as:	leadership	commitment;	accountability;	drug	expertise;	action	to	
support	optimal	antibiotic	use;	antimicrobial	stewardship	intervention	strategies;	
tracking	and	reporting	of	antibiotic	use	and	outcomes;	and	education.	These	core	
elements	of	AMS	are	discussed	in	the	sections	to	follow.		
	 2.1.1	Leadership	commitment	
Leadership	support	is	essential	to	the	success	of	an	AMS	program.	Hospital	
administrators	have	the	responsibility	for	ensuring	the	implementation	and	outcome	
evaluation	of	AMS	policy	(Duguid	&	Cruickshank,	2011).	Hospital	management	
support	should	also	provide	dedicated	resources	for	AMS	activities	and	finance	the	
necessary	infrastructure	to	support	antimicrobial	use	and	monitoring,	such	as	
resources	for	information	technology	(CDC,	2014;	Dellit	et	al.,	2007;	Duguid	&	
Cruickshank,	2011).	The	Australian	Commission	on	Safety	and	Quality	in	Health	Care	
recommend	that	hospital	leaders	express	their	explicit	support	for	AMS	programs	by	
allocating	an	executive	sponsor,	identifying	AMS	as	a	strategic	goal	of	an	
organisation,	communicating	to	staff	and	other	leaders	about	the	AMS	programs,	
setting	a	time	schedule	to	review	progress	and	provide	suggestions,	allocating	high-
performing	staff	to	the	team	and	providing	sufficient	resources	(Duguid	&	
Cruickshank,	2011).	
Several	reports	show	that	multidisciplinary	AMS	is	beneficial	in	reducing	
antibiotic	costs	and	consumption	and	patient	length	of	hospital	stay	(Bantar	et	al.,	
2003;	Lin	et	al.,	2013b).	Multidisciplinary	AMS	programs	involve	processes	for	
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understanding	patterns	of	antibiotic	usage	and	resistance	within	an	organisation,	
selecting	the	appropriate	AMS	strategies	needed,	and	seeking	the	support	of	
hospital	administration	(Paskovaty	et	al.,	2005b).	Hospital	leaders	therefore,	should	
organise	multidisciplinary	AMS	teams	and	allocate	time	and	resources	for	team	
members	including	training	and	education	(CDC,	2014;	Duguid	&	Cruickshank,	2011).	
Gap	analysis	of	antimicrobial	use	requires	participation	and	communication	from	
many	professional	groups,	including	as	appropriate:	infection	control	personnel;	
hospitalists;	intensivists;	emergency	department	physicians;	microbiologists;	
pharmacists;	nurses	and	infectious	disease	experts	(CDC&IHI,	2012).		
Antimicrobial	stewardship	is	a	component	of	overall	clinical	governance	for	
quality	improvement	and	patient	safety.	The	implementation	and	management	of	an	
AMS	program	should	include	clear	lines	and	links	of	accountability	between	the	AMS	
team,	hospital	executive,	director	of	clinical	governance,	drug	and	therapeutics	
committee,	and	infection	prevention	and	control	committees	(Duguid	&	
Cruickshank,	2011;	Nathwani,	2006).	The	process	and	outcome	of	AMS	indicators	
should	be	measured	and	reported	to	the	hospital	executive	(Duguid	&	Cruickshank,	
2011).	The	recommendation	of	an	AMS	team	framework	of	a	Scottish	hospital	is	an	
example	of	a	pathway	to	monitor	and	influence	antimicrobial	prescribing	within	a	
hospital	governance	structure	(Figure	2.1).	The	commitment	of	hospital	
management	and	senior	medical	staff	is	critical	for	the	success	of	AMS	programs	
within	a	patient	safety	framework.		
	
Figure	1.1	Model	of	antimicrobial	prescribing	pathway	and	organization	
in	an	acute	hospital	in	Scotland	(Nathwani,	2006,	p.	1191)		
APP&P	=	antimicrobial	prescribing	policy	and	practice	Recommendation 1: national structure
A national organization should develop the national infrastructure
to support implementation of APP&P. A national clinical
forum should be established to facilitate networking across
NHSScotland in APP&P.
Recommendation 2: NHS Board responsibility
2.1 Chief Executives of NHS Boards, who are responsible for
clinical governance, should also have an overall responsibility
for APP&P in acute hospitals within their NHS Boards. They
should ensure that a local framework is in place for the imple-
mentation of the APP&P. Management processes relating
to APP&P form part of the responsibilities of the Infection
Control Manager [Health Department Letter HDL(2005)8].
2.2 The Board is responsible for establishing systems, including
information technology (IT), for implementing key areas 2–6.
Recommendation 3: hospital structures
3.1 A lead acute hospital Doctor and Pharmacist for Antimicro-
bial Prescribing Policy and Practice in hospitals should be
identified within each NHS Board.
3.2 A multidisciplinary antimicrobial management team (AMT)
for antimicrobial prescribing should be formed. This
should include the above Lead Doctor and Pharmacist,
a microbiologist and/or infectious diseases physician, and a
senior management representative (normally the Infection
Control Manager). This team should be responsible for imple-
menting the Antimicrobial Prescribing Policy and Practice.
A model structure is described in Figure 1
3.3 All acute hospitals should have an antimicrobial policy
and formulary (see Appendix 1). A recent template for
hospital antimicrobial prescribing policies from SACAR
may be helpful.20
Recommendation 4: hospital responsibility and
accountability
4.1 Clear lines of accountability should be defined between the
Chief Executive, the Lead Clinician/Pharmacist, the Drugs and
Therapeutics Committee (DTC) and AMT.
4.2 The local AMT should maintain responsibility for anti-
microbial policy and formulary management, in response to
national guidance and local susceptibility data (see key areas 4
and 5).
4.3 The AMT should have clear responsibilities and ways of
working with the DTCs and Infection Control Committee
(Appendix 2).
4.4 All clinical practitioners have a responsibility to follow good
Antimicrobial Prescribing Policy and Practice in keeping with
Clinical Governance.
Infection Control Manager
Antimicrobial Management
Team (AMT)
Specialty-based Pharmacy leads for
APP&P with responsibility for
antimicrobial prescribing
Ward-based clinical
pharmacists
PRESCRIBER
Chief Executive
Clinical
Governance
Committee
Risk
Management
Committee
Infection
Control
Committee
Drugs and
Therapeutics
Committees
Dissemination and feed back
Microbiologist/Infectious
Diseases Physician
Medical Director
Prescribing support/feedback
Figure 1. Model antimicrobial prescribing practice pathway in acute hospitals. Note: The above figure outlines a proposed pathway to monitor and influence
antimicrobial prescribingwithinahospital or healthcareorganization’s clinical governancestructure. Inparticular, themultidisciplinaryAMTshouldbea subgroupof
and report to theDTC.There should alsobea clear pathof communicationwith the InfectionControlCommitteewhere theremaybeoverlapping interests or expertise.
AnAntimicrobial Pharmacist28 should take the lead in coordinating the implementation and audit of antimicrobial practice, and as such the use of existing pharmacy
structures is essential to support th s activity; the antimicrobi l pharmacist should al o eport to the Chief Pharmacist. Local investment is likely to be required to
support the establishment of lead antimicrobial pharmacists. In some hospitals there may be specialty-based lead pharmacists who could link with ward-based
pharmacists.
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	 2.1.2	Accountability	and	drug	expertise	
Multidisciplinary	involvement	is	a	significant	component	of	AMS	programs	
(CDC,	2014;	Dellit	et	al.,	2007;	Duguid	&	Cruickshank,	2011;	Nathwani,	2006).	A	study	
of	the	impact	of	AMS	programs	in	a	community	public	teaching	hospital	in	Taiwan	
found	that	a	stewardship	intervention	with	multidisciplinary	management	was	
associated	with	a	decrease	in	antimicrobial	costs	by	43%	and	savings	of	
approximately		$US	2.5	million	in	3	years	(Lin	et	al.,	2013b).	The	minimum	core	
members	of	a	multidisciplinary	AMS	team	include	an	infectious	disease	physician	
and	an	infectious	disease-trained	pharmacist	(Dellit	et	al.,	2007;	Duguid	&	
Cruickshank,	2011).	In	the	USA,	the	recommendation	for	achieving	successful	
stewardship	is	that	for	every	150	acute	beds,	there	should	be	designated,	one	full-
time	pharmacist	and	a	part-time	physician	in	the	AMS	team	(Owens,	Fraser,	&	
Stogsdill,	2004).	Meanwhile,	physicians	who	are	practicing	in	AMS	programs	in	
Australian	hospitals	suggest	that	for	every	100	beds,	a	senior	pharmacist	should	
dedicate	10	hours	per	week	and	a	lead	physician	3.5	hours	per	week	to	antimicrobial	
stewardship	activities	(Duguid	&	Cruickshank,	2011).	For	hospitals	without	on-site	
infectious	disease	physicians,	it	is	recommended	that	the	AMS	team	should	be	led	by	
an	interested	clinician	with	a	clinical	pharmacist.	In	small	hospitals	where	on-site	
pharmacists	are	not	available,	advice	from	a	clinical	pharmacist	should	be	sought	
(Duguid	&	Cruickshank,	2011).	
Other	key	support	groups	required	for	AMS	programs	include	the	following	
staff:		
Physicians	who	play	an	important	role	as	the	prescribers	of	antibiotics	(CDC,	
2014).	
Infection	and	hospital	epidemiologists	to	coordinate	monitoring	and	
prevention	of	healthcare-associated	infection,	organise	policies	to	contain	the	
transmission	of	resistant	organisms,	analyse	and	report	the	pattern	of	antibiotic	use	
and	trends	in	bacterial	resistance,	and	educate	staff	in	antibiotic	use	(CDC,	2014;	
Paskovaty	et	al.,	2005b).	
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Quality	improvement	staff	to	collaborate	in	AMS	programs	to	focus	on	
quality	and	patient	safety	issues	(CDC,	2014);	
Laboratory	(Microbiology)	staff	to	provide	appropriate	tests	such	as	patient-
specific	culture	and	susceptibility	data,	be	involved	in	resistant	organism	surveillance	
and	update	local	antibiograms.	In	addition,	the	laboratory	staff	should	present	
laboratory	results	to	support	optimal	antibiotic	use	(CDC,	2013;	Dellit	et	al.,	2007).		
Information	technology	staff	to	supply	electronic	decision	support	systems,	
which	must	be	integrated	into	the	clinical	workflow	to	guide	antimicrobial	
prescribing	in	electronic	health	records.	Moreover,	AMS	teams	should	assess	data	of	
patient	administration,	microbiology	and	drug	use	for	monitoring	and	reporting	
(CDC,	2014;	Duguid	&	Cruickshank,	2011).	
Nurses	who	play	a	role	as	the	one	of	the	key	members	of	the	professional	
team	and	have	the	potential	to	influence	the	prescription	and	use	of	medicines;	for	
example	by	monitoring	prescription	decisions	(Castledine,	2006;	Jutel	&	Menkes,	
2010b).	Nurses	routinely	review	medication	charts	and	play	a	major	role	in	
medication	administration.	Nurses	can	also	ensure	laboratory	culture	reports	are	
available	before	starting	antibiotics,	and	review	medication	orders,	indications	and	
duration	of	antibiotic	treatment	(Edwards,	Drumright,	Kiernan,	&	Holmes,	2011b)	.	
A	multidisciplinary	team	of	physicians,	pharmacists,	nursing,	microbiology	
and	administration	staff	should	discuss	and	consider	aspects	of	antibiotic	use	
together	with	the	goal	of	improving	AMS	outcomes	(CDC&IHI,	2012).	In	addition,	the	
AMS	management	team	should	collaborate	with	existing	committees,	such	as	
therapeutics	committees	and	infection	prevention	and	control	committees,	and	seek	
endorsement	of	the	hospital	executive	for	formal	structural	arrangements	(Dellit	et	
al.,	2007;	Duguid	&	Cruickshank,	2011).		
	 2.1.3	Actions	to	support	optimal	antibiotic	use	
Antimicrobial	stewardship	involves	a	multifaceted	approach	in	order	to	
improve	antibiotic	prescribing	(Tamma	&	Cosgrove,	2011).	Hospital	AMS	programs	
should	include	an	updated	antimicrobial	prescribing	and	management	policy	(Duguid	
&	Cruickshank,	2011;	Nathwani,	2006)	that	should	be	developed	by	the	AMS	team	
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and	authorised	by	an	appropriate	drug	and	therapeutics	committee	(Duguid	&	
Cruickshank,	2011).	Prescribers	should	be	required	to	document	the	indication,	
dose,	route	and	duration	of	antibiotic	therapy	in	medical	records	for	all	antibiotic	
prescriptions	to	ensure	the	appropriate	use	of	medications	(CDC,	2014).	In	addition,	
clinician	teams	should	provide	feedback	to	prescribers	to	improve	processes	
(Paskovaty	et	al.,	2005b).	The	Australian	Commission	on	Safety	and	Quality	in	Health	
Care	(Duguid	&	Cruickshank,	2011)	for	example,	recommend	that	as		a	minimum,	
antimicrobial	prescribing	and	management	policies	should	include:	
• The	latest	version	of	the	national	antibiotic	guidelines	that	include	
evidence-based	practice	recommendations	and	local	susceptibilities	for	
optimising	antimicrobial	prescribing;	
• A	list	of	antimicrobials	and	procedures	that	have	been	restricted;	
• Guidelines	for	prescribing,	including	local	clinical	guidelines;	and	
• Reference	to	the	hospital’s	policy	on	liaising	with	the	pharmaceutical	
industry.	
2.1.3.1	Antimicrobial	stewardship	intervention	strategies	
There	are	three	core	stewardship	strategies	categorised	by	the	Centers	for	
Disease	Control	and	Prevention	(CDC)	though	Core	Element	of	Hospital	Antibiotic	
Stewardship	Programs	(CDC	2014):	broad	interventions;	pharmacy-driven	
interventions;	and	infection	and	syndrome	specific	interventions.	However,	the	CDC	
emphasised	that	hospitals	should	not	implement	too	many	interventions	at	once	
(CDC	2014).	The	chosen	AMS	interventions	should	be	based	on	the	requirements	of	
each	organisation	as	well	as	the	availability	of	resources	to	support	the	successful	
implementation	of	these	initiatives	(CDC	2014).		
Broad	AMS	interventions	include	antibiotic	“time	outs”,	prior	authorisation,	
and	prospective	audit	and	feedback.	The	aim	of	antibiotic	“time	outs”	is	to	review	
the	appropriateness	of	all	antibiotics	48	hours	after	the	initial	orders.	At	that	time	
prescribers	will	have	more	information	such	as	results	of	cultures	and	other	
laboratory	tests,	and	the	clinical	status	of	patients	to	answer	key	questions	including	
(CDC,	2014):		
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• Does	this	patient	have	an	infection	that	will	respond	to	antibiotics?		
• If	so,	is	the	patient	on	the	right	antibiotic(s),	dose,	and	route	of	
administration?	
• Can	a	more	targeted	antibiotic	be	used	to	treat	the	infection	(de-escalate)?	
• How	long	should	the	patient	receive	the	antibiotic(s)?		
	 The	aim	of	prior	authorisation	is	to	control	prescribing	of	specific	
antimicrobial	agents.	The	expertise	in	antibiotic	use	of	physicians	or	pharmacists	will	
be	sought	to	approve	the	use	of	certain	antibiotics	based	on	the	spectrum	of	activity,	
cost	and	toxicity	before	dispensing	(CDC,	2014).		
Prospective	audit	and	feedback	involves	strategies	such	as	prior	authorisation	
with	feedback	to	the	prescriber	before	antimicrobial	prescribing	(Duguid	&	
Cruickshank,	2011).	A	strategy	with	direct	interaction	and	feedback	to	the	prescriber	
by	an	infectious	disease	physician	or	a	clinical	pharmacist,	can	reduce	inappropriate	
use	of	antimicrobials	(Dellit	et	al.,	2007).	An	AMS	team	should	be	responsible	for	
reviewing	and	giving	feedback	in	high	volume	prescribing	wards	(for	example,	
intensive	care	units,	oncology	units);	however,	specialist	nurses	or	clinical	
pharmacists	can	also	be	trained	to	support	this	process	(Nathwani,	2006).			
Pharmacy-driven	interventions	include	automatic	changes	from	intravenous	
to	oral	therapy,	dose	adjustments,	dose	optimisation	and	detection	and	prevention	
of	antibiotic-related	drug	interactions.	Many	physicians	cannot	remember	the	
bioavailability	of	medications	that	may	be	achieved	by	intravenous	and	oral	
administration	(Doron	&	Davidson,	2011).	Many	hospitals	therefore,	encourage	
pharmacists	to	change	antimicrobial	orders	from	the	intravenous	to	oral	route	for	
stable	patients.	Automatic	changes	from	intravenous	to	oral	antibiotics	can	save	
money	and	improve	patient	safety	by	avoiding	intravenous	access.	
At	some	hospitals,	pharmacists	have	the	responsibility	to	calculate	and	adjust	
for	dosing	and	monitoring	of	vancomycin	and/or	aminoglycoside	levels	(Doron	&	
Davidson,	2011),	particularly,	in	cases	of	organ	dysfunction	(CDC,	2014).	Dose	
adjustment	by	pharmacists	can	decrease	the	length	of	hospital	stay	and	reduce	
unnecessary	prescribing	(Bond	&	Raehl,	2007).	Dose	optimisation	depends	on	
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individual	patient	characteristics,	renal	function,	causative	organism,	site	of	
infection,	and	the	pharmacokinetic	and	pharmacodynamics	characteristics	of	the	
drug	(Dellit	et	al.,	2007).	Because	pharmacodynamic	parameters	are	correlated	with	
achieving	efficacy	of	tissue	concentration,	dose	optimisation	is	a	strategy	to	optimise	
antimicrobial	action	and	reduce	the	risk	of	antimicrobial	resistance	(Doron	&	
Davidson,	2011).		Further,	pharmacists	can	also	detect	and	prevent	antibiotic-related	
drug	interactions.	For	example,	interactions	between	some	oral	fluoroquinolone	
therapies	and	certain	vitamins	(CDC,	2014).	
Infection	and	syndrome	specific	interventions	are	largely	guidelines	for	
antimicrobial	prescribing.	Guidelines	for	antimicrobial	prescribing	are	essential	
components	of	AMS	programs.	Hospitals	should	develop	antimicrobial	guidelines	for	
the	treatment	of	specific	common	infections.	In	addition,	the	local	AMR	data	and	
prophylaxis	for	surgical	practice	in	hospitals	should	be	available	(Duguid	&	
Cruickshank,	2011).	In	the	US	Core	Elements	of	Hospital	Antibiotic	Stewardship	
Programs,	CDC,	it	is	suggested	that	hospitals	provide	specific	procedures	to	ensure	
optimal	use	of	antibiotics	to	treat	the	following	common	infections	(CDC,	2014):	
community-acquired	pneumonia;	urinary	tract	infections	(UTIs);	skin	and	soft	tissue	
infections;	empiric	coverage	of	methicillin-resistant	Staphylococcus	aureus	(MRSA)	
infection;	Clostridium	difficile	infections;	as	well	as	targeted	therapy	for	culture-
proven	invasive	infections	(CDC,	2014).	The	United	Kingdom	Specialist	Advisory	
Committee	on	Antimicrobial	Resistance	(SACAR)	also	recommends	minimum	
guidelines	for	treatment	or	prophylaxis	(Tables	2.1).	
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Table	1.1The	minimum	guidelines	for	treatment	or	prophylaxis	(SACAR,	2007,	p.	i89)	
Guidelines	for	treatment	 Guidelines	for	prophylaxis	use	
• Urinary	tract	infections		
• Upper	respiratory	tract	infections	
• Lower	respiratory	tract	infections	
including,	community	and	hospital	
acquired	pneumonia	and	
exacerbations	of	chronic	obstructive	
pulmonary	disease		
• 	Soft	tissue	infections	including	
injuries	or	bites,	cellulitis,	chronic	
ulcers	and	necrotizing	fasciitis		
• Central	nervous	system	infections:	
bacterial	meningitis,	viral	
encephalitis		
• Gastro-intestinal	infections:	food	
poisoning	and	intra-abdominal	sepsis		
• Genital	tract	infections		
• Blood	stream	infections		
• Eye,	ear,	nose	and	throat	infections		
• Sepsis	of	unknown	origin		
• Specific	confirmed	infections:	for	
example,	treatment	regimens	for	
methicillin-resistant	Staphylococcus	
aureus	and	Clostridium	difficile	and	
tuberculosis		
• Endocarditis	
• Prevention	of	bacterial	endocarditis	
(procedure-specific	criteria	should	
be	agreed	to	identify	which	patients	
should	receive	prophylaxis)		
• The	details	of	endoscopic	procedure	
should	be	given	of	which	individuals,	
considered	at	high	risk,	should	
receive	prophylaxis	(for	example	
neutropenia	patients)	
• Surgical	prophylaxis	
(recommendations	should	be	made	
for	all	common	surgical	
interventions	including	timing	of	
initial	dose	and	exceptional	
circumstances	for	repeat	doses)		
• Splenectomy	patients	(provide	
details	of	both	the	immunization	
and	antimicrobial	prophylaxis	
requirements).	
	
	
	 2.1.4	Monitoring	and	reporting	antibiotic	use	and	outcome		
To	measure	the	effectiveness	of	AMS	interventions,	monitoring	and	analysis	
of	antimicrobial	usage	are	required	(Duguid	&	Cruickshank,	2011).	Antimicrobial	
consumption	and	expenditures	are	common	outcome	measures	(Doron	&	Davidson,	
2011)		and	should	be	integrated	into	the	hospital	stewardship	policy	(Dellit	et	al.,	
2007).	Monitoring	and	analysis	of	antimicrobial	usage	requires	infrastructure	
including	information	systems	to	measure	and	monitor	antimicrobial	use	and	
outcomes	of	AMS	programs	(Dellit	et	al.,	2007;	Duguid	&	Cruickshank,	2011).	The	
outcomes	from	AMS	monitoring	need	to	be	reported	to	prescriber	groups	and	
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patient	safety	and	quality	improvement	groups	within	health	care	organisations	
(CDC,	2014;	Duguid	&	Cruickshank,	2011).		
The	measurement	of	process	performance	is	fundamental	to	antimicrobial	
prescribing	improvement.	Effective	antibiotic	consumption	measures	may	include	
intermittent	auditing	of	items	such	as	guideline	adherence	rate,	correct	diagnosis	
criteria	for	infection,	dose,	duration	and	indication	of	antibiotic	therapy,	
consideration	of	cultures	and	relevant	tests	before	initial	treatment,	and	appropriate	
antibiotic	adjustment	in	response	to	microbiological	results	(CDC,	2014).	The	
Australian	Commission	on	Safety	and	Quality	in	Health	Care	(Duguid	&	Cruickshank,	
2011)	recommends	the	use	of	indicators	developed	by	the	NSW	Therapeutic	
Advisory	Group	for	Medicine	Quality	Use	in	Australian	Hospitals,	published	in	2007	
(NSW	Therapeutic	Advisory	Group,	2007,	p.	20).	These	indicators	relate	to	
antimicrobial	prescribing	as	a	percentage	of:	
• Patients	undergoing	specified	surgical	procedures	that	receive	an	
appropriate	prophylactic	antibiotic	regimen.	
• Prescriptions	for	restricted	antibiotics	that	are	concordant	with	drug	and	
therapeutics	committee	approved	criteria.	
• Patients	with	a	toxic	or	sub-therapeutic	aminoglycoside	concentration	
whose	dosage	has	been	adjusted	or	reviewed	prior	to	the	next	
aminoglycoside	dose.	
• Patients	presenting	with	community	acquired	pneumonia	that	are	
prescribed	guideline	concordant	antimicrobial	therapy.		
Antibiotic	use	measures	should	also	be	a	feature	of	antibiotic	use	monitoring.	
The	World	Health	Organisation	(WHO)	publishes	defined	daily	dose	(DDD)	per	1000	
patient	days	as	a	unit	of	measurement	for	calculating	the	total	number	of	grams	of	
an	antimicrobial	agent	used	divided	by	the	number	of	grams	in	an	average	daily	
dose.	For	example,	the	DDD	of	oral	cloxacillin	is	1000	mg,	so	a	patient	receiving	500	
mg	every	eight	hours	for	five	days	consumes	7.5	DDD.	This	measurement	is	useful	
for	comparing	antimicrobial	use	with	other	similar	hospitals	and	is	an	indicator	of	the	
potential	need	for	adjustment.	However,	it	is	not	suitable	for	patients	with	renal	
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impairment	or	for	paediatric	patients	because	DDD	is	based	on	adult	dosing	(Dellit	et	
al.,	2007;	Doron	&	Davidson,	2011;	Nathwani,	2006).	
Another	measure	of	antibiotic	use	is	day	of	therapy	(DOT).	Day	of	therapy	is	
used	to	monitor	the	volume	of	antimicrobial	use	as	the	prescribed	daily	dose.	For	
example,	administration	of	amoxicillin	as	one	1000	mg	dose	or	as	four	1000	mg	
doses	given	six	hours	apart	would	both	represent	one	DOT.	When	a	single	patient	is	
prescribed	both	amoxicillin	and	vancomycin,	the	recording	is	two	DOTs	(Polk,	Fox,	
Mahoney,	Letcavage,	&	MacDougall,	2007).	The	DOT	measure	disregards	the	actual	
number	of	doses	administered	or	dosage	intensity.		
Outcome	measurements	are	defined	as	‘the	degree	to	which	these	outcomes	
are	achieved’	(Dellit	et	al.,	2007,	p.	171).	To	determine	improvement	as	a	result	of	an	
AMS	program,	several	ways	to	investigate	outcomes	include	cost	saving;	AMR	rates	
and	Closidium	difficile	rates	(Dellit	et	al.,	2007;	Patel,	Lawson,	&	Guglielmo,	2008).	
While,	the	overall	cost	of	the	AMS	intervention	is	less	likely	to	be	reported	(Patel	et	
al.,	2008),	changes	in	adverse	event	rates	associated	with	administration	of	
antimicrobial	drugs,	and	antibiotic	expenditure	may	be	useful	outcome	
measurements	of	AMS	programs	(Dellit	et	al.,	2007;	Patel	et	al.,	2008).		
	 2.1.5	Health	professional	education	in	antimicrobial	stewardship		
Hospital	management	has	a	responsibility	to	provide	AMS	education	to	all	
healthcare	professionals	(Duguid	&	Cruickshank,	2011).	The	Infectious	Diseases	
Society	of	America	and	the	Society	for	Healthcare	Epidemiology	of	America	
emphasised	the	importance	of	prioritising	education	as	a	supplement	to	the	core	
strategies	of	AMS	programs	(Dellit	et	al.,	2007).	Antimicrobial	Prescription	Policy	and	
Practice	in	Scotland	(Nathwani,	2006)	recommends	that	any	professionals	who	are	
involved	in	antimicrobial	prescribing	or	administration	should	receive	AMS	training	
with	appropriate	content	in	both	undergraduate	and	post	graduate	curricula.	Web-
based	education	resources	should	be	provided	to	educate	both	healthcare	providers	
and	patients	for	improving	antibiotic	use	to	promote	awareness	(Pagani,	Gyssens,	
Huttner,	Nathwani,	&	Harbarth,	2009).		
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2.2	Nurses’	roles	in	antimicrobial	Stewardship	
In	this	section,	a	search	and	narrative	review	of	the	literature	related	to	
nurses’	role	in	AMS	is	presented	to	explore	what	is	known	about	the	current	and	
potential	role	of	nurses	in	AMS	worldwide.		
The	CINAHL	and	MEDLINE	electronic	databases	were	searched	to	September	
2017	with	no	set,	earlier	cutoff	date.	The	databases	were	searched	using	the	
following	terms:	“nurse*	and	“antibiotic	stewardship”	or	“antimicrobial	
stewardship”	or	"antibiotic	management"	or	"	antimicrobial	management"	or	
"antibiotic	involvement"	or	"	antimicrobial	involvement".	Additionally,	Google	
(Scholar)	databases	were	also	searched	using	the	term	“role	of	nurses	in	
antimicrobial	stewardship”	in	this	literature	review.	Qualitative	and	quantitative	
research,	clinical	reviews,	editorials,	guidelines,	and	recommendations,	which	were	
published	in	English,	were	included	in	the	review.	
The	review	process	revealed	45	relevant	research	papers;	most	of	which	
were	published	in	the	USA	and	the	UK.	The	papers	were	categorised	according	to	the	
specialisation	of	nurses	in	relation	to	infection	control	nurses	(ICNs)	or	clinical	ward	
nurses	(RN)	(Figure	2.2).	Of	the	42	papers	that	focused	on	expert	opinion,	they	
reviewed	clinical	nurses’	role	in	AMS	in	general;	24	were	expert	opinion	reviews,	13	
were	research	papers,	three	editorials,	two	of	guideline/white	paper.	There	were	
three	papers	that	identified	that	ICNs	contributed	in	AMS,	one	guideline	paper,	
published	in	Ireland	addressed	the	need	for	ICNs	to	be	members	of	AMS	teams	and	
another	two	research	papers	reported	the	positive	outcomes	of	ICNs	engaging	in	
AMS.	A	summary	of	RN	papers	is	presented	in	Table	2.2	and	the	ICN	papers	in	Table	
2.3	in	chronological	order	beginning	with	the	most	recent	publications.	Key	themes	
derived	from	a	narrative	review	of	these	papers	are	presented	in	the	section	to	
follow.		
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Figure	2.2	Categories	of	selected	papers	of	nurses'	role	in	AMS	
Selected	
papers	=	45
RN	=	42
Expert	opinion	
reviews=	24
Guidelines/	White	
paper=	2
Editorial	=	3
Research	=	13
ICN	=	3
Guidelines	=	1	
Research	=	2	
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Table	2.2:	Summary	of	published	papers	related	to	clinical	nurses’	role	in	antimicrobial	stewardship	(AMS)	(n=42)	
Author,	Publication	year,	Country,	Title	 Type	of	paper	 Nurses’	roles	in	antimicrobial	stewardship	
1.	Olans,	Olans,	and	Witt	(2017a),	USA	
Good	nursing	is	good	antibiotic	
stewardship	
Expert	opinion	
review	
		
• Nursing	activities	are	connected	to	AMS	initiatives,	as	nurses	are	the	primary	bedside	advocates	and	monitors	of	patient	
safety	and	progress.	
• Nurses	are	the	central	source	of	facilitation	and	communication	among	all	the	participants	in	AMS.		
• Nurses	have	a	role	in	infection	control	management	
• Nurses	should	view	AMS	as	an	integral	part	of	nursing	
2.	Roberts	et	al.	(2017),	USA	
A	survey	of	critical	care	nurses’	practices	
and	perceptions	surrounding	early	
intravenous	antibiotic	initiation	during	
septic	shock	
Research	 • Aim-	To	evaluate	the	knowledge,	practices	and	perceptions	of	critical	care	nurses	regarding	antibiotic	initiation	in	
patients	with	newly	recognised	septic	shock.	
• Findings:	98%	of	participants	recognised	the	existence	of	the	sepsis	protocol	and	nurses	perceived	they	initiated	early	
intravenous	antibiotics	to	manage	septic	shock	in	a	timely	manner	
3.	ANA	and	CDC	(2017),	USA	
ANA	and	CDC	white	paper	on	nurses'	role	
in	antibiotic	stewardship	
White	paper	 • Nurses’	role	in	patient	safety	is	through	1)	improving	antibiotic	use	at	bedside;	2)	improving	participation	in	antibiotic	
use	activities;	3)	improving	education	and	training;	and	4)	engaging	in	a	leadership	role	in	the	AMS.	
4.	Witts	(2016),		USA	
Antibiotic	Stewardship:	The	Nurse’s	Role	
in	Making	a	Difference	
Research	
Poster	
Abstract	
• Being	aware	of	the	national	goals,	clinical	microbiology	concept.		
• Being	able	to	assess	and	accurately	report	changes	in	patients	conditions	
5.	Schellack,	Pretorius,	and	Messina	
(2016),	South	Africa	
Esprit	de	corps':	Towards	collaborative	
integration	of	pharmacists	and	nurses	into	
antimicrobial	stewardship	programmes	in	
South	Africa	
Expert	opinion	
review	
	
• Monitoring	compliance	with	institutional	guidelines	and	best	practice	
• Monitoring	for	drug	allergies	and	side-effects	
• Obtaining	and	reporting	therapeutic	levels,	management	and	administration	of	medicines	with	mixed	dosages,	e.g.	
insulin,	and	ensuring	timely	and	correct	administration	of	antimicrobials.	
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Author,	Publication	year,	Country,	Title	 Type	of	paper	 Nurses’	roles	in	antimicrobial	stewardship	
6.	Safdar	et	al.	(2016),	USA	
Management	of	ventilator-associated	
pneumonia	in	intensive	care	units:	a	mixed	
methods	study	assessing	barriers	and	
facilitators	to	guideline	adherence	
Research	 • Aim:	To	understand	barriers	and	facilitators	to	the	adoption	of	the	IDSA/ATS	guidelines.	
• Results:	Nurses	worked	in	a	multidisciplinary	team	in-patient	rounding	and	being	aware	of	IDSA/ATS	guidelines.		
7.	Olans,	Olans,	and	DeMaria	(2016),	USA	
The	Critical	Role	of	the	Staff	Nurse	in	
Antimicrobial	Stewardship—Unrecognized,	
but	Already	There	
Expert	opinion	
review	
	
• Nurses’	role	can	be	at	many	levels	with	different	activities	related	to	AMS:	
o At	Patient	admission	e.g.	triage	and	isolation,	accurate	allergy	history,	early	and	appropriate	culture,	timely	
antibiotic	initation,	medication	reconciliation	
o Daily	clinical	progress	monitoring	e.g.	monitor	and	report	progress,	preliminary	antibiotic	adjustment,	
administering	antibiotics,	checking	antibiotic	dosing	and	de-escalation	
o Patient	safety	&	quality	monitoring	e.g.	monitoring	adverse	events,	reporting	changes	in	patient	condition,	
final	culture	and	antibiotic	adjustment,	identifying	antibiotic	resistance	
o Clinical	progress/	patient-education/discharge	via	IV	to	PO	antibiotic	administration,	outpatient	antibiotic	
therapy	
8.	Manning,	Pfeiffer,	and	Larson	(2016),	USA	
Combatting	antibiotic	resistance:	The	role	of	
nursing	in	antibiotic	stewardship	
Expert	opinion	
review	
	
• Administering	and	monitoring	antibiotic	therapy	at	bed	side	
• Evaluating	antibiotic	use	on	a	daily	basis	with	other	members	in	the	patient	care	team		
• Being	antibiotic	first	responders,	coordinating	care	including	monitoring	patient	condition	and	response	to	
antibiotic	therapy	
• Educating	patients,	family	members	and	relevant	bodies	on	the	appropriate	use	of	antibiotics	
9.	Manning	(2016),	USA	
Antibiotic	stewardship	for	staff	nurses:	five	
key	ways	you	can	influence	antibiotic	use	
Expert	opinion	
review	
	
• Identifying	AMR	by	participating	in	hospital	AMS	activities.		
• Making	decisions	regarding	safe	antibiotic	administration	and	monitoring	clinical	processes	and	practice.		
10.	Gregory	(2016),	USA	
A	Brief	History	of	Antibiotics	in	the	Neonatal	
Intensive	Care	Unit:	From	Routine	
Prophylaxis	to	Antimicrobial	Stewardship	
Expert	opinion	
review	
	
• Neonatal	nurses	play	a	role	on	AMS	teams.		
• Neonatal	nurses	identify	changes	in	vital	signs	or	subtle	symptoms	that	may	indicate	a	new	infection	or	problem	
associated	with	current	antibiotic	therapy.	
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Author,	Publication	year,	
Country,	Title	
Type	of	paper	 o Nurses’	roles	in	antimicrobial	stewardship	
11.	Dyar,	Beović,	Vlahović-
Palčevski,	Verheij,	and	Pulcini	
(2016),	Sweden	
How	can	we	improve	antibiotic	
prescribing	in	primary	care?	
Expert	opinion	
review	
	
• Nurses	and	pharmacists	should	contribute	to	AMS	in	primary	care		
• Nurses,	with	appropriate	training,	can	contribute	to	patient	education	on	appropriate	use	of	antibiotics	
12.	Brink,	Van	den	Bergh,	
Mendelson,	and	Richards	
(2016),	South	Africa	
Passing	the	baton	to	
pharmacists	and	nurses:	New	
models	of	antibiotic	
stewardship	for	South	Africa?	
Expert	opinion	
review	
	
• Nurses	can	potentially	play	important	roles	in	antimicrobial	prescribing	in	South	Africa		
• Nurses	can	take	an	AMS	role	in	intensive	care	units	
13.	Tyer-Viola	and	Kelly	(2015),	
USA	
Using	Best	Evidence	to	Reduce	
the	Rate	of	Surgical	Site	
Infection		
Research	
Poster		
• Aim:	To	create	a	surgical	site	infection	prevention	bundle		
• Results:	Nurses	initiated	an	evidence-based	care	bundle	e.g.	patient	education	on	wound	care,	hand	hygiene,	and	signs	and	
symptoms	of	infection	which	decreased	surgical	site	infection		
14.	Spruill	and	Folh	(2015),	USA	
Improving	Antibiotic	
Prophylaxis	Prior	to	Cesarean	
Birth	
Research	
Poster	
Presentation	
• Aim:	To	ensure	antibiotic	prophylaxis	compliance	in	scheduled	cesarean	births		
• Results:	The	results	of	99%	compliance	was	met	by	changing	practice	of	nurses	e.g.	eliminating	time	in	finding	blood	
collection	tubes	and	antibiotics	so	that	nurses	could	focus	on	the	woman	in	labour	without	leaving	the	bedside.	
15.	Peate	(2015),	Spain	
Antimicrobial	resistance:	the	
nurse’s	essential	role	
Editorial	 • Pre-registration	nursing	programmes	should	include	the	topic	of	AMR,	supporting	multidisciplinary	engagement	of	AMS		
• Nurses	should	be	present	at	a	global	forum	e.g.	World	Health	Assembly/	WHO	summits	
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Author,	Publication	year,	
Country,	Title	
Type	of	paper	 • Nurses’	roles	in	antimicrobial	stewardship	
16.	Manning	and	Giannuzzi	
(2015),	USA	
Keeping	patients	safe:	antibiotic	
resistance	and	the	role	of	nurse	
executives	in	antibiotic	
stewardship	
Expert	opinion	
review	
	
• Applying	“antibiotic	time-out”	strategy	including	1)	reassessing	antibiotic	therapy	after	2-3	days	and	deciding	management	
based	on	culture	results;	2)	monitoring	Clostridium	difficile	and	ceasing	of	all	unnecessary	antibiotics;	3)	reappraising	
antibiotic	therapy;	4)	assessing	blood	cultures	to	ensure	that	serious	infection	is	treated	in	a	timely	manner;	and	5)	pre-
discharge	evaluation	to	avoid	unnecessary	antibiotic	use	at	a	critical	transition	of	care.	
• Nurses	can	play	an	executive	role	in	AMS	teams	e.g.	spearheading	strategic	nursing	engagement,	raising	awareness	among	
nurses	regarding	the	importance	of	antibiotic	use,	demonstrating	how	nursing	can	be	incorporated	in	AMS.	
17.	Fehily,	Stuart,	Horne,	
Korman,	and	Dendle	(2015),	
Australia	
Who	really	knows	their	patients'	
penicillin	adverse	drug	reaction	
status?	A	cross-sectional	survey	
Research	
	
• Aim:	To	identify	the	extent	of	healthcare	workers‘(HCW)	awareness	of	their	patients’	ADR,	and	antibiotic	use	in	hospital.	
• Results:	Majority	of	nurses	were	more	likely	to	be	aware	of	their	patient’s	penicillin	ADR	compared	with	doctors	and	
pharmacists.		
18.	Bruce,	Maiden,	Fedullo,	and	
Kim	(2015),	USA	
Impact	of	Nurse-Initiated	ED	
Sepsis	Protocol	on	Compliance	
With	Sepsis	Bundles,	Time	to	
Initial	Antibiotic	Administration,	
and	In-Hospital	Mortality	
Research	 • To	(1)	evaluate	the	impact	of	a	nurse-initiated	ED	sepsis	protocol	on	time	to	initial	antibiotic	administration,	(2)	ascertain	
compliance	with	3-hour	Surviving	Sepsis	Campaign	(SSC)	targets,	and	(3)	identify	predictors	of	in-hospital	sepsis	mortality.	
• Results:	Implementation	and	adherence	to	the	ED	Sepsis	protocol	initiated	by	nurses	significantly	reduced	time	to	initial	
antibiotic	administration	and	improved	compliance	with	serum	lactate	level	collection.	The	impact	of	the	protocol	
implementation	did	not	lead	to	significant	change	in	the	in-hospital	mortality	rate	
19.	McGoldrick	(2014),	USA	
Antimicrobial	stewardship	
Expert	opinion	
review	
	
• Identifying	signs	and	symptoms	that	may	indicate	an	infection	
• Applying	the	SBAR	(situation,	background,	assessment,	recommendations)	approach	to	communicate	with	the	prescriber		
• Avoid	requesting	unnecessary	antibiotic	prescriptions	for	patients	
• Ensure	that	a	specimen	culture	is	obtained	prior	to	commencing	antibiotic	therapy	
• Requesting	an	order	for	a	C.	difficile	test	if	the	patient	had	at	least	three	episodes	of	watery	diarrhea	within	a	day.		
• When	a	new	antibiotic	is	prescribed:	administering	antibiotics	according	to	the	prescription,	ensuring	full	compliance	and	
completion	of	the	course	of	treatment.	
• Reassessing	the	patient	48-72	hours	after	starting	an	antibiotic	and	taking	an	“antibiotic	timeout”	
• Documenting	and	communicating	with	prescribers	regarding	patients’	clinical	response	
• Medication	reconciliation	and	medication	monitoring	activities	
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Author,	Publication	year,	
Country,	Title	
Type	of	paper	 • Nurses’	roles	in	antimicrobial	stewardship	
20.	Gallagher	(2014),	UK	
Cutting	antibiotic	use	
Expert	opinion	
review	
	
• Educating	patients	and	the	wider	public		
• Playing	a	role	in	reducing	the	demand	of	antibiotics	and	enhancing	the	effectiveness	of	prescribed	antibiotics		
21.	Curry,	Gallagher,	and	
Donovan	(2014),	UK	
Antimicrobial	resistance	
Guidelines		 • Obtaining	specimens	when	clinically	indicated	and	transferring	the	specimen	to	a	laboratory	in	a	timely	manner		
• Ensuring	the	antibiotic	prescribing	processes	are	clearly	communicated,	implemented	and	monitored		
• Dispensing	antibiotics	in	the	right	time,	under	optimal	circumstances	
• Educating	patients	and	their	carers	about	how	to	take	antibiotics	appropriately,	observe	and	report	any	worsening	sign/symptoms	
22.	Charani,	Castro-Sanchez,	
and	Holmes	(2014),	UK	
The	role	of	behavior	change	in	
antimicrobial	stewardship	
Expert	opinion	
review	
	
• Introducing	evidence-based	AMS	role	by	applying	evidence	to	ensure	optimal	antibiotic	use	and	application	in	nursing	practice.	
• Introduce	new	role	as	AMS	consultant	and	supporting	the	role	in	AMS	as	a	core	competency	in	educational	qualification.	
23.	Amalia	(2014),	South	Africa	
Changing	Southern	African	
Nurses'	Roles	in	Antibiotic	
Stewardship:	An	Innovative	
Pedagogical	Approach	
Research	
Poster	
• Qualitative	description	of	the	current	roles	of	nurses	in	Mozambique,	Malawi	and	South	Africa	related	to:	
o Antibiotic	prescription	
o Antibiotic	administration	
o Antibiotic	management	
• Patient	education		
24.	Ladenheim,	Rosembert,	
Hallam,	and	Micallef	(2013a),	
UK	
Antimicrobial	stewardship:	the	
role	of	the	nurse	
Expert	opinion	
review	
	
• Prescribing	
• Questioning	and	highlighting	suboptimal	antibiotic	therapy.	
o Ensuring	doctors’	prescribing	in	line	with	recommended	guidelines.		
o Reviewing	medication	chart,	blood	cultures.	
o Ensuring	appropriate	switch	of	intravenous	antibiotic	therapy	to	oral.	
• Allergy	status	confirmation	
• Considering	and	confirming	drug	allergy,	side	effects	before	administration.	
• Timing	of	antimicrobial	administration	
o Ensuring	appropriate	time	of	antibiotic	administration.	
o Continuation	of	drug	treatment	
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Author,	Publication	year,	
Country,	Title	
Type	of	paper	 Nurses’	roles	in	antimicrobial	stewardship	
24.	Ladenheim,	Rosembert,	
Hallam,	and	Micallef	(2013a),		
(cont.)	
	 o Ensuring	appropriate	administration	and	continuation	of	treatment		
• Outpatient	parenteral	antimicrobial	therapy		
• Monitoring	antibiotic	treatment,	adverse	effects	and	complications	of	treatment	when	there	are	intravenous	antimicrobial	
therapies	in	the	outpatient	or	community	setting	
25.	Gillespie,	Rodrigues,	Wright,	
Williams,	and	Stuart	(2013a),	
Australia	
Improving	antibiotic	
stewardship	by	involving	nurses	
Research	 • Aim	-	To	assess	nursing	attitudes	and	knowledge	of	AMS	before	and	after	an	education	intervention	that	focused	on	nursing	
involvement	in	AMS		
• Findings	-	IV	antibiotic	use	reduced	in	three	of	six	wards,	Reduction	in	Staphylococcus	aureus	bacteremia	related	to	IV	lines	(3	to	
2).	Nurses	were	more	likely	to	raise	questions	with	the	treatment	team	about	appropriateness	of	treatment.	
26.	Aziz	(2013),	UK	
The	role	of	healthcare	
strategies	in	controlling	
antibiotic	resistance	
Expert	opinion	
review	
	
• Reviewing	antibiotics	history	with	patients	on	admission,	at	handover,	and	when	they	are	being	discharged.		
• Vigilance	about	how	wards	and	departments	use	antibiotics;	cooperate	with	infection	prevention	and	control	teams.	
• Always	administer	antibiotics	on	time	and	avoid	missing	doses.	
• Checking	laboratory	results	of	patients;	blood	cultures,	specimen	cultures	and	sensitivity	then	informing	the	doctor	to	encourage	a	
narrow-spectrum	antibiotics.	
• Monitoring	standard	precautions	and	implementing	infection	prevention	and	control	measures	when	nursing	patients	with	
antibiotic	drug	resistance.	
• Participating	in	unit-based	surveillance	studies	to	learn	about	trends	in	antimicrobial	resistance.	
• Participating	in	antibiotic	committee	meetings	and	learning	about	the	hospital	strategy	to	address	antibiotic	resistance.	
27.	Dryden	et	al.	(2012),	UK	
Antibiotic	stewardship	and	
early	discharge	from	hospital:	
impact	of	a	structured	approach	
to	antimicrobial	management	
Research	 • Aims:	To	assess	the	impact	of	an	infection	team	(doctor,	nurse	and	antibiotic	pharmacist)	review	of	patients	receiving	antibiotics	in	
six	hospitals	across	the	UK	and	to	establish	the	suitability	of	these	patients	for	continued	care	in	the	community.	
• Findings:	Ninety-nine	(23%)	patients	(including	26	on	IV	antibiotics)	had	their	antibiotics	stopped	immediately	on	clinical	grounds.	
The	other	330	(77%)	patients	(including	139	on	IV	antibiotics)	needed	to	continue	antibiotics,	although	47	(34%)	could	be	switched	
to	oral.	Eighty-nine	(21%)	patients	were	considered	eligible	for	discharge,	comprising	10	who	would	have	required	outpatient	
parenteral	antibiotic	therapy	(OPAT),	55	who	were	suitable	for	oral	outpatient	treatment	and	24	who	had	their	antibiotics	
stopped.	
• Conclusions:	Infection	team	review	had	a	significant	impact	on	antimicrobial	use,	facilitating	IV	to	oral	switch	and	a	reduction	in	the	
volume	of	antibiotic	use,	possibly	reducing	the	risk	of	healthcare-associated	complications	and	infections.		
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Author,	Publication	year,	
Country,	Title	 Type	of	paper	 Nurses’	roles	in	antimicrobial	stewardship	
28.	Storr	and	Gallagher	(2012),	
WHO	
Cutting	levels	of	antimicrobial	
resistance	
Expert	opinion	
review	
	
• Professional	responsibilities	
o Researcher	
o Care	providers	
o Infection	prevention	and	health	protection	specialists	
o Clinical	specimen		
• Responsible	prescribing	
o Good	administration	practice;	correct	route,	time.	
• Education	and	collaboration	
o Public	health	education	
o Patient	education	in	antibiotic	use	
o Hygiene	practices	
• Infection	prevention	and	control	
o Infection	prevention	practices	
29.	Galvin	and	Fennell	(2012),	
Ireland	
Antimicrobial	stewardship	
rounds	in	a	general	hospital	in	
Ireland	
Research	
Poster		
• Aim	–	To	determine	the	number	of	interventions	that	resulted	from	weekly	multidisciplinary	rounds	by	an	AMS	team	including	
nurses.		
• Findings	–	Seven	AMS	rounds	were	undertaken.	Course	length	recommendation	was	the	most	common	type	of	intervention	(29%).	
The	following	AMS	interventions	were	implemented:	cease	course	of	antimicrobials,	guide	further	treatment,	guide	alternative	
agent,	IV	to	PO	switch,	dose	recommendation,	add	antimicrobial	to	regimen,	therapeutic	drug	monitoring.	
30.	Gallagher	and	Storr	(2012a),	
UK	
Nurses	can	lead	drive	to	
minimize	antibiotic	use	
Expert	opinion	
review	
	
• Public	health	education	and	teaching	people	about	hygiene	practices.	
• A	leading	position	in	infection	prevention	control,	and	prevention	of	the	spread	of	antibiotic	resistance.	
31.	Fry	(2012),	UK	
Antimicrobial	resistance,	
responsible	prescribing	–	a	call	
to	action	for	nurses	
Editorial	 • Patient	advocates	in	optimal	antibiotic	use.	
• Public	health	education	on	antimicrobial	resistance.		
• Infection	prevention	and	control	practices.	
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Author,	Publication	year,	Country,	
Title	 Type	of	paper	 Nurses’	roles	in	antimicrobial	stewardship	
32.	Daniels	(2012),	UK	
Antibiotic	resistance:	a	crisis	in	the	
making	
Expert	opinion	
review	
	
• Monitoring	antibiotic	prescribing	including	treatment,	duration,	administration	routes	and	timing	
33.	Crombie	(2012a),	UK	
Nurses	can	help	prevent	antibiotic	
resistance	
Expert	opinion	
review	
	
• Raising	awareness	of	patients	in	antibiotic	use	and	provide	clear	written	information	on	self-management	of	common	
infections.	
• Providing	clear	advice	about	correct	antibiotic	use	along	with	minor	side	effects,	influenza	vaccination	uptake	
34.	Edwards,	Loveday,	Drumright,	and	
Holmes	(2011d),	UK	
Should	nurses	be	more	involved	in	
antimicrobial	management?	
Editorial		 • Patient	advocates	and	education	such	as	helping	patients	to	understand	the	need	of	prudent	antibiotic	prescribing.	
35.	Edwards	et	al.	(2011c),	UK	
Covering	more	territory	to	fight	
resistance:	considering	nurses'	role	in	
antimicrobial	stewardship	
Expert	opinion	
review	
	
• Ensuring	antibiotic	treatment	is	in	line	with	microbiology	results	and	minimise	broad-spectrum	antimicrobial	prescribing.		
• Ensuring	appropriate	duration	of	antimicrobial	treatment.		
• Monitoring	intravenous	antimicrobial	treatment	to	oral	therapy.	
• Ensuring	timing	of	administration	and	duration	of	surgical	prophylaxis.	
• Stimulating	an	awareness	of	nurses	in	prompt	and	timely	antimicrobial	administration.	
• Monitoring	blood	results	to	ensure	that	treatments	are	following	antimicrobial	guidelines.		
• Encouraging	suitable	outpatient	antibiotic	therapy.	
36.	Lim	(2010),	USA	
What	nurses	need	to	know	about	
antibiotic	resistance	
Expert	opinion	
review	
	
• Participating	in	Pharmacy	committee	meetings	to	discuss	antibiotic	resistance.	
• Administering	antibiotics	on	time	and	avoiding	missed	doses.	
• Monitoring	patients’	laboratory	result	and	informing	the	physician	to	encourage	narrow-spectrum	antibiotic	use.	
• Participating	in	surveillance	studies	to	learn	trends	in	resistant	infections.	
37.	Shimoni	et	al.	(2009),	Israel	
Empowering	surgical	nurses	improves	
compliance	rates	for	antibiotic	
prophylaxis	after	caesarean	birth.	
Research	 • Aims:	To	report	the	effect	of	empowering	surgical	nurses	to	ensure	that	patients	receive	antibiotic	prophylaxis	after	
caesarean	birth.	
• Findings.	The	compliance	rate	was	increased	from	25%	in	2006	to	100%	in	2007	(chi-square	test,	P	<	0.001).	Suspected	
wound	infection	rates	decreased	from	16.8%	(186/1104)	to	12.6%	(137/1089)	after	the	intervention	(relative	risk	0.75,	
95%	confidence	interval,	0.61–0.92).	
Page	36	
	
	
Author,	Publication	year,	
Country,	Title	 Type	of	paper	 Nurses’	roles	in	antimicrobial	stewardship	
37.	Shimoni	et	al.	(2009),	Israel	
(cont.)	
	 • Conclusion.	Surgical	nurses	can	ensure	universal	compliance	for	antibiotic	prophylaxis	in	women	after	caesarean	birth,	leading	to	a	
reduction	in	wound	infections.	
38.	Turkoski	(2005),	USA	
Fighting	infection	-	An	ongoing	
challenge,	part	2	–	Antibacterial	
Expert	opinion	
review	
	
• Colleting	culture/sensitivity	of	specimens	before	beginning	antimicrobial	therapy.	
• Evaluating	patients’	allergy	history	before	starting	antimicrobials		
• Practicing	and	teaching	hand	hygiene	and	standard	precautions	
• Monitoring	signs	of	extravasation	for	patients	with	IV	antimicrobials.	
• Monitoring	hypersensitivity	reactions	during	and	after	IV	administration.	
• Monitoring	and	educating	patients	to	observe	for	severe	diarrhea,	signs	of	renal	impairment	and	any	specific	side	effects	of	
antibiotics.	
39.	Pagaiya	and	Garner	(2005),	
Thailand	
Primary	care	nurses	using	
guidelines	in	Thailand:	a	
randomized	controlled	trial	
Research	 • Aims:	To	examine	whether	clinical	guidelines	improved	the	quality	of	care	(antibiotic	use,	diazepam	prescribing,	drug	costs	per	
patient,	and	a	composite	process	index	for	diabetes	care)	by	nurse-led	health	centres	
• Results:	Baseline	prescribing	was	high	for	antibiotics	(37%	of	all	attendees),	and	no	difference	between	intervention	and	control	
sites	was	detected	at	follow-up	for	this	variable.	In	children	(0–5	years	old),	antibiotics	were	widely	used	for	acute	respiratory	tract	
infection	(34%),	and	fell	within	guidelines	(intervention:	42%	at	baseline	to	27%	at	follow-up;	control:	27–30%,	P	=	0.022),	with	an	
associated	fall	in	drug	costs	per	patient.	Antibiotics	were	widely	prescribed	for	diarrhoea	in	children	(91%),	but	no	change	was	
detected	with	guidelines.		
• Conclusion:	Staff	at	primary	health	centres	over-prescribe	antibiotics	in	children	and	tranquilizers	in	adults.	Clinical	guidelines	
implemented	with	workshops	and	educational	outreach	visits	improved	some	but	not	all	aspects	of	prescribing	in	the	short-term.	
40.	Glover	(2000a),	USA	
How	drug-resistant	
microorganisms	affect	nursing	
Expert	opinion	
review	
	
• Administering	antibiotics	appropriately	
• Teaching	patients	how	to	use	antibiotics	
• Obtaining	cultures	before	beginning	antibiotics		
• Reviewing	culture	results	and	reporting	to	physicians	for	appropriate	antibiotics	
• Monitoring	adherence	of	physicians	to	guidelines	for	antibiotic	use		
• Collecting	cultures	using	appropriate	method	
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Author,	Publication	year,	
Country,	Title	 Type	of	paper	 Nurses’	roles	in	antimicrobial	stewardship	
41.	Clark	(2000),	P.228,	UK	
Antibiotic	resistance:	a	growing	
and	multifaceted	problem	
	
	
Expert	opinion	
review	
	
• Improve	public	awareness	of	antibiotic	resistance	
• Educate	patients/members	of	the	public	about	infection	where	antibiotics	are	not	indicated	and	promote	palliative	remedies	for	
common	colds	
• Ensure,	where	possible,	that	samples	are	sent	to	the	laboratory	as	appropriate	for	culture	and	antibiotic	sensitivity.		
• Provide	supportive	information	of	the	patient’s	clinical	signs	and	symptoms	of	infection;	a	positive	isolate	from	a	swab	may	not	
necessarily	mean	the	patient	needs	antibiotics,	the	patient	may	be	colonized	as	opposed	to	infected	with	the	bacteria	
• Ensure	compliance	with	treatment	regime	where	antibiotics	are	prescribed	
• Ensure	doctors	review	the	patient’s	antibiotic	therapy	at	regular	intervals	
• Ensure	antibiotics	are	reviewed	in	the	light	of	microbiological	culture	and	sensitivity	results	where	patients	have	been	recommend	
on	broad	spectrum	antibiotics	empirically	
42.	Ashurst	(1994),	UK	
Role	of	nurses	in	antibiotic	
therapy	
Expert	opinion	
review	
	
• Nurses	have	traditionally	been	involved	in	the	administration	of	antibiotics	and	assessment	of	their	efficacy.	
• Nurses	are	in	an	ideal	position	to	overview	and	participate	in	the	appropriate	use	of	antibiotics.	
• Nurses	can	make	significant	contributions	to	the	correct	use	of	antibiotics	by	ensuring	that:	
o Doctors	adhere	to	an	antibiotic	policy	and,	where	possible,	use	the	most	appropriate	narrow-spectrum	antibiotic	
o A	sensible	prescribing	policy	is	used,	especially	for	surgical	prophylaxis	
o The	most	appropriate	route	of	therapy	is	used		
o The	complete	course	of	prescribed	therapy	is	taken	
o Antibiotic	administration	is	not	continued	indefinitely	
o Any	untoward	effects,	such	as	profuse	diarrhoea,	are	reported	immediately	and	specimens	obtained.	
• These	measures	require	some	basic	knowledge	of	pharmacology	and	microbiology,	subjects	that	may	be	given	little	priority	in	
some	nursing	courses		
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Table	2.3	Summary	of	the	paper	regarding	the	role	of	infection	control	nurses	in	antimicrobial	stewardship	(AMS)	(n=3)	
Author,	Publication	year,	
Country,	Title	 Type	of	paper	 Nurses’	roles	in	antimicrobial	stewardship	
1.	Stuart,	Orr,	Kotsanas,	and	
Gillespie	(2015),	Australia	
A	nurse-led	antimicrobial	
stewardship	intervention	in	two	
residential	aged	care	facilities	
Research	 • Aims:	to	assess	the	role	of	the	infection	control	clinical	nurse	consultant	(CNC)	in	the	antimicrobial	stewardship	team	in	
two	residential	aged	care	facilities	(RACFs).	
• Results:	A	nurse-let	AMS	resulted	in	significant	reduction	in	antibiotic	use	in	a	residential	aged	care	facilities		
2.	The	Strategy	for	the	Control	
of	Antimicrobial	Resistance	in	
Ireland	(SARI)	(2009,	p.	14),	
Ireland,	
“Guidelines	for	Antimicrobial	
Stewardship	in	Hospitals	in	
Ireland”	
Guidelines	 • Being	members	of	AMS	team	and	directly	involving	in	AMS	activities	including;		o Pre-authorization	of	restricted	antimicrobials	
o Review	of	patients	on	intravenous	antimicrobials,	for	potential	switch	to	oral	therapy	
o Review	of	patients	receiving	antimicrobials	with	duplicate	spectra,	or	other	potentially	inappropriate	drug	combinations	
o Review	of	patients	on	selected	broad	spectrum	antimicrobials	
o Review	of	patients	with	documented	sterile	site	infections	(e.g.	bloodstream	infection,	meningitis),	to	ensure	
appropriate	antimicrobial	therapy	is	in	place	
o Review	of	patients	receiving	antimicrobials	for	a	duration	that	exceeds	recommendations	in	the	hospital	antimicrobial	
guidelines	
o Participation	in	the	infection	prevention	and	control	program	
o Provision	of	education	on	prudent	antimicrobial	use	to	consultant,	non-consultant	and	nurse	prescribers	
3..Cheng	et	al.	(2009),	China	
Antimicrobial	stewardship	
program	directed	at	broad-
spectrum	intravenous	
antibiotics	prescription	in	a	
tertiary	hospital	
Research	 • Aims:	To	explore	a	sustainable	and	cost-effective	of	AMS	initiatives;	two-stage	immediate	concurrent	feedback	(ICF)	
model,	in	which	the	antimicrobial	prescription	is	audited	by	two	part-time	infection	control	nurses	in	the	first	stage,	
followed	by	"physician	ICF"	in	the	second	stage.	
• Results:	The	overall	compliance	rate	to	antibiotic	prescription	guidelines	was	79.4%,	while	the	compliance	with	ICF	was	
83.8%.	Antibiotics	consumption	reduced	from	73.06	(baseline,	year	2004)	to	64.01	(year	2007)	per	1,000	patient	bed-day-
occupancy.		
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2.2.1	Narrative	summary	of	nurses’	role	in	antimicrobial	stewardship	
The	earliest	paper	retrieved	that	addressed	the	role	of	nurses	in	AMS	was	
published	in	1994.	The	earliest	research	paper	located	was	published	in	2005	and	
interestingly	was	a	Thai	paper	and	the	only	publication	emerging	from	Thailand	
(Pagaiya	&	Garner,	2005).	The	study	was	a	randomised	controlled	trial	of	adherence	
to	guidelines	in	nurse-led	primary	health	care	centres	in	Thailand	and	the	
conclusions	were	that	there	was	over-prescribing	of	antibiotics.		
Nurses	are	recognised	as	important	stakeholders	in	AMS	programs	(Gillespie	
et	al.,	2013b;	Ladenheim	et	al.,	2013b).	There	is	consensus	in	the	literature	that	
nurses	have	a	professional	responsibility	as	members	of	a	multidisciplinary	team	and	
as	patient	advocates	to	promote	safe	and	effective	antimicrobial	therapy,	provide	
patient	education	and	raise	public	awareness	about	appropriate	antibiotic	usage.		
Nurses	are	considered	to	play	a	vital	role	in	ensuring	optimal	antibiotic	
therapy	(Ladenheim	et	al.,	2013a)	through	adjustment	of	timing	and	preparation	of	
medications	(Wentzel	et	al.,	2014)	and	monitoring	for	side	effects	or	adverse	effects	
of	antimicrobials	(Ladenheim	et	al.,	2013b;	Turkoski,	2005).	Renaudin,	Beaudouin,	
Ponvert,	Demoly,	and	Moneret-Vautrin	(2013)	found	that	more	than	half	of	the	side	
effects	associated	with	antibiotic	therapy	occur	while	patients	are	in	hospital.	
Further	nurses	have	a	role	in	initiating	reviews	of	treatment	(Aziz,	2013;	Curry	et	al.,	
2014;	Ladenheim	et	al.,	2013a;	Lim,	2010)	and	obtaining	cultures	and	sensitivities	
before	beginning	antimicrobial	therapy	to	ensure	that	isolates	are	sensitive	to	
antimicrobial	treatment	and	that	treatments	are	in	line	with	recommended	
guidelines	(Aziz,	2013;	Edwards	et	al.,	2011c;	Glover,	2000a;	Ladenheim	et	al.,	2013a;	
Turkoski,	2005).	In	a	study	of	the	outcomes	of	AMS	rounding	in	a	general	hospital	in	
Ireland,	nurses	were	seen	as	important	members	of	the	multidisciplinary	AMS	team.	
The	AMS	teams	conducted	clinical	reviews	regarding	the	appropriateness	of	
antibiotic	treatment	in	terms	of	dose,	choice,	route,	duration	and	clinical	progress	
(Galvin	&	Fennell,	2012)	as	well	as	providing	ongoing	monitoring	for	treatment	
safety	and	effectiveness	(Curry	et	al.,	2014).	
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Patient	advocacy	in	relation	to	antimicrobial	therapy	is	recognised	as	a	
fundamental	role	of	nurses	in	AMS	(Aziz,	2013;	Edwards	et	al.,	2011c;	Ladenheim	et	
al.,	2013a).	Patient	advocacy	involves	ensuring	that	antimicrobial	therapies	are	
appropriate	and	safe	(Edwards	et	al.,	2011d).	Although	nurses	may	not	always	have	
the	authority	to	prescribe	antibiotics	they	can	influence	what	is	prescribed	
(Castledine,	2006;	Jutel	&	Menkes,	2010a).	An	example	of	nurses’	roles	in	the	
ongoing	management	of	antimicrobial	therapy	is	in	decision	making	related	to	the	
transition	from	intravenous	to	oral	antimicrobial	therapy	(Curry	et	al.,	2014;	Edwards	
et	al.,	2011c;	Ladenheim	et	al.,	2013a).	A	study	by	Gillespie	et	al.	(2013a)	showed	
that	after	an	intervention	to	promote	nurses’	involvement	in	decisions	to	change	the	
route	of	antibiotic	treatment,	the	number	of	blood	stream	infections	decreased.	
Surgical	prophylaxis	is	another	area	of	AMS	where	nurses	can	play	a	fundamental	
role.	The	timing	of	administration	and	the	duration	of	surgical	prophylaxis	is	related	
to	AMR	(Harbarth,	Samore,	Lichtenberg,	&	Carmeli,	2000).	Nurses	can	monitor	the	
duration	of	surgical	prophylaxis	in	consultation	with	doctors	and	pharmacists	
(Edwards	et	al.,	2011c).	
One	of	the	most	important	elements	of	the	WHO	strategy	to	fight	antibiotic	
resistance	is	to	actively	educate	patients	about	appropriate	antimicrobial	use	(WHO	
2014).	This	public	health	role	involves	education	and	raising	awareness	about	
optimal	antibiotic	use	in	the	home	setting	(Amalia,	2014;	Clark,	2000;	Crombie,	
2012a;	Storr	&	Gallagher,	2012),	reinforcing	messages	that	antibiotics	are	not	
indicated	for	routine	viral	infections,	promoting	symptom	management	for	common	
colds	to	reduce	antibiotic	resistance	(Clark,	2000),	and	informing	patients	about	
recognising	and	reporting	adverse	effects	and	complications	of	antibiotics	(Curry	et	
al.,	2014;	Glover,	2000a).	As	well	as	ensuring	safe	and	effective	antimicrobial	therapy	
through	education,	nurses	can	play	a	vital	role	in	infection	prevention	and	control	
practices	(Ness,	Price,	Currie,	&	Reilly,	2014)	by	acting	as	role	models	for	good	
hygiene	to	minimise	the	spread	of	antibiotic	resistant	pathogens	through	hand	
hygiene,	standard	precaution	practices,	and	environmental	cleanliness	(Clark,	2000;	
Gallagher	&	Storr,	2012a;	Turkoski,	2005).		
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Infection	control	nurses	(ICNs)	have	a	particular	role	in	AMS	however	there	
has	been	little	attention	to	this	role	in	the	current	literature.	The	two	research	
papers	from	Australia	and	China	reported	the	positive	outcomes	regarding	antibiotic	
use	when	ICNs	engaged	in	AMS	programs.	The	Irish	guidelines	for	infection	control	
nurses	in	AMS	provide	a	useful	framework	for	exploring	this	specialist	role.	
According	to	the	guidelines,	infection	control	nurses	are	recognised	members	of	the	
AMS	team	directly	involved	in	stewardship	for	the	appropriate	use	of	antibiotics	in	
particular	as	outlined	in	Table	2.2	(SARI,	2009,	p.	14).	Nurses	can	play	a	significant	
role	in	AMS	however,	the	role	is	complex,	and	nurses	may	not	recognise	AMS	as	an	
integral	part	of	their	role	or	may	perceive	that	they	do	not	have	the	knowledge,	skills	
or	authority	to	fulfil	the	role.	This	notion	is	explored	further	in	the	section	to	follow.	
2.3	Clinicians’	attitudes	and	perceptions	towards	antimicrobial	stewardship	
In	this	section,	a	search	and	narrative	summary	of	the	literature	related	to	
clinicians’	attitudes	and	perceptions	towards	AMR,	antimicrobial	use	and	AMS	is	
presented	from	a	worldwide	perspective.	This	review	informs	our	understanding	of	
what	is	known	about	the	attitudes	and	perceptions	of	different	AMS	team	members	
as	well	as	identifying	the	measurement	instruments	that	have	been	developed	to	
measure	perceptions	and	attitudes.		
The	CINAHL	and	MEDLINE	electronic	databases	were	searched	from	January	
2000	to	November	2017.	The	databases	were	searched	using	the	following	terms:	
“attitude*	and	perception*”	and	“antimicrobial	resistance”	or	“antimicrobial	use”	or	
“antimicrobial	stewardship”	or	“antibiotic	stewardship”	not	“nursing	home”.	
Additionally,	Google	(Scholar)	databases	were	also	searched	using	the	term	
“clinicians’	attitude	and	perceptions	in	antimicrobial	stewardship”.	Qualitative	and	
quantitative	research	published	in	English	were	included.	The	review	process	
revealed	32	relevant	research	papers.	The	papers	were	categorised	according	to	the	
different	disciplines	of	clinicians	and	included	seven	papers	of	a	multidisciplinary	
nature,	20	papers	focused	on	physicians	and	five	papers	focused	on	pharmacists,	
nurses	and	nurse	practitioners.	The	summaries	of	reviewed	papers	are	presented	in	
Tables	2.4,	2.5	and	2.6	followed	by	a	narrative	discussion	of	the	key	findings.		
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Table	2.4	Summary	of	published	papers	of	attitudes	and	perceptions	towards	antimicrobial	resistance,	antimicrobial	use	and	
antimicrobial	stewardship:	multidisciplinary	clinicians	(n=7).	
Author,	Publication	year,	Country,	Title	 Design	of	study	 Participants	 Perceptions	and	attitudes	towards	AMS	
1.	Fathi	et	al.	(2017),	Egypt	
Knowledge,	attitudes,	and	beliefs	regarding	
antimicrobial	therapy	and	resistance	among	
physicians	in	Alexandria	university	teaching	
hospitals	and	the	associated	prescription	
habits	
Survey	 Physicians,	
Pharmacists	
• Majority	of	respondents	perceived	that	AMR	is	a	problem	at	global	(95%),	national	(97%),	
and	local	levels	(85%)		
• Decisions	regarding	antibiotic	prescribing	are	mainly	based	on	patient	indicators	(78.5%)	
and	socioeconomic	status	(76.3%)		
• Lack	of	engagement	in	educational	activities,	low	awareness	of	local	drug	resistance	
patterns	and	insufficient	patient	education	particularly	side	effects	of	drugs.	
2.	Lim	et	al.	(2014a),	Australia	
Antimicrobial	stewardship	in	residential	aged	
care	facilities:	need	and	readiness	assessment	
Semi-structured	
interviews	and	
focus	groups	
Nurses,	general	
practitioners,	
pharmacists	
• Five	main	perceptions	studied	were:	1)	antibiotic	prescribing	behavior,	2)	AMR,	3)	attitude	
towards	and	understanding	of	AMS,	4)	perceived	barriers/facilitators	of	AMS	
implementation,	and	5)	feasibility	of	AMS	interventions	
• Lower	perceived	over-prescribing	of	antibiotics	in	aged	care	facilities	were	found	in	nurses	
compared	to	GPs	and	pharmacists		
• AMS	implementation	in	RACFs	was	perceived	important		
• Perceived	barriers	to	AMS	implementation	were	workload	and	logistics		
• Nursing-based	education	and	aged-care	specific	antibiotic	guidelines	to	address	scope	of	
AMS	practice	and	interventions		
• The	perceived	most	useful	and	feasible	intervention	was	regular	antibiotic	surveillance	
3.Cotta	et	al.	(2014),	Australia	
Attitudes	towards	antimicrobial	stewardship:	
results	from	a	large	private	hospital	in	
Australia	
Survey	 Specialists,	
nurses,	
pharmacists	
• AMR	was	perceived	by	participants	as	a	serious	problem	(62%	in	Australian	hospital	and	
45%	in	surveyed	hospitals)	
• Half	of	participants	were	willing	to	participate	in	AMS	interventions.	
• 58%	of	participants	agreed	that	improving	antibiotic	prescribing	would	reduce	AMR.	
• 29%	of	participants	have	worked	in	facilities	that	had	AMS	in	place.			
• AMS	was	more	familiar	to	pharmacists	than	other	health	professions	
4.	Sanchez,	Roberts,	Albert,	Johnson,	and	
Hicks	(2014),	USA	
Effects	of	knowledge,	attitudes,	and	practices	
of	primary	care	providers	on	antibiotic	
selection,	United	States	
In-depth	
interviews	
Physicians,	nurse	
practitioners,	
physician	
assistants	
• Participants	were	concerned	about	AMR	but	did	not	consider	resistance	when	choosing	
antimicrobial	medications	for	treatment	because	they	were	more	concerned	about	patient	
and	parent	satisfaction,	and	complications	of	infection.	
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Author,	Publication	year,	Country,	Title	 Design	of	study	 Participants	 Perceptions	and	attitudes	towards	AMS	
5.	Abera,	Kibret,	and	Mulu	(2014a),	Ethiopia	
Knowledge	and	beliefs	on	antimicrobial	
resistance	among	physicians	and	nurses	in	
hospitals	in	Amhara	Region,	Ethiopia	
Survey	 Physicians,	
nurses	
• 98%	of	nurses	and	65%	of	physicians	reported	that	they	need	AMS	training		
• 72.2%	of	respondents	had	knowledge	about	antimicrobial	resistance	(AMR).	
• Most	respondents	agreed	that	AMR	is	a	national	and	global	problem	but	only	few	
respondents	thought	that	AMR	was	a	problem	in	their	own	hospitals.	
• Two	main	factors	causing	AMR	were	poor	adherence	and	anti-microbial	overuse		
• Most	common	causes	of	AMR	were:	self-prescribing,	lack	of	access	to	local	antibiogram	
data,	and	poor	awareness	among	antibiotics	prescribers		
• Patient	driven	and	treatment	failure	were	identified	as	most	common	causes	of	
unnecessary	antibiotic	prescriptions	
6.	Evans,	Rogers,	Weaver,	and	Burns	(2011b),	
USA	
Providers'	beliefs	and	behaviors	regarding	
antibiotic	prescribing	and	antibiotic	resistance	
in	persons	with	spinal	cord	injury	or	disorder	
Survey	 Physicians,	
physician	
assistants,	nurse	
practitioner	
• Most	of	respondents	agreed	with	statements	regarding	the	social	impact	of	antibiotic	
resistance	
• 61%	of	respondents	agreed	that	patient	demand	was	a	major	reason	for	unnecessary	
antibiotic	prescription	
• 17.8%	of	respondents	reported	that	they	overprescribed	antibiotics.	
7.	Giblin	et	al.	(2004a),	USA	
Clinicians'	perception	of	the	problem	of	
antimicrobial	resistance	in	health	care	
facilities	
Survey	and	
focus	groups	
Nurse,	physician,	
microbiologist,	
pharmacist	
• Most	of	participants	perceived	that	AMR	was	a	national	problem	rather	than	in	their	own	
institution/practice.	This	perception	was	in	line	with	results	from	focus	groups		
• Barriers	were	lack	of	knowledge	and	nursing	shortages	which	could	be	resolved	by	
facilitating	education,	improving	information	technology	and	consultation			
• Computer	programs,	posters,	and	local	data	could	be	resources	to	influence	clinicians	
about	AMR		
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Table	2.5	Summary	of	published	papers	of	attitudes	and	perceptions	towards	antimicrobial	resistance,	antimicrobial	use	and	antimicrobial	
stewardship:	Physicians	(n=20)	
Author,	Publication	year,	Country,	Title	 Design	of	study	 Participants	 Perceptions	and	attitudes	towards	AMS	
1.	Wilcock,	Wisner,	and	Powell	(2016),	UK	
GPs'	perceptions	of	AMR	and	antimicrobial	
stewardship	
Survey	 General	practitioners	 • All	participants	accepted	that	AMR	is	a	real	threat	to	their	patients	
• About	half	of	respondents	perceived	that	evidence	of	AMR	was	increasing	over	the	past	
three	years		
• 65%	of	respondents	reported	that	their	patients	were	demanding	antibiotic	prescriptions		
• 25%	of	respondents	suggested	that	campaign	to	raise	patient’s	
awareness/education/information	could	help	improving	antibiotic	prescribing	practice	
2.	Steinberg	et	al.	(2016),	Canada	
National	Survey	of	Critical	Care	Physicians'	
Knowledge,	Attitudes,	and	Perceptions	of	
Antimicrobial	Stewardship	Programs	
Survey	 Physicians	 • 74%	of	respondents	reported	at	least	1	component	of	AMS	at	their	institution.		
• 86%	of	respondents	agreed	or	strongly	agreed	that	the	patients	in	their	ICU	benefit	from	
AMS	and	81%	reported	that	AMS	increased	their	knowledge	and	appropriate	
antimicrobial	use			
• AMS	was	supported	and	believed	to	add	value	to	care		
3.	Paño-Pardo	et	al.	(2016),	Spain	
Opportunities	to	improve	antimicrobial	use	
in	paediatric	intensive	care	units:	a	
nationwide	survey	in	Spain	
Survey	 Physicians	 • 86%	of	respondents	considered	that	AMR	was	a	significant	problem	and	90%	thought	
that	improving	antimicrobial	use	in	their	Paediatric	ICU	(PICU)	should	be	a	priority		
• The	excessive	use	of	antimicrobials	in	patients	with	non-confirmed	infections	and	
excessive	use	of	broad-spectrum	antimicrobials	were	perceived	problems	among	
respondents.		
• Antimicrobial	therapy	guidelines	was	the	most	valuable	AMS	intervention		
• Spanish	PICU	doctors	were	aware	of	the	relevance	of	the	problem	of	AMR	and	the	need	
to	improve	antimicrobial	use	
4.	Chuenchom,	Thamlikitkul,	Chaiwarith,	
Deoisares,	and	Rattanaumpawan	(2016a),	
Thailand	
Perceptions,	attitudes,	and	knowledge	
regarding	antimicrobial	resistance,	
appropriate	antimicrobial	use,	and	infection	
control	among	future	medical	practitioners:	
A	multicenter	study	
Survey		 Final-year	medical	
students.	
• AMR	was	well	recognised	
• Limited	perceptions,	knowledge	and	appropriate	antimicrobial	use	were	found		
• Half	of	respondents	recognized	infection	control	strategies	and	existence	of	an	AMS	
programs	in	their	hospitals.	
5.	Sharma,	Jain,	and	Sharma	(2015),	India	
Knowledge,	attitude	and	perception	of	
medical	and	dental	undergraduates	about	
antimicrobial	stewardship	
Survey	 Second	year	medical	
and	dental	
undergraduate	
course	student	
• Knowledge,	attitude	and	perception	among	future	medical	and	dental	prescribers	
showed	statistically	significant	differences		
• While	the	attitudes	among	undergraduate	students	were	good,	knowledge	and	
perceptions	need	to	be	improved		
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Author,	Publication	year,	Country,	Title	 Design	of	study	 Participants	 Perceptions	and	attitudes	towards	AMS	
6.	Baadani,	Baig,	Alfahad,	Aldalbahi,	and	
Omrani	(2015),	Saudi	Arabia	
Physicians'	knowledge,	perceptions,	and	
attitudes	toward	antimicrobial	prescribing	in	
Riyadh,	Saudi	Arabia	
Survey	 Physicians	 • 56%	of	respondents	perceived	AMR	was	a	significant	problem	in	their	daily	practice	and	
70%	thought	that	AMR	was	a	national	level	problem	
• Two	main	contributors	of	an	increase	in	AMR	were	inappropriate	empirical	therapy	(and	
excessive	use	of	antimicrobials	in	healthcare	settings		
• Physician	education	was	the	most	effective	intervention	to	reduce	AMR.		
• 45%	of	respondents	did	not	feel	confident	in	their	knowledge	of	antimicrobial	prescribing		
• Two-thirds	of	the	respondents	knew	of	the	existence	of	local	antimicrobial	guidelines	and	
67%	found	them	useful		
7.	Al-Harthi	et	al.	(2015),	Saudi	Arabia	
Perceptions	and	knowledge	regarding	
antimicrobial	stewardship	among	clinicians	in	
Jeddah,	Saudi	Arabia	
Survey	 Physicians	 • Patient/parent’s	demand	for	antimicrobials	was	reported	by	33%	of	the	general	physicians	
compared	to	13.2%	of	the	residents,	and	4.3%	of	the	specialists		
• Expensive	antimicrobials	are	more	often	prescribed	by	70%	of	general	physician	(70.4%),	
26%	of	residents	and	30%	of	specialist		
• Knowledge	and	perceptions	regarding	the	current	scope	of	antimicrobial	agents	and	use	
and	misuse	of	antimicrobial	agents	were	indifferent	among	different	types	of	clinicians		
8.	Szymczak,	Feemster,	Zaoutis,	and	Gerber	
(2014),	USA	
Pediatrician	Perceptions	of	an	Outpatient	
Antimicrobial	Stewardship	Intervention	
Semi-	structure	
interview	
Pediatricians	 • Respondents	recognized	that	antibiotic	overuse	is	a	significant	problem,	but	they	believed	
that	this	problem	resulted	from	the	behavior	of	nonpediatric	physicians.	
• Major	barrier	of	antibiotic	prescriptions	was	parent	pressure		
9.	Dallas,	van	Driel,	van	de	Mortel,	and	Magin	
(2014),	USA		
Antibiotic	prescribing	for	the	future:	
exploring	the	attitudes	of	trainees	in	general	
practice	
Semi-	structure	
interview	and	
focus	group	
Trainees	in	
general	practice	
• Participants	were	aware	of	the	importance	of	evidence-base	antimicrobial	prescribing	and	
the	impact	of	their	decisions	on	AMR	
• Prescribing	decisions	can	be	affected	by:	patient	and	system	factors,	diagnosis	uncertainty,	
multiple	clinician	input,	and	the	habits	of	and	relationship	of	trainees’	supervisors	
10.	Steinberg	et	al.	(2014),	Canada	
Vancomycin-resistant	enterococci	(VRE)	and	
the	role	of	the	healthcare	worker	
Survey	 Physicians	 • Most	respondents	agreed	that	patients	in	ICU	benefit	from	an	AMS	program	
• 83%	of	respondents	reported	that	their	knowledge	of	appropriate	antimicrobial	use	
increased	because	of	AMS	programs	implemented	in	ICU	setting	
11.	Chaves	et	al.	(2014),	Australia	
Analysis	of	knowledge	and	attitude	surveys	
to	identify	barriers	and	enablers	of	
appropriate	antimicrobial	prescribing	in	three	
Australian	tertiary	hospitals	
Survey	 Residents,	
interns,	and	
consultant	
hospital	doctors	
• Barriers	included	knowledge	gaps	in	antimicrobial	prescribing,	lack	of	awareness	about	
restricted	antimicrobials	and	reliance	on	senior	colleagues	to	prescribe	antimicrobial	
agents		
• Enablers	included:	an	acknowledgement	of	the	need	for	assistance	in	prescribing	and	
access	to	national	prescribing	guidelines.	
12.	Wood	et	al.	(2013),	European	countries	
Primary	care	clinicians'	perceptions	of	
antibiotic	resistance:	a	multi-country	
qualitative	interview	study	
Qualitative	
interview	study	
Primary	care	
clinicians	
• Most	clinicians	believed	that	AMR	was	not	a	problem	in	their	practice.	
• Clinicians	agreed	that	resistance	will	become	more	serious	without	improved	AMR	or	new	
drug	discovery	
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13.	Thriemer	et	al.	(2013b),	Congo	
Antibiotic	Prescribing	in	DR	Congo:	A	
Knowledge,	Attitude	and	Practice	Survey	
among	Medical	Doctors	and	Students	
Survey	 Doctors	and	
Students	
• Knowledge	about	antibiotic	(AB)	was	low.	
• AMR	was	recognised	more	as	a	worldwide	problem	than	nationally	and	in	their	own	
practice		
• Confidence	in	AB	prescribing	was	high	
• Local	AB	guidelines	and	courses	relating	to	AB	prescribing	were	needed.	
14.	Hardy-Holbrook	et	al.	(2013),	Australia	
Antibiotic	resistance	and	prescribing	in	
Australia:	current	attitudes	and	practice	of	
GPs	
Survey	 General	
practitioners	(GPs)	
• 40%	of	respondents	admitted	that	they	prescribed	antibiotics	to	meet	parent’s	
expectation		
• Antibiotic	resistance	was	generally	not	discussed	with	patients	
15.	Abbo	et	al.	(2013c),	USA	
Medical	students'	perceptions	and	
knowledge	about	antimicrobial	stewardship:	
how	are	we	educating	our	future	
prescribers?	
Survey	 Fourth-year	
medical	students	
• 92%	of	respondents	agreed	that	strong	knowledge	of	antimicrobials	is	important		
• 90%	of	respondents	said	that	they	would	like	to	have	more	education	on	appropriate	
use	of	antimicrobials	
• Two-thirds	of	respondents	perceived	their	preparedness	was	inadequate	in	some	
fundamental	principles	of	antimicrobial	use	
16.	Navarro-San	Francisco	et	al.	(2013),	Spain	
Knowledge	and	perceptions	of	junior	and	
senior	Spanish	resident	doctors	about	
antibiotic	use	and	resistance:	results	of	a	
multicenter	survey	
Survey	 Resident	doctors	 • Over	83%	of	residents	of	all	hospitals,	specialties	and	seniority	considered	that	AMR	
was	an	important	problem	at	a	national	level,	at	their	institution,	and	in	their	daily	
practice		
• Residents	reported	having	insufficient	antibiotics	training	although	87%	prescribed	
antibiotics	in	the	last	month		
• To	improve	antibiotic	prescribing	some	activities	were	suggested	including	availability	
of	local	antibiotic	guidelines	and	advice/specialist,	specific	teaching	sessions,	having	
an	antimicrobial	management	team		
17.	García	et	al.	(2011a),	Peru	
Knowledge,	attitudes	and	practice	survey	
about	antimicrobial	resistance	and	
prescribing	among	physicians	in	a	hospital	
setting	in	Lima,	Peru	
Survey	 Physicians	 • Theoretical	knowledge	was	good,	but	awareness	of	local	antimicrobial	rate	was	poor		
• Most	participants	strongly	agreed	that	AMR	is	a	problem	worldwide	and	in	Peru,	but	
it	is	not	a	problem	in	their	own	practice.	
• Antimicrobial	overuse	was	perceived	in	the	community	and	the	hospital	settings.	
• Antimicrobials	overuse	in	the	community	was	contributed	to	by	patient	pressure		
• Pocket-based	AM	prescribing	guidelines	and	the	internet	were	considered	to	be	
useful	sources	of	information	
• More	AM	prescribing	educational	programs	were	requested.	
18.	Bannan,	Buono,	McLaws,	and	Gottlieb	
(2009),	Australia	
A	survey	of	medical	staff	attitudes	to	an	
antibiotic	approval	and	stewardship	program	
Survey	 Junior	and	
specialist	medical	
staff	
• Most	participants	stated	that	the	AMS	program	is	important	
• Most	staff	believed	that	seeking	approval	made	teams	think	carefully	about	antibiotic	
choice	and	the	approval	system	provided	was	a	useful	educational	material		
• The	AMS	program	was	perceived	as	a	time	consuming	and	distracting	activity			
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Author,	Publication	year,	Country,	Title	 Design	of	study	 Participants	 • Perceptions	and	attitudes	towards	AMS	
18.	Bannan	et	al.	(2009),	Australia	(cont)	
	
	 	 • Advice	through	the	AMS	program	improved	patient	outcomes		
• The	AMS	program	was	well	supported	by	all	staff	and	helped	maintain	AMs	program	
policy	
19.	Brinsley,	Sinkowitz-Cochran,	and	Cardo	
(2005a),	USA	
Assessing	motivation	for	physicians	to	
prevent	antimicrobial	resistance	in	
hospitalized	children	using	the	Health	Belief	
Model	as	a	framework	
Focus	groups	 Physicians	 • Physicians	perceived	that	AMR	was	a	problem	at	a	national	level	rather	than	in	their	
institution		
20.	Walker,	Grimshaw,	and	Armstrong	
(2001),	UK	
Salient	beliefs	and	intentions	to	prescribe	
antibiotics	for	patients	with	a	sore	throat	
Survey	 General	
practitioners	
(GPs)	
• The	majority	of	participants	tended	to	prescribe	antibiotics	to	less	than	half	of	their	
patients	with	sore	throats		
Intervention	targeting	salient	beliefs	associated	with	motivation	to	antimicrobial	
prescribing	was	suggested	
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Table	2.6	Summary	of	published	papers	of	attitudes	and	perceptions	towards	antimicrobial	resistance,	antimicrobial	use	and	antimicrobial	
stewardship:	Pharmacists,	Nurses	and	Nurse	Practitioners	(n=5)	
	
Author,	Publication	year,	Country,	Title	 Design	of	study	 Participants	 • Perceptions	and	attitudes	towards	AMS	
1.Toska	and	Geitona	(2015),	Greece	
Antibiotic	resistance	and	irrational	prescribing	
in	paediatric	clinics	in	Greece	
Survey	 Nurses	 • 87%	of	participants	reported	irrational	prescribing	was	an	important	cause	of	AMR		
• Uncertainty	of	diagnostic	was	a	main	cause	of	irrational	antibiotic	prescribing	
• 94%	of	participants	suggested	the	use	of	protocols	and	guidelines	to	control	
overprescribing.		
• Parent’s	demand	for	antibiotics	in	hospitals	increased		
• Nurse	involvement	in	AMS	could	educate	patients	and	parents	on	antibiotic	
overprescribing	and	AMR.	
2.	Broom,	Broom,	Kirby,	Plage,	and	Adams	
(2015),	Australia	
What	role	do	pharmacists	play	in	mediating	
antibiotic	use	in	hospitals?	A	qualitative	study	
Semi-structured	
interviews	
	
	
Pharmacists	 • Mixed	attitudes	towards	the	significance	of	AMR	was	found	and	optimal	use	of	antibiotics	
was	perceived	as	a	low	priority		
• Pharmacists	had	limited	influence	on	antibiotic	decision-making	of	physicians	
• Identified	existing	barriers	included	medical	hierarchy,	limited	contact	with	senior	doctors,	
insufficient	pharmacy	workforce	to	foster	collaborative	relationship	and	facilitate	the	
uptake	of	doctors’	advice	
3.	Pawluk,	Black,	and	El-Awaisi	(2014),	Qatar	
Strategies	for	improving	antibiotic	use	in	
Qatar:	a	survey	of	pharmacists'	perceptions	
and	experiences	
Survey	 Pharmacists	 • The	most	common	barrier	to	implementing	AMS	programs	were	lack	of	infectious	disease	
specialists	and	training	for	healthcare	providers.	
4.	Abbo,	Smith,	Pereyra,	Wyckoff,	and	
Hooton	(2012),	USA	
Nurse	Practitioners'	attitudes,	perceptions,	
and	knowledge	about	antimicrobial	
stewardship	
Survey	 Nurse	
Practitioners	
• Most	participants	agreed	that	AMR	was	a	local	and	national	problem.	
• All	of	participants	agreed	that	appropriate	antibiotic	use	would	decrease	AMR	and	over	
90%	of	participants	needed	more	antibiotic	education	
• 	
5.	Itokazu	et	al.	(2006b),	USA	
Pharmacists'	perceptions	of	the	effectiveness	
of	antimicrobial	control	programs	
Survey	 Pharmacists	 • 73%	of	pharmacists	perceived	that	their	AMS	program	effectively	addressed	AMR,	
improved	patient	outcomes.	
• Many	pharmacists	indicated	the	effectiveness	of	their	AMS	was	uncertain	mainly	due	to	
inadequate	support	for	the	AMS		
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2.3.1	Narrative	summary	of	clinicians’	attitudes	and	perceptions	towards	
antimicrobial	stewardship		
In	order	for	AMS	programs	to	be	effective,	clinical	stakeholders	need	to	be	
aware	of	the	problems	of	AMR	and	appropriate	antimicrobial	use	(Abera,	Kibret,	&	
Mulu,	2014b;	Cotta	et	al.,	2014;	Evans	et	al.,	2011b;	Szymczak	et	al.,	2014).		Although	
this	review	of	clinicians’	perceptions	and	attitudes	towards	AMR,	antimicrobial	use	
and	AMS	interventions	identified	literature	related	to	several	groups	of	healthcare	
professionals	such	as	doctors,	nurse	practitioners	and	nurses,	pharmacists,	general	
practitioners,	medical	students,	and	microbiologists,	most	studies	were	focused	on	
doctors’	perceptions	and	attitudes.	Investigation	of	the	attitudes	and	perceptions	of	
healthcare	professionals	about	AMR	and	antibiotic	use	is	important	for	successful	
AMS	and	to	develop	interventions	to	minimise	AMR.		
Many	of	the	surveys	of	clinicians’	attitudes,	beliefs	and	perception	identified	
that	clinicians	in	general	recognised	that	AMR	is	a	problem	internationally	and	a	
public	health	problem	(Abbo	et	al.,	2012;	Abbo	et	al.,	2013b;	Abera	et	al.,	2014b;	
Cotta	et	al.,	2014;	García	et	al.,	2011a;	Giblin	et	al.,	2004c;	Navarro-San	Francisco	et	
al.,	2013;	Szymczak	et	al.,	2014).	Perceptions	of	the	extent	of	AMR	were	studied	in	
developing	and	first	world	countries	and	findings	were	largely	consistent.	For	
example,	in	surveys	of	physicians	and	nurses	in	Ethiopia,	medical	doctors	and	
students	in	the	Congo,	and	physicians	in	Peru,	most	participants	perceived	that	AMR	
is	a	worldwide	problem	(Abera	et	al.,	2014b;	García	et	al.,	2011a;	Thriemer	et	al.,	
2013b).	However,	clinicians	in	first	world	countries	agreed	that	AMR	was	a	major	
problem	but	perceived	that	AMR	was	more	serious	problem	nationally	or	
internationally,	than	within	their	institutions	(Abbo	et	al.,	2012;	Abera	et	al.,	2014a)	
or	their	personal	practice	(Brinsley,	Sinkowitz-Cochran,	&	Cardo,	2005b;	Cotta	et	al.,	
2014;	García	et	al.,	2011a;	Giblin	et	al.,	2004c;	Thriemer	et	al.,	2013b).		
Another	area	of	worldwide	consensus	is	the	recognition	that	overuse	of	
antimicrobial	medicines	in	hospitals	and	communities	contributes	to	AMR	(Abbo	et	
al.,	2012;	Abbo	et	al.,	2013c;	Abera	et	al.,	2014a;	Cotta	et	al.,	2014;	García	et	al.,	
2011a).	For	example	in	a	study	of	general	practice	trainees’	attitudes	towards	
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antibiotic	prescribing,	respondents	believed	that	their	decisions	in	antimicrobial	
prescribing	would	impact	on	AMR	(Dallas	et	al.,	2014).	Further,	100%	of	pharmacists	
in	a	large	private	hospital	in	Australia	(Cotta	et	al.,	2014)	and	96%	of	nurse	
practitioners	and	medical	students	in	the	United	States	(US)		believed	that	improving	
antimicrobial	prescribing	would	help	reduce	AMR	(Abbo	et	al.,	2012;	Abbo	et	al.,	
2013c).		
There	is	evidence	from	a	variety	of	disciplines	that	prescribers	recognised	
that	they	had	insufficient	knowledge	and	training	about	optimal	antimicrobial	usage.	
Again,	this	was	the	case	in	studies	conducted	in	both	first	and	third	world	countries	
(Abbo	et	al.,	2012;	Abbo	et	al.,	2013b;	Abera	et	al.,	2014b;	García	et	al.,	2011a;	Giblin	
et	al.,	2004c;	Pawluk	et	al.,	2014;	Steinberg	et	al.,	2014).	In	a	US	study,	91.2%	of	
nurse	practitioners	surveyed	reported	that	they	required	more	education	about	
antimicrobial	prescribing	(Abbo	et	al.,	2012;	Giblin	et	al.,	2004c).	A	study	of	
knowledge	of	antibiotic	prescribing	of	medical	doctors	and	students	in	the	Congo	
showed	that	39%	of	participants	perceived	that	their	antibiotic	knowledge	was	low	
although	they	felt	highly	confident	about	their	antibiotic	prescribing	(Thriemer	et	al.,	
2013b).	Surveys	of	antimicrobial	prescribing	knowledge,	especially	among	interns,	
have	identified	knowledge	as	a	problem	in	three	Australian	tertiary	hospitals	(Chaves	
et	al.,	2014)	and	in	Peru	(García	et	al.,	2011a).	There	is	recognition	by	clinicians	that	
more	education	and	training	is	needed	to	improve	antimicrobial	usage	(Abbo	et	al.,	
2013c;	Abera	et	al.,	2014b;	Chaves	et	al.,	2014;	García	et	al.,	2011a)	as	well	as	more	
resources	to	assist	antimicrobial	decision-making	such	as	antimicrobial	guidelines	
(García	et	al.,	2011a;	Thriemer	et	al.,	2013a)	and	internet-based	programs	(García	et	
al.,	2011a).			
Another	barrier	to	optimal	antimicrobial	use	is	pressure	from	patients’	
expectations	(Abera	et	al.,	2014b;	Evans	et	al.,	2011b;	García	et	al.,	2011a;	Hardy-
Holbrook	et	al.,	2013;	Sanchez	et	al.,	2014;	Szymczak	et	al.,	2014).	Responding	to	
patient	requests	for	antimicrobials	has	been	identified	in	many	countries	including	
Ethiopia	(Abera	et	al.,	2014b)	and	the	US,	where	as	many	as	61%	of	prescribers	
perceived	that	a	major	cause	of	unnecessary	antibiotic	prescribing	was	patient	
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demand	(Evans,	Rogers,	Burns,	Lopansri,	&	Weaver,	2011a;	Szymczak	et	al.,	2014).	
The	problem	of	patient	expectations	is	augmented	in	countries	where	antibiotics	can	
be	purchased	without	a	prescription	(Abera	et	al.,	2014b).		
In	order	for	AMS	to	be	effective	it	needs	engagement	of	multidisciplinary	
clinicians.	Support	for	the	potential	benefits	of	AMS	programs	was	identified	in	
surveys	conducted	in	Europe	(Wood	et	al.,	2013),	Australia	(Bannan	et	al.,	2009),	
Canada	(Steinberg	et	al.	2014)	and	the	USA	(Bannan	et	al.,	2009;	Itokazu	et	al.,	
2006b;	Steinberg	et	al.,	2014).	However,	there	are	barriers	to	effective	AMS	
including	lack	of	specialised	personnel,	training	and	education	(Pawluk	et	al.,	2014)	
as	well	as	low	levels	of	experience	in		AMS	programs	because	of	the	slow	
implementation	of	AMS	programs	within	healthcare.	For	example,	only	7%	of	nurses	
in	an	Australian	survey	had	experience	of	working	in	healthcare	facilities	with	AMS	
programs	(Cotta	et	al.,	2014).	Willingness	of	clinicians	to	participate	in	AMS	may	be	
variable	as	AMS	can	be	time	consuming,	may	interfere	with	clinical	responsibilities	
(Bannan	et	al.,	2009)	and	may	be	perceived	by	physicians	to	impact	on	their	
prescribing	autonomy.		
Understanding	clinicians’	perceptions	and	attitudes	toward	AMS	is	important	
in	determining	the	difference	and	similarities	between	professions	and	the	barriers	
and	facilitators	to	effective	AMS.	Perceptions	and	attitudes	towards	AMS	held	by	
multidisciplinary	clinicians	are,	in	general	positive,	however,	there	are	potential	
barriers	to	effective	AMS	that	are	related	to	the	need	for	education,	training	and	
resources,	willingness	of	clinicians	to	participate	and	external	pressure	from	patients	
that	impact	on	prescribing.	Patients	play	an	important	role	in	the	use	of	antibiotics	
and	are	key	stakeholders.	In	the	section	to	follow	the	literature	related	patient	
participation	in	AMS	is	reviewed	with	the	intent	of	determining	how	patients’	roles	
can	be	augmented	and	supported.		
2.4	Patient	participation	in	antimicrobial	stewardship		
In	this	section,	a	search	and	narrative	review	of	the	literature	related	to	
patient	participation	or	engagement	in	antimicrobial	use	and	AMS	is	presented	in	
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order	to	understand	current	and	potential	patient	participation	in	AMS	from	the	
perspectives	of	different	cultures	and	contexts	worldwide.		
The	CINAHL	and	MEDLINE	electronic	databases	were	searched	from	January	
2000	to	September	2017.	The	databases	were	searched	using	the	following	terms:	
"patient	participation"	or	"patient	engagement"	or	"patient	involvement"	or	"patient	
decision"	and	“antibiotic*	or	antimicrobial”.	Additionally,	Google	(Scholar)	databases	
were	also	searched	using	the	term	“patient	participation	in	antimicrobial	
stewardship”	in	this	literature	review.	Qualitative	and	quantitative	research	and	
clinical	reviews	that	were	published	in	English	were	included.	The	review	process	
revealed	12	papers	that	met	the	search	criteria	including	11	research	papers	and	one	
review	paper.	An	additional	Thai	language	paper	was	found	however	this	was	
excluded	(Porisutiwutiporn	&	Hemchayat,	2014b).	A	summary	of	the	findings	is	
presented	in	Table	2.7	followed	by	a	narrative	summary	of	the	major	themes	related	
to	patient	participation	in	AMS.	
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Table	2.7	Summary	of	published	papers	of	patient	participation	or	engagement	in	antimicrobial	use	and	stewardship	(n=12)	
Author,	Publication	year,	Country,	Title	 Participants	 Intervention	 Type	of	research	 Significant	outcomes	of	patient	participation/	engagement	
1.	Heid,	Knobloch,	Schulz,	and	Safdar	(2016),	
USA	
	
Use	of	the	Health	Belief	Model	to	Study	
Patient	Perceptions	of	Antimicrobial	
Stewardship	in	the	Acute	Care	Setting	
	
Patients	 None	 Qualitative		
Semi-
structured	
interviews	
• Participants	perceived	AMS	as	a	serious	public	health	problem	
but	recognised	low	perceived	susceptibility	to	being	personally	
affected	by	AMR.		
• Participants	had	a	high	degree	of	trust	in	physicians	and	
misperceptions	regarding	the	mechanisms	underlying	resistance.		
• Participants	perceived	high	self-efficacy	and	a	desire	to	
participate	in	their	treatment.		
• Patients	perceived	their	roles	in	appropriate	use	of	antibiotics	
were	asking	questions	and	speaking	up	regarding	concerns	to	
active	sharing	in	decision-making	regarding	antibiotic	
treatments.	
• Few	participants	expressed	being	offered	the	chance	to	share	in	
decision	making	during	a	hospital	admission.	
• Patient	participation	has	not	been	recognised	as	a	significant	
component	of	AMS	programs.		
2.	Rosati	et	al.	(2014),	Italy	
Are	parents	of	children	hospitalized	with	
severe	community-acquired	pneumonia	more	
satisfied	with	care	when	physicians	allow	
them	to	share	decisions	on	the	antibiotic	
route?	
Doctors	 Informed	parents	of	
medical	shared-
decision	making	in	
choosing	injected	or	
oral	therapy		
Comparison	
group	Survey	
• Parents	were	more	satisfied	with	information	received.	
• Children	were	more	likely	to	be	prescribed	an	oral	therapy	if	
parents	participated	in	shared	decision-making.	
3.Légaré	et	al.	(2013),	Canada	
	
Impact	of	DECISION	+	2	on	patient	and	
physician	assessment	of	shared	decision	
making	implementation	in	the	context	of	
antibiotics	use	for	acute	respiratory	infections	
Physicians	and	
patients		
Implementing	
DECISION	+	2,	a	
training	program	for	
physicians	and	
evaluated	the	impact	
Parallel	
randomized	
clustered	trial	
• Antibiotics	were	used	less	in	the	shared	decision	making	group	
(27.2%)	compared	with	the	control	group	(52.2%).	
• Patients	in	the	intervention	group	perceived	playing	more	
proactive	role	in	shared	decision	making	of	antibiotic	use	
(67.1%)	than	in	the	control	group	(49.2%)	(p	=	0.04)	for	acute	
respiratory	tract	infections.		
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Author,	Publication	year,	Country,	Title	 Participants	 Intervention	 Type	of	research	 Significant	outcomes	of	patient	participation/	engagement	
4.	Gudnadottir	et	al.	(2013),	USA	
	
Reducing	health	care-associated	infections:	
patients	want	to	be	engaged	and	learn	about	
infection	prevention	
Patients	 None	 Interviewer-
administered	
questionnaire	
• 98%	of	participants	perceived	that	their	participation	in	
multidrug	resistant	organisms	(MDROs)	was	important.		
• Majority	of	participants	expressed	that	being	informed	regarding	
MDROs	would	help	them	in	decision-making	about	choices	and	
that	would	improve	their	health	care.		
• Preferences	of	patients	must	be	involved	in	education	to	
increase	participation	for	prevention	of	MDROs	and	HAIs.	
5.	Coenen	et	al.	(2013),	
13	European	countries	
	
Are	patient	views	about	antibiotics	related	to	
clinician	perceptions,	management	and	
outcome?	A	multi-country	study	in	
outpatients	with	acute	cough	
Patients	
Clinicians	
None	 Prospective	
observational	
study	
• Participants’	beliefs	about	antibiotic	effectiveness	were	not	
useful	for	identifying	those	who	will	benefit	from	antibiotics.		
• Clinician	perceptions	did	not	match	with	patient	perspectives,	
but	influenced	antibiotic	prescribing.		
• In	general	participants	were	satisfied	with	care.	Those	patients	
not	prescribed	antibiotics	were	less	satisfied.		
• Clinicians	should	be	more	active	to	support	patient	participation	
in	antibiotic	use.		
6.	Legare	et	al.	(2012),	Canada		
	
Training	family	physicians	in	shared	decision-
making	to	reduce	the	overuse	of	antibiotics	in	
acute	respiratory	infections:	A	cluster	
randomized	trial	
Family	
physician	
Trained	Physicians	in	
shared	decision	
making	about	the	use	
of	antibiotics	for	
acute	respiratory	
infection	
Cluster	
randomized	
trial	
• The	percentage	of	patients	who	decided	to	use	antibiotics	after	
consultation	was	52.2%	in	the	control	group	versus	27.2%	in	the	
shared	decision-making	group.	
7.	Legare	et	al.	(2011a),	Canada		
	
Training	family	physicians	in	shared	decision	
making	for	the	use	of	antibiotics	for	acute	
respiratory	infections:	a	pilot	clustered	
randomized	controlled	trial	
Family	
physician	
Implemented	a	
shared	decision-
making	program	
about	antibiotic	use	
for	acute	respiratory	
infection	
Two	arm	
parallel	
clustered	pilot	
randomized	
controlled	
trial		
• The	percentage	of	patients	who	decided	to	use	antibiotics	after	
consultation	was	49%	in	the	control	group	versus	33%	in	the	
shared	decision-making	group.	
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Author,	Publication	year,	Country,	Title	 Participants	 Intervention	 Type	of	research	 Significant	outcomes	of	patient	participation/	engagement	
8.	Alden,	Tice,	and	Berthiaume	(2006),	USA	
	
Antibiotics	and	upper	respiratory	infections:	
The	impact	of	Asian	and	Pacific	island	
ethnicity	on	knowledge,	perceived	need,	and	
use	
Doctors	 None	 Survey		 • Filipino	patients	had	lower	levels	of	antibiotic	knowledge	and	
higher	perceived	need	and	reported	more	frequent	use	when	
compared	to	caucasion	and	Asian	American	and	Hawaiian	
Pacific	islander	patients.	
• There	were	ethnic	differences	in	attitudes	towards	shared	
decision	making.	
9.	Merenstein,	Diener-West,	Krist,	Pinneger,	
and	Cooper	(2005),	USA	
	
An	assessment	of	the	shared-decision	model	
in	parents	of	children	with	acute	otitis	media	
Parents	 Evaluated	outcomes	after	
implementing	intervention	
of		
a	shared-decision	model	
(SDM)	and	paternalistic	
model	
	
A	cross-
sectional	
survey	
• Participants	in	the	shared	decision-making	model	had	less	
antibiotic	usage	and	greater	levels	of	parental	satisfaction	with	
treatment	of	acute	otitis	media	than	participants	in	the	
paternalistic	model.	
10.	Davey,	Pagliari,	and	Hayes	(2002),	UK		
	
The	patient's	role	in	the	spread	and	control	of	
bacterial	resistance	to	antibiotics	
Doctors	 Exploration	of	the	theory	
and	process	of	patient	
centred	care	in	the	
treatment	of	community	
acquired	RTIs	
Review	
article	
• Empowering	patients	to	share	decision-making	in	conjunction	
with	education,	can	change	attitudes	and	behaviors	and	
improve	access	to	and	completion	of	appropriate	antimicrobial	
therapy,	and	reduce	the	development	of	antimicrobial	
resistance.	
11.Macfarlane	et	al.	(2002),	England	
	
Reducing	antibiotic	use	for	acute	bronchitis	in	
primary	care:	blinded,	randomised	controlled	
trial	of	patient	information	leaflet	
Patients	 Providing	an	information	
leaflet	about	the	natural	
course	of	lower	
respiratory	tract	
symptoms	and	the	
advantages	and	
disadvantages	of	antibiotic	
use	to	intervention	group		
Nested,	
single	blind,	
randomised	
controlled	
trial	
• The	use	of	the	patient	information	leaflet	and	verbal	advice	
reduced	the	use	of	antibiotics	in	patients.		
• Sharing	with	the	patient	the	uncertainty	about	the	decision	to	
prescribe	was	more	likely	to	be	safe	and	effective.		
12.	Scott	et	al.	(2001),	USA	
	
Antibiotic	use	in	acute	respiratory	infections	
and	the	ways	patients	pressure	physicians	for	
a	prescription	
Physician-
patient	
communicatio
n	
Physician-patient	
interactions	were	
categorized	into	6	
influence	categories	and	
antibiotic	prescribing	
compared	across	
categories	
A	multi	
method	
comparative	
case	study	
• Patients	strongly	influence	the	antibiotic	prescribing	of	
physicians.	
• Providing	education	about	appropriate	antibiotic	use	would	
decrease	antibiotic	use	for	acute	respiratory	infections	
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2.4.1	Narrative	summary	of	patient	participation	in	antimicrobial	stewradship		
Patient	participation	is	commonly	recognised	as	a	key	component	high	quality	
care	(WHO,	2013).		Patient	participation	can	be	defined	as	‘…the	involvement	of	
patients	in	the	decision-making	process	regarding	health	issues’	(Longtin	et	al.,	2010,	
p.	54).	The	terms	“patient	participation”	“patient	involvement”	“patient	
engagement”	and	“patient	empowerment”	are	often	used	interchangeably	(Longtin	
et	al.,	2010).	The	potential	benefits	of	active	patient	participation	in	healthcare	are	
increased	acceptability	and	effectiveness	of	treatments	(Davey	et	al.,	2002)	and	
improved	patient	safety	(Pittet	&	Donaldson,	2005).	Patients	can	participate	in	their	
own	safety	by	monitoring	and	reporting	of	adverse	events;	checking	that	they	are	
given	correct	and	timely	medications;	observing	and	asking	staff	about	hand	washing	
practices;	and	ensuring	they	have	been	appropriately	identified	prior	to	treatment	
(Rathert,	Huddleston,	&	Pak,	2011).	
Unnecessary	use	of	antibiotics,	particularly	in	primary	care,	can	be	linked	to	
patients’	attitudes	and	perceptions	about	antimicrobial	therapy	(Coenen,	Michiels,	
Renard,	Denekens,	&	Van	Royen,	2006;	Edgar,	2012;	Moro,	Marchi,	Gagliotti,	Di	
Mario,	&	Resi,	2009).	Patients	often	have	misconceptions	about	the	benefits	of	
antibiotic	treatment	for	viral	illness	(Edgar,	Boyd,	&	Palamé,	2009a;	Saengcharoen,	
Lerkiatbundit,	&	Kaewmang,	2012)	and	inappropriate	behaviors	related	to	
antimicrobial	use	such	as	skipping	doses	and	sharing	antimicrobial	medicines	(Edgar,	
Boyd,	&	Palamé,	2009b;	Saengcharoen	et	al.,	2012;	Shehadeh	et	al.,	2012).	As	
discussed	earlier,	patient	expectations	relating	to	antibiotic	treatment	puts	pressure	
on	clinicians	to	prescribe	antibiotics	when	they	are	not	necessary,	for	example,	in	
the	presence	of	a	respiratory	tract	infection	(McNulty,	Boyle,	Nichols,	Clappison,	&	
Davey,	2007;	Saengcharoen	et	al.,	2012).	There	is	also	a	widely	held	view	among	
patients	that	antibiotics	can	kill	viruses	and	a	reason	to	take	antibiotics	is	“to	get	
better	faster”	(Edgar	et	al.,	2009b).		
In	Thailand,	inappropriate	antibiotic	use	is	a	major	problem.	Saengcharoen	et	
al.	(2012)	conducted	a	survey	of	Thai	high	school	and	high	vocational	students	about	
their	knowledge,	attitudes,	and	behaviors	regarding	antibiotic	use	for	upper	
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respiratory	tract	infections.		More	than	75%	of	students	had	misconceptions	about	
antibiotic	use;	45%	had	taken	an	incomplete	course	of	antibiotics,	and	half	of	the	
students	surveyed	had	taken	antibiotics	for	less	than	five	days	(Saengcharoen	et	al.,	
2012).	In	a	study	of	Thai	clients	in	a	community	hospital,	the	only	factor	influencing	
appropriate	antibiotic	use	was	their	level	of	knowledge	of	appropriate	use	of	
antibiotics.	Other	factors	such	as	age,	level	of	education	and	how	often	they	had	
received	an	explanation	about	antibiotic	use	from	health	care	professionals	were	not	
significant	influences	on	antibiotic	use	(Porisutiwutiporn	&	Hemchayat,	2014a).		
Responding	to	the	problem	of	AMR	and	overuse	of	antimicrobial	medicines	
requires	that	both	patients	and	clinicians	make	appropriate	decisions	about	
antimicrobial	treatments.	Patient	engagement	and	participation	can	impact	
positively	on	quality	of	care	and	has	been	shown	to	enhance	outcomes	related	to	
pain	control	(Manias	&	Williams,	2007;	Manias	&	Williams,	2008;	McTier,	Botti,	&	
Duke,	2014;	Street	et	al.,	2014),	medication	errors	(Longtin	et	al.,	2010;	Pittet	&	
Donaldson,	2005)	achievement	of	treatment	outcomes	(Dillon,	2012;	Heggland,	
Mikkelsen,	&	Hausken,	2013;	Heggland,	Mikkelsen,	Øgaard,	&	Hausken,	2014;	
Shepherd,	Tattersall,	&	Butow,	2008)and	patient	satisfaction	(Moral	et	al.	(2011).		
There	is	emerging	although	limited	evidence	that	patient	participation	
through	shared	decision	making	may	impact	significantly	on	the	optimal	use	of	
antimicrobial	medicines	(Légaré	et	al.,	2013;	Legare	et	al.,	2012;	Legare	et	al.,	
2011a).	Empowering	patients	to	share	decision-making	regarding	antibiotic	use	in	
respiratory	infections	reduced	the	development	of	AMR	(Davey	et	al.,	2002).	
However,	there	are	important	differences	between	ethnic	groups	not	only	in	their	
antibiotic	knowledge,	perceived	need	and	frequency	of	use,	but	also	in	their	
preferences	for	interaction/decision	making	style	between	patients	and	their	doctors	
(Alden	et	al.,	2006).		
While	there	has	been	very	limited	research	into	patient	participation	in	AMS,	
there	is	little	doubt	that	patients	do	influence	antibiotic	prescribing	and	therefore	
impact	on	AMR.	There	is	also	the	suggestion	that	ethnicity	may	be	a	factor	in	
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antibiotic	use	and	behaviors	and	may	also	influence	preferred	patient	participation	
roles.		
2.5	Chapter	summary	
Antimicrobial	stewardship	programs	have	emerged	in	response	to	the	
problem	of	AMR	and	the	inappropriate	use	of	antibiotics.	A	key	component	of	AMS	
is	multidisciplinary	involvement.	There	is	consensus	in	the	literature	that	nurses	have	
a	professional	responsibility	as	members	of	a	multidisciplinary	team	and	as	patient	
advocates	to	promote	safe	and	effective	antimicrobial	therapy,	provide	patient	
education	and	raise	public	awareness	about	appropriate	antibiotic	usage.		
As	AMS	programs	continue	to	develop,	whether	nurses	claim	their	place	as	
key	stakeholders	in	organisational	AMS	systems	will	be	influenced	by	whether	
nurses	feel	that	they	have	the	knowledge	and	skills	to	actively	participate	in	AMS.	
The	particular	skills	that	nurses	need	to	be	effective	partners	in	AMS	are	effective	
communication	with	other	members	of	the	AMS	team,	challenging	multidisciplinary	
clinicians	about	evidence-based	antimicrobial	therapy,	understanding	infection	
surveillance	data,	and	educating	patients	about	their	role	in	AMS	and	AMR.	Little	is	
known	about	current	roles	that	nurses	assume	in	AMS	programs	worldwide,	
particulaly	in	Thailand.		
Patient	participation	is	recognised	as	a	key	component	of	high	quality	care.	
There	has	been	very	limited	research	into	patient	participation	in	AMS,	particularly	
In	Thailand,	where	antibiotics	are	sold	without	prescription	and	professional	
involvement.	Nurses,	as	the	only	hospital	clinicians	with	a	24	hour	per	day	direct	
patient	care	role	are	important	stakeholders	in	AMS	programs	and	are	in	a	key	
position	to	collaborate	with	AMS	teams	and	patients.		
The	chapter	to	follow	provides	a	description	of	the	methods	used	to	address	
the	aims	of	this	program	of	research	including	research	design,	conceptual	
framework,	research	setting,	research	participants,	and	data	collection,	analysis	and	
ethical	considerations.	
Page	59	
	
 
Chapter	3	
Methods	
The	purpose	of	this	chapter	is	to	present	the	design	and	methods	used	to	
address	the	aims	of	the	research.	The	chapter	has	eight	sections.	The	research	
purpose	and	aims	are	outlined	in	the	first	section.	In	the	second	section,	the	overall	
design	of	the	research	program	is	outlined	and	includes	a	description	of	the	site,	
setting	and	contextual	background	of	the	healthcare	system	in	Thailand.	The	
subsequent	five	sections	provide	a	detailed	description	of	the	methods	used	in	the	
four	phases	of	the	research	program.	The	ethical	considerations	of	this	research	are	
addressed	in	the	final	section	of	this	chapter.		
3.1	Research	aims	
The	purpose	of	this	research	was	to	explore	the	current	and	potential	roles	of	
nursing	in	antimicrobial	stewardship	(AMS)	in	acute	healthcare	in	Thailand	within	
the	broader	context	of	clinical	governance	and	attitudes	and	perceptions	of	
antimicrobial	resistance	and	stewardship	using	a	single	organisational	case	study	
with	the	intent	of	informing	nursing	education	and	professional	development	in	
relation	to	AMS,	health	service	AMS	governance,	and	strategies	to	engage	patients	
both	within	the	hospital	and	the	community	through	education	and	health	
promotion.		
The	specific	aims	were	to:		
I. Explore	the	perceptions	and	attitudes	toward	AMS	among	clinicians	in	
acute	healthcare	in	Thailand;	
II. Identify	strengths	and	weaknesses	of	AMS	clinical	governance	structures	
and	activities	as	perceived	by	organisational	leaders	(executives	and	
clinical	leaders)	and	nurses	working	in	acute	healthcare	in	Thailand,	using	
the	CDC	recommendations	as	a	framework	for	the	analysis;	
III. Explore	current	and	potential	for	patient	participation	in	AMS	in	Thailand;	
and	
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IV. Explore	how	organisational	leaders	and	nurses	perceive	potential	future	
roles	for	nurses	in	AMS	in	Thailand	within	the	current	governance,	
educational	and	practice	context.		
The	four	aims	addressed	factors	pertinent	to	understanding	the	status	of	
AMS	within	a	Thai	healthcare	organisation.	Detailed	analysis	of	health	service	clinical	
governance	for	AMS	is	important	to	identify	alignment	with	international	best	
practice,	gaps	in	best	practice,	and	where	nurses	could	best	contribute	to	AMS	
clinical	governance.	Understanding	clinicians’	perceptions	and	attitudes	toward	AMS	
is	important	in	determining	the	differences	and	similarities	between	professions	and	
the	barriers	and	facilitators	to	effective	AMS	in	order	to	inform	feasible	and	clinically	
useful	AMS	policy.	Patient	involvement	in	AMS	is	a	major	international	strategy	to	
decrease	AMR	(WHO,	2014b)	and	an	area	in	which	nurses	can	play	a	major	role.	
Exploration	of	how	leaders	and	nurses	perceive	potential	future	roles	for	nurses	in	
AMS	within	the	current	governance,	educational	and	practice	context	is	fundamental	
to	informing	future	patient	engagement	and	education	strategies.	Understanding	
current	and	potential	for	patient	participation	in	AMS	provides	the	framework	for	
patient	and	family	education,	the	development	of	information	materials	and	
contributes	to	the	AMS	practices	of	doctors,	nurses	and	pharmacists.		
3.2	Research	design		
A	multiple	methods,	exploratory	and	descriptive	design	was	employed	within	
a	single	organisational	case	study	in	Thailand.	The	program	was	conducted	in	four	
phases	in	order	to	provide	a	comprehensive,	multi-lens	exploration	of	the	current	
and	potential	roles	of	nurses	in	AMS	in	acute	healthcare	in	Thailand	by	investigating	
key	stakeholders’	perceptions	and	attitudes	toward	AMS,	the	strengths	and	
weaknesses	of	existing	AMS	clinical	governance	structures	and	activities	and	
potential	future	roles	for	nurses	in	AMS.	Patient	participation	in	AMS	was	explored	
from	the	perspectives	of	nurses	and	patients.	The	multi-lens	framework	is	illustrated	
in	Figure	3.1.	The	multiple	methods	involved	survey,	in-depth	interview	and	focus	
groups.	Methodological	triangulation	was	used	to	fully	address	the	aims	of	the	
research.		
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An	exploratory	descriptive	research	design	was	considered	appropriate	to	
address	the	significant	gaps	in	our	understanding	of	nurses’	contribution	to	AMS	in	
the	Thailand	within	the	broader	context	of	clinical	governance	and	attitudes	and	
perceptions	of	antimicrobial	resistance	and	stewardship.	Exploratory	research	adds	
further	depth	to	descriptive	approaches	as	it	enables	the	full	nature	of	phenomena	
and	related	factors	to	be	examined	(Loiselle,	2007).	This	in-depth	understanding	is	
necessary	to	inform	future	policy,	change	in	nursing	education	and	professional	
practice,	health	service	AMS	governance,	and	strategies	to	engage	patients	both	
within	acute	care	services	and	the	community.		
	
	
Figure	3.1	A	multi-lens	framework	for	exploring	the	current	and	potential	
roles	of	nursing	in	AMS	
	 3.2.1	Setting	
The	research	was	conducted	in	a	1,000-	bed	university	public	hospital	located	
in	Bangkok,	the	capital	city	of	Thailand.	The	study	hospital	provides	advanced	
medical	services	with	approximately	5,000	outpatient	visits	per	day	and	over	45,000	
in-patient	separations	per	year.	The	hospital	provides	the	following	specialty	
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services:	pediatrics;	ophthalmology;	psychiatry;	pathology;	diagnostic	and	
therapeutic	radiology;	anesthesiology;	family	medicine;	rehabilitation	medicine;	
surgery;	obstetrics	and	gynecology;	otolaryngology;	orthopedics;	medicine;	
emergency	medicine	and	community	medicine.	A	full	description	of	the	
organisational,	governance	and	reporting	structures	is	provided	in	Chapter	5	(p	133)	
and	outlined	in	Figure	5.1	(p	138).	The	case	study	hospital	employs	1,450	nurses,	10	
Infection	Control	Nurses	(ICNs),	95	pharmacists	and	7	Infectious	diseases	physicians.	
Nurse/patient	ratios	in	the	wards	are	1:5	and	1:1	in	critical	care	units.	The	proportion	
of	nurses	who	are	female	in	Thailand	is	greater	than	90%.	
Thailand,	officially	called	the	Kingdom	of	Thailand,	is	located	at	the	heart	of	
the	Indochina	peninsula	of	South-East	Asia	(Figure	3.2).	The	country	is	classified	as	
an	upper	middle-income	nations	by	the	World	Bank	with	a	per	capita	income	of	USD	
5,640	(The	World	Bank,	2017b).	In	2016,	Thailand’s	gross	domestic	product	(GDP)	
was	calculated	to	be	USD	406.84	billion	of	total	GDP	(The	World	Bank,	2017b).	There	
are	five	main	regions	in	Thailand:	Northern,	Eastern,	Northeastern,	Central,	and	
Southern	divided	into	77	provincial	administrations,	and	an	estimated	population	of	
68.8	million	in	2016	(The	World	Bank,	2017a).	Approximately	93.6%	of	Thais	are	
Buddhists.	The	official	language	of	Thailand	is	Thai	(National	Statistical	Office,	2011).		
	
  
Figure	3.2	Research	setting;	Bangkok,	Thailand	
(Source:	http://pattayavillaholidays.com/Maps-thailand/map-thailand-6.html	
and	http://ontheworldmap.com/thailand/thailand-location-map.jpg)	
Deakin	University	CRICOS	Provider	Code:	00113B	
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	 3.2.2	Healthcare	services	in	Thailand	
The	Ministry	of	Public	Health	(MOPH),	established	in	1942,	is	the	main	
national	health	agency	playing	an	important	role	in	health	program	development	
and	improvement	of	the	health	status	of	Thai	people	(MOPH	2000).	Both	private	and	
public	institutions	provide	healthcare	services	in	Thailand.	Most	hospitals	in	Thailand	
are	operated	by	MOPH	while	the	Medical	Registration	Division	of	the	MOPH	
regulates	private	hospitals	(Lefemine,	2012).		
Other	government	divisions	also	operate	public	hospitals,	including	the	
military,	local	governments,	the	Red	Cross,	the	Bangkok	Metropolitan	Administration	
and	the	Ministry	of	Education.	In	2013,	there	were	1,286	public	hospitals	and	326	
registered	private	hospitals	in	Thailand	(MOPH,	2013).	
	 Health	services	in	Thailand	are	classified	into	five	levels	as	follows:	
1. Self	Care	Level.	In	this	level,	self-care	capacity	is	enhanced	and	people	are	
encouraged	to	make	decisions	about	their	own	health.		
2. Primary	Health	Care	Level.	Each	community	organises	services	related	to	health	
promotion	and	prevention,	and	curative	and	rehabilitative	care.	Village	health	
volunteers	are	service	providers	at	this	level	of	care.			
3. Primary	Care	Level.	Medical	and	health	personnel	provide	healthcare	services	
for	people	in	different	health	units	as	follows:	
I. Community	health	services.	This	health	unit	provides	health	services	at	
village	level	in	remote	areas	covering	a	population	of	500-1,000.	Community	
health	workers	provide	health	promotion	and	prevention,	and	primary	
medical	care	to	people	in	this	level.		
II. Health	centers.	This	health	service	level	provides	health	services	such	as	health	
promotion	and	prevention,	and	primary	health	services	at	sub	district	or	village	
level	covering	a	population	of	1,000-5,000.	Health	service	staff	including	public	
health	 administrators,	 public	 health	 officers,	 and	 community	 public	 health	
staff	that	work	at	this	level	are	under	supervision	and	support	from	community	
hospitals.		
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III. Health	centers	of	municipalities,	outpatient	departments	of	public	and	private	
hospitals,	 and	 private	 clinics.	 At	 these	 services,	 outpatient	 treatment	 is	
provided	by	doctors	and	health	professionals.		
4. Secondary	Care	Level.	Health	care	at	this	level	is	provided	by	different	
healthcare	professional	specialists.	The	general	and	specialised	facilities	are	as	
follows:	
I. Community	hospitals.	These	facility	health	services	are	located	in	a	district,	
covering	a	population	of	10,000	or	more	with	10-150	inpatient	beds.	
II. General	hospitals	or	regional	hospitals	and	other	large	public	hospitals.	These	
hospitals	are	located	in	provinces	or	large	district	areas	with	200-500	
inpatient	beds.		
III. Private	hospitals.	There	hospitals	are	run	as	commercial	entities.	People	have	
to	pay	for	their	healthcare	treatments	and	services.		
5. Tertiary	Care	Level.	The	facilities	at	this	level	provide	advanced	healthcare	
services	and	specialized	health	professionals.	This	level	includes	General	
Hospitals,	Regional	hospitals,	University	Hospitals,	and	large	private	hospitals.		
University	Hospitals	provide	all	services	with	the	highest	quality	of	healthcare	
facilities	and	healthcare	professionals.	University	Hospitals	are	supervised	by	the	
Ministry	of	Education	in	order	to	provide	medical	education	and	health	research	and	
innovation.	The	Ministry	of	Public	Health	controls	the	quality	standards	all	of	
hospitals	in	Thailand.	There	are	eight	public	University	Hospitals	in	Thailand,	three	
are	located	in	Bangkok,	and	one	in	each	of	the	five	main	regions	of	Thailand.	Most	
University	Hospitals	have	at	least	500	inpatient	beds.	Several	studies	have	shown	
that	the	incidence	of	inappropriate	antibiotic	use	in	University	Hospitals	in	Thailand	
from	1990	to	2006	was	between	24.8%	and	91%	(Apisarnthanarak,	Danchaivijitr,	
Bailey,	&	Fraser,	2006;	Aswapokee,	Vaithayapichet,	&	Heller,	1990;	Ayuthya,	
Matangkasombut,	Sirinavin,	Malathum,	&	Sathapatayavongs,	2003;	Thamlikitkul,	
Danchaivijitr,	Kongpattanakul,	&	Ckokloikaew,	1998;	Udomthavornsuk	et	al.,	1990).	
A	fifth	level	tertiary	care	hospital	was	selected	as	the	case	study	organisation	
for	this	study	because	of	its	specialised	and	educational	functions.	It	was	expected	
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that	the	large	university	teaching	hospital	where	the	research	was	conducted	would	
be	representative	of	fifth	level	healthcare	and	would	provide	an	understanding	of	
the	highest	level	of	AMS	governance	and	activities	currently	practiced	in	Thailand.		
The	design,	methods	and	analysis	frameworks	for	each	of	the	four	phases	of	
this	program	of	research	are	outlined	separately	in	the	sections	to	follow.	
3.3	Phase	1:	Clinicians’	perceptions	and	attitudes	towards	antimicrobial	
stewardship	
Phase	1	addressed	aspects	of	the	first	aim	of	this	research	to	explore	the	
perceptions	and	attitudes	towards	AMS	among	clinicians	in	acute	healthcare	in	
Thailand	using	survey	methods.	
The	specific	objectives	were	to:		
I. Describe	the	perceptions	and	attitudes	of	doctors,	nurses	and	
pharmacists	towards	AMS	in	acute	healthcare	in	Thailand;	
II. Explore	differences	in	the	perceptions	and	attitudes	of	clinicians	of	
different	disciplines	towards	AMS		
	 3.3.1	Design	
The	design	of	this	first	phase	was	a	prospective	hospital-wide,	self-
administered	survey	employing	closed-ended	questions	completed	by	doctors,	
nurses	and	pharmacists.	Effective	hospital-wide	antimicrobial	stewardship	programs	
need	engagement	with	multidisciplinary	professionals	who	are	involved	in	
antimicrobial	use	(Cotta	et	al.,	2014).	Surveys	are	common	approaches	for	collecting	
data	to	describe,	compare,	or	explain	knowledge,	attitudes	and	behavior	(Fain,	2009,	
p.	127).	Saks	and	Allsop	(2012)	state	that	survey	methods	are	essential	in	examining	
comparisons	and	variation	between	groups,	especially	in	large	populations.		
	 3.3.2	Sample		
Doctors,	nurses,	and	pharmacists	play	important	roles	in	AMS	
implementation	in	acute	care	settings.	In	Thailand,	to	study	medicine,	pharmacy	and	
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nursing,	students	need	to	complete	12	years	of	basic	education	and	meet	the	
admission	requirement	of	each	institution.		
The	Medical	Council	of	Thailand	is	responsible	for	verifying	all	medical	
education	curricula	in	Thailand.	The	duration	of	study	for	this	program	is	six	years.	
Students	who	successfully	complete	the	program	receive	a	M.D.	degree	(Doctor	of	
Medicine).	The	pharmacy	curriculum	is	five	years	in	duration.	Students	who	
complete	this	program	obtain	a	Bachelor	of	Pharmacy	(B.	Pharm).	The	curriculum	for	
the	Bachelor	of	Nursing	in	Thailand	is	four	years	in	duration.	Graduates	receive	the	
Bachelor	of	Nursing	Science	(B.N.S).	In	addition,	there	are	some	universities	that	
provide	a	2-year	program	for	technical	nursing.	This	program	provides	an	award	of	
Certificate	in	Nursing	Science	(Technical	Level).	Nurses	who	complete	this	program	
can	continue	their	education	to	Bachelor	degree	level.	The	category	of	technical	
nurse	was	not	employed	in	the	study	hospital.		
	 3.3.3	Survey	tool	
The	survey	tool	used	in	this	study	was	based	on	a	survey	used	in	an	
Australian	study	(Cotta	et	al.,	2014).	There	were	26	items	in	the	Australian	survey	of	
which	24	were	retained:	the	two	items	deleted	were	related	to	Australian	guidelines	
so	not	relevant	to	the	Thai	context.	As	antibiotics	can	be	purchased	without	
prescription	in	Thailand	and	therefore	are	widely	used,	four	additional	questions	
related	to	patient	influences	on	antibiotic	prescribing	decisions,	patients’	ability	to	
buy	over-the-counter	antibiotics	and	antibiotic	use	in	the	study	hospital	were	added,	
as	these	are	important	contextual	issues	for	Thai	healthcare.	The	full	clinician	survey	
is	available	in	Appendix	C.	
Validity	and	reliability	of	the	survey	was	established	before	collecting	the	
data	to	ensure	that	results	were	consistent	and	accurate	(Creswell,	Fetters,	&	
Ivankova,	2004;	Houser,	2012).	The	survey	was	examined	for	content	and	face	
validity.	Content	validity	is	‘the	extent	to	which	an	instrument	or	test	measures	an	
intended	content	area’	(Fain,	2009,	p.	117)	while	face	validity	is	‘how	a	measure	
appears	on	the	surface	and	whether	all	the	required	questions	are	framed	in	the	
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appropriate	language’	(Saks	&	Allsop,	2012,	p.	196).	In	this	survey,	the	original	
English	version	was	developed	based	on	a	literature	review	(Cotta	et	al.,	2014)	and	
the	additional	questions	were	based	on	the	Thai	contextual	setting.	The	survey	was	
reviewed	by	the	principal	(MB)	and	associate	supervisors	(JC	and	AH)	to	determine	
the	survey	items	were	clear,	that	the	content	of	the	survey	was	comprehensive	and	
culturally	appropriate.	The	English	version	was	translated	into	Thai	by	the	researcher	
(NS).	A	nursing	educator	from	a	Thai	University	who	holds	a	PhD	in	Nursing	(written	
in	English)	performed	a	back	translation	from	Thai	to	English.	The	consistency	of	
meaning	between	versions	of	the	Thai	and	the	back-translated	English	was	
compared	by	the	researcher	(NS).	Inconsistencies	in	the	Thai	survey	were	revised	if	
they	were	identified.	The	content	validity	relevant	to	the	Thai	context	and	face	
validity	of	the	final	Thai	language	version	of	the	survey	was	established	by	a	Thai	
panel	review	consisting	of	specialists	in	infection	and	prevention	control.	These	
specialists	were	infectious	disease	physicians,	an	AMS	specialist	pharmacist	and	a	
prevention	and	control	specialist	nurse	who	evaluated	the	items	for	relevance	and	
accuracy.	
To	ensure	the	survey	had	adequate	content	coverage,	the	judgment	of	
experts	needs	to	be	employed	(Loiselle	2007).	In	this	study,	a	content	validity	index	
(CVI)	was	used	to	indicate	the	extent	of	expert	agreement	of	the	final	Thai	language	
version	of	the	survey	(Loiselle,	2007,	p.	322).	Experts	were	ask	to	independently	rate	
the	relevance	of	each	item	to	the	objectives,	using	a	4-point	rating	scale	as:	(1	point)	
not	relevant,	(2	point)	somewhat	relevant,	(3	point)	quite	relevant,	and	(4	point)	
very	relevant	(Waltz,	Strickland,	&	Lenz,	2010).	The	CVI	of	this	survey	was	0.90		while	
a	CVI	score	of	0.80	was	minimally	acceptable	(Loiselle,	2007).		
Reliability	is	defined	as	‘the	extent	to	which	research	instruments	and	
concepts	are	stable	and	able	to	yield	an	unvarying	measurement’	(Saks	&	Allsop,	
2012,	p.	476).	Internal	reliability	is	stability	within	an	instrument	(Houser,	2012,	p.	
211).	To	ensure	this	survey	had	internal	consistency,	a	pilot	test	was	conducted	to	
enable	tests	of	internal	consistency.	Fain	(2009)	recommended	10	subjects,	as	the	
minimum	number	of	pilot	participants	required	to	uncover	questions	and/or	
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instrument	that	might	be	unclear.	The	final	developed	version	of	the	survey	in	this	
study	was	tested	with	10	healthcare	professionals	at	the	study	hospital	before	the	
survey	was	implemented.	Coefficient	alpha	was	used	to	test	internal	consistency.	A	
higher	coefficient	alpha	represents	higher	internal	consistency	reliability	(Waltz,	
Strickland	&	Lenz	2010).	A	value	of	0.7	or	greater	of	the	coefficient	alpha	was	
considered	acceptable	as	a	minimum	(Houser,	2012).	The	coefficient	alpha	of	this	
survey	was	0.89.	
	 3.3.4	Data	collection	procedures	
In	Phase	1,	a	paper-based	survey	was	distributed	to	1,753	doctors,	nurses	
and	pharmacists	in	the	following	departments:	surgery;	pediatrics;	medicine;	
operating	room;	pharmacy;	obstetrics	and	gynecology;	orthopedics;	ophthalmology;	
emergency	medicine;	community	health	nurses;	family	medicine	and	anesthesiology.	
The	minimum	acceptable	response	rate	was	set	at	30%	for	each	of	the	clinician	
discipline	groups	sampled	(Dillman,	1978;	Fain,	2009).		
Clinical	nurse	supervisors,	head	nurses,	senior	doctors	and	senior	
pharmacists	of	each	department	and	ward	were	asked	to	distribute	the	survey	to	
participants	and	reminded	them	to	complete	the	survey	within	the	timeframe.	
Potential	participants	were	given	four	weeks	to	complete	the	survey.	Department	
clerks	were	asked	to	gather	the	completed	surveys	in	a	box	provided	to	them.	The	
survey	included	a	covering	letter	explaining	how	to	complete	the	survey,	while	
maintaining	anonymity.	A	comprehensive	participant	Information	sheet	was	given	to	
the	participants	explaining	the	intent	of	the	survey	and	the	voluntary	nature	of	
completion	in	line	with	the	ethical	considerations	of	the	research.	Consent	was	
implied	by	return	of	the	surveys.	Participants	were	asked	to	complete	the	
questionnaires	themselves.	The	expected	time	to	complete	the	survey	was	
approximately	10	minutes.	Head	nurses,	senior	doctors	and	senior	pharmacists	of	
each	ward	and	department	were	asked	to	remind	participants	to	complete	the	
survey	every	two	weeks.	Surveys	were	collected	every	2	weeks	to	monitor	the	
response	rate	and	ensure	that	reminders	or	replacement	surveys	were	sent	to	
maximise	the	response	rate.		
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	 3.3.5	Data	analysis		
All	entered	data	were	cleaned	and	checked	for	errors	prior	to	starting	data	
analysis.	The	completed	questionnaires	were	analysed	using	the	Statistical	Package	
for	Social	Science	(SPSS)	version	22.0	for	Windows®	(IBM	Inc.,	Chicago,	IL,	USA).	The	
response	rate	for	each	clinician	group	was	calculated.	Descriptive	statistics	
(frequencies,	percentages,	means	and	standard	deviation)	were	used	to	summarise	
the	study	data.	As	the	data	did	not	conform	to	the	normal	distribution,	medians	and	
quartiles	one	and	three	(Q1-Q3)	were	presented.	For	survey	items	that	were	
categorical	in	nature,	clinicians’	responses	were	described	as	frequencies	and	
comparisons	were	made	using	the	Chi-Square	test.	For	continuous	data,	Kruskal	
Wallis	test	was	used	to	compare	the	responses	of	different	professional	groups	
(doctors,	nurses	and	pharmacists).	
3.4	Phase	2:	Clinical	governance	for	antimicrobial	stewardship	
Phase	2	addressed	the	second	aim	of	this	research,	which	was	to	identify	the	
strengths	and	weaknesses	of	AMS	clinical	governance	structures	and	activities	as	
perceived	by	organisational	leaders	(executives	and	clinical	leaders),	and	nurses	in	
acute	care	in	Thailand	using	the	Core	Elements	of	Hospital	AMS	Programs,	Centers	
for	Disease	Control	and	Prevention	(CDC)	recommendations	(referred	to	as	the	CDC	
recommendations)	as	a	framework	for	the	analysis.		
The	specific	objectives	of	this	phase	were	to:	
I. Describe	the	current	clinical	governance	structure	and	AMS	activities	
in	the	case	hospital	based	on	organisational	leaders	as	key	informants		
II. Explore	perceptions	of	the	strengths	and	weaknesses	of	the	current	
clinical	governance	structures	and	activities	related	to	AMS		
	 3.4.1	Design	
The	design	of	this	second	phase	was	qualitative	using	in-depth,	individual	
semi-structured	key	informant	interviews.	In	order	to	explore	the	current	clinical	
governance	structure	and	AMS	activities	and	the	perceptions	of	the	strengths	and	
weaknesses,	it	was	considered	important	to	examine	a	range	of	views	from	
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organizational	leaders	and	acute	care	nurses	so	data	from	Phase	4	(to	be	described)	
were	analysed	to	address	Aim	2.	In	Phase	2,	analyses	of	the	outcomes	of	semi-
structured	interviews	were	used	to	identify	alignment	of	current	AMS	governance	
with	international	best	practice,	gaps	in	best	practice,	and	where	nurses	could	best	
contribute	to	AMS	clinical	governance.	Details	of	participants,	sampling	approach,	
data	collection,	and	data	analysis	are	presented	in	the	sections	to	follow.	
	 3.4.2	Sample		
In	order	to	examine	the	current	status	of	AMS	clinical	governance,	
organisational	leaders	at	the	study	hospital;	who	were	involved	in	AMS	programs	
were	invited	to	participate	as	key	informants.	Participants	in	this	phase	were	
selected	purposively	as	follows:	the	medical	director;	the	nursing	director;	infection	
control	and	prevention	committee	members	including	an	ID	physician	(Committee	
Chair),	nurse	manager	of	the	infection	control	department	(Committee	Secretary),	
the	pharmacy	director,	head	of	the	epidemiology	department,	head	of	
anesthesiology	department,	head	of	surgical	department,	head	of	medical	
department,	nurse	manager	of	operating	department,	nurse	manager	of	medical	
department,	nurse	manager	of	surgical	department	and	nurse	manager	of	pediatric	
department;	antibiotic	committee	members	including	an	ID	physician	from	the	
medical	department,	an	ID	physician	from	the	pediatric	department,	a	family	
medicine	physician,	surgeons	and	a	pharmacist.				
	 3.4.3	Semi-structured	interview	
A	semi-structured	interview	was	used	to	collect	Phase	2	data.	Interviewees	
were	respected	and	encouraged	to	express	their	own	opinions.	In	the	semi-
structured	interview,	flexibility	was	valued	and	impromptu	questions	were	
responsive	to	the	answers.	The	Core	Elements	of	Hospital	AMS	Programs,	Centers	
for	Disease	Control	and	Prevention	(CDC)	recommendations	were	adapted	to	
identify	alignment	of	clinical	governance	for	AMS	in	the	study	hospital	with	
international	best	practice,	therefore	enabling	gaps	in	best	practice	to	be	identified.	
The	CDC	recommendations	were	used	to	frame	the	topic	guide	and	to	analyse	the	
Page	71	
	
 
data.	Data	from	organisational	leaders	provided	insight	into	the	strengths	and	
weaknesses	of	the	current	clinical	governance	structures	and	activities	related	to	
AMS.	In	addition,	topics	regarding	the	current	and	potential	role	of	nurses	in	AMS	in	
Thailand	were	included	to	explore	perceptions	about	nurses’	involvement	in	AMS.	
The	full	interview	guide	is	available	in	Appendix	A.	
	 3.4.4	Data	collection	procedures	
All	identified	organisational	leaders	were	invited	to	participate	in	this	study	
though	a	face-to-face	invitation	by	the	researcher.	After	receiving	agreement	to	
participate,	administrative	assistants	of	each	participant	were	contacted	to	identify	
suitable	times	to	meet	and	interview	times	and	place	were	then	scheduled.	The	
participants	were	asked	to	complete	a	written	consent	form	before	starting	the	
interview.	As	the	participants	in	this	study	and	the	student	researcher	speak	Thai	as	
their	first	language,	the	interviews	were	conducted	in	Thai.	Each	interview	was	
audiotaped	and	took	approximately	20-30	minutes	using	the	interview	guide.		
	 3.4.5	Data	analysis	
The	qualitative	data	were	analysed	using	a	combination	of	general	inductive	
method	and	thematic	analysis.	Audio-recordings	and	field	notes	from	the	interviews	
were	transcribed	in	Thai	by	the	researcher	(NS)	who	conducted	the	interviews.	The	
accuracy	of	the	Thai	transcripts	was	checked	against	the	recordings.	Next,	a	
professional	translator	translated	the	Thai	transcripts	into	English.	The	researcher	
(NS)	then	reviewed	the	accuracy	and	consistency	of	the	English	and	Thai	transcripts,	
especially	the	clinical	terms.	Then,	a	Thai	nursing	educator	who	holds	a	PhD	in	
Nursing	(written	in	English)	verified	the	consistency	of	the	English	and	Thai	
transcripts.	The	data	analysis	to	follow	was	conducted	using	the	English	transcripts.	
To	ensure	the	rigour	of	data	analysis	in	a	qualitative	study,	peer	debriefing	with	
supervisors	occurred	throughout	all	stages	of	the	data	analysis	including	the	
generation	of	the	coding	frame	and	identification	of	major	sub	themes.	
Representative	quotations	from	the	transcribed	text	used	in	relation	to	major	
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themes	and	subthemes	were	also	confirmed.	The	analytical	process	is	auditable	in	
the	raw	data	and	coding	documents.	
For	the	first	objective	of	describing	the	current	clinical	governance	structure	
and	activities	in	the	case	hospital	and	their	relationship	with	the	CDC	guidelines,	data	
were	analysed	using	general	inductive	method	(Thomas,	2006).	The	steps	taken	
involved	close	reading	of	the	text	of	each	transcript	(familiarisation)	and	listening	to	
the	audio	recording.	The	next	step	involved	coding	the	transcript	data	into	the	CDC	
categories.	The	CDC	guidelines	provided	clear	categories	for	recommended	AMS	
governance	and	enabled	the	analysis	of	gaps	in	governance.	Category	creation	was	
inductive	and	progressive.	Refining	the	category	system	continued	as	analysis	
progressed.		
For	the	second	objective	of	exploring	the	perceived	strengths	and	
weaknesses	of	the	current	clinical	governance	structures	and	activities	and	nurses’	
roles	in	AMS,	thematic	analysis	was	used.	Braun	and	Clarke	(2006,	p.	79)	defined	
thematic	analysis	as	‘a	method	for	identifying,	analysing	and	reporting	patterns	
(themes)	within	data’.	While	Saks	and	Allsop	(2012)	describe	that	‘a	thematic	
analysis	involves	identifying	recurring	themes	within	the	data;	exploring	typologies	
of	these	themes;	and	looking	at	variations	and	relationships	between,	and	within,	
themes’.	Thematic	analysis	is	a	useful	and	flexible	method	for	qualitative	data	
analysis	(Braun	&	Clarke,	2006).		
In	this	phase,	steps	for	data	analysis	involved	the	processes	of	thematic	
analysis	described	by	Saks	and	Allsop	(2012,	p.	139)	and	Spencer	et	al.	(Ritchie,	
Lewis,	Nicholls,	&	Ormston,	2014).	The	first	step	was	to	become	thoroughly	familiar	
with	the	interview	data	in	order	to	identify	issues	of	recurrent	interest	across	the	
data.	This	process	allowed	the	identification	of	the	initial	themes	that	would	be	used	
to	sort	the	data	and	was	the	beginning	of	the	process	of	abstraction.		Each	transcript	
was	reviewed	individually	and	data	were	highlighted	manually	into	topic	themes	of	
strengths,	limitations	and	nurses’	roles.	During	this	stage,	data	of	interest	were	
identified,	and	coded,	using	a	simple	coding	list	developed	from	the	topic	headings	
of	the	interview	guide.		
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The	next	step	was	to	develop	the	coding	frame,	a	list	of	concepts	and	their	
labels	(‘codes’),	in	order	to	organise	the	data.	This	process	involved	using	the	a	priori	
issues	introduced	by	the	interview	topic	guide	and	emergent	issues	raised	by	
respondents	and	this	was	a	deductive	and	inductive	process.	Coding	labels	evolved	
as	coding	progressed.		
The	third	step	involved	sorting	and	coding	the	data	and	was	the	process	of	
systematically	applying	the	coding	frame	to	the	data	(Ritchie	et	al.,	2014).	Care	was	
taken	to	ensure	data	were	interpreted	accurately.	The	data	extracts	were	then	
reviewed	for	coherence	between	the	data	extracted	and	to	begin	the	process	of	
refining	the	thematic	framework	(Ritchie	et	al.,	2014).	The	framework	was	refined	
over	time	and	in	response	to	peer	debriefing.		
The	formal	interpretation	process	commenced	once	the	coding	of	all	
transcripts	was	complete.	Major	and	sub	themes	were	identified	that	explained	the	
meaning	of	the	data.	This	process	involved	identifying	the	connections	between	the	
subthemes	and	interpreting	the	unifying	features	of	the	data	within	the	subthemes.		
3.5	Phase	3:	Patient	participation	in	antimicrobial	stewardship	
Phase	3	addressed	aspects	of	the	third	aim	of	this	research	to	explore	current	
and	potential	patient	participation	in	AMS	in	Thailand	using	survey	methods.	
The	specific	objectives	were	to:		
I. Explore	patients’	perceived	behaviours,	attitudes	and	knowledge	relating	
to	antibiotic	use	in	the	community;	
II. Determine	how	patients	participate	in	AMS	in	the	community	and	during	
hospital	admission	from	patients’	perspectives	
	 3.5.1	Design	
The	design	of	this	third	phase	was	a	prospective,	self-administered	survey	
employing	closed-ended	questions	administered	to	patients	during	an	acute	care	
admission	episode.	Inappropriate	antibiotic	use	in	hospitals	leads	to	AMR	and	
increased	risk	of	worse	clinical	outcomes	and	death	(WHO,	2014b).	In	Thailand,	the	
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causes	of	AMR	are	not	only	from	inappropriate	use	of	antibiotics	in	the	hospitals	
(Apisarnthanarak	et	al.,	2006)	but	also	because	antibiotics	can	be	purchased	over	the	
counter	without	a	prescription	(Moongtui	et	al.,	2011;	Thamlikitkul,	1988).	
Therefore,	understanding	patients’	attitudes	and	behaviors	regarding	AMS	and	use	
of	antimicrobial	medicines	underpins	strategies	for	patient	and	family	participation	
in	AMS.	Further,	understanding	patient	participation	in	AMS	also	informs	AMS	
practices	of	clinicians.		
	 3.5.2	Sample		
The	sample	for	Phase	3	was	derived	from	patients	who	were	admitted	to	six	
medical	and	surgical	wards	at	the	study	hospital	January	to	March	2016.	The	six	
wards	were	female	medical,	male	medical,	combined	female	and	male	medical,	
female	surgical,	male	surgical	ward,	and	combined	female	and	male	surgical	wards.		
Most	antimicrobial	medicines	are	prescribed	in	medical	wards	and	surgical	
wards	(Lesprit,	Landelle,	&	Brun-Buisson,	2013).	Patients	who	are	admitted	to	
medical	and	surgical	wards	are	therefore	more	likely	to	be	taking	antimicrobial	
medicines.	Patients	were	recruited	into	the	study	if	they	had	been	prescribed	
antibiotics	and	had	been	admitted	in	hospital	for	two	days	or	longer	and	were	able	
to	communicate	verbally	in	Thai.	These	criteria	were	to	ensure	that	patients	had	
adequate	time	to	become	familiar	with	the	hospital	and	clinicians.	
Consecutive	sampling	was	used	to	recruit	patients	to	the	study.	Consecutive	
sampling	is	“a	nonprobability	sampling	approach	involving	all	people	from	the	
accessible	population	over	the	specific	time	interval”	Polit	and	Beck	(2014,	p.	179).	
Consecutive	sampling	is	preferable	to	convenience	sampling	in	terms	of	sampling	
representation	because	it	decreases	the	risk	of	selection	bias	if	the	sampling	period	
is	long	enough	(Polit	&	Beck,	2012).	In	this	study,	205	inpatients	completed	the	
survey.	
	 3.5.3	Survey	tool	
In	Phase	3,	a	survey	was	used	to	collect	data	related	to	patients’	attitudes	
and	behaviors	in	antibiotic	use,	and	patients’	perceptions	of	participation	in	AMS.	
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The	questionnaire	was	a	modified	version	of	tools	developed	and	used	by	
Porisutiwutiporn	and	Hemchayat	(2014b)	and	Saengcharoen	et	al.	(2012),	and	
additional	items	were	based	on	the	literature	review.	The	full	version	of	the	patient	
survey	is	available	in	Appendix	D.	
Validity	and	reliability	of	the	survey	was	established	before	collecting	the	
data	to	ensure	that	results	were	consistent	and	accurate	(Creswell	et	al.,	2004;	
Houser,	2012).	An	English	version	of	the	survey	was	developed	by	the	researcher	
(NS)	based	on	a	literature	review	and	tools	used	in	previous	studies.	In	order	to	
ensure	content	and	face	validity,	the	survey	was	reviewed	by	the	principal	(MB)	and	
associate	supervisors	(JC	and	AH)	to	determine	that	survey	items	were	clear	and	that	
the	content	of	the	survey	covered	the	concepts	required	(Houser,	2012).		
The	processes	for	the	development	of	the	patient	survey	was	similar	to	those	
used	in	the	clinician	survey.	The	English	version	was	translated	into	Thai	by	the	
researcher	(NS).	A	nursing	educator	from	a	Thai	University	who	holds	a	PhD	in	
Nursing	(written	in	English)	performed	a	back	translation	from	Thai	to	English.	The	
consistency	of	meaning	between	versions	of	the	Thai	and	the	back-translated	English	
version	was	compared	by	the	researcher	(NS).	Inconsistencies	in	the	Thai	survey	
were	revised	if	they	were	identified.	The	content	validity	relevant	to	the	Thai	context	
and	face	validity	of	the	final	Thai	language	version	of	the	survey	was	established	by	a	
Thai	panel	review	consisting	of	specialists	in	infection	and	prevention	control.	These	
specialists	were	infectious	disease	physicians,	an	AMS	specialist	pharmacist	and	a	
prevention	and	control	specialist	nurse	who	evaluated	the	items	for	relevance	and	
accuracy.	
An	expert	panel	reviewed	the	survey	to	ensure	adequate	content	coverage	
(Loiselle	2007).	Content	validity	index	(CVI)	was	used	to	indicate	the	extent	of	expert	
agreement	of	the	final	Thai	language	version	of	the	survey	(Loiselle,	2007,	p.	322).	
The	CVI	was	0.87	in	this	survey	while	a	CVI	score	of	0.80	was	minimally	acceptable	
(Loiselle,	2007).		
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To	ensure	this	survey	had	internal	consistency,	a	pilot	test	was	conducted	
with	10	patients	who	were	admitted	to	female	and	male	surgical	wards	at	the	survey	
hospital	before	the	actual	study	was	implemented.	The	coefficient	alpha	was	used	to	
test	internal	consistency.	A	higher	coefficient	alpha	represents	higher	internal	
consistency	reliability	(Waltz,	Strickland	&	Lenz	2010).	A	value	of	0.7	or	greater	of	the	
coefficient	alpha	is	acceptable	as	a	minimum	(Houser,	2012).	The	coefficient	alpha	of	
this	survey	was	0.91.	
	 3.5.4	Data	collection	procedure	
The	paper-based	copy	of	the	survey	was	distributed	to	patients	who	met	the	
study	inclusion	criteria.	Patients	were	approached	to	participate	by	the	researcher	
(NS)	who	introduced	herself	and	the	purpose	of	the	study.	The	survey	included	a	
covering	letter	explaining	how	to	complete	the	survey	while	maintaining	anonymity.	
The	comprehensive	Participant	Information	Form	was	given	to	participants	to	keep	
and	they	were	informed	that	consent	would	be	implied	by	completing	the	survey.	
Patients	were	asked	to	complete	the	questionnaires	themselves.	When	collecting	
the	completed	surveys	from	patients,	the	researcher	reviewed	patients’	responses	
and	clarified	any	missing	responses	to	questions	to	minimise	missing	data.	The	time	
taken	for	patients	to	complete	the	survey	was	approximately	15	minutes.	The	
researcher	was	available	for	patients	to	address	any	difficulties	or	questions	arising	
from	the	survey	tool	or	process.	
	 3.5.5	Data	analysis		
All	entered	data	were	cleaned	and	checked	for	errors	prior	to	starting	data	
analysis.	The	completed	questionnaires	were	analysed	using	the	Statistical	Package	
for	Social	Science	(SPSS)	version	22.0	for	Windows®	(IBM	Inc.,	Chicago,	IL,	USA).	
Descriptive	statistics	(frequencies,	percentages,	means	and	standard	deviation)	were	
used	to	summarise	participants’	demographic	characteristics	such	as	education,	
gender,	age,	antimicrobial	use	behaviors,	attitudes	and	beliefs	in	antimicrobial	use	of	
patients.		
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3.6	Phase	4:	Nurses'	role	in	AMS		
Phase	4	addressed	the	fourth	aim	of	this	research,	to	explore	how	key	
organisational	leaders	and	senior	clinicians,	and	nurses	perceive	potential	future	
roles	for	nurses	in	AMS	in	Thailand	within	the	current	governance,	educational	and	
practice	context.		
The	specific	objectives	of	this	phase	were	to:	
i. Describe	the	current	roles	of	nurses	in	AMS?	
ii. Identify	perceived	barriers	and	facilitators	to	nurses	taking	a	broader	role	
in	AMS?	
iii. Describe	the	potential	future	roles	of	nurses	in	AMS?	
	 3.6.1	Design	
The	design	of	this	fourth	phase	was	qualitative	using	focus	group	interviews	
with	two	groups	of	nurses:	infection	control	nurses	and	clinical	ward	nurses.	Nurses	
are	the	largest	group	of	healthcare	professionals	and	are	the	only	healthcare	
professionals	with	patients	24	hours	a	day	in	acute	care	environments	(Mensik,	
2014).	They	are	in	a	unique	position	to	educate	patients	and	family	regarding	use	of	
antimicrobial	medicines,	ensure	safe	administration	of	antimicrobial	medicines,	
monitor	the	effectiveness	of	antimicrobial	medicines,	identify	unnecessary	
antimicrobial	medicines	and	contribute	to	multidisciplinary	plans	of	care	(Edwards	et	
al.,	2011c;	Galvin	&	Fennell,	2012;	Gillespie	et	al.,	2013b;	Ladenheim	et	al.,	2013b;	
Lim,	2010;	Storr,	2012).	A	multidisciplinary	approach	is	considered	best	practice	in	
AMS	(Lin	et	al.,	2013b),	however	not	all	AMS	programs	include	nurses	(Edwards	et	
al.,	2011c).	Despite	the	important	role	that	nurses	play	in	AMS,	little	is	known	about	
nurses’	contribution	to	AMS	(Edwards	et	al.,	2011d)	in	particular	the	current	and	
potential	role	of	nurses	in	AMS	in	Thailand.		
	 3.6.2	Sample	
Two	groups	of	nurses	were	invited	to	participate	in	Phase	4	of	the	study:	
clinical	nurses	working	in	medical	and	surgical	wards	and	infection	control	nurses	
(ICNs).	The	reason	medical	and	surgical	ward	nurses	were	selected	was	because	
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most	antimicrobial	medicines	are	prescribed	in	medical	and	surgical	wards	(Lesprit	et	
al.,	2013;	Vessal,	Namazi,	Davarpanah,	&	Foroughinia,	2011).		Nurses	who	work	in	
medical	and	surgical	wards	are	more	likely	to	be	familiar	with	administration	of	
antimicrobial	medicines	and	engaging	patients	in	AMS.	Clinical	ward	nurses	were	
separated	into	junior	and	senior	nurse	focus	groups	as	a	deliberate	strategy	because	
senior	and	junior	nurses	have	different	working	experience	and	communication	skills	
(Gerrish,	Ashworth,	Lacey,	&	Bailey,	2008).	Further,	avoiding	different	hierarchical	
levels	within	a	group	enabled	participants	to	express	their	own	view	in	a	non-
threatening	environment	(Fain,	2009;	Watson,	2008).	A	senior	nurse	was	defined	as	
a	nurse	undertaking	advanced	clinical	practice	in	a	senior	management	position	
within	a	ward	(for	example	head	nurses,	the	nurse	in	charge	of	nurses	or	shift	
managers).	A	junior	nurse	was	defined	as	a	registered	nurse	undertaking	clinical	
practice	under	the	supervision	of	a	senior	nurse	(Kingston,	Evans,	Berry,	&	Smith,	
2004).	The	focus	groups	with	ICNs	were	also	conducted	separately	to	explore	the	
perceptions	and	involvement	of	nurses	who	have	a	specialist	role	in	infection	
prevention	and	control.	In	some	countries	such	as	Ireland,	ICNs	have	been	
recognised	to	be	important	members	of	the	AMS	team	and	are	involved	directly	in	
AMS	activities	(SARI,	2009).			
	 3.6.3	Focus	groups		
Focus	groups	are	a	method	of	interview	designed	for	small	groups,	that	allow	
the	collection	of	qualitative	data	in	a	particular	topic	of	interest	(Andrew	&	Halcomb,	
2009).	As	described	by	Shaha,	Wenzel,	and	Hill	(2011),	this	method	can	provide	
deeper	information	than	survey	or	individual	interview	by	encouraging	interactive	
exploration	of	issues	and	group	resolution	of	key	issues.	The	focus	group	discussions	
were	used	in	this	phase	to	explore	the	current	and	potential	roles	of	nurses	in	AMS	
and	how	nurses	interact	with	patients	in	relation	to	AMS	throughout	the	care	
trajectory	from	admission,	during	hospitalisation	and	in	preparation	for	discharge.	In	
addition,	this	approach	was	used	to	investigate	perceived	barriers	to	nurses’	
engagement	in	AMS	in	order	to	inform	future	involvement	and	the	potential	to	
enhance	patient	engagement	and	education	strategies.		
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It	is	recommended	that	focus	groups	have	at	least	six	to	eight	attendees	
(Shaha	et	al.	(2011).	In	this	study,	three	focus	groups	were	conducted	with	nurses:	
seven	nurses	participated	in	the	ICN	group,	five	nurses	participated	in	the	senior	
nurse	group	and	six	nurses	participated	in	the	junior	nurse	group.		
The	focus	group	discussions	were	guided	by	open-ended	questions	and	
prompts	to	encourage	group	discussion.	The	full	version	of	interview	guide	is	
available	in	Appendix	B.			
	 3.6.4	Data	collection	procedure		
Nurses	who	were	working	in	medical	or	surgical	wards	in	the	case	hospital	
were	invited	to	participate	in	focus	groups	though	a	face-to-face	invitation.	ICNs	
were	invited	to	participate	in	the	study	though	a	face-to-face	meeting	in	the	
infection	prevention	and	control	department.	The	researcher	invited	nurses	to	
participate.	The	three	focus	groups	were	conducted	separately;	senior	ward	nurses,	
junior	ward	nurses,	and	ICNs.	The	participants	were	asked	to	complete	written	
consent	forms	before	starting	the	focus	group.	All	focus	groups	were	conducted	by	
the	researcher	(NS)	within	the	hospital	at	a	time	that	was	convenient	for	nurses	and	
by	agreement	from	the	hospital	executive.	All	participants	were	provided	with	an	
opportunity	to	debrief	and	feedback.	The	focus	groups	were	conducted	in	
approximately	60	minutes	using	a	topic	guide.	Two	types	of	recording	methods	were	
used:	written	notes	were	taken	and	the	groups	were	audio-recorded.	
	 3.6.5	Data	analysis		
The	qualitative	data	were	analysed	using	thematic	analysis.	The	procedure	
for	the	management	of	data	was	the	same	as	that	of	Phase	2.	Audio-recordings	and	
field	notes	from	focus	group	interviews	were	transcribed	in	Thai	by	the	researcher	
(NS)	who	conducted	the	focus	groups.	The	accuracy	of	the	Thai	transcripts	was	
checked	against	the	recordings	by	the	researcher	(NS).	Next,	a	professional	
translator	translated	the	Thai	transcripts	into	English.	After	that,	the	researcher	(NS)	
reviewed	the	accuracy	and	consistency	of	the	English	and	Thai	transcripts,	especially	
the	clinical	terms.	Then,	a	Thai	nursing	educator	who	holds	a	PhD	in	Nursing	(written	
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in	English)	verified	the	consistency	of	the	English	and	Thai	transcripts.	The	data	
analysis	was	conducted	using	the	English	transcripts.		
Again	as	in	Phase	2,	to	ensure	the	rigour	of	data	analysis	peer	debriefing	with	
supervisors	occurred	throughout	all	stages	of	the	data	analysis	including	the	
generation	of	the	coding	frame	and	identification	of	major	themes	and	sub	themes.	
Representative	quotations	from	the	transcribed	text	used	in	relation	to	major	
themes	and	subthemes	were	also	confirmed.	The	analytical	process	is	auditable	in	
the	raw	data	and	coding	documents.	Data	analysis	was	conducted	using	the	steps	
outlined	in	Section	3.4.5.		
3.7	Methodological	triangulation	
The	four	phases	of	research	were	conducted	as	described	in	Sections	3.3,	3.4,	
3.5	and	3.6.	However,	for	the	purpose	of	addressing	the	full	aims	and	objectives	of	
the	research,	the	data	derived	from	the	clinician	and	patient	surveys	were	
triangulated	with	data	derived	from	interviews	and	focus	groups	in	the	final	
analyses.	The	process	was	a	sequential	analysis	where	the	qualitative	and	
quantitative	data	were	analysed	separately	and	then,	to	address	the	aims	of	the	
research,	both	the	qualitative	and	quantitative	analysis	findings	were	combined	to	
better	understand	the	data	and	provide	a	context	for	responses	to	the	clinician	and	
patient	surveys.	
3.8	Ethical	considerations	
The	full	protocol	for	the	four	phases	of	the	research	was	submitted	for	
approval	to	the	Human	Research	Ethics	Committee	at	Deakin	University	(HREC)	and	
the	Institutional	Review	Board	(IRB)	of	the	study	hospital.	Data	collection	did	not	
commence	until	ethical	approval	was	obtained.	The	ethical	issues	of	relevance	to	
this	research	are	discussed	below.	
	 3.8.1	Informed	consent	
Participation	in	this	study	was	voluntary.	In	Phase	2	and	Phase	4,	potential	
participants	received	a	face-to-face	invitation	to	participate	where	they	could	ask	
questions	and	clarify	expectations.	The	focus	group	and	organisational	leaders	were	
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informed	in	writing	of	the	purpose	of	the	study,	the	possible	risks	and	benefits	of	
participation	and	how	the	research	data	were	to	be	maintained,	used	and	
disseminated.	Potential	participants,	who	did	not	wish	to	take	part	of	the	study	or	
changed	their	mind	after	signing	consent,	were	free	to	withdraw	from	the	study	
without	effect	on	their	relationship	with	colleagues,	the	researcher	or	the	
institutions	involved.	Those	who	agreed	to	participate	in	these	phases	were	invited	
to	complete	written	consent	forms	before	commencing	the	interview	or	focus	
groups.	Potential	participants	were	informed	that	if	they	changed	their	mind	about	
participation	they	could	withdraw	their	data	until	the	time	when	the	data	were	
analysed,	after	which	it	would	not	be	possible	to	withdraw	data.	
In	Phases	1	and	3,	all	eligible	patients	and	clinicians	were	provided	with	a	
copy	of	the	approved	Patient	Information	Form.	In	the	information	forms,	potential	
participants	were	informed	about	the	nature,	scope	and	consequences	of	the	study.	
Consent	to	participate	was	implied	by	completing	the	survey	instruments.	All	
participants	were	given	a	copy	of	the	Patient	Information	Form	to	keep	so	that	they	
could	refer	back	to	the	details	of	their	participation.	Completion	of	the	surveys	was	
anonymous,	participants	were	not	be	able	to	withdraw	data	once	the	surveys	were	
submitted.	
	 3.8.2	Anonymity,	Privacy	and	Confidentiality	
All	participants	at	each	phase	of	the	research	were	assured	that	any	
information	provided	by	them	would	not	be	reported	publically	in	a	way	that	could	
identify	them.	However,	given	the	nature	of	the	case	study	research,	full	anonymity	
could	not	be	assured	for	participants	in	the	organisational	leaders	in	Phase	2	and	this	
was	disclosed	at	the	outset.	Data	from	the	survey	questionnaires	were	not	
identifiable.	Data	from	focus	groups	and	interviews	were	transcribed	verbatim,	
identifiers	permanently	removed	and	a	study	identification	code	allocated	to	each	
participant’s	data.	The	information	obtained	in	connection	with	the	research	project	
was	kept	confidential	and	were	only	used	for	the	purpose	of	the	research	project.	
Page	82	
	
 
In	Phase	4,	focus	group	participants	were	informed	that	in	focus	groups	data	
collection	is	not	anonymous	by	the	nature	of	a	group	interview,	nor	can	
confidentiality	of	the	discussion	be	assured.	At	the	beginning	of	each	focus	group,	
participants	were	reminded	to	respect	the	confidentiality	of	the	discussion	and	not	
to	discuss	the	group	discussion	outside	of	the	group.	Participants	in	focus	groups	
could	not	be	identified	by	stored	or	reported	characteristics	or	findings.	
	 3.8.3	Data	management	and	storage	
All	of	the	participant	data	were	maintained	confidentially	throughout	the	
study.	Paper-based	questionnaire	data	were	entered	into	the	statistics	software	then	
stored	in	a	locked	cabinet	in	a	locked	research	office	during	data	collection	and	then	
archived	within	the	School	of	Nursing	and	Midwifery,	Deakin	University,	Australia.	
The	audiotapes	of	individual	interviews	and	focus	groups	were	transcribed	in	full.	
Digital	interview	data	were	kept	on	a	password-protected	computer.	Only	the	
researcher	and	principal	supervisors	could	assess	the	records.	The	original	surveys	
and	audiotapes	were	to	be	retained	in	a	secure	location	at	Deakin	University	for	a	
minimum	of	seven	years	from	the	date	of	publication	of	findings.	After	that	time,	all	
electronic	data	will	be	deleted.	These	include	audiotape	recordings,	transcripts,	SPSS	
data	files,	other	descriptive	data,	graphs,	and	spread	sheets.	Hard	copy	paper	data	
will	be	shredded	using	a	secure	disposal	service.	
The	research	findings	are	presented	in	the	next	four	chapters	in	alignment	
with	the	four	aims	of	the	research.	
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Chapter	4		
Perceptions	and	Attitudes	Towards	Antimicrobial	Stewardship	Among	
Clinicians	
	
In	this	chapter,	the	analyses	of	the	clinician	survey,	interview	and	focus	group	
data	related	to	perceptions	and	attitudes	towards	AMS	are	presented	in	two	major	
sections.	In	the	first	section,	the	results	of	the	clinician	survey	are	presented.	In	the	
second	section,	the	results	of	the	organisational	leader	interviews	and	nurse	focus	
groups	are	described.	This	is	followed	by	a	discussion	of	the	findings.		
Aim	and	objectives		
	 The	first	specific	aim	of	this	research	program	was	to	explore	the	perceptions	
and	attitudes	toward	AMS	among	clinicians	in	acute	healthcare	in	Thailand.	The	specific	
objectives	were	to:	
1. Describe	perceptions	and	attitudes	of	doctors,	nurses	and	pharmacists	
towards	AMS	using	a	clinician	survey.	
2. Explore	perceptions	and	attitudes	of	organisational	leaders,	infection	control	
nurses	and	clinical	nurses	regarding	antimicrobial	resistance	using	semi-
structured	interviews	and	focus	groups.	
3. Explore	differences	in	the	perceptions	and	attitudes	of	clinicians	from	
different	disciplines	towards	AMS.		
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4.1	Clinician	survey	results		
In	this	section,	the	results	of	the	clinician	survey	regarding	perceptions	and	
attitudes	towards	AMS	of	doctors,	nurses	and	pharmacists	are	presented.	The	aim	of	
the	clinician	survey	was	to	describe	the	attitudes	and	perceptions	of	doctors,	nurses	and	
pharmacists	towards	AMS	and	explore	differences	among	clinicians	in	acute	health	care	
in	Thailand.	The	results	are	presented	in	two	sections:	the	description	of	participant	
characteristics;	and	the	survey	findings.			
	 4.1.1	Participant	characteristics	
	 There	were	a	total	of	1,087	participants:	392	(36.1%)	were	doctors,	613	(56.4%)	
were	nurses	and	82	(7.5%)	were	pharmacists	(Table	4.1).	A	total	of	1,753	surveys	were	
distributed	and	the	overall	response	rate	was	62%	(1,087/1,753).	The	specific	response	
rates	per	group	were	41.4%	(392/948)	among	doctors	and	86.3%	among	nurses	
(613/710)	and	pharmacists	(82/95).		
Table	4.1	Response	rate	of	participants	according	to	discipline	(n=1,087)	
Professions	 n	 N	(Total)	 %	(Total)	
Doctors	
Resident	 192	 	
392	 36.1	Fellow	 		64	
Staff	 136	
Nurses	
Ward	nurse	 602	 	
613	
	
56.4	Advanced	Practice	Nurse	 		11	
Pharmacist	
Pharmacist	 78	 	
82	 7.5	
Advanced	Practice	Pharmacist	 4	
Total	 1,087	 100	
	 	
	 Overall,	80.9%	(n=879)	of	participants	were	female.	Females	comprised	52.6%	
(n=	206)	of	doctors	97.7%	(n=599)	of	nurses	and	90.2%	(n=74)	of	pharmacists.	Table	4.2	
shows	that	participants	were	most	commonly	working	in	the	areas	of	surgery	(20.8%),	
paediatrics	(18%)	and	medicine	(17.6%).	Almost	half	the	participants	(42.3%)	had	1-5	
years	of	clinical	experience	(n=460).		
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Table	4.2	Participant’s	employment	characteristics	
Demographic	data	
All	
participants	
(N=1087)	
Doctors	
(N=392)	
Nurses	
(N=613)		
Pharmacists	
(N=82)		
				n	(%)	 										n	(%)	 											n	(%)	 											n	(%)	
Hospital	departments	
Surgery	 226	(20.8)	 76	(19.4)	 150	(24.5)	 −	
Paediatrics	 196	(18.0)	 51	(13.0)	 145	(23.7)	 −	
Medicine	 191	(17.6)	 115	(29.3)	 76	(12.4)	 −	
Operating	room	nurses	 86	(7.9)	 −	 86	(14.0)	 −	
Pharmacy	department	 82	(7.5)	 −	 −	 82	(100)	
Obstetrics	and	gynaecology	 61	(5.6)	 28	(7.1)	 33	(5.4)	 −	
Orthopaedics	 60	(5.5)	 24	(6.1)	 36	(5.9)	 −	
Ophthalmology	 51	(4.7)	 24	(6.1)	 27	(4.4)	 −	
Emergency	medicine	 49	(4.5)	 22	(5.6)	 27	(4.4)	 −	
Community	health	nurses	 33	(3.0)	 −	 33	(5.4)	 −	
Family	medicine	 28	(2.6)	 28	(7.1)	 −	 −	
Anaesthesiology	 24	(2.2)	 24	(6.1)	 −	 −	
Years	of	experience	since	qualification	
<	1	year	 94	(8.6)	 2	(0.5)	 76	(12.4)	 16	(19.5)	
1	to	5	years	 460	(42.3)	 171	(43.6)	 252	(41.1)	 37	(45.1)	
6	to	10	years	 247	(22.7)	 122	(31.1)	 107	(17.5)	 18	(22)	
11	to	20	years	 204	(18.8)	 61	(15.6)	 135	(22)	 8	(9.8)	
>	20	years	 82	(7.5)	 36	(9.2)	 43	(7)	 3	(3.7)	
Age	
Median	 29	 31	 28	 29	
IQR	 26-35	 28-37	 24-35	 26-34	
	
	 The	median	age	was	29	years	(IQR=	26-35	years).	The	youngest	participant	was	
22	years	of	age	and	the	oldest	was	70	years	of	age.	As	shown	in	Figure	4.1	most	
participants	were	aged	between	22	and	35	years	(76.4%,	n	=	830).	
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																																																															Years	of	age		
Figure	4.1	Distribution	of	participants’	age		
	 	
	 The	study	findings	will	be	presented	as	per	the	following	sections	of	the	survey:	
i)	perceptions	about	AMR;	ii)	participants’	perceptions	of	AMS	programs;	iii)	previous	
involvement	and	experience	with	AMR	and	AMS;	iv)	estimation	of	inappropriate	
antibiotic	orders	and	surgical	prophylaxis;	v)	frequent	problems	associated	with	surgical	
prophylaxis;	vi)	clinicians’	knowledge	about	appropriate	antibiotic	prescribing	and	vii)	
patient	groups	at	greatest	and	lowest	risk	of	inappropriate	antibiotic	prescriptions.			
	 Participants’	rated	their	responses	on	a	Likert	Scale	(1	=	not	a	problem	and	7	=	
very	serious	problem	or	1=	does	not	contribute	and	7=	Strongly	contributes).	As	the	
survey	data	were	not	normally	distributed,	the	median	score	and	quartiles	1	and	3	(Q1-
Q3)	are	presented	as	indicators	of	interquartile	range	for	each	survey	item.	Comparisons	
between	professional	groups	(doctors,	nurses	and	pharmacists)	were	made	using	
Kruskal	Wallis	test.	The	proportion	of	responses	that	were	rated	as	6	or	7	(agreed)	
versus	1	to	5	(disagreed	or	neutral)	were	also	calculated	for	each	survey	item	and	the	
professional	groups	were	compared	using	ANOVA	and	post	hoc	tests.	Likert	scale	data	is	
ordinal	therefore	non-parametric	tests	(median,	Q1,	Q3,	and	Kruskal	Wallis	test)	were	
used	in	the	first	instance.	The	decision	to	use	ANOVA	and	post	hoc	tests	for	further	
analysis	was	based	on	the	premise	by	Norman	(2010)	who	asserted	that		ANOVA	is	
highly	robust	to	issues	such	as	skewness	and	non-normality	(Norman,	2010).	For	survey	
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items	that	were	categorical	in	nature,	the	participants’	responses	are	presented	as	
frequencies	and	comparisons	were	made	using	Chi	Square	test.		
	 4.1.2	Perceptions	about	antimicrobial	resistance		
	 Participants’	perceptions	in	relation	to	antimicrobial	resistance	(AMR)	are	
presented	in	Table	4.3.	Overall,	participants	considered	that	AMR	was	a	serious	problem	
worldwide,	in	Thai	Hospitals	and	at	the	study	hospital	as	indicated	by	the	median	rank	
of	7.0.	AMR	in	the	Thai	community	was	considered	less	important	as	indicated	by	
median	rank	of	6.0.	Doctors	(median	=	7.0)	were	more	likely	than	nurses	and	
pharmacists	to	agree	that	AMR	was	a	serious	problem	worldwide,	in	Thai	hospitals,	and	
at	the	study	hospital	(median	=	6.0)	(p<0.001).	Nurses	however	were	less	likely	to	agree	
(median	=	5.0)	than	doctors	and	pharmacists	(median	=	6.0)	that	AMR	was	a	serious	
problem	in	the	Thai	community.	Most	respondents	believed	that	antimicrobial	use	in	
Thai	Hospitals	contributed	to	AMR	(median=6.0).	One	contributing	factor	was	that	
patients	were	able	to	buy	antibiotics	over	the	counter.	This	was	indicated	by	median	
rank	of	6.0	for	all	professions.	Antimicrobial	use	in	Thai	animal	or	agriculture	sectors,	
the	Thai	community	and	patient	pressure	to	receive	antibiotics	as	part	of	their	
treatment	were	viewed	less	likely	contribute	to	AMR	as	indicated	by	median	rank	of	5.0	
(Table	4.3).	Nurses	were	less	likely	to	agree	than	doctors	and	pharmacists	that	
antimicrobial	use	in	Thai	animal	or	agriculture	sectors	(median	5.0	versus	6.0,	p<0.001)	
and	in	the	Thai	community	(median	4.0	versus	5.0,	p<0.001)	contributed	to	AMR	at	the	
study	hospital.	Doctors	were	more	likely	to	agree	(median	=	6.0)	than	nurses	and	
pharmacists	(median	=	5.0)	that	antimicrobial	use	at	the	study	hospital	contributed	to	
its	own	AMR.	Nurses	were	less	likely	to	agree	(median	=	5.0)	than	doctors	and	
pharmacists	(median	=	6.0)	that	patient	pressure	for	antibiotics	as	part	of	treatment	
contributed	to	AMR	at	the	study	hospital	(p<0.001).	
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Table	4.3	Responses	by	profession	to	survey	items	related	to	antimicrobial	resistance	
Questions	
All	participants	
(N=1087)	
Doctors		
(N=392)	
Nurses		
(N=613)	
Pharmacists		
(N=82)	 X2	 df	 p*		Median	
Q1-Q3	
Indicate	how	serious	a	problem	you	believe	antimicrobial	resistance	is	in	the	following	places:	
	
Q1:	World-wide	
	
7.0	
5.0-7.0	
	
7.0	
6.0-7.0	
	
6.0	
5.0-7.0	
	
6.0	
6.0-7.0	
	
61.53	
	
2	
	
<	0.001	
	
Q2:	Thai	Community	
	
	
6.0	
4.0-7.0	
	
6.0	
5.0-7.0	
	
5.0	
4.0-6.0	
	
6.0	
5.0-7.0	
	
62.74	
	
2	
	
<	0.001	
	
Q3:	Thai	Hospitals	
	
	
7.0	
6.0-7.0	
	
7.0	
6.0-7.0	
	
6.0	
5.0-7.0	
	
6.0	
6.0-7.0	
	
18.96	
	
2	
	
<	0.001	
	
Q4:	The	study	hospital		
									
	
7.0	
6.0-7.0	
	
7.0	
6.0-7.0	
	
6.0	
6.0-7.0	
	
6.0	
5.0-7.0	
	
38.34	
	
2	
	
<	0.001	
														
Likert	scale:	1	=	Not	a	problem	and	7	=	Very	serious	problem	
Indicate	how	strongly	you	believe	the	following	contribute	to	antimicrobial	resistance	at		the	study	hospital:	
	
Q5:	Antimicrobial	use	in	
Thai	animal	/	agricultural	
sectors		
	
5.0	
4.0-5.0	
	
5.0	
4.0-6.0	
	
4.0	
3.0-5.0	
	
5.0	
4.0-6.0	
	
51.37	
	
2	
	
<	0.001	
	
Q6:	Antimicrobial	use	in	
Thai	community	
	
5.0	
4.0-6.0	
	
6.0	
5.0-7.0	
	
5.0	
4.0-6.0	
	
6.0	
5.0-6.0	
	
123.18	
	
2	
	
<	0.001	
	
Q7:	Antimicrobial	use	in	
Thai	Hospitals	
	
6.0	
5.0-7.0	
	
6.0	
6.0-7.0	
	
6.0	
5.0-7.0	
	
6.0	
5.0-6.0	
	
85.01	
	
2	
	
<	0.001	
	
Q8:	Antimicrobial	use	at	the	
study	hospital	
	
6.0	
5.0-7.0	
	
6.0	
5.0-7.0	
	
5.0	
4.0-6.0	
	
5.0	
5.0-6.0	
	
52.48	
	
2	
	
<	0.001	
	
Q9:	Patient	pressure	for	
antibiotics	as	part	of	
treatment	
	
5.0	
4.0-6.0	
	
6.0	
5.0-7.0	
	
5.0	
3.0-6.0	
	
6.0	
5.0-6.0	
	
80.77	
	
2	
	
<	0.001	
	
Q10:	Patients	are	able	to	
buy	antibiotics	over	the	
counter	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-6.0	 25.72	 2	 <	0.001	
Likert	scale:	1	=	Does	not	contribute	and	7	=	Strongly	contributes	
*	Kruskal-Wallis	Test		
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	 To	enable	further	analysis	of	differences	between	professions,	the	proportion	
of	responses	related	to	the	seriousness	of	AMR	that	were	rated	as	6	or	7	(agreed)	
were	compared	with	responses	rated	as	1	to	5	(disagreed	or	neutral)	by	profession.	
Participants’	responses,	by	profession,	to	statements	about	the	seriousness	of	AMR	
along	with	the	results	of	ANOVA	and	post	hoc	tests	are	shown	in	Figures	4.2-	4.5.	
There	were	significant	between	group	differences	in	perceptions	of	the	seriousness	
of	AMR.	Nurses	were	significantly	less	likely	than	doctors	to	agree	that	AMR	is	a	
worldwide	problem	(64.4%	vs.	85.2%,	p<0.001)	(Figure	4.2)	or	that	AMR	is	a	problem	
in	Thai	hospitals	(74.2%	vs.	85.5%,	p<0.001)	(Figure	4.4)	but	there	were	no	
differences	between	nurses	and	pharmacists	for	either	of	these	survey	items.	Nurses	
were	also	less	likely	than	both	doctors	(41.6%	vs.	60.5%,	p<0.001)	and	pharmacists	
(41.6%	vs.	69.5%,	p<0.001)	to	perceive	AMR	as	a	problem	in	the	Thai	community	
(Figure	4.3).	Doctors	were	more	likely	than	nurses	(86.7%	vs.	75.2%,	p<0.001)	and	
pharmacists	(86.7%	vs.	72.0,	p=0.001)	to	agree	that	AMR	was	a	problem	at	the	study	
hospital	(Figure	4.4).		
	
	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 68.210	 2	 34.105	 28.916	 <	0.001	
Within	
groups	 1278.501	 1084	 1.179	 	 	
Total	 1346.710	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 0.052	
• Nurse	vs.	Pharmacist	 0.180	
Figure	4.2	Q1:	AMR	as	worldwide	problem	
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	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 166.262	 2	 83.131	 37.046	 <	0.001	
Within	
groups	 2432.452	 1084	 2.244	 	 	
Total	 2598.714	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 0.296	
• Nurse	vs.	Pharmacist	 <	0.001	
Figure	4.3	Q2:	AMR	as	problem	in	Thai	community	
	
	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	
	
31.798	 2	 15.899	 15.949	
	
<	0.001	
Within	
groups	
	
1080.598	 1084	 .997	 	
	
Total		 1112.396	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 		<	0.001	
• Doctor	vs.	Pharmacist	 0.001	
• Nurse	vs.	Pharmacist	 0.720	
Figure	4.5	Q4:	AMR	as	problem	at	the	study	hospital	
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	 ANOVA	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 20.080	 2	 10.040	 10.134	 <	0.001	
Within	
groups	 1073.882	 1084	 .991	 	 	
Total		 1093.961	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 0.321	
• Nurse	vs.	Pharmacist	 0.583	
	
Figure	4.4	Q3:	AMR	as	problem	in	Thai	Hospitals	
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The	proportion	of	responses	rated	as	6	or	7	(agreed)	to	statements	about	the	
factors	that	may	contribute	to	AMR	at	the	study	hospital	were	compared	to	those	
rated	1	to	5	(disagreed	or	neutral)	by	profession.	Participants’	responses,	by	
profession,	to	statements	about	contributing	factors	to	AMR	along	with	the	results	
of	ANOVA	analyses	and	post	hoc	tests	are	shown	in	Figures	4.6	-	4.11.	Nurses	were	
significantly	less	likely	than	doctors	or	pharmacists	to	agree	that	AMR	at	the	study	
hospital	was	influenced	by	Thai	animal	or	agricultural	sectors	(17.5%	vs.	33.9%	
p<0.001	and	17.5%	vs.	30.5%,	p<0.001)	(Figure	4.6),	the	Thai	community	(29.7%	vs.	
60.5%	p<0.001	and	29.7%	vs.	59.8%,	p<0.001)	(Figure	4.7),	other	Thai	hospitals	
(52.4%	vs.	78.1%	p<0.001	and	52.4%	vs.	74.4%,	p=0.003)	(Figure	4.8)	and	patient	
pressure	to	receive	antibiotics	as	part	of	their	treatment	(29.5%	vs.	53.3%	p<0.001	
and	29.5%	vs.	53.7%,	p<0.001)	(Figure	4.10).	There	were	no	significant	differences	
between	doctors	and	pharmacists	for	these	survey	items.	Doctors	were	more	likely	
than	nurses	(67.9%	vs.	46.5%,	p<0.001)	and	pharmacists	(67.9%	vs	46.3%,	p=0.002)	
to	agree	that	the	study	hospital	contributes	to	its	own	AMR	problems	(74.0%	vs.	
58.1%,	p<0.001)	(Figure	4.9)	or	that	AMR	at	the	study	hospital	was	influenced	by	
patients	being	able	to	buy	antibiotics	over	the	counter	and	without	prescription	
(74.0%	vs.	62.2%	p=0.030)	(Figure	4.11).	There	were	no	significant	differences	
between	nurses	and	pharmacists	in	their	perceptions	that	the	study	hospital	
contributes	to	its	own	AMR	problems	or	that	patients	purchasing	antibiotics	over	the	
counter	and	without	prescription	influences	AMR	at	the	study	hospital.		
	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 119.423	 2	 59.711	 26.180	 <	0.001	
Within	
groups	 2472.423	 1084	 2.281	 	 	
Total	 2591.845	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 0.557	
• Nurse	vs.	Pharmacist	 <	0.001	
Figure	4.6	Q5:	Thai	animal/agricultural	sectors	contribute	to	AMR	at	the	study	hospital	
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	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 264.795	 2	 132.397	 66.319	 <	0.001	
Within	
groups	 2164.075	 1084	 1.996	 	 	
Total	 2428.870	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 			0.865	
• Nurse	vs.	Pharmacist	 <	0.001	
Figure	4.7	Q6:	Thai	community	contribute	to	AMR	at	the	study	hospital	
	
	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 127.993	 2	 63.996	 46.657	 <	0.001	
Within	
groups	 1486.857	 1084	 1.372	 	 	
Total		 1614.850	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 0.131	
• Nurse	vs.	Pharmacist	 0.003	
Figure	4.8	Q7:	Other	Thai	Hospitals	contribute	to	AMR	at	the	study	hospital	
	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 90.898	 2	 45.449	 27.665	 <	0.001	
Within	
groups	 1780.850	 1084	 1.643	 	 	
Total		 1871.748	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 0.002	
• Nurse	vs.	Pharmacist	 0.852	
Figure	4.9	Q8:	the	study	hospital	contributes	to	own	AMR	problems	
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	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 203.984	 2	 101.992	 42.799	 <	0.001	
Within	
groups	 2583.212	 1084	 2.383	 	 	
Total		 2787.196	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 0.997	
• Nurse	vs.	Pharmacist	 <	0.001	
Figure	4.10	Q9:	Patient	pressure	contributes	to	AMR	at	the	study	hospital	
	
	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 49.999	 2	 25.000	 13.992	 <	0.001	
Within	
groups	 1936.755	 1084	 1.787	 	 	
Total		 1986.754	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 0.030	
• Nurse	vs.	Pharmacist	 0.968	
Figure	4.11	Q10:	Patients	are	able	to	buy	over	the	counter	antibiotics	contribute	to	AMR	at	the	
study	hospital	
	 4.1.3	Participants’	responses	to	antimicrobial	stewardship	programs	
Participants’	attitudes	towards	antimicrobial	stewardship	(AMS)	programs	
are	presented	in	Table	4.4.	Participants’	rated	their	responses	on	a	Likert	Scale	(1	=	
strongly	disagree	and	7	=	strongly	disagree).		The	majority	of	participants	from	all	
professions	agreed	AMR	would	be	reduced	by	improving	antimicrobial	prescribing	
and	that	improved	antimicrobial	prescribing	should	be	a	hospital	priority	supported	
by	a	formal	policy:	each	of	these	three	survey	items	had	a	median	rank	of	6.0	for	all	
professions.	All	participants	perceived	that	local	antimicrobial	guidelines	and	
protocols,	and	a	computer	application	to	guide	selection	and	duration	of	
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antimicrobial	therapy	would	be	clinically	useful	as	indicated	by	median	rank	of	6.0	
for	all	professional	groups.	However,	doctors	(median	=	5.0)	were	less	likely	than	
nurses	and	pharmacists	(median	score	=	6.0)	to	agree	with	a	policy	that	limits	the	
antimicrobial	prescribing	(p	<	0.001).	Doctors	also	were	less	likely	to	be	interested	in	
participating	in	AMS	education	and	training	(median=5.0)	than	nurses	and	
pharmacists	(median	score	=	6.0)	(p	<	0.001).	Pharmacists	were	more	likely	to	agree	
(median	=	7.0)	that	a	team	consisting	of	an	ID	specialist	physician	and	pharmacist	to	
individualised	antimicrobial	prescribing	advice	and	feedback	would	assist	with	
antimicrobial	selection	than	doctors	and	nurses	(median	=	6.0)	(p	<0.001).	
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Table	4.4	Participants’	attitudes	towards	antimicrobial	stewardship	programs	by	
profession		
Questions	
All	
participants	
(N=1087)	
Doctors		
(N=392)	
Nurses	
(N=613)	
Pharmacists		
(N=82)	 X2	 df	 p*	
Median	
	IQR	
	
Q17:	Improving	antimicrobial	
prescribing	at	the	study	hospital	will	
help	decrease	AMR.		
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-6.25	 9.79	 2	 0.008	
	
Q18:	Improving	antimicrobial	
prescribing	should	be	an	organisational	
priority.	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-6.0	 1.17	 2	 0.558	
	
Q19:	A	formal	policy	for	the	use	of	
antimicrobials	should	be	introduced	at	
the	study	hospital.	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	 1.38	 2	 0.501	
	
Q20:	A	policy	that	limits	the	
prescribing	of	selected	antimicrobials	
to	certain	clinical	indications	via	an	
approval	process	should	be	introduced	
at	the	study	hospital.		
6.0	
5.0-7.0	
5.0	
4.0-6.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	 33.73	 2	 <	0.001	
	
Q21:	Local	antimicrobial	guidelines	and	
protocols	should	be	introduced	at	the	
study	hospital.	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	 3.10	 2	 0.212	
	
Q22:	A	computer	application	which	
gives	advice	on	selection	and	duration	
of	antimicrobial	therapy	for	specific	
clinical	conditions	would	be	clinically	
useful.		
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
6.0-7.0	 13.38	 2	 0.001	
	
Q23:	A	team	consisting	of	an	ID	
specialist	physician	and	Pharmacist	
providing	individualized	antimicrobial	
prescribing	advice	and	feedback	would	
assist	with	antimicrobial	selection.		
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
7.0	
6.0-7.0	 18.05	 2	 <	0.001	
	
Q27:	I	would	be	interested	in	
participating	in	education	session	
about	AMS.	
6.0	
5.0-7.0	
5.0	
4.0-6.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	 22.45	 2	 <	0.001	
	
Q28:	I	would	be	willing	to	participate	
in	any	activities	to	improve	the	quality	
of	antimicrobial	use	at	the	study	
hospital.	
	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
5.0-7.0	
6.0	
6.0-7.0	 16.08	 2	 <	0.001	
*	Kruskal-Wallis	Test
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	 Participants’	responses,	by	profession,	to	statements	about	attitudes	towards	
antimicrobial	stewardship	programs	along	with	the	results	of	ANOVA	and	post	hoc	
tests	are	shown	in	Figures	4.12	-	4.18.		
	 There	were	no	significant	between	group	differences	in	statements	that	
improving	antimicrobial	prescribing	should	be	an	organisational	priority	(p=0.376),	a	
formal	policy	for	the	use	of	antimicrobials	should	be	introduced	at	the	study	hospital	
(p=0.395),	local	antimicrobial	guidelines	and	protocols	should	be	introduced	at	the	
study	hospital	(p=0.358)	(Figures	4.13,	4.14	and	4.16).	For	each	of	these	three	survey	
items,	the	proportion	of	responses	rated	as	6	or	7	(agreed)	ranged	from	55.0%	
to73.0%.	Nurses	were	significantly	less	likely	than	doctors	(54.8%	vs.	64.8%,	p=0.004)	
to	agree	that	improving	antimicrobial	prescribing	at	the	study	hospital	will	help	
decrease	AMR	(Figure	4.12).	Doctors	were	less	likely	than	nurses	or	pharmacists	to	
agree	that	a	policy	that	limits	the	prescribing	of	selected	antimicrobials	to	certain	
clinical	indications	via	an	approval	process	should	be	introduced	at	the	study	
hospital	(48.0%	vs.	60.0%,	p<0.001	and	48.0%	vs.	69.5%,	p<0.001)	(Figure	4.15).	
Doctors	were	also	less	likely	than	nurses	or	pharmacists	to	agree	that	a	computer	
application	to	guide	selection	and	duration	of	antimicrobial	therapy	would	be	
clinically	useful	(60.7%	vs.	64.8%,	p<0.001	and	60.7%	vs.	82.9%,	p<0.001)	(Figure	
4.17).	There	were	no	significant	differences	between	nurses	and	pharmacists	for	
these	two	survey	items.	Pharmacists	were	significant	more	likely	than	doctors	
(89.0%	vs.	71.9%,	p<0.001)	and	nurses	(89.0%	vs.	74.9%,	p=0.048)	to	agree	that	a	
team	consisting	of	an	ID	specialist	physician	and	pharmacist	providing	individualised	
antimicrobial	prescribing	advice	and	feedback	would	assist	with	antimicrobial	
selection	(Figure	4.18).	Nurses	were	also	more	likely	than	doctors	to	agree	with	this	
statement	(74.9%	vs.	71.9%,	p=0.005).	
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	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 20.448	 2	 10.224	 6.067	 .002	
Within	
groups	 1826.710	 1084	 1.685	 	 	
Total		 1847.157	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 0.004	
• Doctor	vs.	Pharmacist	 0.960	
• Nurse	vs.	Pharmacist	 0.103	
Figure	4.12	Q17:	Improving	antimicrobial	prescribing	at	the	study	hospital	will	help	decrease	AMR.	
	 	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 3.010	 2	 1.505	 .978	 .376	
Within	
groups	 1667.237	 1084	 1.538	 	 	
Total		 1670.247	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 0.477	
• Doctor	vs.	Pharmacist	 0.930	
• Nurse	vs.	Pharmacist	 0.569	
Figure	4.13	Q18:	Improving	antimicrobial	prescribing	should	be	an	organizational	priority	
	 	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 3.076	 2	 1.538	 .928	 .395	
Within	
groups	 1795.930	 1084	 1.657	 	 	
Total		 1799.006	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 0.982	
• Doctor	vs.	Pharmacist	 0.376	
• Nurse	vs.	Pharmacist	 0.406	
Figure	4.14	Q19:	A	formal	policy	for	the	use	of	antimicrobials	should	be	introduced	at	the	study	hospital	
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		 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 2.406	 2	 1.203	 1.030	 .358	
Within	
groups	 1266.562	 1084	 1.168	 	 	
Total		 1268.968	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 0.459	
• Doctor	vs.	Pharmacist	 0.927	
• Nurse	vs.	Pharmacist	 0.553	
Figure	4.16	Q21:	Local	antimicrobial	guidelines	and	protocols	should	be	introduced	at	the	study	hospital	
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	 ANOVA	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 84.876	 2	 42.438	 22.275	 <	0.001	
Within	
groups	 2065.212	 1084	 1.905	 	 	
Total		 2150.088	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 <	0.001	
• Nurse	vs.	Pharmacist	 0.838	
	
Figure	4.15	Q20:	A	policy	that	limits	the	prescribing	of	selected	antimicrobials	to	certain	clinical	indications	
via	an	approval	process	should	be	introduced	at	the	study	hospital.	
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	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 39.887	 2	 19.943	 11.871	 <	0.001	
Within	
groups	 1821.046	 1084	 1.680	 	 	
Total		 1860.933	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 <	0.001	
• Doctor	vs.	Pharmacist	 <	0.001	
• Nurse	vs.	Pharmacist	 0.143	
Figure	4.17	Q22:	A	computer	application	which	gives	advice	on	selection	and	duration	of	antimicrobial	
therapy	for	specific	clinical	conditions	would	be	clinically	useful	
	 	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 21.862	 2	 10.931	 9.857	 <	0.001	
Within	
groups	 1202.122	 1084	 1.109	 	 	
Total		 1223.983	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 0.005	
• Doctor	vs.	Pharmacist	 <	0.001	
• Nurse	vs.	Pharmacist	 0.048	
Figure	4.18	Q23:	A	team	consisting	of	an	ID	specialist	physician	and	Pharmacist	providing	individualized	
antimicrobial	prescribing	advice	and	feedback	would	assist	with	antimicrobial	selection	
The	proportion	of	responses	rated	as	6	or	7	(agreed)	versus	1	to	5	(disagreed	
or	neutral)	by	profession	to	statements	about	readiness	to	participate	in	AMS	along	
with	the	results	of	ANOVA	and	post	hoc	tests	are	presented	in	Figure	4.19	and	4.20.	
Pharmacists	were	significantly	more	likely	than	doctors	and	nurses	agree	that	they	
would	be	interested	in	participating	in	education	session	about	AMS	(72.0%	vs.	
46.9%,	p<0.001	and	72.0%	vs.	55.0%,	p=0.003)	(Figure	4.19).	Nurses	were	also	more	
likely	than	doctors	to	agree	to	this	statement	(55.0%	vs.	46.9%,	p=0.008).	
Pharmacists	were	also	more	willing	agree	to	participate	in	any	activities	to	improve	
the	quality	of	antimicrobial	use	at	the	study	hospital	than	doctors	and	nurses	(79.3%	
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vs.	51.3%,	p<0.001	and	79.3%	vs.	55.5%,	p=0.003)	(Figure	4.20).	There	were	no	
differences	between	doctors	and	nurses	for	this	survey	item.		 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 46.723	 2	 23.362	 12.408	 <	0.001	
Within	
groups	 2040.960	 1084	 1.883	 	 	
Total		 2087.684	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 0.008	
• Doctor	vs.	Pharmacist	 <	0.001	
• Nurse	vs.	Pharmacist	 0.003	
Figure	4.19	Q27:	I	would	be	interested	in	participating	in	education	session	about	AMS.	
	 	 ANOVA	
	
	
	
	
Sum	of	
Squares	 df	
Mean	
Square	 F	 Sig.	
Between	
groups	 28.732	 2	 14.366	 8.361	 <	0.001	
Within	
groups	 1862.604	 1084	 1.718	 	 	
Total		 1891.336	 1086	 	 	 	
Post	Hoc	Tests	
• Doctor	vs.	Nurse	 0.225	
• Doctor	vs.	Pharmacist	 <	0.001	
• Nurse	vs.	Pharmacist	 0.003	
Figure	4.20	Q28:	I	would	be	willing	to	participate	in	any	activities	to	improve	the	quality	of	antimicrobial	
use	at	the	study	hospital.	
	
	 4.1.4	Previous	involvement	and	experience	with	antimicrobial	resistance	and	
antimicrobial	stewardship	
	 Participants’	responses	to	questions	related	to	previous	involvement	and	
experience	with	antimicrobial	resistance	(AMR)	and	antimicrobial	stewardship	(AMS)	
are	presented	in	Table	4.5.	The	majority	of	participants	had	previously	been	involved	
in	the	care	of	patients	with	an	antibiotic	resistant	infection	(88.1%),	however	less	
pharmacists	reported	being	involved	in	the	care	of	patients	with	an	antibiotic	
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resistant	infection	than	doctors	or	nurses	(59.8%	vs.	93.1%	vs.	88.7%,	p<0.001).	The	
majority	of	participants	also	reported	that	they	had	noticed	increasing	number	of	
antimicrobial	resistance	infections	over	the	past	five	years	(82.3%).	Again	fewer	
pharmacists	reported	this	change	over	time	than	doctors	or	nurses	(68.3%	vs	85.5%	
vs	82.2%,	p=0.001).	Overall,	less	than	one	in	five	participants	(17.2%)	had	heard	of	
AMS	terminology	in	English.	A	significantly	higher	percentage	of	pharmacists	had	
heard	of	the	term	AMS	than	doctors	or	nurses	and	nurses	reported	the	lowest	level	
of	awareness	of	the	term	AMS	(48.8%	vs.	20.4%	vs.	10.2%,	p<0.001).	Less	than	half	
the	participants	(37.6%)	worked	in	healthcare	facilities	with	AMS	programs.	More	
pharmacists	reported	working	in	healthcare	facilities	with	AMS	programs	than	
doctors	or	nurses	(46.3%	vs.	39.3%	vs.	35.4%,	p<0.001).		
	
Table	4.5	Previous	involvement	and	experience	with	AMR	and	AMS	by	profession		
Questions	
All	participants	
(N=1087)		
Doctors	
(N=392)	
Nurses	
(N=613)	
Pharmacists	
(N=82)	 X2
	*
	 df	 p		
Yes	n	(%)	 Yes	n	(%)	 Yes	n	(%)	 Yes	n	(%)	
	
Q11:	Previously	involved	in	care	of	
patients	with	an	antibiotic	resistant	
infection	
958	
(88.1)	
365	
(93.1)	
554	
(88.7)	
49	
(59.8)	 79.52	 4	 <	0.001	
	
Q12:	Have	noticed	increasing	
number	of	antimicrobial	resistance	
infections	over	past	5	years	
895	
(82.3)	
335	
(85.5)	
504	
(82.2)	
56	
(68.3)	 18.58	 4	 0.001	
	
Q24:	Have	heard	of	term	AMS		
(English	term)	
187	
(17.2)	
80	
(20.4)	
67	
(10.9)	
40	
(48.8)	 99.49	 4	 <	0.001	
	
Q25:	Worked	in	healthcare	facilities	
with	AMS	programs		
409	
(37.6)	
154	
(39.3)	
217	
(35.4)	
38	
(46.3)	 42.16	 4	 <	0.001	
*	Chi	Square		
	 4.1.5	Estimation	of	inappropriate	antibiotic	orders	in	inpatient	and	surgical	
prophylaxis	in	the	study	hospital	 	
	 Participants’	responses	related	to	estimation	of	inappropriate	orders	in	
inpatient	antimicrobial	agents	and	surgical	prophylaxis	are	presented	in	Table	4.6	
and	Table	4.7.	Overall,	77.5%	of	participants	estimated	that	10	to	50%	of	inpatient	
antibiotic	orders	at	the	study	hospital	were	inappropriate	(n=843,	p<0.001)	(Table	
4.6).	Only	8.6%	of	participants	estimated	that	inappropriate	antibiotic	orders	in	
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inpatient	and	surgical	prophylaxis	in	the	study	hospital	were	less	than	10%.	However	
13.8%	of	participants	indicated	that	more	than	50%	of	inappropriate	antibiotic	
inpatient	orders.	Nearly	60%	(59.8%)	of	pharmacists	indicated	that	26-50%	of	
inpatient	antibiotic	orders	were	inappropriate.		
	
Table	4.6	Participants’	estimation	of	the	percentage	of	inpatient	antibiotic	orders	
that	are	inappropriate	at	the	study	hospital	by	profession		
Items	
All	participants	
(N=1087)		
Doctors	
	(N=392)	
Nurses	
	(N=613)	
Pharmacists		
(N=82)	 		X2*	 df	 p	
n	(%)	 n	(%)	 n	(%)	 n	(%)	
Less	than	10%		 94	(8.6)	 13	(3.3)	 80	(13.1)	 1	(1.2)	
		15.53	 2	 		<	0.001	10	to	25%		 398	(36.6)	 171	(43.6)	 209	(34.1)	 18	(22.0)	
26	to	50%		 445	(40.9)	 164	(41.8)	 232	(37.8)	 49	(59.8)	
50%	or	greater	 150	(13.8)	 44	(11.2)	 92	(15.0)	 14	(17.1)	
*	Chi	Square	
	 Overall,	72.1%	(n	=	783)	of	participants	estimated	that	inappropriate	surgical	
prophylaxis	orders	occurred	in	10%	to	50%	of	patients	(Table	4.7).	There	were	similar	
percentages	of	doctors	(42.9%)	nurses	(41.4%)	and	pharmacists	(40.2%)	that	viewed	
an	inappropriate	order	in	surgical	prophylaxis	to	be	10%-25%.	Only	9.5%	of	
participants	estimated	that	more	than	50%	of	surgical	prophylaxis	orders	were	
inappropriate.	
	
Table	4.7	Participants’	estimation	of	the	percentage	of	surgical	prophylaxis	orders	
that	are	inappropriate	at	the	study	hospital	by	profession	
Items	
All	participants	
(N=1087)		
Doctors	
	(N=392)	
Nurses	
	(N=613)	
Pharmacists		
(N=82)	 X2*	 df	 p	
n	(%)	 n	(%)	 n	(%)	 n	(%)	
Less	than	10%		 201	(18.5)	 67	(17.1)	 124	(20.2)	 10	(12.2)	
5.89	 2	 0.053	10	to	25%		 455	(41.9)	 168	(42.9)	 254	(41.4)	 33	(40.2)	
26	to	50%		 328	(30.2)	 114	(29.1)	 188	(30.7)	 26	(31.7)	
50%	or	greater	 103	(9.5)	 43	(11.0)	 47	(7.7)	 13	(15.9)	
*	Chi	Square	
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	 4.1.6	Frequent	problems	associated	with	surgical	prophylaxis	at	the	study	
hospital		
	 Participants	were	asked	to	rate	the	most	frequent	problems	associated	
surgical	prophylaxis	at	the	study	hospital	(Figure	4.21).	Inappropriate	antimicrobial	
choice	was	considered	by	53%	of	all	participants	as	the	most	frequent	issue	(n=576)	
followed	by	inappropriately	stopping	time	(30.0%,	n=326)	and	timing	of	first	dose	
(15.5%,	n=169)	(Table	4.8).	Inappropriate	stopping	time	includes	stopping	
antimicrobials	too	early	but	also	more	commonly	stopping	antimicrobials	too	late.	
Problems	with	the	time	of	first	does	can	include	the	first	dose	being	too	early	(e.g.	
on	ward	before	operation	time)	or	less	commonly	too	late.		
	
Figure	4.21	Most	frequent	problems	associated	with	surgical	prophylaxis	at	the	study	
hospital	by	profession		
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Table	4.8	Responses	by	profession	to	survey	item	related	to	most	frequent	problems	
associated	with	surgical	prophylaxis	at	the	study	hospital	
Items	
All	
participants	
(N=1087)	
Doctors	
(N=392)	
Nurses	
(N=613)	
Pharmacists	
(N=82)	 X
2*	 df	 p	
n	(%)	 n	(%)	 n	(%)	 n	(%)	
Timing	of	first	dose	 169	(15.5)	 48	(12.2)	 103(16.8)	 18	(22.0)	
9.94	 6	 0.127	
	
Inappropriate	
antimicrobial	chosen	
	
576	(53.0)	
	
225	(57.4)	
	
308	(50.2)	
	
43	(52.4)	
	
Inappropriate	
stopping	time	
	
326	(30.0)	
	
112	(28.6)	
	
194	(31.6)	
	
20	(24.4)	
	
Others	 16	(1.5)	 7	(1.8)	 8	(1.3)	 1	(1.2)	
*	Chi	Square	 	 	 	 	 	 	 	
	 4.1.7	Participants’	rating	of	their	knowledge	about	appropriate	antibiotic	
prescribing	
	 The	participants’	ratings	of	their	knowledge	about	antibiotic	prescribing	are	
shown	in	Figure	4.22.	More	than	half	of	participants	perceived	that	they	had	an	
average	knowledge	about	appropriate	antibiotic	prescribing	(63.9%,	n=695).	Only	
10.7%	(n=	116)	of	participants	reported	they	had	good	or	very	good	knowledge	
about	this	topic.	Only	4.8%	(n=29)	of	nurses	perceived	that	they	had	a	knowledge	
about	antibiotics	prescribing	(Table	4.9).		
	
	
Figure	4.22	Clinicians’	rating	of	their	knowledge	related	to	antibiotic	prescribing	
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Table	4.9	Participants’	perceptions	related	to	their	knowledge	about	antibiotic	
prescribing		
Items	
All	
participants	
(N=1087)	
Doctors	
(N=392)	
Nurses	
(N=613)	
Pharmacists	
N=82)	 X
2*	 df	 p	
n	(%)	 n	(%)	 n	(%)	 n	(%)	
Minimal	 32	(2.9)	 5	(1.3)	 25	(4.1)	 2	(2.4)	
104.314	 2	 <	0.001	
Limited	 244	(22.4)	 39	(9.9)	 191	(31.2)	 14	(17.1)	
Average	 695	(63.9)	 274	(69.9)	 368	(60.0)	 53	(64.6)	
Good	 110	(10.1)	 69	(17.6)	 28	(4.6)	 13	(15.9)	
Very	good	 6	(0.6)	 5	(1.3)	 1	(0.2)	 0	
*	Chi	Square	
	
	 4.1.8	Participant’s	perceptions	of	risk	of	inappropriate	antibiotic	
prescriptions		
	 Participants	were	asked	to	rank,	in	order,	which	patient	groups	they	thought	
were	most	at	risk	of	inappropriate	prescriptions	at	the	study	hospital	(Figure	4.23).	
The	rankings	ranged	from	1	(most	at	risk)	and	6	(least	at	risk).	Patients	with	
community-acquired	infection	were	ranked	as	the	group	with	the	highest	risk	of	
inappropriate	antimicrobial	orders	while	patients	with	immune	suppressive	
condition	were	ranked	as	lowest	risk	for	inappropriate	antimicrobial	orders	by	all	
participants	(Figure	4.23).The	Table	4.10	shows	that	pharmacists	were	more	likely	to	
report	that	inappropriate	antimicrobial	orders	were	more	common	in	surgical	
patients	(exclude	surgical	prophylaxis)	when	compared	with	doctors	and	nurses	
(ranking	order	2nd	vs.	ranking	order	4th	vs.	ranking	order4th,	p=0.001).	Doctors	were	
more	likely	to	report	that	patients	being	treated	in	the	ward	assigned	to	very	
important	persons	(VIP)	were	prescribed	inappropriate	antimicrobials	when	
compared	with	nurses	(ranking	order	2nd	vs.	ranking	order	5th,	p	<	0.001).	
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	 Note:	 1	=	Most	at	risk	of	inappropriate	prescriptions	in	the	hospital	
	 	 6	=	Least	at	risk	of	inappropriate	prescriptions	in	the	hospital	
Figure	4.23	Patient	groups	considered	at	greatest	and	lowest	risk	of	inappropriate	
antibiotic	prescriptions	by	profession		
	
Table	4.10	Participants’	raking	patient	groups	at	greatest	and	lowest	risk	of	
inappropriate	antibiotic	prescriptions	
Items	
All	participants	
(N=1087)	
Doctors		
(N=392)	
Nurses		
(N=613)	
Pharmacists	
(N=82)	 X2*	 df	 p	
Rank	 n	(%)	 Rank	 n	(%)	 Rank	 n	(%)	 Rank	 n	(%)	
Patients	with	community	
acquired	infection	 1st	
394	
(36.2)	 1st	
133	
(33.9)	 1st	
204	
(33.3)	 1st	
57	
(69.5)	 40.435	 2	 <	0.001	
	
Patients	with	immune	
suppressive	condition		
6th	 282	
(25.9)	
6th	 125	
(31.9)	
6th	 130	
(21.2)	
6th	 26	
(31.7)	
30.928	 2	 <	0.001	
	
Surgical	patients	(exclude	
surgical	prophylaxis)		
4th	 251	
(23.1)	
4th	 85	
(21.7)	
4th	 153	
(25.0)	
2nd	 27	
(32.9)	
14.911	 2	 0.001	
	
Patients	being	treatment	
in	critical	care		
6th	 248	
(22.8)	
5th	 90	
(23)	
6th	 135	
(22.0)	
6th	 30	
(36.6)	
30.692	 2	 <	0.001	
	
Patients	being	treatment	
in	general	ward	
3rd	 288	
(26.5)	
4th	 118	
(30.1)	
3rd	 159	
(25.9)	
3rd	 26	
(31.7)	
1.732	 2	 0.421	
	
Patients	being	treatment	
in	VIP	ward	
2nd	 227	
(20.9)	
2nd	 100	
(25.5)	
5th	 118	
(19.2)	
3rd	 34	
(41.5)	
18.948	 2	 <	0.001	
*	Kruskal-Wallis	Test	 	
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4.2	Findings	from	the	interviews	and	focus	groups	
	 In	this	section,	the	key	themes	emerging	from	the	organisational	leader	
(executives	and	clinical	leaders)	interviews	and	focus	groups	with	clinical	and	
infection	control	nurses	(ICNs)	relating	to	their	perceptions	and	attitudes	toward	
AMR	are	presented.	The	aim	of	the	interviews	with	key	informants	and	focus	groups	
with	nurses	was	to	explore	perceptions	and	attitudes	of	organisational	leaders	and	
nurses	towards	AMR.	The	findings	are	presented	in	two	sections:	the	description	of	
participant	characteristics;	and	the	description	of	key	themes.		
	 4.2.1	Participant	characteristics	
	 There	were	33	participants	in	the	interviews	and	focus	groups	(Table	4.11)	of	
which,	15	were	organisational	leaders	who	were	interviewed	individually.	Purposeful	
sampling	was	used	to	enroll	participants.	The	organisational	leaders	interviewed	
were	the	Director	of	the	hospital,	Director	of	Nursing,	Director	of	Pharmacy,	Chair	of	
infection	prevention	and	control	(IPC)	committee,	nurse	manager	of	IPC	department,	
infection	control	specialists	(2),	surgeons	(2),	ID	specialists	(1),	nurse	manager	in	
operating	room	(1),	nurse	manager	in	ICU	(1),	AMS	and	clinical	pharmacists	(2)	and	
Head	of	Virology	Department	(1).		
	 There	were	two	groups	of	nurses	who	participated	in	the	focus	groups:	seven	
infection	control	nurses,	and	11	clinical	ward	nurses	(senior	nurses	(n=5)	and	junior	
nurses	(n=6)).	Clinical	nurses	were	working	in	either	the	medical	or	surgical	wards	of	
the	study	hospital.	The	years	of	nursing	experience	for	participants	in	the	senior	
nurse	group	was	greater	than	ten	years	and	in	the	junior	nurse	group	was	less	than	
three	years.	
Table	4.11	Individual	interviews	and	focus	group:	participant	categories	
Category	 Number	of	interviews	 Number	of	participants	
Individual	interviews		 15	 15	
Focus	group	interviews	 3	 18	
Total	interviews		 18	 33	
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	 4.2.2	Underlying	causes	of	antimicrobial	resistance	in	Thailand	
	 Attitudes	and	perceptions	of	organisational	leaders	and	nurses	regarding	the	
main	issues	that	contribute	to	antimicrobial	resistance	(AMR)	in	Thailand	emerged	as	
four	themes.	These	were:	1)	lack	of	regulatory	control,	2)	poor	consumer	knowledge	
of	antibiotic	use,	3)	inappropriate	use	in	clinical	practice	and	4)	poor	implementation	
of	infection	prevention	and	control	(IPC)	policies	in	Thailand	(Table	4.12)	
Table	4.12	Underlying	causes	of	antimicrobial	resistance	in	Thailand	
Theme		 Subthemes	
1)	Lack	of	regulatory	control	 1.1	Widespread	use	in	agriculture,	and	health	
1.2	Over	the	counter	availability	for	
consumers	
2)	Poor	consumer	knowledge	of	
antibiotic	use	
2.1	Inappropriate	use	of	antibiotic	for	viral	
infections	
2.2	Antibiotic	not	used	therapeutically	
2.3	Patient	expectations	
3)	Inappropriate	use	in	clinical	
practice	
3.1	Lack	of	prescriber	awareness		
3.2	Lack	of	prescriber	knowledge	
3.3	Influence	of	the	pharmaceutical	industry	
4)	Poor	implementation	of	IPC	
policies	in	Thailand	
	
4.1	Spread	of	resistant	organisms	within	
healthcare		
4.2	Environmental	impact	of	antibiotic	
disposal		
	
1)	Lack	of	regulatory	control	
	 The	participants	perceived	that	AMR	in	Thailand	is	caused	by	the	lack	of	
regulatory	control.	Widespread	use	of	antibiotics	in	agriculture	and	health,	and	over	
the	counter	availability	of	antibiotics	for	consumers	were	identified	as	subthemes,	
exacerbated	by	lack	of	government	policy	and	regulation	of	antibiotic	distribution	in	
Thailand.	The	widespread	use	of	antibiotics	in	agriculture	and	health	is	problematic	
as	there	is	no	system	of	monitoring	where	antibiotics	are	being	used	and	individuals	
or	groups	are	unaware	that	they	have	secondary	exposure	to	antibiotics.	In	contrast,	
over	the	counter	availability	of	antibiotics	to	the	layperson	is	related	to	individual	
behavior.	The	lack	of	regulation	means	that	the	individual	can	decide	to	purchase	
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antibiotics	without	any	consultation	with	a	healthcare	professional	about	their	need	
for	antibiotics.	
	
	 1.1	Widespread	use	in	agriculture	and	health	
	 The	participants	believed	that	the	lack	of	regulatory	control	from	
government	agencies	such	as	the	Thai	Ministry	of	Health,	meant	there	was	little	
information	about	the	volume	of	consumption	of	antimicrobials	in	Thailand.	
Participants	identified	that	Thailand	does	not	have	the	systems	to	monitor	antibiotic	
use	and	they	suggested	that	a	better	system	to	regulate	antibiotic	use	in	Thailand	
was	urgently	needed.		
	
“The	use	is	high	[antibiotic	use]	but	we	do	not	know	how	high,	how	much	is	
imported,	and	how	much	we	use.	It	[antibiotics]	might	go	into	animals	or	
humans.”	(D1)	
	
“The	AMR	problem	would	not	be	as	bad	if	we	had	a	formal	system	to	monitor	
antibiotic	use	in	Thailand.”	(N2)	
	
“Because	our	country	does	not	have	laws	that	strictly	control	the	selling	of	
drugs	for	humans,	plants,	and	animals,	there	is	a	dramatic	spread	of	
antimicrobial		 resistance”	(ICN2)	
	 	
	 The	widespread	availability	of	antibiotics	across	Thailand	was	identified	as	an	
issue	because	individuals	could	be	exposed	to	antibiotics	both	directly	and	indirectly.	
Participants	mentioned	that	Thai	people	are	able	to	acquire	antibiotics	easily	in	both	
community	and	healthcare	settings.	The	consequence	of	this	is	an	increase	in	
antimicrobial	resistance	across	Thai	hospitals,	as	individuals	presenting	for	acute	
health	care	are	already	colonised	with	microbes	that	are	resistant	to	widely	available	
antibiotics.		
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“Because	in	the	community,	Thai	people	have	too	easy	access	to	antibiotics,	
they	can	get	antibiotics	from	the	agricultural	section	of	a	drug	store.	When	
they	see	a	doctor	in	hospital	they	already	have	an	antimicrobial	resistant	
infection.	This	means	doctors	need	to	step	up	antibiotic	treatment.	Patients	
come	to	hospital	with	antimicrobial	resistance.”	(P2)	
	
“	Previously	we	used	to	implement	isolation	precautions	for	patients	with	
Extended-Spectrum	beta-lactamases	(ESBLs)	infection	as	a	contact	
precaution.	But	now	we	no	longer	do	that	because	there	are	so	many	
patients.	We	also	realise	that	ESBLs	infections	are	from	the	community	and	
not	from	the	hospitals.”	(N3)	
	 	
	 The	widespread	availability	of	antibiotics	across	Thailand	results	in	increased	
exposure	to	antibiotics,	(and	potentially	antibiotic	resistant	organisms)	in	the	food	
consumed.	The	use	of	antibiotics	in	crop	and	animal	agriculture	in	Thailand	means	
that	antimicrobials	are	used	at	all	levels	in	the	food	chain.	Antibiotic	use	in	animals	
was	particularly	emphasised	as	a	significant	issue	contributing	to	AMR	in	Thailand.	
Participants	state	that	there	is	overuse	of	antibiotics	in	animal	agriculture,	so	when	
people	consume	meats	and	vegetables	they	are	exposed	to	AMR	organisms.		
	
“Also….	the	use	of	antibiotics	in	animals	such	as	in	shrimps	[and]	pigs.	So,	we	
will	receive	these	drugs	[antibiotics]	when	we	eat	them”	(N1)	
	
	 One	participant	mentioned	that	antibiotic	resistant	genes	were	found	in	
chicken,	pork	and	shrimps.	
	
	 “	When	I	joined	the	infection	control	conference	last	time,	one	of	researchers	
	 presented	that	they	found	the	genes	of	antimicrobial	resistance	in	prawns	
	 chicken	and	pork.”	(N3)	
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	 1.2	Over	the	counter	availability	to	the	lay	person	 	
	 Antibiotic	use	is	not	only	widely	available	but	also	used	inappropriately.		
From	the	participants’	perspective	in	the	Thai	context,	antibiotics	are	overused	by	all	
people	in	both	clinical	contexts	and	by	lay	people	outside	the	hospital.	One	of	the	
consumer	endpoints	for	this	lack	of	regulatory	control	over	the	import	and	
distribution	of	antibiotics	was	identified	as	the	availability	of	antibiotics	over	the	
counter	to	consumers.	In	Thailand	people	can	buy	antibiotic	without	prescription.	To	
purchase	antibiotics	over	the	counter	is	easy	and	convenient.		
	
“	We	can	see	that	when	people	feel	unwell,	they	will	purchase	antibiotics	over	
the	counter	at	a	chemist.”	(L1)	
	
“	In	our	country	we	can	buy	drugs	at	the	drugstores.	A	seller	does	not	give	
advice.	If	patients	want	antibiotics,	they	(sellers)	will	sell	them	without	asking	
about	the	condition	so	it	results	in	excessive	and	unreasonable	antibiotic	use.	
(JRN2)	
	 	
2)	Poor	consumer	knowledge	of	antibiotic	use	
	 Poor	consumer	knowledge	of	antibiotic	use	was	identified	as	another	major	
issue	contributing	to	AMR	in	Thailand.	Participants	described	inappropriate	use	of	
antibiotics	for	viral	infections,	failure	to	use	antibiotics	therapeutically,	and	patient	
expectations	of	antibiotic	use.	Participants	believed	that	poor	consumer	knowledge	
of	antibiotic	use	includes	the	belief	that	an	antibiotic	can	cure	the	flu	and	minor	
infection	so	people	have	an	expectation	to	be	prescribed	antibiotics.	Once	people	
take	antibiotics,	they	stop	taking	them	as	soon	as	they	feel	better	so	they	often	do	
not	complete	a	full	course	of	antibiotics.		
	
2.1	Inappropriate	use	of	antibiotics	for	viral	infections	
	 Lack	of	consumer	knowledge	and	awareness	of	the	potential	problems	
associated	with	regular	antibiotic	use	was	identified	as	a	significant	problem.	When	
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Thai	people	get	the	flu	they	go	to	a	drug	store	to	buy	antibiotics	with	the	belief	that	
antibiotics	will	make	them	feel	better	and	recover	faster.			
	 	
“	When	they	have	flu,	they	buy	medicines	themselves	without	knowing	
whether	they	are	infected	with	a	virus	or	bacteria.”	(ICN4)	
	
	 2.2	Antibiotics	not	used	therapeutically	
	 Another	problem	contributing	to	AMR	in	Thailand	is	that	people	fail	to	
complete	a	course	of	antibiotics.	After	commencing	antibiotics	they	sometimes	stop	
taking	them	when	they	feel	better.	As	participants	noted,		
	
“	And	when	they	feel	better,	they	instantly	stop	taking	medicines	without	
taking	the		full	course.”	(ICN4)	
	 	
	 2.3	Patient	expectations	
	 Patients	expect	to	recieve	antibiotics	when	they	have	infections	irrespective	
of	whether	the	infection	is	viral	or	bacterial,	
	 	
“	[A]	friend	of	mine	told	me	that	when	she	had	flu,	[she]	went	to	see	a	doctor	
at	a	clinic	because	she	wanted	antibiotics.	She	kept	changing	doctors	when	
the	condition	was	not	getting	better.	She	said	each	doctor	also	prescribed	
different	antibiotics	for	the	same	condition.”	(ICN5)	
	
3)	Inappropriate	use	in	clinical	practice	
	
	 Antimicrobial	resistance	in	Thailand	was	also	related	to	inappropriate	
antibiotic	use	in	clinical	practice.	The	categories	of	lack	of	prescriber	awareness	and	
knowledge	along	with	the	influence	of	the	pharmaceutical	industry	were	major	
perceived	components	of	inappropriate	use	in	clinical	practice.	Lack	of	prescriber	
awareness	was	defined	failing	to	consider	the	impact	of	inappropriate	use	when	
deciding	to	prescribe	antibiotics;	while	lack	of	prescriber	knowledge	was	defined	as	
prescribers	having	insufficient	knowledge	of	antibiotic	prescribing.	The	influence	of	
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the	pharmaceutical	industry	on	a	doctor’s	decision-making	in	relation	to	antibiotic	
prescribing	was	also	noted.	There	was	a	pervasive	sentiment	from	participants	that	
“regulation	of	antibiotic	use	in	Thai	hospitals	is	not	strict	enough.”	(D4)	
	 	
	 3.1	Lack	of	prescriber	awareness		
	 In	clinical	practice,	inappropriate	use	of	antibiotics	occurs	because	some	
doctors	are	not	aware	of	the	importance	of	AMR	and	not	concerned	about	ensuring	
that	they	adhere	to	best-practice	principles	when	they	prescribe	antibiotics.	One	of	
the	participants	stated	that	some	doctors	always	prescribe	antibiotics	as	a	routine	
rather	than	when	they	are	clinically	indicated.	They	sometimes	start	antibiotics	
without	obtaining	a	specimen	to	investigate	whether	there	is	an	infective	cause	or	
whether	the	infection	is	caused	by	bacteria	or	viruses.	Also	when	patients	are	
admitted	to	the	hospital	to	treat	infection	sometimes	doctors	start	treatment	with	
board	spectrum	antibiotic	without	pre-laboratory	tests	for	antimicrobial	sensitivities.	
	
	 “The	main	problem	is	doctors	often	prescribe	antibiotics	as	a	routine	when	
	 people		get	a	cold”.	(N4)		
	 	
	 “They	[doctors]	often	treat	patients	who	have	the	flu	with	a	broad-spectrum	
	 antibiotic.	This	is	especially	a	problem	with	doctors	in	some	departments.”	
	 (N3)	
	
“	Moreover,	a	friend	of	mine	at	a	community	hospital	told	that	when	[she]	
sees	patients	who	have	flu	come	into	the	hospital,	if	doctors	cannot	think	of	
anything,	they	firstly	inject	Ceftriaxone	without	the	confirmation	of	a	culture	
result.	And	they	do	not	have	a	laboratory.”	(ICN2)	
	 	
	 3.2	Lack	of	prescriber	knowledge		
	 Inappropriate	use	of	antibiotics	in	the	clinical	setting	may	also	occur	as	a	
result	of	lack	of	prescriber	knowledge	and	expertise	in	AMS	and	inappropriate	use	of	
antibiotics.	One	participant	identified	that	this	was	a	particular	problem	in	surgical	
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units.	The	area	of	infection	management	has	become	more	complex	and	doctors’	
training	does	not	prepare	them	to	use	best	practice	in	antibiotic	prescribing,		
		
“	There	are	not	many	doctors	who	have	knowledge	about	appropriate	
antibiotic	prescribing”	(D4)	
	 	
“Doctors	have	poor	knowledge	about	antibiotic	prescribing,	they	often	treat	
patients	who	have	the	flu	with	a	broad-spectrum	antibiotic.	This	is	especially	
a	problem	with	doctors	in	some	departments”	(N3)	
	 	
	 3.3	Influence	of	the	pharmaceutical	industry	
	 Pharmaceutical	companies	can	impact	on	doctors’	decisions	in	antibiotic	
prescribing.	It	was	reported	that	it	was	common	to	see	pharmaceutical	sales	
representatives	in	Thai	hospitals,	and	their	main	objective	was	to	increase	the	
purchase	of	medical	products	including	antibiotics	rather	than	providing	prescribers	
with	evidence-based,	scientific	information	about	their	products.	Some	doctors	may	
be	unduly	influenced	by	their	sales	pitch,	which	may	influence	their	decision	to	
prescribe	a	particular	antibiotic	as	empirical	treatment	in	routine	clinical	practice.		
	
	 “I	sometimes	see	doctors	try	new	antibiotics	when	they	are	offered	by	
	 pharmaceutical	sales	representatives.”	(N5)	
	
“Once,	I	heard	a	medical	representative	trying	to	convince	a	doctor	to	use	
broad-spectrum	antibiotics.	She	said	this	antibiotic	could	kill	[a	wide	range	of	
organisms],	covering	both	gram	positive	and	negative	bacteria	and	that	this	
product	could	prevent	and	cure	patients’	infections”	(N3)	
	
4)	Poor	implementation	of	infection	prevention	and	control	in	Thailand		
	 Lack	of	infection	prevention	and	control	(IPC)	practice	was	raised	as	an	
important	issue	regarding	AMR	control.	Spread	of	resistant	organisms	within	
healthcare	and	the	environmental	impact	of	antibiotic	disposal	were	categorised	by	
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participants	as	a	potential	cause	of	poorly	implemented	IPC	policies	in	Thailand.	A	
theme	that	emerged	from	the	interviews	was	that	IPC	policies	were	not	strict	
enough	to	prevent	the	spread	of	AMR	across	the	organisation.	Additionally,	
participants	described	that	the	lack	of	IPC	policy	in	Thailand	was	considered	to	
impact	the	spread	of	AMR	to	the	environment.	Important	aspects	of	IPC	policy	were	
identified	as:	(i)	the	need	for	strict	IPC	policies	across	all	health	care	providers	
including	the	residential	aged	care	sector	and	(ii)	stricter	guidelines	around	the	
disposal	of	leftover	antibiotics.	
	
	 4.1	Spread	of	resistant	organisms	within	healthcare	
A	number	of	participants	perceived	that	most	of	the	hospitals	in	Thailand	do	
not	have	adequate	IPC	policies	including	residential	aged	care.	It	was	identified	that	
once	patients	got	antibiotic-resistant	infections	in	the	hospital,	that	if	the	hospital	
had	poor	IPC	policy	and	practices,	then	AMR	could	be	rapidly	disseminated	across	
the	health	service.	Participants	reported	that	some	hospitals	including	residential	
aged	care	facilities	in	Thailand	do	not	have	an	IPC	policy.		
	 	
“We	do	not	have	good	enough	policy	to	control	antimicrobial	resistance	for	
elderly	people	in	residential	aged	care	yet.”	(D4)	
	
	 4.2	Environmental	impact	of	antibiotic	disposal	
	 Concerns	about	the	environmental	impact	of	antibiotic	disposal	were	also	
expressed	by	participants.	They	believed	that	incorrect	antibiotic	disposal	was	
another	potential	mechanism	through	which	antibiotics	entered	the	environment	
and	increased	the	incidence	of	AMR	throughout	Thailand.	
	
“Another	cause	is	the	inappropriate	method	of	drug	[antibiotics]	disposal	
which	impacts	on	the	environment.	“(D2)	
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4.2.3	Underlying	causes	of	antimicrobial	resistance	in	the	study	hospital	
	 Attitudes	and	perceptions	of	organisational	leaders	regarding	the	main	issues	
that	contribute	to	antimicrobial	resistance	(AMR)	in	the	study	hospital	emerged	as	
four	themes.	These	were:	1)	complex	patients	with	complex	infections,	2)	spread	of	
infection	within	the	study	hospital	and	infection	prevention	control	practice,	3)	the	
barriers	to	good	AMS,	and	4)	resources	to	develop	an	AMS	program	(Table	4.13).	
Table	4.13	Underlying	causes	of	antimicrobial	resistance	in	the	study	hospital	
	
	
1)	Complex	patients	with	complex	infections	
	 Health	services	in	Thailand	are	classified	into	five	levels.	The	study	hospital	is	
categorised	as	the	highest-level	of	tertiary	care,	as	it	provides	advanced	healthcare	
services.	Most	patients	who	are	treated	in	the	hospital	have	complicated	illnesses	
and	this	affects	the	volume	of	antibiotics	used.	Also	a	number	of	patients	presenting	
to	the	study	hospital	already	have	AMR	infection	before	admission,	so	during	their	
Themes	 	 Subthemes	
1)	Complex	patients	with	complex	
infections	
1.1	Complex	patient	cohort	(multiple	
comorbidities	and	antimicrobial	resistant	
organisms	present	on	admission)	
1.2	Microorganisms	mutate	and	develop	
resistance	during	admission	
2)	Limitations	of	infection	
prevention	control	practices	within	
the	study	hospital		
2.1	Inadequate	IPC	
2.2	Poor	knowledge	of	IPC	practice	at	the	
bedside	
2.3	Inadequate	hospital	infrastructure	in	
particular,	overcrowding	decreases	the	
effectiveness	of	IPC	
3)	There	are	barriers	to	good	AMS	 3.1	Lack	of	staff	knowledge	
3.2	Empirical	antibiotic	use	
3.3	Lack	of	medical	engagement	in	AMS.	
3.4	Misconception	around	antibiotic	use	in	
junior	nurses	and	patients		
3.5	Undue	influence	of	the	pharmaceutical	
industry	on	prescribers	
4)	Inadequate	resources	to	develop	
an	AMS	program	
4.1	Lack	of	resources	to	support	appropriate	
prescribing	
4.2	Ineffective	process	to	gain	expert	advice	
when	prescribing	antibiotics	
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hospitalisation	there	is	also	the	potential	for	microorganisms	to	mutate	and	develop	
resistance	to	antibiotics.	The	micro-ecology	of	the	hospital	also	means	that	there	is	
potential	for	horizontal	transfer	of	AMR	between	different	gram-negative	
microorganisms	via	sharing	of	resistance	genes	between	species.	
1.1	Complex	patient	cohorts	(multiple	comorbidities	and	antimicrobial	
resistant	organisms	present	on	admission)	
	 Participants	perceived	that	the	study	hospital	provided	complex	treatments	
for	a	complex	patient	cohort.	There	were	many	patients	admitted	to	the	study	
hospital	that	already	had	AMR	infections	prior	to	admission	that	increased	the	
organisations’	spending	and	use	of	antibiotics.	As	stated	by	participants,	
	
“	I’m	not	sure	how	much	[monetary]	value	in	total	that	the	hospital	uses	on	
antimicrobial	prescribing.	But	the	ratio	of	using	[expensive]	antibiotics	is	quite	
high…		the	cost	associated	with	carbapenam	use	in	the	study	hospital	is	
around	60	million	baht	per	year	[equivalent	is	US$1.7	million	per	annum].”	
(D1)	
	
	 “This	is	a	university	teaching	hospital	we	treat	patients	with	a	lot	of	
	 complications.	More	than	50	%	of	patients	have	AMR	infection	before	being
	 admitted	to	the	hospital.”	(N6)	
	
	 1.2	Microorganisms	mutate	and	develop	resistance	during	admission	
	 Study	participants	perceived	the	spread	of	resistance	between	
microorganisms	as	a	factor	contributing	to	the	problem	of	AMR.	Once	patients	get	
infections,	the	organisms	mutate	and	increase	the	risk	of	AMR.	Participants	
described	that	although	doctors	treat	an	AMR	infection	with	an	appropriate	
antibiotic	regimen,	the	microorganisms	can	mutate	during	treatment	and	develop	
more	complex	antimicrobial	resistance	patterns.		
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“The	problem	is	due	to	patients	who	use	antibiotics	for	a	long	time	and	
eventually	AMR	occurs.	That	means	that	even	though	we	use	appropriate	
antibiotics	the	bacteria	mutate	and	develop	resistance.”	(N3)		 	
	
2)	Limitations	of	infection	prevention	control	practices	within	the	study	hospital	
	 Participants	identified	inadequate	IPC	practice,	and	inadequate	hospital	
infrastructure	resulting	in	AMR	transmission	within	the	hospital.	Participants	
explained	that	inappropriate	IPC	practice	by	healthcare	providers	and	lay	staff	
continued	to	be	a	problem	in	the	hospital.	Additionally,	inadequate	infrastructure	
and	overcrowding	in	the	hospital	was	perceived	as	an	additional	factor.	
	
	 2.1	Inadequate	infection	prevention	and	control		
Inadequate	IPC	practices	such	as	poor	hand	hygiene	or	failure	to	use	personal	
protective	equipment	(PPE)	were	identified	as	risks,		
	
	 “	…caused	by	medical	personnel	due	to	not	washing	hands.”	(ICN2)	
	
“	…	staff	think	that	their	heavy	workloads	justify	cutting	corners	not	wearing	
any	protective	equipment.”	(ICN1)	
	
“Since	the	hospital	is	a	medical	school	we	have	rapid	staff	turnover.	This	
means	that	new	staff		may	not	know	about	the	policies	about	controlling	the	
spread	of	infections.”	(ICN6)	
	
2.2	Poor	knowledge	of	infection	prevention	and	control	practice	at	the	
bedside	
	 Knowledge	of	appropriate	infection	prevention	and	control	practices	of	
doctors	and	nurses	was	perceived	to	contribute	to	the	ease	of	AMR	transmission	in	
the	hospital,	
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“For	example,	we	teach	nurses	that	caring	for	patients	with	antimicrobial	
resistant	infection,	they	have	to	wear	gloves	and	they	do	this.	But	after	they	
take	them	off,	they	don’t	wash	their	hands	before	putting	on	new	gloves”(N1)	
	
	 “Doctors	are	still	not	on	the	same	page	or	have	misconceptions	about	wearing	
	 protective	equipment.”	(ICN1)	
	
2.3	Inadequate	hospital	infrastructure	in	particular	overcrowding	decrease	
the	effectiveness	of	infection	prevention	and	control	
	 Inadequate	hospital	infrastructure	was	one	of	the	major	perceived	problems	
for	the	ICN	participants	The	ICNs	perceived	that	the	structure	of	the	hospital	
buildings	were	issues	along	with	overcrowding	of	patients	and	staff	in	the	clinical	
wards.	These	factors	contribute	to	the	ineffectiveness	of	IPC	and	spread	of	AMR	
within	the	hospital,		
	
“	In	medical	wards,	we	have	a	space	problem	where	patients	are	too	close	to	
each	other	and	this	is	a	risk	for	the	spread	of	antimicrobial	resistance.”	(ICN1)	
	
	 “	…	too	many	medical	and	nursing	students	in	the	ward	make	it	difficult	to	
	 control	infection	risk.”	(ICN1)	
	
“	…we	do	not	have	enough	separate	rooms	for	patients	with	infections.”	
(ICN2)	
	
3)	There	are	barriers	to	good	AMS	
	 Barriers	to	good	AMS	were	perceived	to	be	one	of	the	underlying	causes	of	
AMR	in	the	study	hospital.	Issues	related	to	prescribers	such	as	knowledge	of	
antibiotics,	supervision	of	junior	doctors	and	empirical	antibiotic	use	were	identified	
as	obstacles	to	achieving	sound	use	of	antibiotics	by	prescribers.	Misconceptions	
about	antibiotic	use	were	found	in	clinicians,	junior	nurses	and	patient	participants	
in	this	study.	Participants	considered	the	influence	of	the	pharmaceutical	industry	
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and	patients’	pressure	for	antibiotics	as	additional	barriers	to	the	development	of	
good	AMS	in	the	study	hospital.	
	
	 3.1	Lack	of	staff	knowledge	
	 Participants	explained	that	the	study	hospital	was	a	medical	school	where	
interns,	residents	and	other	less-experienced	medical	staff	were	able	to	gain	
experience	in	treating	patients	with	multi-drug	resistant	organisms.	Participants	
perceived	that	patients	were	more	likely	to	be	treated	with	antibiotics	
inappropriately	if	there	is	poor	supervision	for	junior	doctors,	
	
“Our	hospital	is	a	medical	school.	There	are	medical	students	who	come	here	
to	study	so,	sometimes,	it	feels	like	this	place	is	an	antibiotic	experiment.	
There	are	a	lot	of	antibiotics	used	and,	eventually,	this	causes	antimicrobial	
resistance.”	(SRN2)			
	
	 As	most	of	the	junior	medical	staff	had	little	clinical	experience,	they	were	
less	likely	to	withhold	antibiotics	until	sensitivities	and	cultures	were	obtained	and	
they	did	not	always	prescribe	the	most	appropriate	antibiotics	for	a	given	clinical	
presentation,		
	
“Poor	clinical	judgment	for	example,	even	though	the	laboratory	results	show	
an	infection	with	a	gram	negative	cocci	bacteria,	they[prescriber]	treat	with	
meropenem.”	(D2)	
	
	 Participants	also	reported	that	some	senior	doctors	prescribed	antibiotics	as	
routine	treatment	irrespective	of	whether	the	patient	had	an	infection(s),	
	
“In	a	ward,	there	is	a	doctor	who	is	a	professor	and	no	matter	what	kind	of	
wounds	patients	have,	the	doctor	would	prescribe	Clindamycin	and	Ceftazidine	
as	a	routine.	It	is	like	an	antibiotic	formula	which	the	doctor	prescribes	for	
his/her	patients	almost	in	every	case.”	(SRN1)”.		
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	 3.2	Empirical	antibiotic	use	
	 Empiric	therapy	was	considered	an	underlying	cause	of	AMR	in	the	study	
hospital	particularly	from	the	perspectives	of	clinical	nurse	participants.	Participants	
considered	that	starting	broad-spectrum	antibiotics	before	the	specific	bacterium	
causing	an	infection	is	known,	was	a	cause	of	AMR,		
	
“Doctors	are	another	factor.	Initially,	they	like	to	use	broad-spectrum	
antibiotics	and	then	when	culture	results	come	back,	they	will	change	to	less	
strong	antibiotics.”	(SRN2)	
	
“In	some	wards,	if	there	are	patients	with	fever	after	surgery,	doctors	would	
start	with	very	strong	antibiotics,	such	as,	Ertapenem	Carbapenem.	Doctors	
can	prescribe	these	antibiotics	for	3	days,	so	they	prefer	to	use	them	without	
waiting	for	the	results	of	antibiotic	sensitivity	tests.	Sometimes	that	particular	
bacteria	is	sensitive	to	first	generation	antibiotics	but	doctors	have	already	
used	third	generation	antibiotics.”	(JRN4)	
	
	 Additionally,	many	prescribers,	who	are	not	ID	specialists,	treat	patients	with	
multi	drug	resistant	infections	without	consulting	with	ID	specialists,	
	
	 “		Some	surgeons	like	to	treat	infection	themselves	first.	If	they	cannot	treat	it	
	 or	a	fever	is	not	reducing,	they	would	consult	the	ID	doctors.	By	the	time	an	ID	
	 doctor	comes,	the	bacteria	is	already	CRE	(Carbapenem-Resistant	
	 Enterobacteriaceae)	or	VRE	(Vancomycin-Resistant	Enterococci).”	(JRN4)	
	
	 3.3	Lack	of	medical	engagement	in	antimicrobial	stewardship	
	 Although	there	was	a	program	to	control	antibiotic	use	in	the	study	hospital,	
not	all	doctors	thought	that	AMR	was	a	serious	problem.	Participants	described	that	
some	doctors	prescribed	antibiotics	without	considering	whether	there	was	a	clinical	
need	or	research	evidence	to	support	their	use.	Some	doctors	believed	in	their	own	
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prescribing	decisions	and	did	not	change	the	prescription	even	when	the	pathology	
results	for	microscopy,	culture	and	sensitivities	were	available.			
	
	 “When	their	patients	have	fever	they	will	start	antibiotics	before	waiting	for	
	 the	culture	results.	Sometimes	the	culture	shows	that	there	is	no	infection,	but	
	 they	still	continue	the	antibiotics	for	up	to	7-10	days.	If	we	did	not	mention	
	 this,	they	would	continue	the		antibiotic	order.	Some	doctors	have	very	high	
	 self-confidence,	they	would	not	stop	the	antibiotics	even	we	raised	the	issue	
	 with	them.	They	say	that	they	prefer	to	complete	the	antibiotic	course.”	(N2)	
	
	 The	size	of	the	study	hospital	was	a	perceived	contributing	factor	in	the	lack	
of	widespread	awareness	of	the	importance	of	appropriate	antibiotic	prescribing	
because	the	size	made	it	dificult	to	raise	awareness	of	the	issues	across	the	hospital,		
		
“We	are	in	a	transitional	period	for	developing	antibiotic	use	awareness.	After	
trying	to	foster	awareness	for	a	while,	some	staff	have	started	to	realise	that	
antibiotic	resistance	and	use	are	a	big	problem.	However	because	the	hospital	
is	quite	big,	it	takes	time	to	change	the	perceptions	and	attitudes	of	every	
staff	members“	(P2)	
	 	
	 3.4	Misconceptions	about	antibiotic	use	in	junior	nurses	and	patients	
	 Nurses	who	were	less	experienced	in	clinical	practice	mistakenly	considered	
empirical	antibiotic	use	as	inappropriate	treatment.	
	
“	When	patients	have	a	fever	and	doctors	do	a	septic	workup,	doctorsstart	
prophylactic	antibiotics	straight	away	without	the	results	[of	sensitivity	
testing).	Once	the	result	come	in,	doctors	have	to	change	antibiotics	into	
stronger	antibiotics	because	the	old	antibiotic	was	not	sensitive	to	the	
bacteria.	That	means		patients	are	given	antibiotics	unnecessarily	and	then	
becomes	resistant	to	the	antibiotic.”	(JRN2)	
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	 Misconceptions	about	antibiotic	use	also	occurred	in	patients	where	patients	
perceived	that	imported	antibiotics	were	superior	to	cheaper	generic	brands,		
	
“	I’ve	had	an	experience	with	a	high-class	patient	and	his/her	relatives.	The	
patient	asked	for	strong	or	imported	antibiotics	because	he/she	could	afford	
the	medical	fee”	(SRN2)	
	
4)	Inadequate	resources	to	develop	antimicrobial	stewardship	programs	
Another	major	concern	raised	by	participants	was	the	perceived	lack	of	
resources	to	develop	and	implement	an	AMS	program	in	the	study	hospital.	
Participants	identified	lack	of	resources	to	support	appropriate	prescribing	and	
ineffective	processes	to	gain	expert	advice	to	support	prescribing	decision-making	as	
critical	barriers	to	decreasing	the	overuse	of	antibiotics	in	the	study	hospital.		
	 	
	 4.1	Lack	of	resources	to	support	appropriate	prescribing	
	 Participants	explained	that	the	current	AMS	program	in	the	study	hospital	
was	not	able	to	drive	consistent	change	in	prescriber	behaviour.	For	example,	the	
hospital	had	no	antibiotic	prescribing	guidelines	and	empiric	antibiotic	use	was	not	
able	to	be	linked	with	laboratory	data	of	antibiotic	sensitivities.	The	lack	of	an	
effective	laboratory	reporting	system	and	follow-up	of	pathology	reports	was	also	
identified	as	problematic,	
	
“I	am	in	doubt	about	the	effectiveness	of	the	reporting	system	in	the	
pathology	department.”	(P1)	
	
	 Participants	also	raised	the	issue	that	there	was	no	multidisciplinary	team	to	
monitor	antibiotic	use	in	the	study	hospital.	Further,	the	service	currently	offered	by	
clinical	pharmacists	was	perceived	to	be	inadequate	as	there	were	insufficient	staff	
to	monitor	every	ward	and	every	antibiotic	prescription	in	the	hospital.	It	was	
suggested	that	more	resources	needed	to	be	put	into	clinical	pharmacy	services	to	
ensure	that	effective	monitoring	systems	were	in	place.	
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	 “If	we	have	a	better	cover	of	clinical	pharmacists	on	the	wards,	this	would	
	 help	a		lot	in	monitoring	appropriate	antibiotic	use	in	the	hospital.”	(N5)		
	
	 4.2	Ineffective	processes	to	gain	expert	advice	when	prescribing	antibiotics		
	 The	pharmaceutical	department	in	the	study	hospital	provides	clinical	
pharmacists	to	monitor	appropriate	antibiotic	use,	however	participants	were	
questioning	the	effectiveness	of	the	consultation	process,	
	
	 “We	have	clinical	pharmacists	who	are	specialists	in	antibiotic	prescribing	but	
	 there	is	no	formal	consultation	process.	I	am	also	not	sure	if	the	consultations	
	 happen	too	late.”	(P1)	
4.3	Discussion	
	 Two	major	findings	emerged	from	the	clinician	survey,	interviews	and	focus	
groups.	First,	all	participants	surveyed	perceived	AMR	as	a	major	problem,	and	that	
improved	prescribing	and	use	of	antibiotics	was	important.	Second,	there	were	some	
differences	between	professions	regarding	AMR	and	AMS.	Key	themes	that	emerged	
from	the	organisational	leader	interviews	and	focus	group	discussion	supported	the	
findings	of	the	staff	survey.	These	findings	are	discussed	in	detail	in	the	sections	to	
follow.	
4.3.1	Similarities	in	participants’	perceptions	of	antimicrobial	resistance	and	
antimicrobial	stewardship		
In	this	first	section,	similarities	in	participants’	perceptions	of	AMR,	and	
participants’	attitudes	and	perceptions	of	AMS	and	antibiotic	use	in	the	study	
hospital	are	presented	in	the	following	section.		
4.3.1.1	Participants’	perceptions	of	antimicrobial	resistance	
	 All	participants	surveyed	perceived	AMR	as	a	major	problem,	particularly	in	
hospitals,	as	indicated	by	a	median	score	of	7.0	for	survey	items	related	to	AMR	
globally,	in	Thai	hospitals,	and	at	the	study	hospital.	Participants	perceived	that	AMR	
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was	less	of	a	problem	in	community	settings	(median	score=6).	Similarly,	the	themes	
emerging	from	organisational	leader	interviews	and	focus	groups	with	nurses	
supported	that	AMR	was	a	substantial	problem	across	all	sectors	of	Thailand.	
Organisational	leaders	believed	that	the	widespread	availability	of	antimicrobials	
across	all	sectors	of	Thai	life	was	one	of	the	major	drivers	of	AMR	in	Thailand.	In	
contrast	to	the	organisational	leaders,	although	the	nurses	who	participated	in	the	
focus	groups	recognised	AMR	as	problem	in	Thailand,	it	appears	that	they	were	less	
concerned	about	AMR	in	Thailand	overall	and	had	specific	concerns	about	AMR	and	
IPC	issues	in	the	hospital.	The	perception	that	AMR	was	a	major	problem	globally	
was	reported	in	many	other	studies	(Abbo	et	al.,	2012;	Abera	et	al.,	2014a;	Brinsley,	
Sinkowitz-Cochran,	&	Cardo,	2005c;	Cotta	et	al.,	2014;	García	et	al.,	2011b;	Giblin	et	
al.,	2004b;	Navarro-San	Francisco	et	al.,	2013;	Sanchez	et	al.,	2014;	Thriemer	et	al.,	
2013b;	Wood	et	al.,	2013).		
	 In	this	study,	clinician	survey	participants,	organisational	leaders			and	focus	
group	nurse	participants	all	reported	that	AMR	was	a	major	problem	for	Thai	
hospitals	and	for	the	study	hospital.	The	lack	of	regulatory	control	over	the	
distribution	of	antimicrobials	in	Thailand	and	poor	implementation	of	IPC	practice	
were	reported	to	be	important	drivers	of	AMR.	Only	a	few	studies,	including	another	
study	from	Thailand,	have	reported	that	participants	perceived	AMR	as	a	major	
problem	in	their	hospital	(Chuenchom,	Thamlikitkul,	Chaiwarith,	Deoisares,	&	
Rattanaumpawan,	2016b;	Navarro-San	Francisco	et	al.,	2013).	Focus	group	
participants	reported	that	in	their	clinical	practice	they	cared	for	complex	patients	
who	required	long-term,	combination	antimicrobial	treatment	for	their	condition.		If	
these	patients	developed	antibiotic	resistance	it	was	possible	that	this	resistance	
pattern	could	spread	to	other	patients	in	the	hospital.		The	concerns	raised	by	
clinicians	in	this	study	were	in	contrast	to	previous	reports	that	found	that	although	
participants	believe	AMR	is	a	major	problem,	they	do	not	perceive	that	AMR	is	a	
problem	that	affects	their	practice	at	their	hospital	(Abera	et	al.,	2014a;	Brinsley	et	
al.,	2005c;	Cotta	et	al.,	2014;	García	et	al.,	2011b;	Giblin	et	al.,	2004c;	Thriemer	et	al.,	
2013b;	Wood	et	al.,	2013).		These	findings	are	concerning	as	AMR	is	an	increasing	
and	serious	quality	and	safety	issue	(Ventola,	2015).	Further,	AMR	is	one	of	the	
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biggest	public	health	threats	that	requires	cooperation	across	government	sectors	
globally	to	prevent	and	control	the	spread	of	resistant	infections	(CDC,	2016;	WHO,	
2016a).	Resolving	AMR	will	be	challenging	if	healthcare	providers,	often	mistakenly,	
do	not	perceive	that	AMR	is	an	issue	in	their	hospital	so	are	not	willing	to	change	
their	practice	to	address	problems	related	to	AMR.	The	themes	emerging	from	the	
interviews	in	this	study	indicated	that	there	was	a	greater	awareness	of	the	
importance	of	AMR	and	its	impact	on	clinical	care	amongst	clinicians.		
	 Many	health	professionals	report	being	concerned	about	AMR	as	a	major	
issue	in	healthcare	however,	they	did	not	think	it	was	an	issue	in	their	hospital.	One	
possible	reason	for	this	disparity	may	be	the	different	regulation	of	purchasing	and	
use	of	antibiotics	in	different	countries.	Antibiotics	are	purchased	over	the	counter	
in	many	countries	across	the	world	including	Thailand	(Apisarnthanarak,	
Tunpornchai,	Tanawitt,	&	Mundy,	2008;	Kagashe,	Minzi,	&	Matowe,	2011;	Morgan,	
Okeke,	Laxminarayan,	Perencevich,	&	Weisenberg,	2011b;	Tomson	&	Sterky,	1986).	
Similarly,	studies	from	Ethiopia	and	Peru	where	people	can	buy	antibiotics	without	a	
prescription	also	showed	that	the	most	of	participants	agreed	AMR	is	serious	
problem	worldwide	but	less	so	in	their	own	practice	(Abera	et	al.,	2014a;	García	et	
al.,	2011a).	These	studies	from	countries	where	prescriptions	are	not	required	to	buy	
antibiotics	may	explain	participants’	perceptions	that	AMR	is	a	problem	originating	
from	outside	their	hospital	and	from	the	broader	community.	Likewise,	the	results	
from	the	organisational	leader	interviews	support	the	finding	that	it	is	the	
widespread	availability	of	antimicrobials	in	all	sectors	of	Thai	life	that	is	driving	the	
emergence	of	AMR.	The	lack	of	antimicrobial	regulation	was	viewed	as	creating	a	
problem	that	was	beyond	the	direct	control	of	organisational	leaders.	The	
organisational	leaders	also	raised	the	issue	of	widespread	use	of	antibiotics	in	
agriculture,	which	impacts	on	both	the	volume	of	antimicrobials	entering	the	food	
chain	and	the	dispersion	of	antimicrobials	into	the	natural	environment.	Some	
organisational	leaders	also	highlighted	that	inappropriate	disposal	of	antimicrobials	
meant	that	these	products	could	enter	the	waterways	in	Thailand	and	from	there	be	
dispersed	throughout	the	environment.			
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	 In	Thailand,	antibiotics	are	easily	bought	over	the	counter	at	grocery	stores	or	
drug	stores.	Thai	people	commonly	seek	basic	advice	from	the	pharmacist	at	a	drug	
store	if	they	are	feeling	unwell	(Khamsarn	et	al.,	2016).	The	clinicians	surveyed	in	this	
study	reported	that	antibiotic	use	and	patients’	buying	over	the	counter	antibiotics	
was	a	major	influence	on	AMR	(median=6).	Additionally,	interviews	with	
organisational	leaders	and	focus	groups	with	nurses	identified	that	poor	consumer	
knowledge	of	when	antibiotics	should	be	used	was	also	a	contributor	to	AMR.	
Patient	expectations	that	it	is	helpful	to	use	antibiotics	when	they	get	a	cold	or	other	
minor	infection	was	also	reported	to	increase	antibiotic	use	in	the	community	
context.	Also	there	was	the	tendency	for	patients	in	the	community	not	to	complete	
a	full	course	of	antibiotic	treatment	further	demonstrating	that	consumers	in	
Thailand	lacked	the	knowledge	about	how	to	use	antibiotics	in	a	therapeutic	
manner.		
	 The	majority	of	survey	participants	(88%)	in	this	Thai	study	reported	that	
caring	for	patients	with	antibiotic	resistant	infections	was	common,	which	may	
explain	the	perceptions	of	participants	that	AMR	was	a	major	issue	in	the	study	
hospital.	A	perception	that	AMR	was	common	is	also	supported	by	the	themes	that	
emerged	from	the	focus	groups	with	clinical	nurses	as	they	reported	regularly	caring	
for	patients	with	AMR	infections.	Clinical	nurses	perceived	that	AMR	was	a	major	
problem	at	the	study	site	and	that	overcrowding	in	the	clinical	areas	and	inadequate	
infrastructure	to	support	IPC	best	practice	was	contributing	to	the	spread	of	AMR	
within	the	hospital.	However,	the	perceptions	of	AMR,	as	a	major	problem	in	
hospitals	and	as	an	issue	when	caring	for	patients	with	antibiotic	resistant	infection	
were	not	the	same	in	all	studies.	An	Australian	study	showed	that	although	84%	of	
the	participants	reported	they	cared	for	patients	with	antibiotic	resistance,	only	45%	
of	them	reported	AMR	as	a	major	problem	in	their	hospital	(Cotta	et	al.,	2014).	
4.3.1.2	Participants’	attitudes	and	perceptions	of	antimicrobial	stewardship	
and	antibiotic	use	in	the	study	hospital			
	 Inappropriate	antibiotic	prescribing	was	identified	as	a	significant	barrier	to	
achieving	best	practice	in	AMS.	Participants	perceived	that	lack	of	prescriber	
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knowledge	was	a	major	contributing	factor	to	inappropriate	antibiotic	use	in	the	
study	hospital.	Participants	considered	that	they	needed	to	improve	their	
supervision	of	junior	doctors’	prescribing	of	antimicrobials.	Organisational	leaders	
mentioned	that	the	pharmaceutical	industry	had	too	much	influence	over	junior	
staff	prescribing	behaviour	and	that	more	resources	were	needed	to	raise	awareness	
of	AMS	and	appropriate	prescribing	practice	across	the	study	hospital.		
	 The	majority	of	survey	participants	in	this	study	agreed	that	systems	for	
improving	antibiotic	prescribing	were	important	to	reduce	the	occurrence	of	AMR	
and	should	be	a	hospital	priority	(median	score=6).	All	participants	surveyed	
perceived	that	systems	to	improve	decisions	related	to	antibiotic	use	would	be	
useful,	as	indicated	by	a	median	score	of	6	for	survey	items	related	to	local	antibiotic	
guidelines.	They	indicated	that	a	computer	application	to	guide	antibiotic	prescribing	
and	an	AMS	team	to	give	antibiotic	advice	and	feedback	would	be	vital.	The	notion	
of	decision	support	for	antibiotic	prescribing	as	a	useful	strategy	to	decrease	AMR	
and	improve	antibiotic	use	was	also	supported	in	the	organisational	leader	
interviews	who	also	highlighted	the	lack	of	resources	to	develop	and	implement	an	
AMS	program.		
	 Many	other	studies	also	report	that	systems	to	improve	antibiotic	prescribing	
would	be	clinically	useful	to	ensure	the	optimal	prescribing	and	use	of	antibiotics	
(Abbo	et	al.,	2012;	Abbo	et	al.,	2013c;	Bannan	et	al.,	2009;	Cotta	et	al.,	2014;	García	
et	al.,	2011a;	Giblin	et	al.,	2004a;	Itokazu	et	al.,	2006a;	Navarro-San	Francisco	et	al.,	
2013;	Pawluk	et	al.,	2014;	Steinberg	et	al.,	2014;	Wood	et	al.,	2013),	and	that	would	
in	turn,	support	AMS	programs	to	decrease	inappropriate	antibiotic	use,	reduce	
healthcare	costs,	decrease	the	occurrence	of	AMR,	and	minimise	adverse	drug	
events,	all	of	which	improve	patient	care	(Buising	et	al.,	2008c;	Dellit	et	al.,	2007;	Lin	
et	al.,	2013b;	Raymond	et	al.,	2001).	Therefore,	the	strategies	and	systems	that	
promote	appropriate	antibiotic	use	or	AMS	programs	have	been	set	as	a	worldwide	
agenda	(WHO,	2016a).	In	2011,	WHO	launched	the	WHO	global	strategy	on	
containment	of	antimicrobial	resistance	campaign	to	empower	every	country	in	the	
world	to	respond	to	the	AMR	problem	(Leung	et	al.,	2011).	
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	 In	many	countries,	systems	for	improvement	antibiotic	prescribing	have	been	
initiated	as	a	national	agenda.	For	example,	in	Australia,	the	AMS	strategy	in	
hospitals	is	one	of	the	compulsory	criteria	for	approval	of	hospital	accreditation	
(Duguid	&	Cruickshank,	2011).	In	USA,	the	Infectious	Disease	Society	of	America	
(IDSA)	published	guidelines	for	improving	the	use	of	antimicrobial	agents	in	the	
hospital	as	far	back	as	1988.	Recently	in	2016,	the	National	Action	Plan	for	
Combating	Antibiotic	Resistant	Bacteria	has	been	approved	in	the	National	Action	
Plan	in	the	USA	(CDC,	2016).	In	England,	the	Department	of	Health	has	launched	
activities	to	support	AMS	and	the	AMS	guideline	is	updated	regularly.	Antimicrobial	
Stewardship	Toolkit	for	English	Hospitals	was	the	latest	AMS	guideline	to	be	
published	by	Public	Health	England	(PHE)	(PHE,	2015).	All	of	the	above	strategies	
demonstrate	that	many	countries	across	the	world	have	responded	to	the	
emergence	of	AMR	as	a	major	issue.		An	AMS	strategy	is	effective	in	improving	the	
appropriateness	of	antimicrobial	use.	
4.3.2	Differences	in	participants’	perceptions	of	antimicrobial	resistance	
and	antimicrobial	stewardship	
	 Nurses	had	a	different	perception	of	community	issues	and	AMR	than	
doctors	and	pharmacists.	Nurses	(median	=5)	were	less	likely	than	doctors	and	
pharmacists	to	agree	that	AMR	was	a	serious	problem	in	the	Thai	community,	and	
antibiotic	use	in	community	contributed	to	AMR	at	the	study	hospital	(median	=	6)	
(p<0.001).	One	possible	explanation	for	this	finding	was	that	the	nurses	surveyed	in	
this	study	were	hospital-based	nurses	who	rarely	worked	in	community	settings	
therefore	their	knowledge	of	AMR	issues	in	the	community	may	be	poor.	Although	
both	nurses	and	doctors	take	a	health	history	that	includes	antibiotic	use	in	the	
community,	doctors	have	the	responsibility	for	prescribing	so	are	more	likely	than	
nurses	to	have	to	considered	antibiotic	use	in	the	community	in	their	decision	
making.	Doctors	also	consult	pharmacists	for	advice	regarding	antibiotic	prescription	
so	pharmacists	may	also	have	a	deeper	understanding	than	nurses	of	the	
consequences	of	antibiotic	use	in	the	community	than	nurses.	The	finding	that	
nurses	were	less	concerned	than	doctors	and	pharmacists	about	AMR	in	the	
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community	is	similar	to	the	results	of	an	Australian	study.	This	study	showed	that	
nurses,	doctors	and	pharmacists	believed	that	antibiotic	use	in	the	Australian	
community	contributed	to	AMR	at	their	hospital	by	38%,	57%	and	70%	respectively	
(Cotta	et	al.,	2014).			
	 In	this	Thai	study,	nurses	(89%)	were	more	likely	than	pharmacists	(60%)	to	
report	being	involved	in	the	care	of	patients	with	antibiotic	resistance.	This	was	
confirmed	by	emerging	themes	from	the	focus	group	discussion	that	clinical	nurses	
were	more	concerned	about	preventing	the	spread	of	infection	within	the	study	
hospital	and	a	lack	of	consistent	IPC	practice	in	the	clinical	setting.	Therefore,	this	
was	an	important	consideration	when	providing	education	to	nurses	about	antibiotic	
use	in	community	and	their	consequences	because	nurses	have	a	major	role	in	
antibiotic	management	during	patient	hospitalisation	and	patient	education	about	
antibiotics	before	discharge	from	the	hospital	(Aziz,	2013;	Ladenheim	et	al.,	2013b;	
Storr,	2012).	
	 Despite	doctors	agreeing	that	guidelines	and	protocols	to	support	antibiotic	
prescribing	would	be	useful,	doctors	(median	=	5)	were	significantly	less	likely	than	
nurses	and	pharmacists	(median	=	6)	to	agree	with	any	interventions	that	limited	
prescribing	and	prescribing	decisions	(p<0.001).	These	findings	were	supported	by	
the	organisational	leader	interviews	and	nurse	focus	groups,	both	of	which	
highlighted	the	lack	of	medical	engagement	in	AMS.	These	results	showed	that	
although	the	study	hospital	had	a	program	to	control	the	use	of	some	antibiotics,	
not	all	doctors	took	the	issue	seriously.	Some	prescribers	had	their	own	beliefs	and	
lack	awareness	when	prescribing	antibiotics	even	though	those	antibiotics	were	not	
identified	as	sensitive	to	the	pathology	results	for	microscopy,	culture	and	
sensitivities.	The	finding	that	doctors	do	not	support	interventions	that	limit	
prescribing	have	also	been	reflected	in	other	studies	(Cotta	et	al.,	2014;	Wester	et	
al.,	2002).	Additionally,	there	may	be	cultural	factors	that	may	have	influenced	these	
results.	Doctors	have	a	high	status	in	Thailand	so	are	well	respected	and	rarely	
challenged.	The	findings	from	the	organisational	leader	interviews	support	that	in	
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Thailand	doctors	have	too	much	power,	and	that	they	are	unable	to	accept	expert	
advice	as	they	view	this	as	interfering	with	their	professional	autonomy.	Therefore,	
implementing	and	enforcing	programs	restricting	prescribing	behaviour	would	be	
challenging	in	Thailand,	particularly	if	AMS	initiatives	were	not	supported	by	medical	
staff.		
	 Pharmacists	seemed	to	have	a	higher	focus	on	system	improvements	than	
doctors	and	nurses.	Pharmacists	were	more	likely	to	agree	with	policies	related	to	
AMS	programs	than	doctors	and	nurses	as	indicated	by	median	rank	of	6	for	the	
survey	items	regarding	limitation	of	antibiotic	prescribing,	computer	applications	to	
guide	antibiotic	selection	and	an	AMS	team	to	provide	antibiotic	advice	and	
feedback	(P<0.001).	Almost	half	of	pharmacists	reported	that	they	have	heard	of	
AMS	terminology	(49%)	and	worked	in	healthcare	facilities	with	AMS	programs	
(46%).	However,	only	20%	of	doctors	and	11%	of	nurses	knew	about	AMS	as	a	
specific	term.	Other	studies	from	Australia	have	also	shown	that	pharmacists	are	
more	engaged	with	AMS	systems	than	doctors	and	nurses	(Cotta	et	al.,	2014).	One	
possible	reason	for	this	difference	in	pharmacists’	perceptions	of	systems	to	improve	
AMS	may	be	because	pharmacists	have	more	of	an	overview	of	the	whole	hospital	
whereas	doctors	and	nurses	only	know	the	patients	and	practices	on	their	wards.	In	
the	study	hospital,	it	is	general	practice	for	pharmacists	to	work	throughout	the	
whole	hospital	where	nurses	typically	only	work	in	one	ward	and	doctors	may	visit	
two	or	three	wards.		It	is	probable	that	these	working	conditions	of	pharmacists,	
doctors	and	nurses	are	similar	in	other	countries.	
4.4	Chapter	summary	
	 This	is	the	first	results	chapter	addressing	perceptions	and	attitudes	towards	
AMS	among	clinicians.	The	staff	survey,	which	was	based	on	a	survey	used	in	an	
Australian	study	(Cotta	et	al.,	2014),	semi-structured	interviews	with	organisational	
leaders	and	focus	groups	with	nurses	were	used	to	explore	the	perceptions	and	
attitudes	towards	AMS	among	clinicians	in	acute	healthcare	in	Thailand.	The	major	
findings	were	that	all	participants	surveyed,	interviewed	or	who	participated	in	focus	
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groups	perceived	AMR	as	a	major	problem	and	that	improved	prescribing	and	use	of	
antibiotics	was	important.	Further,	there	were	differences	between	professions	
regarding	AMR	and	AMS.	The	study	findings	also	highlighted	barriers	and	facilitators	
to	effective	AMS	programs	in	the	study	hospital.		
The	findings	of	the	qualitative	data	analyses	of	the	current	clinical	governance	
structure	related	to	AMS	in	the	study	site	is	presented	in	Chapter	5.			
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Chapter	5	
Clinical	Governance	and	Antimicrobial	Stewardship	
In	this	chapter,	the	analyses	of	the	organisational	leaders’	interview	and	
nurse	focus	group	data	related	to	current	clinical	governance	structures	and	
activities	for	AMS	in	the	case	study	hospital	are	presented	in	three	major	sections.	In	
the	first	section	is	a	contextual	description	of	the	clinical	governance	structure	and	
AMS	activities	in	the	case	study	hospital	as	described	by	the	organisational	leaders	
as	key	informants.	The	Core	Elements	of	Hospital	AMS	Programs,	Centers	for	Disease	
Control	and	Prevention	(CDC)	recommendations	provided	the	framework	for	the	
interviews,	analysis	and	interpretation.	In	the	second	section,	findings	of	the	
analyses	of	the	perceived	strengths	and	weaknesses	of	clinical	governance	and	AMS	
activities	among	organisational	leaders,	clinical	nurses	and	infection	control	nurses	
(ICNs)	are	presented.	The	significance	of	the	findings	is	discussed	in	relation	to	the	
CDC	guidelines	and	the	international	literature	in	the	final	section	of	the	chapter.	
Aim	and	objectives		
The	analyses	presented	in	this	Chapter	address	the	second	specific	aim	of	this	
research	program,	that	was	to	identify	strengths	and	weaknesses	of	AMS	clinical	
governance	structures	and	activities	as	perceived	by	key	organisational	leaders	and	
nurses	working	in	acute	healthcare	in	Thailand.	The	specific	objectives	related	to	this	
aim	were	to:	
I. Describe	the	current	clinical	governance	structure	and	AMS	activities	in	
the	case	hospital	based	on	hospital	documentation	and	organisational	
leaders	as	key	informants.	
II. Explore	perceptions	of	the	strengths	and	weaknesses	of	the	current	
clinical	governance	structures	and	activities	related	to	AMS	among	
organisational	leaders,	clinical	nurses	and	infection	control	nurses.	
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5.1	Methods	
The	methodological	approach	for	this	research	program	is	described	in	detail	
in	Chapter	3.	Data	used	in	the	analyses	to	address	the	second	aim	of	the	research	
and	the	related	objectives,	were	collected	in	Phases	2	and	4.	Semi-structured	
interviews	were	used	to	explore	the	current	clinical	governance	structure	and	AMS	
activities	and	identify	gaps	in	best	practice	by	analysing	activities	in	relation	to	the	
CDC	recommendations.	These	interviews	were	conducted	with	organisational	
leaders.	Exploration	of	the	perceived	strengths	and	weakness	of	AMS	governance	
structures	in	the	case	study	hospital,	involved	the	analysis	of	data	derived	from	both	
organisational	leaders	and	nurse	focus	groups.	The	Core	Elements	of	Hospital	
Antibiotic	Stewardship	Programs	of	the	CDC	were	used	to	frame	the	semi-structured	
interview	question	and	prompt	guide.	Refer	to	Appendix	A	for	the	full	interview	
guide.	The	topics	included:	leadership	support;	accountability	and	drug	expertise;	
interventions	to	support	optimal	antimicrobial	use;	tracking	and	reporting	
antimicrobial	prescribing;	use	and	resistance;	and	education.	
Organisational	leaders	as	defined	in	Chapter	3	were	interviewed	to	explore	
current	clinical	governance	structures	and	AMS	activities	at	the	case	hospital.	
Content	analyses	of	the	interview	transcripts	allowed	extraction	of	content	to	
complement	documentation	derived	from	the	hospital	website	relating	to	its	
governance	structure	and	are	presented	in	Section	5.2.	In	Section	5.3,	the	findings	of	
the	thematic	analyses	of	organisational	leaders’	and	clinicians’	perceptions	of	the	
strengths	and	weaknesses	of	the	current	clinical	governance	structures	are	
presented.		
5.2	The	clinical	governance	structure	and	AMS	activities	in	the	case	study	Hospital	
This	analysis	of	the	current	clinical	governance	structure	was	informed	and	
framed	by	the	Core	Elements	of	Hospital	AMS	programs	based	on	the	CDC	
recommendations	(CDC,	2014).	This	section	is	presented	as	follows	i)	leadership	
commitment;	ii)	accountability	and	drug	expertise;	iii)	current	AMS	interventions	to	
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support	optimal	antibiotic	use;	iv)	tracking	and	reporting	antibiotic	use	and	
outcomes	and,	v)	staff	education	and	training	regarding	AMR	and	AMS.		
5.2.1	Leadership	Commitment	
Leadership	support	is	a	significant	element	for	successful	AMS	programs.	
Clear	reporting	lines	and	links	in	accountability	between	the	AMS	team,	the	hospital	
executives,	director	of	clinical	governance,	drug	and	therapeutics	committee	and	IPC	
committee	is	a	strong	recommendation	in	international	AMS	practice	guidelines	
(Duguid	&	Cruickshank,	2011;	Nathwani,	2006).	The	AMS	governance	structure	in	the	
case	hospital	is	presented	in	Figure	5.1;	the	key	committees	that	have	involvement	
in	AMS	are	highlighted.	Governance	related	to	AMS	occurs	within	the	operational	
area	of	Healthcare	Process.	The	IPC	Committee	and	the	Pharmacy	and	Therapeutics	
Committee	are	the	two	major	committees	that	operate	and	support	the	AMS	
program.	The	Pharmacy	and	Therapeutics	Committee	is	the	main	hospital	
committee	that	monitors	overall	medication	distribution	and	use	across	the	hospital	
including	antimicrobial	prescribing,	whereas	the	IPC	committee	oversees	the	policies	
and	activities	relating	to	infection	prevention	and	control	and	hospital	acquired	
infections.	
The	Antibiotics	and	Vaccines	Working	Group	(AVWG),	which	reports	to	the	
Pharmaceutical	Oversight	Subcommittee,	and	the	Rational	Drug	Use	Subcommittee	
(RDUSC),	are	the	main	two	groups	that	work	in	the	oversight	of	antibiotic	prescribing	
policies	and	AMS	activities	across	the	hospital.	These	two	groups	report	to	the	
Pharmacy	and	Therapeutics	Committee.	For	inpatient	departments,	the	AVWG	has	a	
role	in	making	recommendations	about	which	antibiotics	should	be	available	as	
standard	antibiotics	on	hospital	ward	imprest	lists.	This	working	group	also	develops	
policies	for	prescribing	and	monitoring	the	use	of	specific	antibiotics	such	as	the	
carbapenems.	Additionally,	the	AVWG	has	the	role	of	setting	up	the	criteria	for	
determining	which	prescribers	are	authorised	to	prescribe	specific	restricted	
antibiotics.	For	outpatient	departments,	the	RDUSC	operates	the	Antibiotics	Smart	
Use	(ASU)	program	that	follows	the	recommendations	of	The	National	Strategic	Plan	
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on	Antimicrobial	Resistance	(WHO,	2016b).	This	program	promotes	appropriate	
antibiotic	use	for	upper	respiratory	tract	infections	(URTI)	and	diarrhoea.		
The	Pharmacy	and	Therapeutics	Committee	and	the	IPC	committee	work	
cooperatively	to	support	AMS	activities	and	monitor	the	outcomes	of	antibiotic	use	
across	the	hospital.	Both	these	committees	report	to	the	Healthcare	Service	
Committee,	which	is	directed	by	the	Faculty	Executive	Committee.	It	was	noted	that	
the	IPC,	the	AVWG	and	the	RDUSC	currently	have	the	same	chairperson	who	is	an	
infectious	disease	(ID)	specialist	with	an	interest	in	AMS	and	IPC.	
The	AMS	recommendations	of	the	CDC	identify	the	need	for	organisations	to	
facilitate	a	formal	or	written	policy	to	support	improvements	in	antibiotic	use.	Also,	
AMS	leadership	commitment	needs	to	include	dedicating	the	necessary	human,	
financial	and	information	technology	resources	to	support	AMS	activities.	In	the	case	
hospital,	the	major	hospital	quality	and	safety	policy	known	as	Patient	Safety	Goals	
that	includes	the	surgical	safety	checklist,	medication	reconciliation,	emergency	
response	(early	warning	signs)	and	infection	control	(hand	hygiene),	was	promoted	
in	2015.	At	the	time	of	data	collection	for	this	study,	the	organisational	leaders	
interviewed	stated	that	a	formal	policy	or	statement	about	AMS	was	not	included	as	
a	primary	strategy	to	promote	patient	safety	in	the	hospital.		
The	CDC	guidelines	recommend	that	hospital	leaders	should	include	
stewardship-related	duties	in	clinicians’	job	descriptions	and	that	staff	should	be	
given	sufficient	time	within	their	workload	to	support	AMS	activities.	Organisational	
leaders	identified	the	ID	specialist	who	currently	chairs	the	IPC	and	noted	his	
commitment	to	controlling	AMR	in	the	hospital.	All	participants	acknowledged	that	
he	was	recognised	as	the	key	individual	who	had	initiated	AMS	programs	within	the	
case	hospital.	This	ID	specialist	was	also	a	clinical	champion	for	AMS.	However,	the	
current	AMS	team	did	not	have	multidisciplinary	representatives	and	it	was	
identified	by	the	participants	that	there	was	insufficient	executive	level	support	in	
terms	of	financial	and	information	technology	resources.	
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“	There	is	no	additional	compensation	and	staff.	They	[the	hospital	executive]	
do	not	allocate	pharmacists	or	nurses	specifically	to	be	part	of	the	team.	It	is	
not	an	ideal	AMS	team	right	now.	At	the	moment,	we	ask	each	department	
for	help	but	they	already	have	their	own	duties.	It’s	not	a	system	like	other	
countries	that	has	a	full-time	job	for	AMS	team	members.”	(D1)	
“	I	found	that	only	Dr.	[name]	has	been	taking	action	in	this	program	(AMS	
programs).	I	have	not	seen	other	teams	or	staff	support	him	properly.	Dr.	
[name]has	been	trying	to	encourage	the	pharmacist	team	and	pediatric	ID	
specialist	team	to	participate	in	the	AMS	team.”	(P2)
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	 Figure	5.1	The	AMS	governance	structure	in	the	study	hospital
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5.2.2	Accountability	and	drug	expertise	
Multidisciplinary	engagement	is	a	significant	element	of	AMS	programs	(CDC,	2017a;	
Dellit	et	al.,	2007;	Duguid	&	Cruickshank,	2011;	Nathwani,	2006).	The	AMS	guidelines	
suggest	that	a	single	leader	who	is	responsible	for	AMS	outcomes	needs	to	be	identified.	At	
the	case	hospital,	an	ID	physician	has	been	recognised	as	providing	effective	leadership	for	
the	AMS	program	and	a	pharmacy	leader	was	also	identified	by	organisational	leaders	as	a	
co-lead	for	the	program.	Additionally,	the	CDC	recommends	that	key	members	of	the	
multidisciplinary	team	are	part	of	the	AMS	leadership	team.	Key	disciplines	that	should	be	
represented	include:	clinicians	and	department	heads,	infection	prevention	leads	and	
hospital	epidemiologists,	quality	improvement	staff,	laboratory	staff,	information	
technology	staff	and	clinical	nurses.	According	to	the	CDC	guidelines,	multidisciplinary	team	
membership	enhances	the	effectiveness	of	AMS	programs	and	initiatives	(CDC,	2014).		
The	organisational	leaders	in	this	study	identified	the	role	of	the	key	role	of	the	
AVWG	and	RDUSC	in	facilitating	AMS	activities	and	programs.	The	AVWG	membership	was	
identified	as	functioning	as	the	main	AMS	team	in	the	organisation.	In	terms	of	membership	
of	the	AVWG,	the	main	members	included	ID	specialists,	surgeons	and	a	clinical	pharmacist.	
The	leader	participants	identified	the	ID	specialist	who	chairs	the	AVWG,	the	RDUSC	and	the	
IPC	committee,	as	the	AMS	program	leader	and	the	clinical	pharmacist	as	having	a	role	in	
providing	drug	expertise	and	as	the	appointed	pharmacy	leader	in	AMS.	These	two	
individuals	are	both	members	of	the	AVWG.	However	other	key	groups	in	the	hospital,	
which	the	CDC	recommends	are	represented	on	the	AMS	committee	to	support	the	work	of	
stewardship	program	leaders,	are	not	currently	part	of	the	membership	of	the	AVWG.		
5.2.3	Current	AMS	interventions	to	support	optimal	antibiotic	use		
According	to	the	CDC,	organisations	should	initiate	policies	to	support	optimal	
antibiotic	use	and	then	undertake	activities	to	implement	their	AMS	policies	into	clinical	
practice.	AMS	strategies	are	categorised	into	the	three	major	groups:	broad	interventions,	
pharmacy-driven	interventions	and	infection	related	or	syndrome-specific	interventions.	
Additionally,	an	organisation	should	choose	AMS	interventions,	based	on	specific	local	
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hospital	requirements	and	the	availability	of	local	resources	to	support	their	
implementation	(CDC,	2014).	
Organisational	leaders	reported	that	the	AVWG	and	the	RDUSC	were	the	two	main	
subcommittees	responsible	for	AMS	polices	and	activities	in	the	case	hospital.	Current	
interventions	to	improve	antibiotic	use	are	described	under	the	three	major	categories	
below:	
5.2.3.1	Broad-based	interventions	
The	AVWG	had	implemented	two	broad-based	AMS	interventions	by	controlling	the	
prescribing	and	use	of	specific	antibiotics.	The	use	of	broad-spectrum	beta-lactam	
antibiotics	such	as	carbapenems	was	controlled	in	the	hospital	using	a	computerised	
software	program.	This	formulary	restriction	intervention	operates	by	requiring	prescribers	
to	obtain	pre-authorisation	to	continue	treatment	with	this	class	of	antibiotics.	The	
computer	program	allows	doctors	to	prescribe	carbapenem	for	the	first	three	days	of	
treatment;	once	this	time	period	has	elapsed	if	doctors	continue	to	use	carbapenems	they	
are	required	to	obtain	additional	authority	from	the	hospital	ID	specialists	and	confirm	that	
there	is	an	appropriate	clinical	indication	based	upon	patients’	diagnosis	and	microbiology	
results.	The	pharmacist	participants	described	that	this	system	to	control	antibiotic	
prescribing	was	initiated	by	the	members	of	the	AVWG	who	considered	which	
antimicrobials	were	available	for	prescription	within	the	hospital	and	any	restrictions	
associated	with	their	use.	These	restrictions	include	criteria	for	which	prescribers	had	the	
authority	to	prescribe	which	agents,	and	the	duration	of	treatment	allowed	without	further	
expert	review.	
Another	vital	strategy	to	control	antibiotic	prescribing	was	the	rationalisation	of	the	
antibiotics	available	for	use	at	hospital.	Doctor	and	nurse	participants	in	the	organisational	
leader	group	reported	this	strategy	impacted	on	the	available	antibiotic	lists	in	the	hospital	
and	each	specific	clinical	area.	A	doctor	participant	reported	removal	of	a	number	of	
outdated	or	unbeneficial	antibiotics	from	the	formulary	stocked	in	the	hospital	pharmacy	
department.		
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5.2.3.2	Pharmacy-driven	interventions	
Pharmacist	participants	identified	the	role	of	clinical	pharmacists	in	monitoring	the	
occurrence	of	errors	in	antibiotic	use	and	providing	advice	about	dose	optimisation	to	
prescribers.	One	of	the	major	roles	of	clinical	pharmacists	is	the	responsibility	for	
Therapeutic	Drug	Monitoring	(TDM),	to	ensure	dose-adjustment	and	dose-optimisation	is	
instigated	for	patients	who	are	prescribed	specific	antibiotics	such	as	Vancomycin.			
5.2.3.3	Syndrome-specific	measures	
More	recently	a	syndrome	specific	intervention	program	had	been	commenced	in	
the	outpatient	department	(OPD)	by	the	RDUSC.	This	interventional	called	‘Antibiotic	Smart	
Use’	(ASU)	was	implemented	for	specific	indications.	The	ASU	program	was	designed	to	
encourage	greater	awareness	by	doctors	of	appropriate	antibiotic	prescribing	for	patients	
attending	the	OPD	by	providing	them	with	evidence-based	treatment	guidelines.	The	first	
two	conditions	that	the	ASU	program	had	focused	on	were	appropriate	antibiotic	use	for	
Upper	Respiratory	Tract	Infection	(URTI)	and	diarrhoea.		
Additional	AMS	interventions	to	support	optimal	antibiotic	use	in	the	hospital	
included	the	provision	of	software	programs	for	decision	support	and	access	to	experts	for	
consultation	about	complex	cases.	The	hospital	provided	resources	for	prescribers	to	
support	decision	making	in	antibiotic	prescribing.	The	participants	reported	that	there	was	a	
software	application	(available	for	smart	phone	and	android	devices)	that	provided	detailed	
local	antibiogram	information	for	prescriber	decision	support.	The	software	application	
provided	data	to	support	prescribers	at	the	hospital	to	choose	antibiotics	that	were	targeted	
according	to	the	sensitivities	of	the	infecting	pathogens.	A	nurse	participant	from	
organisational	leader	group	reported	that	the	application	was	convenient	to	use	because	it	
could	be	downloaded	into	doctors’	smartphone,	which	encouraged	doctors	to	use	the	
information	more	often	than	was	previously	the	case	when	this	data	were	only	available	as	
hard	copies.		
A	system	to	support	prescribers	in	accessing	specialist	expertise	was	reported	as	a	
resource	for	better	antibiotic	prescribing	in	the	hospital.	The	consultation	system	included	
ID	specialists	and	clinical	pharmacists	who	could	provide	advice	in	regards	to	optimal	
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antibiotic	use	for	complex	clinical	cases.	The	ID	specialist	system	was	reported	to	increase	
access	to	expertise	by	the	doctor	and	ICN	participants.	A	doctor	participant	noted	that	this	
system	was	useful	in	providing	advice	when	the	antibiotic	dose	for	patients	with	
comorbidities	needed	to	be	adjusted.	
One	nurse	leader	discussed	the	strategy	of	making	antibiotics	less	accessible	in	the	
operation	rooms.	Previously	for	the	convenience	of	the	surgeons,	the	common	antibiotics	
used	for	surgical	prophylaxis	were	stocked	in	the	operating	room.	After	the	hospital	had	
launched	its	ASU	policy,	the	nurse	manager	applied	this	policy	by	not	stocking	routine	
antibiotics	in	the	operation	room,	thereby	making	antibiotics	less	accessible.	The	nurse	
manager	hoped	that	staff	would	think	more	carefully	about	their	use	and	consciously	plan	
for	what	antibiotics	were	required	for	surgical	prophylaxis	prior	to	commencement	of	the	
procedure.	By	requiring	conscious	planning	and	decision	making,	the	nurse	manager	hoped	
to	decrease	routine	antibiotic	use.		
A	small	number	of	participants	spoke	about	best	AMS	practice	in	regards	to	
controlling	antiviral	medication	prescribing.	Strict	governance	and	clear	processes	for	the	
implementation	of	policies	around	the	use	of	antiviral	medications	was	identified	as	a	key	
element	to	achieving	this	goal.	A	virologist	participant	described	that	in	Thailand,	the	
national	anti-viral	medication	guidelines	had	been	made	available	to	clinicians	along	with	
strict	national	policies	about	their	use.	Antiviral	prescribing	(HIV,	influenza)	is	overseen	by	ID	
physicians	although	all	doctors	are	eligible	to	prescribe	them	and	are	encouraged	to	consult	
ID	physicians	in	cases	of	advanced	viral	infections.	The	clear	processes	about	how	antiviral	
national	guidelines	policies	should	be	applied	in	practice	had	already	seen	improvements	in	
the	behaviours	and	caution	of	prescribers	about	the	use	of	antiviral	medications	in	the	
hospital.		
5.2.4	Tracking	and	reporting	antibiotic	use	and	outcomes	
Monitoring	antibiotic	prescribing	and	use,	as	well	as	tracking	local	patterns	of	
antibiotic	resistance,	combined	with	providing	timely	data	feedback	to	staff	are	suggested	
as	key	to	improving	antibiotic	use	and	decreasing	resistance	in	organisations	(CDC,	2014).	
Page	143	
	
	
The	participants	identified	the	systems	available	in	the	hospital	to	track	and	report	
antibiotic	use	and	outcomes.		
5.2.4.1	Tracking	and	reporting	antibiotic	use	
The	two	main	AMS	committees,	RDUSC	and	AVWG,	supported	by	the	IT	division	
were	responsible	for	tracking	and	reporting	antibiotic	use	across	the	hospital.	For	the	
outpatient	department,	the	RDUSC	monitors	the	volume	of	antibiotic	use	in	each	
department.	When	the	overall	antibiotics	used	by	a	particular	department	or	specialist	
group	is	high,	the	RDUSC	investigates	and	provides	feedback	to	that	department	or	
specialist	group	to	improve	their	antibiotic	prescribing	choices.	For	example,	this	committee	
might	provide	feedback	to	the	surgical	team	about	appropriate	surgical	antibiotic	
prophylaxis	in	terms	of	antibiotic	choice,	timing	and	duration	of	therapy.	At	the	same	time,	
the	RDUSC	has	a	role	in	tracking	antibiotic	prescribing	for	gastrointestinal	and	upper	
respiratory	tract	infections	in	the	outpatient	department.	
The	AVWG	specifically	monitors	carbapenem	use	in	all	departments	and	provides	
feedback	to	prescribers.	The	pharmacist	participants	reported	that	the	data	of	antibiotic	use	
such	as	volume	and	purchasing	are	available	on	the	hospital	intranet	system	and	that	
department	heads	and	individuals	can	access	the	data	via	this	site.	The	RDUSC	and	AVWG	
monitor	these	reports	and	report	data	on	antimicrobial	prescribing	and	consumption	to	the	
Pharmacy	and	Therapeutics	committee.	Although	the	data	about	antibiotic	use	is	available	
on	the	hospital	intranet	system,	these	data	are	not	reported	directly	to	frontline	staff	such	
as	nurses	and	doctors	working	in	the	clinical	areas.	Clinical	staff	do	not	therefore	receive	
data	relating	specifically	to	their	department	or	the	hospital	volumes	as	timely	or	ongoing	
feedback	about	their	prescribing	choices.	
5.2.4.2	Tracking	and	reporting	antibiotic	resistant	infection	and	treatment	outcomes	
Infection	control	nurses	based	in	the	IPC	Department	cooperate	with	the	IT	Division	
and	Microbiology	Department	to	monitor	the	incidence	of	antibiotic	resistant	bacteria	such	
as	methicillin-resistant	Staphylococcus	aureus	(MRSA),	carbapenem-resistant	
Enterobacteriaceae	(CRE),	vancomycin-resistant	enterococci	(VRE),	and	C.difficile	across	the	
hospital.	The	occurrence	of	patients	with	antibiotic	resistant	infections	are	reported	to	the	
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clinical	nurses	who	work	on	the	ward	so	that	the	frontline	nursing	staff	can	implement	
appropriate	IPC	measures	in	a	timely	manner.	ICNs	who	are	all	members	of	the	IPC	
committee	develop	a	three	monthly	report	for	the	committee,	for	each	clinical	area	
summarising	the	number	and	type	of	patients	admitted	with	resistant	infections.	The	IPC	
committee	then	reports	this	data	to	the	Healthcare	Service	committee	and	the	Faculty	
Executive	Committee	(the	hospital	board).	
At	the	same	time,	when	staff	working	in	the	hospital	wards	are	informed	by	the	
Microbiology	Department	about	a	new	patient	who	has	tested	positive	for	high	alert	multi-
drug	resistance	organisms	(for	example	VRE	or	CRE),	nursing	staff	will	notify	the	ICNs	and	ID	
specialists,	who	have	the	role	to	investigate	and	develop	procedures	to	minimise	the	spread	
of	the	identified	AMR	infections.	Additionally,	these	data	are	reported	to	the	IPC	Committee	
to	facilitate	communication	of	this	data	to	the	clinical	team	leaders	on	the	wards	and	
department	heads	so	that	strict	IPC	policies	and	procedures	are	implemented	across	the	
organisation.		
5.2.5	Staff	education	regarding	antimicrobial	resistance	and	antimicrobial	
stewradship		
Organisations	have	a	responsibility	to	provide	clinical	updates	and	education	on	
topics	such	as	antibiotic	prescribing,	AMR,	and	infectious	disease	management	to	all	
healthcare	professionals	(CDC,	2014).	According	to	participants,	the	case	study	hospital	
provides	training	courses	regarding	AMR	and	IPC	practice	to	healthcare	staff	routinely	and	
when	an	outbreak	occurs.		
5.2.5.1	Education	for	doctors	in	the	case	hospital		
For	doctors,	participants	identified	training	courses	to	treat	infectious	diseases	in	
both	the	undergraduate	course	and	in	postgraduate	training	sessions.	However,	one	
participant	noted,	“…doctors	are	trained	in	terms	of	diseases	and	their	treatment	but	not	in	
terms	of	stewardship	(D1)”.	There	was	a	shared	perception	that	doctors	tend	to	focus	on	the	
individual	patient	and	their	treatment	needs	rather	than	looking	at	optimal	antibiotic	use	
across	the	hospital	as	a	whole.	
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At	the	case	hospital,	the	undergraduate	medical	curriculum	includes	subjects	in	
microbiology	and	infectious	diseases	and	the	topic	of	Rational	Drug	Use	(RDU)	has	been	
added	recently.	In	relation	to	on	the	job	training,	participants	explained	that	resident	
medical	officers	received	additional	training	about	the	treatment	of	common	infectious	
diseases	seen	in	the	hospital.	As	stated	by	a	surgeon	participant,		
	“For	doctors,	the	basic	science	of	infectious	diseases	and	the	use	of	antibiotics	is	
already	a	topic	in	the	curriculum	and	it	is	part	of	the	surgical	trainees’	specialty	education	
program.	Residents	must	learn	and	pass	an	exam	[on	this	topic].	And	of	course,	surgeons	
must	have	basic	knowledge	about	antibiotics	and	what	should	be	used	with	which	
infections.”	(D2)		
The	chair	of	the	IPC	committee	was	mentioned	as	an	educator	who	had	conducted	
sessions	about	prophylactic	antibiotics	for	surgical	residents	along	with	organising	
additional	training	when	there	is	an	outbreak	in	the	hospital.		
5.2.5.2	Education	for	nurses	in	the	case	hospital		
Nurse	leaders	reported	that	the	training	courses	for	nurses	are	provided	regularly	by	
infection	control	nurses	on	a	twice	yearly	basis.	Topics	regarding	AMR	and	IPC	practice	such	
as	hand	hygiene,	isolation	precautions	and	personal	protective	equipment	(PPE)	are	
provided	for	nurses	and	nurse	assistants	and	particularly	target	nurses	who	are	working	in	
the	intensive	care	unit	(ICU).	The	IPC	department	that	includes	ID	specialists	and	infection	
control	nurses	run	these	training	sessions.	Additional	training	sessions	occur	when	the	rate	
of	antibiotic	resistance	is	high	as	an	alert	to	staff	of	the	problem.	As	stated	by	one	
participant,	“…Once	there	is	an	outbreak,	the	ID	doctor	will	communicate	with	the	executive	
nurses	to	pass	the	information	on	to	their	subordinates.	His	action	is	quite	timely.”	(N2).		
In	relation	to	AMS	and	antibiotic	use,	participants	reported	that	the	hospital	had	not	
provided	any	specific	education	sessions	for	ward	nurses,	however	education	about	AMS	
and	antibiotic	use	was	offered	to	students	undertaking	a	specialty-training	course	in	
infection	control.	As	part	of	this	specialty	course,	ID	specialists	are	invited	to	speak	about	
AMR	and	AMS.	Participants	discussed	that	the	concept	of	AMS	had	been	mentioned	in	the	
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general	hospital	training	for	nurses	when	a	speaker	introduced	a	topic	providing	background	
information	about	the	occurrence	of	AMR,	its	prevention	and	patient	outcomes.		
“According	to	the	concept	of	AMS,	students	who	undertake	a	4-months	specialty-
training	course	in	infection	control	are	provided	the	concept	of	AMS	when	a	speaker	
(an	ID	specialist)	talks	about	the	problem	of	AMR.”	(N3)	
5.2.5.3	Education	for	pharmacists	in	the	case	hospital		
According	to	pharmacist	leaders,	training	sessions	are	regularly	provided	for	
pharmacists	but	are	not	focused	on	best	practice	in	antibiotic	use.	The	need	for	pharmacists	
to	have	current	knowledge	of	the	vast	range	of	medicines	prescribed	across	the	hospital,	
emphasis	on	antibiotic	use	and	the	problem	of	AMR	to	the	exclusion	of	other	clinically	
important	topics	was	not	considered	feasible.	As	one	participant	stated,	“	…The	training	for	
pharmacists	[about	AMS]	is	not	a	priority.	”	(D1).	One	or	two	hospital	pharmacists	a	year	
however,	are	able	to	participate	in	continuing	education	opportunities.	For	example,	a	
program	named	‘The	Communities	of	Practice’,	organised	by	the	Association	of	Hospital	
Pharmacy	(Thailand)	and	the	Infectious	Diseases	Association	of	Thailand	that	focuses	on	
antibiotic	use,	antimicrobial	resistance	and	pharmacology	is	available.		
5.2.6	Section	summary	
Current	AMS	activities	at	the	study	hospital	are	reported	to	the	executive	leadership	
group	through	the	clinical	governance	structure	that	has	been	established	to	oversee	
medication	use	overall	at	the	study	hospital.	Based	on	the	findings	from	the	organisational	
leaders,	development	of	a	clinical	governance	structure,	and	organisational	policies	specific	
to	AMS	were	not	yet	developed	at	the	study	hospital.	This	is	discussed	in	more	detail	in	the	
following	section.		
A	wide	range	of	AMS	related	activities	were	being	run	at	the	study	hospital,	these	
included:	broad-based	restrictive	interventions	such	as	the	carbapenem	control	program,	
syndrome-specific	interventions	such	as	the	ASU	campaign,	and	projects	to	facilitate	
prescriber	decision	making	by	providing	access	to	infectious	diseases	specialist	consultations	
and	decision-support	applications	being	made	available	on	mobile	phones.	The	
organisational	leaders	reported	that	antibiotic	use,	and	the	incidence	of	AMR	infections	
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were	tracked	and	there	were	processes	in	place	to	report	this	information	to	the	hospital	
executive	committee	and	to	individual	prescribers.	In	addition,	AMS	and	AMR	training	were	
reported	as	being	provided	for	healthcare	staff.	
The	organisational	leaders	identified	that	there	are	specific	AMS	initiatives	that	
address	each	of	the	core	elements	of	AMS	recommended	by	the	CDC.	These	findings	
demonstrate	that	there	is	organisational	support	for	the	development	of	a	hospital-wide	
AMS	program	at	the	study	hospital.	Despite	these	positive	reports,	the	organisational	
leaders	and	clinical	nurses	interviewed	in	the	focus	groups	reported	that	there	were	
limitations	around	the	extent	to	which	these	initiatives	had	become	fully	operational	and	
had	been	embedded	into	clinical	practice	at	the	bedside.	
In	the	next	section	an	exploration	of	strengths	and	weaknesses	in	the	current	AMS	
clinical	governance	structure	and	activities	as	identified	by	organisational	leader	interviews	
and	the	clinical	ward	nurse	and	ICN	focus	groups	are	described.		
5.3	Perceived	strengths	and	weakness	of	current	clinical	governance	in	the	case	hospital		
Organisational	leaders	and	nurses	were	asked	to	consider	the	strengths	and	
weaknesses	of	current	clinical	governance	related	to	AMS	within	the	case	hospital.	The	
interviews	and	focus	groups	revealed	four	themes	related	to	the	level	of	leadership	
commitment	to	AMS:	(1)	executive	seen	to	endorse	but	not	support	AMS	activities;	(2)	lack	
of	AMS	policy	and	resources	to	optimise	antibiotic	prescribing,	tracking	and	reporting;	(3)	
lack	of	multidisciplinary	engagement	in	the	AMS	team;	and	(4)	that	knowledge	was	acquired	
through	experience	not	education	[Table	5.1].		
1)	Executive	seen	to	endorse	but	not	support	AMS	activities	
One	of	the	barriers	identified	by	the	organisational	leaders	to	developing	and	
implementing	a	sustainable	AMS	program	was	the	hospital	executive	group	were	seen	to	
endorse	having	an	AMS	program	at	the	study	hospital,	but	did	not	provide	additional	
support	for	program	development.	Sub-themes	related	to	this	major	theme	were	that	(i)	
authority	was	delegated	to	clinical	leaders	but	the	hospital	executive	were	not	actively	
engaged	in	promoting	AMS	across	the	organisation,	(ii)	the	AMS	clinical	champion	acts	as	
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lobbyist	to	obtain	executive	support	and	(iii)	in	contrast,	IPC	activities	are	seen	as	core	
hospital	business.		
1.1	Authority	delegated	to	clinical	leaders	but	executive	not	actively	engaged	
There	were	mixed	perceptions	about	executive	support	for	AMS	projects.	In	general,	
all	of	the	key	organisational	leaders,	clinical	nurses	and	ICNs	groups	perceived	that	hospital	
administrators	had	endorsed	the	introduction	of	the	AMS	program	at	the	case	hospital.	As	
participants	in	the	organisational	leader	interviews	and	clinical	nurse	group	identified,	a	
number	of	useful	AMS	activities	had	been	established	and	endorsed	by	the	hospital	
executive	such	as	the	Antibiotic	Smart	Use	(ASU)	project	and	the	program	to	control	
carbapenem	prescribing	[Table	5.1,	Q1,	Q2].	One	doctor	noted	that	senior	executives	were	
concerned	about	antibiotic	prescribing	within	the	hospital,	and	they	had	given	the	authority	
to	the	ID	doctors	to	resolve	this	problem	[Table	5.1,	Q3].	Despite	this,	there	was	a	
perception	that	the	senior	executives	at	the	study	hospital	were	not	fully	supportive	of	the	
AMS	program	and	did	not	provide	additional	financial	resources	to	support	the	
development	of	the	program.	One	doctor	participant	described	that	senior	executives	did	
not	consider	all	the	details	of	AMS	activities	[Table	5.1,	Q4]	and	another	identified	that	
there	was	no	additional	compensation	for	staff	to	be	involved	in	the	AMS	team	or	activities.	
The	organisational	leaders	reported	that	executive	level	support	for	AMS	activities	appeared	
to	be	intermittent,	and	that	this	was	challenging	when	intending	to	embed	a	sustainable	
program	of	AMS	activities	into	clinical	care	[Table	5.1,	Q5,	Q6].		 	
1.2	Central	clinical	champion	acts	as	a	lobbyist	
One	of	the	perceived	strengths	of	the	AMS	program	was	that	there	was	a	highly	
visible	clinical	champion	who	was	the	chair	of	the	AVWG,	the	RDUSC	and	the	IPC	
committees.	This	provided	strong	clinical	leadership	and	continuity	to	AMS	activities	across	
the	study	hospital.	The	organisational	leaders	and	nurse	participants	in	the	ICN	focus	group	
identified	how	the	proactive	actions	taken	by	this	clinical	leader	had	raised	the	profile	of	
AMS	at	an	executive	level.	For	example,	he	had	convinced	the	hospital	executive	committee	
that	AMR	and	AMS	are	major	problems	in	the	hospital	and	that	steps	should	be	taken	to	
address	these	issues	[Table	5.1,	Q7,	Q8].	Similarly,	a	doctor	participant	in	the	key	
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organisational	leader	group	agreed	that	the	IPC	chairman	performed	effectively	by	both	
promoting	and	championing	the	implementation	of	an	AMS	program.	Despite	this	it	was	
acknowledged	that	the	level	of	support	from	the	hospital	executive	committee	was	
intermittent	[Table	5.1,	Q6].	
1.3	IPC	activities	are	part	of	core	business	
In	contrast	to	the	intermittent	support	provide	for	the	AMS	programs	the	
organisational	leaders	recognised	that	there	was	strong	executive	level	support	for	IPC	
activities	and	that	these	activities	were	seen	to	be	part	of	core	hospital	business	[Table	5.1,	
Q9].	The	doctor	and	nurse	participants	perceived	that	the	hospital	executive	committee	
provided	high	level	support	for	projects	to	improve	IPC	practice	such	as	providing	support	to	
the	hand	hygiene	project,	which	cost	a	lot	of	money	to	maintain	[Table	5.1,	Q9-	Q10].	
Furthermore,	when	there	were	outbreaks	of	the	multidrug	resistant	organism	in	the	
hospital,	a	nurse	leader	reported,	that	the	senior	executives	of	the	hospital	completely	
supported	any	IPC	initiatives	or	actions	taken	by	ICN	team	(Table	5.1,	Q11).	It	appears	that	
this	finding	may	reflect	the	fact	that	AMS	is	a	relatively	new	concept	in	contrast	to	IPC	which	
is	recognised	standard	for	high	quality	care.	
2)	Lack	of	AMS	policies	and	resources	to	optimise,	track,	and	enforce	good	antimicrobial	
prescribing	practice.		
The	second	major	theme	identified	that	there	was	a	lack	of	formal	AMS	policies	and	
resources	to	optimise,	track	and	enforce	good	antimicrobial	prescribing	practice.	Sub-
themes	relating	to	this	major	theme	were	that	on	the	one	hand	prescribers	reported	that	
there	were	(2.1)	no	local	antibiotic	prescribing	guidelines	and	(2.2)	the	currently	IT	
infrastructure	at	the	study	hospital	was	inadequate	so	they	had	limited	access	to	resources	
to	support	good	prescribing	practice.	On	the	other	hand	as	there	were	gaps	in	the	current	
tracking	and	reporting	of	antimicrobial	prescribing	across	the	hospital,	prescribers	were	not	
accountable	for	their	decisions.	
2.1	No	formal	AMS	policy	and	antibiotic	guidelines	
	Organisational	leaders	and	clinical	nurses	perceived	that	an	important	barrier	to	
effective	implementation	of	AMS	programs	was	the	lack	of	formal	AMS	policies	and	
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antibiotic	guidelines.	Although	most	of	the	study	participants	recognised	that	the	IPC	
chairperson	was	a	strong	champion	of	AMS	as	this	was	the	only	individual	promoting	this	
issue,	it	was	thought	that	AMS	initiatives	had	not	penetrated	into	all	aspects	of	clinical	care	
provision.	A	pharmacist	participant	explained	that	the	lack	of	a	formal	policy	was	a	barrier	
to	continuing	and	embedding	AMS	activities	into	clinical	care	across	the	organisation	[Table	
5.1,	Q12].	Similarly,	a	junior	nurse	participant	who	worked	in	a	clinical	role	reported	that	
although	the	hospital	leadership	team	was	trying	to	raise	awareness	of	appropriate	
antibiotic	use,	the	practicality	of	how	to	implement	AMS	in	practice,	was	unclear	to	frontline	
staff	[Table	5.1,	Q14].		
Additionally,	the	lack	of	antibiotic	guidelines	developed	specifically	for	the	Thai	
context	was	considered	to	be	an	important	deficit	in	the	resources	available	to	support	the	
successful	implementation	of	AMS	policy.	Doctor	participants	in	the	organisational	leader	
group	reported	that	at	the	moment	there	were	no	national	or	local	antibiotic	guidelines,	
this	meant	that	they	had	to	rely	on	international	guidelines	that	did	not	take	into	
consideration	the	local	epidemiology	of	infections	and	patterns	of	antibiotic	sensitivities.	
[Table	5.1,	Q15].	In	contrast,	the	virologist	participant	identified	that	the	availability	of	
antiviral	prescribing	guidelines	was	one	of	the	key	elements	that	supported	the	success	of	
the	programs	controlling	use	of	anti-viral	medications	in	the	hospital	and	in	Thailand	as	a	
whole.	Participants	thought	that	the	lack	of	local	Thai	antibiotic	prescribing	guidelines	could	
decrease	clinician’s	confidence	that	the	guidelines	they	were	using	were	relevant	and	
appropriate	for	the	clinical	context	in	which	they	were	working	[Table	5.1,	Q16].	
2.2	Inadequate	IT	infrastructure	to	support	optimal	antibiotic	prescribing	
The	organisational	leaders	and	clinical	nurses	discussed	the	problem	of	limited	IT	
infrastructure	at	the	study	hospital	to	support	AMS	activities.	The	pharmacist	participant	
identified	that	the	current	IT	system	was	inadequate	and	did	not	have	the	capacity	to	
provide	the	bedside	clinician	with	decision	support	and	was	not	designed	to	link	pathology	
reports	(which	provide	information	about	the	organisms	cultured	and	their	antibiotic	
sensitivities)	to	patient	therapy	and	prescriptions	[Table	5.1,	Q17].	Similarly,	the	clinical	
nurses	also	mentioned	that	the	lack	of	effective	IT	systems	could	limit	their	role	in	
monitoring	the	appropriateness	of	antibiotic	prescribing	[Table	5.1,	Q18].	A	doctor	
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participant	suggested	that	the	hospital	executive	committee	was	supposed	to	support	the	
development	of	an	IT	system	that	would	support	the	introduction	of	decision	support	
software	for	prescribers	[Table	5.1,	Q19],	however	this	had	not	yet	been	made	available.	
2.3	Gaps	in	the	current	tracking	and	reporting	of	antimicrobial	use	
Both	the	organisational	leaders	and	the	clinical	nurses	interviewed	identified	gaps	in	
the	current	tracking	and	reporting	of	AMS	activities	and	practices.	Although	the	antibiotic	
tracking	and	reporting	system	was	available	in	the	hospital,	a	lack	of	a	systematical	process	
for	reporting	of	antimicrobial	use	was	identified	as	a	barrier	to	expanding	the	program	and	
fully	embedding	AMS	principles	into	practice.	A	doctor	participant	discussed	that	although	
the	hospital	had	a	system	to	control	some	specific	antibiotics,	an	improvement	in	antibiotic	
prescribing	would	only	progress	slowly	if	the	hospital	has	no	system	to	monitor	compliance	
[Table	5.1,	Q20].	Also,	nurse	and	doctor	participants	in	the	organisational	leader	group	
reported	that	the	reporting	system	at	the	study	hospital	for	antibiotic	use	was	not	
systematic	and	did	not	provide	timely	feedback	to	the	frontline	staff	[Table	5.1,	Q21-Q23].	
Clinical	nurses	reported	that	although	the	occurrence	of	AMR	was	tracked	and	reported	to	
frontline	staff,	the	lack	of	systems	to	support	monitoring	and	tracking	of	antibiotic	
prescribing	was	hampering	efforts	to	implement	a	sustainable	AMS	program	[Table	5.1,	
Q24,	Q25].	Additionally,	a	doctor	participant	suggested	that	a	prospective	audit	and	
feedback	system	should	be	set	up	in	the	hospital	in	order	to	improve	the	behaviour	of	
prescribers.	[Table	5.1,	Q26].	These	findings	indicate	that	although	antibiotic	use	is	reported	
through	the	RDUSC	to	the	hospital	executive	committee,	the	is	limited	feedback	provided	to	
individual	clinical	units	and	prescribers,	therefore	individual	prescribers	were	not	being	
made	accountable	for	their	own	practice.		
3)	Lack	of	multidisciplinary	engagement	in	AMS	team	
The	third	major	theme	to	emerge	from	the	organisational	leader	interviews	and	
focus	group	discussions	was	the	lack	of	multidisciplinary	engagement	in	the	AMS	team	and	
associated	activities.	The	identified	sub-themes	were	that	(3.1)	there	was	not	an	ideal	AMS	
team,	(3.2)	the	lack	of	doctor	engagement	in	AMS,	(3.3)	and	divergent	opinions	about	
nurses’	involvement	in	AMS	governance	and	on	the	AMS	team.	
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3.1	Not	an	ideal	AMS	team	
The	lack	of	multidisciplinary	engagement	in	AMS	was	identified	as	a	gap	in	the	
current	leadership	commitment	by	all	of	the	organisational	leaders,	clinical	nurses	and	ICNs	
groups.	It	was	identified	that	the	current,	membership	of	AVWG	and	RDUSC	in	the	hospital	
was	not	ideal	and	did	not	include	all	members	of	the	multidisciplinary	team.	A	doctor	
participant	explained	that	currently,	the	hospital	had	no	formal	AMS	policy	that	encouraged	
healthcare	staff	working	in	the	clinical	area	to	work	as	an	effective	multidisciplinary	AMS	
team.	Also,	there	was	no	extra	benefits	or	recognition	of	staff	who	participated	in	the	AMS	
team.	This	was	perceived	by	participants	as	an	obstacle	to	the	effective	promotion	of	the	
AMS	program	across	the	organisation	[Table	5.1,	Q27].	Another	pharmacist	in	the	
organisational	leader	group	reported	that	having	only	one	person	running	the	AMS	program	
is	problematic	and	the	lack	of	support	from	executive	staff	limited	the	programs	capacity	to	
introduce	and	mandate	change.	[Table	5.1,	Q28].	Additionally,	to	support	multidisciplinary	
teamwork	for	AMS,	it	was	suggested	that	training	of	the	of	all	clinicians	and	craft	groups	
across	the	organisation	was	needed.	[Table	5.1,	Q29]			
3.2	Lack	of	doctor	engagement	in	AMS	
Organisational	leaders	and	clinical	nurses	identified	a	lack	of	doctor	engagement	was	
one	of	the	barriers	to	multidisciplinary	involvement	in	AMS.	At	the	time	of	the	study,	the	
study	hospital	did	not	have	a	comprehensive	AMS	policy	that	covered	the	use	of	all	
antimicrobials,	therefore	the	AMS	team	leaders	had	limited	authority	over	doctor’s	
prescribing	choices.	Participants	from	the	organisational	leader	group	explained	that	as	the	
hospital	has	no	robust	system	to	monitor	or	limit	antibiotic	prescribing	overall,	individual	
prescribers	may	not	believe	that	they	are	accountable	for	their	antibiotic	use.	A	nurse	
leader	identified	that	some	doctors	might	not	consider	the	impact	of	their	individual	
prescribing	decisions	and	that	others	appeared	to	believe	that	they	were	too	senior	to	be	
made	accountable	to	the	hospital	executive.	[Table	5.1,	Q30].	Similarly,	another	nurse	
leader	identified	that	the	hospital	executive	had	limited	authority	over	some	senior	
members	of	the	medical	team	to	alter	their	current	practice	[Table	5.1,	Q31].	Additionally,	
the	doctor	and	junior	nurse	participants	raised	concerns	about	the	impact	of	the	hierarchy	
amongst	healthcare	professionals	on	developing	a	multidisciplinary	team	approach.	There	
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was	the	perception	that	doctors	had	more	power	than	other	healthcare	professions	and	had	
the	sole	authority	to	prescribe	medications	and	treatment.	There	was	the	perception	that	
doctors’	clinical	decision-making	could	not	be	challenged	by	other	members	of	the	team	
and	this	was	raised	as	a	barrier	to	full	doctor	engagement	in	AMS	program.	As	other	
members	of	the	multidisciplinary	team	were	not	empowered	to	question	their	treatment	
decisions	doctors	were	not	required	to	make	the	reasons	behind	for	their	treatment	choices	
transparent	and	were	not	being	made	accountable	for	their	prescribing	practice	[Table	5.1,	
Q32,	Q33].	
3.3	Divergent	opinions	about	nurses’	involvement	in	AMS		
There	were	differences	of	opinions	amongst	those	interviewed	about	whether	
nurses	should	be	involved	in	AMS	governance	and	whether	they	should	be	members	of	the	
AVWG	committee.	Doctors	from	the	organisational	leadership	group	identified	that	the	
membership	of	the	AVWG	was	not	the	ideal	group	to	support	AMS	activities	across	the	
organisation	or	to	form	the	basis	of	a	multidisciplinary	AMS	team.	A	number	of	participants	
explained	the	reason	why	nurses	have	not	had	a	formal	role	in	AMS	and	were	not	members	
of	this	committee	such	as	the	responsibilities	of	the	AVWG	were	not	directly	relevant	to	
nursing,	that	there	were	important	contributions	that	nurses	could	make	to	this	
committee’s	decision	making	[Table	5.1,	Q34].	One	doctor	participant	explained	that	the	
main	role	of	nurses	is	to	implement	and	support	effective	IPC	practice,	therefore,	it	was	
better	for	nurses	to	lead	IPC	activities	and	that	prevented	the	spread	of	AMR	infections	
across	the	hospital	rather	than	being	members	of	the	AVWG	committee	[Table	5.1,	Q35].		
As	nurses	were	responsible	for	antibiotic	administration,	patient	safety	and	
educational	activities,	some	study	participants	thought	that	nurses	should	be	the	members	
of	the	AVWG	committee	and	have	the	opportunity	to	participate	in	the	leadership	team	for	
AMS	activities	at	the	study	hospital.	A	pharmacist	participant	explained	that	because	the	
AVWG	was	linked	to	AMS	activities	such	as	Antibiotic	Smart	Use	program,	which	related	to	
nursing	care,	that	nurses	should	be	included	on	the	committee	overseeing	this	program	
[Table	5.1,	Q36].	A	doctor	participant	also	expressed	the	view	that	nurses	should	be	
involved	on	the	committee	as	this	group	was	making	decisions	that	affected	the	provision	of	
nursing	care.	Nurses	could	receive	antibiotic	use	policies	and	promote	implementation	of	
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these	recommendations	into	nursing	practice	in	activities	such	as	medication	
administration.	[Table	5.1,	Q37].	Furthermore,	nurse	participants	from	the	organisational	
leader	group	and	clinical	nurses	agreed	that	nurses	should	be	included	in	the	AVWG	team	in	
order	to	support	multidisciplinary	work	and	monitoring	of	patient	safety	in	antibiotic	use.	
[Table	5.1,	Q38,	Q39].	Nurse	leaders	and	nurses	from	the	ICN	focus	group	suggested	that	
nurses	who	get	involved	in	the	AVWG	should	have	experience	in	IPC	practice	or	sufficient	
relevant	clinical	practice	to	make	an	active	contribution	to	the	committee’s	decision-making	
processes	[Table	5.1,	Q40-	Q41].	However,	one	clinical	nurse	participant	suggested	that	
nurses	who	are	involved	on	the	AVWG	committee	should	work	in	a	clinical	ward	because	
they	understand	the	real	problems	faced	by	clinicians	providing	care	at	the	frontline	[Table	
5.1,	Q42].		
4)	Lack	of	clinician	expertise	and	education	about	AMS	is	a	major	hurdle		
The	fourth	major	theme	that	emerged	was	that	the	majority	of	clinicians	(from	
across	a	range	of	disciplines)	lacked	expertise	in	AMS	and	that	this	was	a	major	hurdle	that	
needed	to	be	overcome	before	the	principles	of	AMS	activities	could	be	consistently	
embedded	into	routine	clinical	care.	The	associated	sub-themes	were	that	clinicians’	AMS	
knowledge	was	acquired	through	clinical	experience	rather	than	formal	education	programs	
and	that	an	organisation-wide	structured	approach	to	AMS	education	was	needed	to	
address	this	knowledge	deficit.	
4.1	Knowledge	acquired	through	experience	not	education		
Knowledge	gaps	relating	to	appropriate	antibiotic	use	were	identified	across	all	
members	of	the	multidisciplinary	team.	All	of	the	participants	interviewed	reported	that	in	
general,	healthcare	staff	at	the	study	hospital	did	not	have	adequate	knowledge	about	AMS,	
and	how	AMS	principles	should	be	applied	in	practice.	Only	relatively	small	numbers	of	
professionals	who	had	experience	in	treating	patients	with	antibiotic	resistant	organisms	
were	recognised	as	having	expertise	in	antibiotic	prescribing	choices	and	treatment	
regimens.	Participants	from	the	organistaional	leadership	group	and	the	ICNs	perceived	that	
doctors’	knowledge	of	antibiotic	prescribing	depended	on	their	sub-specialty	area	of	
practice.	ID	specialists	and	paediatricians	were	recognised	as	having	a	high-level	knowledge	
Page	155	
	
	
in	antibiotic	prescribing.	[Table	5.1,	Q43,	Q44]	and	one	doctor	participant	indicated	that	
because	he	was	not	ID	specialist,	he	did	not	consider	himself	an	expert	in	AMS	[Table	5.1,	
Q45].	Participants	reported	that	variations	in	prescribers’	knowledge	and	clinical	experience	
resulted	in	variability	in	clinical	prescribing	practice	at	the	study	hospital.	The	availability	of	
expert	prescribers	overnight	and	on	weekends	was	identified	as	a	barrier	to	consistent	
implementation	of	AMS	principles.	One	nurse	leader	reported	that	they	had	noticed	that	
inappropriate	antibiotics	were	more	likely	to	be	prescribed	on	the	weekend	when	junior	
staff	had	less	access	to	expert	advice	[Table	5.1,	Q46].		
Both	nurse	leaders	and	clinical	nurses	reported	that	nurses	were	more	likely	than	
other	professionals	groups	to	have	a	sound	knowledge	of	IPC,	but	that	they	did	not	enough	
knowledge	to	evaluate	whether	antibiotic	prescribing	choices	were	appropriate	[Table	5.1,	
Q47].	Similar	to	other	professions,	nurses’	level	of	knowledge	about	antibiotic	use	
depended	on	their	sub	specialty	of	practice	and	experience	caring	for	patients	with	
antibiotic	resistant	infections.	Nurse	participants	from	organisational	leader	group	and	
clinical	nurses	agreed	that	ICNs	and	ICU	nurses	had	a	higher	level	of	knowledge	about	
appropriate	antibiotic	use	than	general	ward	nurses	[Table	5.1,	Q48].	The	nurse	participants	
expressed	the	view	that	nurses	typically	acquired	this	knowledge	by	direct	clinical	
experience	rather	than	through	a	formal	educational	program	[Table	5.1,	Q49].	Likewise	the	
pharmacists	interviewed	perceived	that	the	clinical	pharmacists	(particularly	those	on	the	
AMS	team	did	have	expert	knowledge	in	antibiotic	prescribing	and	use.	[Table	5.1,	Q50],	
however	not	all	pharmacists	were	experts	in	this	area	[Table	5.1,	Q51].		
4.2	Need	for	organisation-wide,	multi-disciplinary	antimicrobial	stewardship	
education	
All	the	study	participants	identified	that	knowledge	about	antibiotic	use	and	AMS	is	
based	on	clinical	experience	rather	than	on	formal	education	provided	by	the	study	hospital.	
A	pharmacist	participant	commented	that	the	current	AMS	training	were	not	
multidisciplinary	but	organised	separately	by	each	professional	group	[Table	5.1,	Q52].	The	
doctor	and	pharmacist	participants	suggested	that	the	hospital	should	provide	a	program	of	
multidisciplinary	AMS	training	[Table	5.1,	Q52-Q53].	Similarly,	an	ICN	participant	stated	the	
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hospital	should	organise	a	campaign	about	antibiotic	use	and	resistance	to	raise	awareness	
amongst	healthcare	staff	across	the	organisation	[Table	5.1,	Q54].			
5.3.1	Section	summary		
In	the	second	section	of	this	chapter,	the	data	from	organisational	leaders,	clinical	
nurses	and	infection	control	nurses	were	analysed	using	thematic	analysis.	The	results	show	
that	there	were	both	perceptions	of	strengths	and	weaknesses	of	the	current	clinical	
governance	structures	in	the	study	hospital.	The	study	participants	perceived	that	strong	
executive	level	support	IPC	activities	and	having	a	central	champion	for	AMS	activities	were	
advantages	of	the	current	clinical	governance	structure	at	the	study	hospital.	A	number	of	
important	barriers	to	the	implementation	of	a	sustainable,	organisation-wide	AMS	program	
were	identified	by	participants.	Participants	perceived	that	the	health	service	executive	
acknowledged	the	importance	of	tackling	the	issue	of	AMR	and	therefore	endorsed	the	roll-
out	of	a	number	of	AMS	projects	at	activities	at	the	study	hospital.	There	was	not	however	
organisational	investment	or	the	provision	of	sufficient	resources	(including	personnel,	IT	
infrastructure,	staff	education	and	training)	to	ensure	that	these	projects	were	sustainable.	
While	maintaining	a	high	standard	of	IPC	was	recognised	as	part	of	the	core	quality	and	
safety	agenda	of	the	hospital,	it	appears	from	the	participants’	responses	that	AMS	remains	
a	relatively	new	concept	and	that	AMS	activities	are	project	based	rather	than	fully	
integrated	into	the	clinical	governance	structure	of	the	health	service.	It	was	identified	that	
the	central	clinical	champion	made	a	major	contribution	by	lobbying	the	executive	team	to	
acknowledge	the	importance	of	AMS	and	to	support	AMS	activities	at	the	study	hospital.				
Participants	identified	that	a	multidisciplinary	approach	to	AMS	that	included	all	
healthcare	disciplines,	including	nursing,	was	an	important	gap	that	needed	to	be	addressed	
before	AMS	activities	could	be	integrated	into	clinical	care	across	the	whole	organisation.	
The	lack	of	a	formal	AMS	policy,	and	resources	to	monitor	antibiotic	prescribing	practice	
were	identified	as	barriers	to	achieving	full	engagement	of	clinicians	in	AMS.	It	was	also	
identified	that	without	the	appropriate	organisational	policies,	and	the	provision	of	ongoing	
audit	and	feedback	that	it	was	not	possible	to	make	all	prescribers	accountable	for	their	
antibiotic	prescribing	choices.	Variability	in	the	educational	preparation	of	prescribers’	and	
inadequate	access	to	evidence	–based	resources	were	seen	as	important	contributors	to	
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variation	in	antibiotic	prescribing	practice.	The	need	for	a	structured	multidisciplinary	AMS	
education	program	was	seen	as	essential	to	address	current	perceived	deficits	in	clinicians’	
knowledge	about	AMS.
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Table	5.1	Perceived	strengths	and	weakness	of	current	clinical	governance	in	the	case	hospital	
Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs	and	Clinical	nurses	
1.	Executive	
seen	to	endorse	
but	not	support	
AMS	activities	
Authority	
delegated	to	
clinical	leaders	
but	executive	
not	actively	
engaged	
Q1	“I	think	the	hospital	director	fully	supports	[AMS].	At	the	moment,	we	are	focusing	on	Antibiotic	Smart	Use	in	the	
Rational	Drug	Use	program.”	(P1)	
Q2	“I	think	that	the	senior	hospital	administrators	are	very	supportive.	We	know	that	ID	specialists	have	been	given	
authority	to	control	antibiotic	use	in	the	hospital.	If	they	[ID	specialists]	find	antibiotics	are	prescribed	inappropriately	they	
can	take	action.”	(D4)	
Q4	“It	[executive	support]	depends	on	the	level	of	administrator.	The	senior	executive,	they	probably	do	not	get	into	the	
details	[of	AMS	programs].	But	for	the	middle	managers	such	as	the	IPC	chairman,	he	is	very	involved”	(D3)	
Q5	“It	[AMS	leadership	support]	seems	good	but	I’m	not	sure	because	there	is	no	additional	compensation	and	staff	for	
AMS	team”	(D1)	
Q2	“I	think	the	hospital	executive	is	
aware	of	the	AMR	problem.	You	can	
firstly	see	from	the	program	in	
controlling	some	antibiotics	use,	such	
as	carbapenems	in	which	general	
doctors	are	limited	to	prescribing	[this	
antibiotic]	for	only	three	days.	After	
that,	they	have	to	consult	ID	specialist”	
(SRN3)	
	
		
		
Central	clinical	
champion	acts	
as	a	lobbyist	
Q6	"Personally	I	don't	think	the	senior	executives	are	fully	supportive	of	AMS	programs.	I	found	that	only	Dr.	[name]	is	
active	in	this	program	[AMS	programs].	I	have	not	seen	other	teams	or	staff	support	him	properly.	…..	Also,	when	Dr.	
[name]	presents	to	hospital	executive	committees,	the	committee	provided	just	intermittent	support.”	(P2)		
Q7	“Personally,	I	think	because	the	IPC	chairman	is	a	doctor	and	has	an	authority	to	approach	the	hospital	executive	
committee.	He	is	also	able	to	convince	them	that	they	should	be	concerned	about	this	problem	along	and	with	how	to	
implement	IPC	and	AMS	policies	within	the	hospital.”	(N3)		
Q8	“I	think	the	hospital	director	fully	
supports	[AMS	programs]	but	the	
chairman	[of	the	IPC	and	AVWG	
committees]	has	to	put	the	project	
forward.”	(ICN3)	
	 IPC	activities	
are	part	of	core	
business	
	
Q9	“Of	course,	we	[the	hospital	executive]	are	very	supportive.	The	IPC	committee	has	the	role	in	proposing	the	project,	
and	we	will	find	out	the	best	solution”	(D2)	Q9	“	I	think	the	hospital	executive	committee	support	us	very	well	especially	in	
relation	to	IPC	activities	for	example	the	hand	hygiene	campaign.	I	have	never	heard	that	they	rejected	even	one	project.”	
(N3)	
Q10	“When	I	identify	problems	and	suggest	a	policy	[IPC	activities],	the	senior	executives	always	support	us.”	(D3)	
Q11	“Once	we	had	an	outbreak	of	Vancomycin	Resistant	Enterococcus	(VRE)	in	the	hospital,	that	meant	that	everyone	in	
the	hospital	was	on	full	alert.	From	that	experience,	we	also	found	that	the	senior	executive	committee	launched	quickly	
into	action	implementing	a	policy	of	strict	patient	isolation	and	infection	control	precautions	along	with	controlling	
Vancomycin	prescribing.”(N5)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs	and	Clinical	nurses	
2.	Lack	of	AMS	
policies	and	
resources	to	
optimise	track	
and	enforce	
good	
antimicrobial	
prescribing	
practice	
No	formal	AMS	
policy	and	
antibiotic	
guidelines	
Q12	“They	[the	senior	executives]	have	not	been	consistent	in	establishing	a	formal	AMS	policy.	This	is	very	important	
barrier	[to	effective	program	implementation].”	(P2)	
Q13	“The	problem	is	we	[the	AMS	team]	report	the	volume	of	carbapenem	use	in	the	hospital	to	the	Pharmacy	and	
Therapeutics	Committee.	When	the	committee	[Pharmacy	and	Therapeutics	Committee]	see	the	data,	they	said	thank	
you	and	do	nothing.	(P2)			
Q15	“We	have	not	done	the	hospital	antibiotic	guidelines	yet.	At	present,	we	are	using	international	guidelines.”	(D1)	
Q16	“We	have	anti-viral	drug	use	guidelines	and	clear	work	flow	plan	that	is	regularly	updated.	They	were	developed	as	
national	guidelines.	It	is	a	very	useful	reference.	However,	there	is	no	guideline	for	antibiotics	which	doctors	who	are	
able	to	prescribe	from	all	departments	…	[could	consult].	When	guidelines	are	absent,	it	is	hard	to	control	antibiotics	
use.”	(L1)	
Q14	“I	think	they	give	priority	to	the	
issue	of	AMS,	but	the	policy	that	is	
communicated	to	frontline	staff	is	still	
not	clear,	it	only	raises	awareness.”	
(JRN4)	
	
	 Inadequate	IT	
infrastructure	
to	support	
optimal	
antibiotic	
prescribing	
Q17	“The	missing	program	right	now	is	the	program	that	links	the	data	between	antibiotic	prescribe	and	microbiology	
laboratory	reporting	sensitivities.”	(P2)		
Q19	“We	heard	that	the	AMS	team	was	trying	to	develop	the	guidelines	of	antibiotic	prescribing	in	the	hospital.	
Once	we	had	some	training	about	antibiotic	use	and	we	got	some	antibiotic	use	guidelines	as	a	paper	copy	which	
was	easy	to	lose.	It	would	be	better	if	we	have	a	smart	application	or	decision	support	software	on	the	hospital	
intranet	that	we	can	access	everywhere,	whenever	we	have	to	prescribe	antibiotics.”	(D5)	
Q18	“If	we	had	a	system	that	identified	
particular	bacteria	and	could	indicate	
what	antibiotics	we	should	give	to	the	
patient	[that	match	that	organism’s	
bacterial	sensitivities]	that	would	help	us.	
At	the	moment,	we	do	not	have	anything	
like	that.”	(JRN4)	
	 Gaps	in	the	
current	tracking	
and	reporting	
of	antimicrobial	
use	
Q20	“We	have	a	program	to	control	carbapenem	prescribing,	but	we	should	monitor	the	compliance	with	this	program	
too.”	(D2)	“	
Q21	“We	do	not	have	a	systematic	approach	to	reporting	antibiotic	use	[to	the	clinical	staff].	Although,	if	the	healthcare	
staff	would	like	to	know	this	data	they	can	access	it	through	the	hospital	database.”	(N4)	
Q22	“Dr.	K	is	monitoring	antibiotic	use	in	the	hospital	but	we	do	not	systematically	report	either	the	volume	of	antibiotic	
use	or	the	[incidence	of]	multiple	drug	resistant	organisms.	Personally	I	would	like	the	data	to	be	reported	to	frontline	
staff	such	as	nurses	and	nurse	assistants.”	(N6)	
Q23	“These	days	we	do	not	receive	a	report	about	antibiotic	use	in	the	hospital	that	is	specific	enough.	I	believed	that	
every	doctor	would	be	interested	in	the	overall	use	of	antibiotics.	Last	time	we	[surgeons]	received	the	surgical	site	
infections	report,	I	noticed	that	they	all	looked	so	excited	to	see	their	operation	outcomes	reported.”	(D5)	
Q24	“We	know	that	there	is	a	serious	
problem	of	antimicrobial	resistance	in	
the	hospital,…	for	example,	when	there	
was	an	outbreak	of	VRE,	we	were	on	high	
alert.		
There	is	only	a	report	specifically	about	
patients	with	antimicrobial	resistance.	
But	we	do	not	have	an	overview	of	the	
infections	in	the	hospital	overall.”	(JRN	6)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs	and	Clinical	nurses	
2.	Lack	of	
AMS	policies	
and	resources	
to	optimise	
track	and	
enforce	good	
antimicrobial	
prescribing	
practice	
(Cont)	
Gaps	in	the	
current	
tracking	and	
reporting	of	
antimicrobial	
use	(cont)	
Q26	“	I	would	like	to	have	prospective	audit	and	feedback	systemthat	included	annual	reporting.	Say,	each	
year	every	department	receives	feedback,	an	antibiotic	prescribing	report.	Personally,	I	would	accept	the	
feedback	because	I	am	afraid	that	my	patients	may	get	AMR	infections	too.	I	believe	everyone	wants	his	or	
her	patients	to	experience	AMR	infections	as	little	as	possible.	If	we	don’t	start	taking	action	and	no	
feedback	is	provided,	we	will	never	know	when	our	prescribing	practice	is	poor,	and	everyone	has	only	
excuses	[for	their	prescribing	choices].”	(D5)	
Q25	“	At	the	moment,	we	have	not	yet	
received	a	report	about	the	amount	of	
antibiotics	we	used	and	how	much	it	cost.	
It	would	be	good	if	we	have	those	reports	
made	available.	It	may	make	us	more	
aware	of	using	antibiotics	wisely	and	we	
don’t	want	to	waste	money.	At	least	
reporting	to	us	once	a	year	would	be	
good”.	(SRN4)	
3.	Lack	of	
multidisciplinary	
engagement	in	
AMS	team	
Not	an	ideal	
AMS	team	
and	training	
Q27	“It	[AMS	leadership	support]	seems	good	but	I’m	not	sure	because	there	is	no	additional	compensation	and	staff.	
They	[the	hospital	executive]	do	not	distribute	pharmacists	or	nurses	to	be	part	of	the	team.	It	is	not	an	ideal	AMS	team	
right	now.	At	the	moment,	we	ask	each	department	for	help	but	they	already	have	their	own	duties.	It’s	not	an	AMS	
system	like	other	countries	that	has	a	full-time	job	for	members	of	the	AMS	team.”	(D1)	
	
	 	 Q28	"	….I	found	that	only	Dr	K	has	been	taking	action	in	this	program	[AMS	programs].	I	have	not	seen	other	teams	or	
staff	support	him	properly.	Dr	K	was	trying	to	ask	the	pharmacist	team	and	pediatric	ID	specialist	team	to	participate	AMS	
team.“	(P2)	
Q29	“It	seems	like	each	profession	has	their	training,	but	there	is	no	multidisciplinary	training	or	a	multidisciplinary	
conference.	We	have	not	had	a	multidisciplinary	conference	in	which,	an	ID	specialist	educates	staff	about	antimicrobial	
resistance,	a	microbiologist	presents	on	the	microbiology	of	AMR,	and	pharmacists	talk	about	dose	adjustment	yet”	(P2)	
	
	 Lack	of	
doctor	
engagement	
in	AMS	
Q30	“Although	we	realised	that	the	senior	executives	give	priority	to	this	issue	[AMS]	more	than	before,	but	there	is	a	
group	of	doctors	that	still	use	antibiotics	improperly	even	though	several	antibiotics	have	restricted	prescribing.	For	
example,	one	particular	department	has	prescribed	a	lot	of	Augmentin	even	if	[patients]	only	have	a	mild	sore	throat.	The	
hospital	policy	is	going	to	address	this	problem.”	(N2)	
Q31	“I	thought	the	senior	executives	have	not	been	strong	enough	to	control	antibiotic	prescribing	in	the	hospital.	Some	
doctors	use	high-level	broad-spectrum	antibiotics	as	prophylactic	antibiotics	prior	to	surgery.	Even	though	the	hospital	
leaders	have	discussed	this	with	him..	[that	it	is	not	ideal	practice]…he	doesn’t	care	and	keeps	on	prescribing	that	
antibiotic.”	(N4)	
Q32	“Most	importantly,	in	our	country,	doctors	have	too	much	power,	so	there	would	be	no	accepting	of	other	
professional	groups	[becoming	involved	in	AMS]	if	it	[the	extension	of	their	role]	would	interfere	with	doctors’	
[professional]	boundaries”	(D1)	
Q33	“I	think	it’s	about	the	power	to	
make	a	decision,	like,	when	we	
[nurses]	notice	that	a	doctor	has	
prescribed	antibiotics	at	a	high	dose,	
we	[nurses]	and	the	pharmacist	tried	
to	remind	the	doctor	[that	this	is	not	
ideal	practice],	but	he/she	insisted	on	
the	same	order.	Some	doctors	have	
huge	egos.	They	think	they	have	
more	power.	They	feel	that	they	lose	
authority	when	we	oppose	them.”	
(JRN4)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs	and	Clinical	nurses	
3.	Lack	of	
multidisciplinary	
engagement	in	
AMS	team	(Cont)	
Divergent	
opinions	
about	the	
participation	
of	nurses	in	
AMS		
Q34	“Personally,	I	thought	that	it	is	okay	if	nurses	are	not	involved	on	this	[AVWG]	committee	because	they	
consider	what	antibiotics	should	be	available	in	the	hospital.	The	members	consider	in	detail	antimicrobial	
pharmacodynamics,	which	might	not	relate	to	nursing	knowledge.	If	nurses	would	like	to	get	involved	on	this	
committee	those	nurses	should	have	an	in-depth	knowledge	of	the	pharmacology	of	antibiotics.”	(D4)	
Q35	“Currently,	nurses	have	a	role	in	infection	and	prevention	control	committee	where	they	monitor	
prevention	and	control	of	antimicrobial	resistance”	(D1)			
Q36	“The	Pharmaceutical	Consideration	sub-committees	consider	treatment	choices	for	cardiovascular,	pain,	
bone	and	joints,	and		digestive	tract	conditions,	including	the	use	of	antibiotics.	These	committees	do	not	
include	nurses	because	it	is	all	about	considering	the	list	of	medicines	available	in	the	hospital	or	to	specify	who	
can	prescribe	particular	medications	and	to	determine	if	[a	patient]	is	eligible	for	a	health	insurance	scheme.	
Actually,	nurses	were	in	those	groups,	but	they	said	there	is	nothing	related	to	their	professional	role.	They	do	
not	have	an	authority	to	control	or	prescribe.	However,	I	agree	that	nurses	should	be	included	in	the	
Antibiotics	and	Vaccines	team	because	there	are	other	activities	e.g.	Antibiotics	Smart	Use	program	in	OPD	
which	is	quite	related	to	nursing	care.	I	think	nurses	should	be	in	this	team	because	they	could	receive	the	
policies	and	implement	these	in	their	practice”	(P1)	
Q37	“If	the	Antibiotics	and	Vaccines	team	considers	how	medication	are	administrated	such	as	how	to	drip	
[administer]	each	antibiotic.	Nurses	should	be	involved	because	all	of	the	multidisciplinary	team	should	be”	
(D4)		
Q38	“In	my	opinion,	if	this	team	[the	Antibiotics	and	Vaccines	committee	members]	have	pharmacists,	they	
should	have	a	nurse	as	well.	Pharmacists	might	have	more	knowledge	about	medicines,	but	my	question	is	
whether	they	know	more	about	the	patients	or	not?	Do	they	check	the	lab	results?	I	do	not	think	so.	Thus,	I	
think	this	team	should	have	physicians,	nurses	and	pharmacists	working	together.”	(N2)	
Q40	“I	would	like	to	have	at	least	one	infection	control	nurse	involved	on	the	Antibiotics	and	Vaccines	team	
because	at	least	infection	control	nurses	do	surveillance	of	AMR	in	the	hospital.	That	would	give	us	continuity	
and	clarity	to	support	the	AMS	work.”	(N3)	
Q39	“I	think	we	should	have	nurses	in	this	
committee	[AVWG]	because	nurses	are	
involved	with	administering	antibiotic	
therapy	24	hours/day.	We	know	the	
conditions	of	the	patients.	We	know	what	
medications	they	are	allergic	to.”	(JRN6)	
	
Q41	“Nurses	who	participate	in	this	board	
should	be	senior	nurses	such	as	the	charge	
nurse	of	the	ward	and	I	think	an	ICN	should	
also	participate	in	order	to	update	[staff]	on	
the	situation	in	regards	to	using	antibiotics	
and	to	see	the	whole	picture	of	antibiotic	
use	across	the	hospital”	(ICN1)	
	
Q42	“I	think	[the	committee]	should	have	
nurses	from	different	levels	on	this	board	
because	sometimes	the	executives	do	not	
know	the	problems	or	things	we	really	
encounter	[on	the	ward],	even	ICNs	do	not	
work	with	the	patients	all	the	time.”	(JRN4)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Key	organisational	leaders	 ICNs	and	Clinical	nurses	
4.	Lack	of	clinician	
expertise	and	
education	about	
AMS	is	a	major	
hurdle	
	Knowledge	
acquired	through	
experience	not	
education	
Q43	“[as	they	have	more	knowledge…]	ID	specialists	and	pediatrics	are	more	concerned	about	antibiotic	use.	
Surgical	doctors	and	gynecologists	have	less	knowledge	about	this	issue.”	(N3)		
Q45	“I	have	not	much	knowledge	in	antibiotic	use,	particularly	the	mechanisms	of	AMR,	how	to	use	
antibiotics	appropriately	to	reduce	AMR,	also	the	best	route	of	antibiotic	administration	to	use.”	(D5)	
Q46	“I	have	noticed	that	on	weekends	broad-spectrum	antibiotics	are	prescribed	a	lot.	Then	on	Monday	the	
ID	fellows	and	staff	come	to	change	that.”	(N6)	
Q47	“Nurses	have	a	good	knowledge	about	how	to	isolate	patients	who	have	infectious	diseases.	Probably	
they	[nurses]	have	knowledge	more	than	doctors	in	isolation	precautions.	But	nurses	do	not	have	much	
knowledge	about	antibiotic	use.”	(N3)	
Q49	“About	antibiotic	use,	nurses	who	take	care	patients	who	have	AMR	infections	would	be	more	
knowledgeable.	For	example,	when	there	was	CRE	outbreak	in	the	hospital,	nurses	would	know	that	[a	
contributing	factor]	was	that	patients	had	used	carbapenem	inappropriately	of	or	when	there	was	a	VRE	
outbreak,	nurses	knew	that	this	is	caused	by	Vancomycin.	Nurses	also	realised	that	even	though	some	
patients	did	not	use	those	antibiotics,	but	they	still	developed	the	infections	[with	resistant	organisms],	which	
meant	that	there	had	been	the	transmission	of	pathogens	[between	patients].	Through	this	experience,	I	
believe	that	nurses	have	gained	more	knowledge.”	(N6)	
Q50	“In	general,	pharmacists	have	basic	knowledge	about	antibiotic	use	particularly	clinical	pharmacists”	(P3)	
Q51	“Not	all	pharmacists	know	all	about	antibiotic	use	because	they	get	less	involved	with	AMR	pathogens.	
Only	clinical	pharmacists	have	expertise	in	antibiotics.	But	they	would	know	more	about	antibiotics	than	
nurses.”	(P2)	 	
Q44	“For	doctors,	[I]	think	they	
have	good	knowledge	about	
antimicrobial	resistance	and	use,	
particularly	ID	specialists	they	have,	
well	both	knowledge	about	
antibiotics	and	infection	and	
prevention	control	practice.	(ICN	2)	
	
Q48	“Actually	from	my	experience,	
if	we	regularly	use	particular	
antibiotics	for	specific	patient	types,	
we	eventually	remember	it	[the	
indication	for	antibiotics],	but	[our	
knowledge]	is	not	in	depth.”	(SRN	2)	
	 Need	for	
organisation-
wide,	multi-
disciplinary	AMS	
education		
Q52	“It	seems	like	each	profession	has	their	training,	but	there	is	no	multidisciplinary	training	or	a	
multidisciplinary	conference.	We	have	not	yet	had	the	conference	that,	an	ID	specialist	educates	about	
antimicrobial	resistance,	a	microbiologist	presents	microbiology,	and	pharmacists	talk	about	dose	adjustment	
”	(P2)	
Q53	“We	should	have	the	conference	like	the	IPC	conference	which	have	doctors	nurses	and	pharmacists	as	
speakers	annually.	Each	department	has	to	send	their	staff	to	attend	to	update	their	knowledge	along	with	
presenting	antibiotic	use	of	their	own	department.	In	addition,	the	report	of	the	overall	antibiotic	use	in	the	
hospital,	the	top	ten	of	adverse	drug	reactions	to	antibiotics	should	be	presented	at	the	conference.”	(D5)	
	
Q54	“We	should	have	a	campaign	to	
empower	personnel	to	see	the	
importance	of	it	[antibiotic	use	and	
resistance].”	(ICN1)	
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5.4	Discussion	
Four	major	topics	findings	emerged	from	the	key	stakeholder	interviews	and	
focus	groups.	The	discussion	topics	of	leadership	commitment,	accountability	and	
drug	expertise,	AMS	Interventions	and	AMS	training	and	education	are	presented	in	
the	section	to	follow.		
5.4.1	Leadership	commitment	 	
To	initiate	AMS	programs,	international	guidelines	suggest	that	a	clinical	
champion	such	as	an	ID	physician	and/or	clinical	pharmacist	provide	leadership	as	a	
minimum	requirement	for	an	effective	program	(CDC,	2014;	Doron	&	Davidson,	2011;	
Duguid	&	Cruickshank,	2011).	Participants	perceived	that	at	the	study	hospital	there	
was	a	high	profile,	expert,	who	was	successfully	providing	leadership	and	direction	
for	new	AMS	initiatives.	Previous	studies	in	Australia	also	recommended	ensuring	
support	and	authorisation	from	the	organisation’s	executive	leadership	and	
involvement	of	key	clinical	stakeholders	before	implementation	of	AMS	programs	as	
this	would	result	in	successful	uptake	of	the	program	(Cotta	et	al.,	2015;	Loh	et	al.,	
2015a).		
Several	studies	showed	that	clinical	champions,	from	disciplines	such	as	
infectious	diseases,	pharmacy	and	microbiology,	typically	led	successful	AMS	
programs	(Septimus	&	Owens,	2011;	Yam,	Fales,	Jemison,	Gillum,	&	Bernstein,	2012).	
In	this,	study	the	participants	recognised	that	because	the	local	AMS	champion	is	a	
doctor	and	a	recognised	expert	in	the	field,	it	was	easier	to	convince	the	hospital	
executive	committee	and	clinicians	to	support	AMS	activities.	An	American	study	that	
interviewed	physicians	and	pharmacists	about	the	key	to	successful	AMS	programs	
found	that	these	stakeholders	believed	that	the	having	a	dedicated	physician	as	a	
program	champion	increased	the	likelihood	of	success	(Pakyz	et	al.,	2014b).	A	study	
of	the	key	influences	on	successful	implementation	of	AMS	programs	in	Canada	
found	that	having	a	strong	program	leader	was	the	vital	factor	needed	to	inspire	
other	clinicians	to	participate	in	AMS	programs	and	to	have	an	impact	on	optimal	
antimicrobial	use	(Jeffs	et	al.,	2015).		
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The	CDC	recommendations	for	Core	Elements	of	Hospital	Antibiotic	
Stewardship	Programs	also	identified	that	to	achieve	an	effective	AMS	program,	a	
highly	respected	and	recognisable	physician	leader	was	needed	to	both	oversee	the	
program	and	to	obtain	support	from	the	hospital	executive	(Pollack	&	Srinivasan,	
2014).	In	this	study,	the	AMS	clinical	champion	is	a	doctor	who	is	also	the	chair	of	the	
IPC	committee,	and	this	appears	to	have	strengthened	the	integration	of	IPC	and	
AMS	activities	at	the	study	site.	The	strength	of	having	the	same	person	leading	AMS	
and	IPC	programs	is	that	it	improves	the	flow	of	information	and	facilitates	
implementation	of	policy	from	the	hospital	executive	level	into	practice	by	front	line	
staff.	
A	potential	disadvantage	of	this	approach	is	that	implementing	IPC	policies	
and	AMS	policies	in	tandem	could	confuse	healthcare	workers	about	reporting	lines	
and	the	responsibilities	of	different	members	of	the	multidisciplinary	team.	Some	
participants	in	our	study	expressed	the	view	that	AMS	is	about	doctors’	and	
pharmacists’	practice	while	nurses	are	the	major	professional	group	responsible	for	
IPC	activities.	By	integrating	the	leadership	of	these	two	programs,	there	is	the	
potential	to	underplay	the	importance	and	contribution	of	nurses	(Laundy,	Gilchrist,	
&	Whitney,	2016).	This	highlights	the	need	to	proactively	encourage	a	
multidisciplinary	team	approach	to	AMS	implementation	so	that	clinicians	are	aware	
that	AMS	is	everyone’s	business.	
The	CDC	recommendations	for	the	core	elements	of	AMS	programs	suggest	
that	the	hospital	administrators	should	provide	ease	of	access	to	current	clinical	
guidelines	for	all	clinicians	(CDC,	2014).	It	is	recommended	that	guidance	should	be	
available	to	guide	prescribing	decision-making	for	both	infection	treatment	and	
prophylaxis	(CDC,	2014;	Nathwani,	2006).	Previous	studies	suggest,	implementing	
clinical	guidelines	that	take	into	account	local	microbiology	and	antimicrobial	
susceptibility	patterns	are	an	essential	element	in	an	effective	AMS	strategy	(James	
et	al.,	2013;	Pakyz	et	al.,	2014b).	In	this	study,	the	lack	of	local	antimicrobial	
guidelines	was	mentioned	as	a	substantial	barrier	to	effective	AMS	implementation	
at	a	local	level.	Participants	in	this	study	reported	that	prescribers	were	using	
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international	antimicrobial	guidelines	that	did	not	take	into	account	local	bacterial	
ecology	or	resistance	patterns.	The	lack	of	easily	accessible,	locally	relevant	decision	
support	systems	appeared	to	undermine	local	AMS	initiatives.	A	recurring	theme	
through	the	stakeholder	interviews	and	focus	groups	was	that	prescribers	lacked	
knowledge	and	skills	around	appropriate	antibiotic	choice	and	that	accessing	
expertise	was	difficult	in	a	busy	clinical	environment.	
Inadequate	IT	resources	to	support	decision-making	and	monitoring	of	
antimicrobial	use	were	reported	as	a	gap	in	the	local	AMS	program	at	the	study	
hospital.	Previous	studies	have	identified	that	a	lack	of	electronic	decision-support	
tools	deceases	appropriate	antibiotic	prescribing	(Pakyz	et	al.,	2014b).	At	the	study	
hospital,	there	are	currently	computerised	surveillance	systems	being	used	to	control	
carbapenem	use,	and	a	smart	phone	application	has	been	introduced	that	provide	
clinicians	with	antibiogram	data.	While	acknowledging	the	usefulness	of	these	
initiatives,	the	study	participants	indicated	that	they	needed	additional	access	to	
locally	relevant	decision–support	software	at	the	bedside.		
Clinical	surveillance	systems	that	are	able	to	provide	prescribers	with	updates	
and	decision-support	in	real-time	are	considered	to	be	key	to	effective	
implementation	of	AMS	programs	(Dellit	et	al.,	2007;	Pakyz	et	al.,	2014b).	A	previous	
study	showed	that	IT	systems	that	provide	clinical	decision	support	when	selecting	
appropriate	antibiotic	therapy	improved	antibiotic	prescribing	practices	in	Australia	
(Buising	et	al.,	2008a;	Dellit	et	al.,	2007)	suggest	that	a	software	program	that	
analyses	patients’	antibiotic	prescriptions	and	matches	these	with	their	microbiology	
results	to	provide	clinicians	with	automated	updates	and	real-time	information	could	
be	used	to	improve	antibiotic	prescribing	practice.	This	type	of	data	linkage	and	
decision	support	is	however	dependent	on	having	adequate	IT	infrastructure	in	the	
health	service,	and	electronic	prescribing	
5.4.2	Accountability	and	drug	expertise	
International	AMS	guidelines	such	as	those	from	the	USA,	Australia,	Scotland	
and	the	UK	recommend	that	hospital-wide	multidisciplinary	approach	is	considered	
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to	be	effective	and	best	practice	in	AMS	programs	(CDC,	2014;	Duguid	&	Cruickshank,	
2011;	Lin	et	al.,	2013a;	Nathwani,	2006;	SACAR,	2007).	In	this	study	however,	the	lack	
of	a	multidisciplinary	team	approach	was	identified	as	one	of	the	barriers	in	the	
current	AMS	programs.	From	the	key	stakeholder	interviews,	it	appears	that	not	all	
members	of	the	multidisciplinary	team	were	engaged	with	the	hospital	AMS	
program.	As	several	studies	have	demonstrated	that	a	multidisciplinary	AMS	team	
impacts	on	patient	safety	and	healthcare	cost	outcomes,	this	is	an	important	gap	in	
AMS	activities	at	the	study	hospital.		
One	Australian	study	of	a	rapid	review	by	a	multidisciplinary	AMS	team	found	
improvements	in	the	time	to	and	use	of	appropriate	antimicrobial	therapy	(Cairns	et	
al.,	2016).	In	a	tertiary	hospital	in	Singapore,	the	AMS	multidisciplinary	team	provided	
prospective	review	with	immediate	concurrent	feedback	to	prescribers	and	found	a	
decrease	in	the	duration	of	antimicrobial	use	in	renal	patients	(Cai	et	al.,	2016).	In	
Taiwan,	the	cooperation	of	an	AMS	multidisciplinary	team	including	infection	
diseases	specialists,	attending	physicians,	clinical	pharmacists,	nurses,	and	laboratory	
scientists	resulted	in	decreasing	antibiotic	cost	and	consumption	in	a	community	
healthcare	hospital	(Lin	et	al.,	2013b).	Another	Australian	study	concluded	that	AMS	
programs	would	be	effective	if	all	healthcare	staff	participate	and	understand	how	
they	could	contribute	to	the	program	(Cotta	et	al.,	2014).	These	studies	confirm	that	
a	multidisciplinary	team	needs	to	be	established	at	the	study	hospital	to	support	AMS	
implementation.		
In	the	current	study	a	lack	of	clarity	about	the	AMS	clinical	governance	
structure	and	the	roles	and	responsibilities	of	clinical	staff	was	identified	as	a	barrier	
for	clinicians,	as	they	were	unclear	when	and	how	they	could	be	involved	in	AMS	
activities.	Core	Elements	of	Hospital	Antibiotic	Stewardship	Programs	(2014)	
recommended	that	barriers	to	effective	implementation	of	AMS	could	be	overcome	
by	providing	a	formal	hospital	AMS	policy.	This	policy	should	describe	key	AMS	
related	activities,	specify	performance	criteria	in	staff	job	descriptions,	and	include	
participation	in	AMS	activities	in	staff	members’	annual	performance	reviews.	
Additionally,	a	full-time	dedicated	multidisciplinary	team	was	recognised	as	
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fundamental	to	maintaining	AMS	activities	and	improving	clinical	and	economic	
outcomes	(Paskovaty	et	al.,	2005b).	Therefore,	developing	a	clear	clinical	AMS	
structure,	establishment	of	a	multidisciplinary	AMS	team	and	a	policy	that	describes	
AMS	responsibilities	for	clinical	staff	(including	nursing	and	allied	health)	is	suggested	
as	important	next	steps	to	imbed	AMS	activities	into	clinical	care	at	the	study	
hospital.	
5.4.3	Antimicrobial	stewardship	interventions	
The	study	participants	reported	that	current	interventions	to	improve	
antibiotic	use	in	the	hospital	were	operating	in	both	outpatient	and	inpatient	
departments.	The	introduction	of	a	number	of	quality	improvement	projects	
targeting	antimicrobial	prescribing	such	as	the	‘Antibiotic	Smart	Use’	campaign	in	the	
outpatients	department	(OPD)	and	the	carbapenem	control	program	in	inpatient	
department	were	perceived	as	strengths	of	the	current	AMS	initiatives	at	the	study	
hospital.	The	outpatient	project	is	a	syndrome	specific	intervention	that	focuses	on	
improving	prescribing	for	Upper	Respiratory	Tract	Infection	(URTI)	and	diarrhoea.	
This	is	in-line	with	international	AMS	initiatives	for	ambulatory	and	outpatient	care;	a	
systemic	review	in	2015	showed	that	most	AMS	activities	in	outpatient	settings	
target	treatment	of	respiratory	tract	infections	(Drekonja	et	al.,	2015a).	Similarly,	
acute	respiratory	tract	infections	(ARTIs)	were	prioritised	for	AMS	programs	in	a	
network	of	25	pediatric	primary	care	practices	in	USA	(Gerber	et	al.,	2013).	
Previous	studies	showed	that	majority	of	antibiotics	are	prescribed	in	
outpatient	settings	(Drekonja	et	al.,	2015b;	Gerber	et	al.,	2013).	A	US	study	of	
antibiotic	use	for	upper	respiratory	infections	in	outpatient	settings	found	that	65%	
patients	were	treated	with	antibiotics	(Gill	et	al.,	2006).	Similarly,	community-based	
studies	in	Thailand	found	that	most	patients	with	upper	respiratory	tract	infection	
were	treated	with	antibiotics	(Apisarnthanarak	&	Mundy,	2009;	Suttajit,	Wagner,	
Ross-Degnan,	Tantipidoke,	&	Sitthi-amorn,	2005).	These	findings	may	explain	why	
improving	antibiotic	prescribing	for	respiratory	tract	infections	is	a	priority	in	
outpatient	settings.	Initiating	an	AMS	intervention	that	provides	guidelines	for	URTI	
and	diarrhea	is	therefore	considered	as	a	good	starting	point	when	introducing	AMS	
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programs	in	a	new	context.	These	outpatient-based	interventions	also	provide	the	
AMS	team	with	insights	about	current	practice	in	the	community	and	the	incidence	of	
AMR	in	the	general	Thai	population.	As	this	is	a	new	program	at	the	study	hospital	
there	has	been	limited	evaluation	of	its	impact,	further	assessment	of	the	programs	
impact	on	prescribing,	patient	outcomes	and	costs	would	be	informative	to	the	
organisation.	
An	AMS	intervention	that	restricts	prescriber	access	to	specific	antibiotics	had	
been	established	in	the	inpatient	setting,	the	‘carbapenem	control	program’	uses	a	
computerised	software	program	to	monitor	and	limit	the	use	of	broad-spectrum	
beta-lactam	antibiotics.	This	program	has	started	by	focusing	on	improving	the	
appropriate	use	of	carbapenems	and	there	are	plans	to	expand	this	process	to	other	
classes	of	antibiotics.	This	type	of	AMS	intervention	to	restrict	access	and	use	of	
specific	antibiotics	has	been	described	as	a	‘behavioural	intervention’	that	uses	‘rules	
to	reduce	the	opportunity	to	engage	in	the	target	behaviour	or	increase	the	target	
behaviour	by	reducing	the	opportunity	to	engage	in	competing	behaviours’	(Davey	et	
al.,	2017).	A	previous	review	suggested	that	restrictive	strategy	in	AMS	had	better	
impact	on	prescribing	behaviours	than	education	or	persuasion	(Davey	et	al.,	2013).	
Several	studies	confirmed	that	interventions	that	restrict	antibiotic	use	are	affective	
in	improving	antibiotic	use	in	inpatient	settings.	For	example,	a	US	study	found	that	
using	computerised	monitoring	software,	with	AMS	team	oversight,	for	active	
monitoring	of	restricted	antibiotic	orders	had	a	positive	impact	decreasing	antibiotic	
use	and	hospital	expenditure	(McGregor	et	al.,	2006).	Another	American	study	found	
that	the	use	of	restrictive	interventions	to	limit	prescribing	of	broad-spectrum	
antibiotics	and	restrict	the	maximum	daily	dose	of	antibiotics	resulted	in	a	reduction	
in	antibiotic	use	and	pharmacy	costs	(Coleman,	Rodondi,	Kaubisch,	Granzella,	&	
O'Hanley,	1991).	In	the	Australian	context	a	study	of	using	a	computerised	
antimicrobial	approval	system	to	limit	use	of	restricted	antimicrobials	decreased	the	
use	of	third	and	fourth-generation	cephalosporins	(Buising	et	al.,	2008b).	These	
studies	demonstrate	that	AMS	strategies	that	restrict	access	and	provide	consumer	
feedback	improve	antibiotic	use	and	healthcare	cost.	At	the	study	hospital,	the	
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impact	of	this	program	needs	to	be	formally	evaluated	and	reported,	before	this	
approach	is	extended	to	include	other	classes	of	antimicrobials.		
5.4.4	AMS	training	and	education	
In	this	study	healthcare	professionals	who	have	more	experience	in	treating	
and	taking	care	of	patients	with	antibiotic	resistant	organisms	were	recognised	as	
having	more	knowledge	about	appropriate	antibiotic	use.	Most	of	the	participants	
perceived	that	they	do	not	have	enough	knowledge	about	AMR,	and	the	evidence	
underpinning	antibiotic	prescribing	choices	to	lead	AMS	activities.	These	results	are	
similar	to	previous	studies	in	which	the	lack	of	up-to-date	knowledge	regarding	
antimicrobial	use	was	reported	by	some	senior	specialists	in	an	Australian	private	
hospital	(Cotta	et	al.,	2015).		
Participants	in	this	study	reported	that	they	would	like	to	have	more	
education	and	training	related	to	antimicrobial	use.	Similar	to	previous	studies,	nurse	
practitioners	and	medical	students	agreed	that	a	sound	knowledge	of	antibiotics	is	
important	and	they	would	like	more	education	in	antibiotic	selection,	timing	and	
duration	of	treatment	(Abbo	et	al.,	2012;	Abbo	et	al.,	2013a).	Another	study	reported	
that	residents	and	advanced	trainees	perceived	that	more	education	about	antibiotic	
use	during	residency	would	decrease	inappropriate	prescribing	by	junior	medical	staff	
(Stach,	Hedican,	Herigon,	Jackson,	&	Newland,	2012).		
Insufficient	staff	education	and	training	related	to	antimicrobial	usage	have	
been	commonly	identified	in	previous	studies.	For	example,	a	lack	of	training	and	
education	in	antimicrobial	use	was	reported	as	a	major	barrier	to	AMS	
implementation	in	Australian	hospitals	(James	et	al.,	2015;	James	et	al.,	2013).	
Insufficient	education	and	training	for	nursing	staff	on	aspects	of	AMS	is	a	common	
barrier	to	effective	implementation	of	AMS	programs	in	Australian	hospitals	(Chen,	
Khumra,	Eaton,	&	Kong,	2011).	The	AMS	in	Australian	hospitals	guidelines	suggest	
that	providing	education	to	prescribers,	pharmacists	and	nurses	about	good	
antimicrobial	prescribing	practice	and	AMR	should	be	the	priority	and	that	this	
underpins	effective	AMS	implementation	(Duguid	&	Cruickshank,	2011).	
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At	the	study	hospital	it	is	recommended,	based	on	the	participants	feedback,	
that	staff	are	provided	with	greater	access	to	resources	such	as:	eHealth	applications	
to	support	clinicians	in	AMS	(Wentzel	et	al.,	2014),	and	other	web-based	educational	
resources	(CDC,	2014)	In	addition	it	would	be	beneficial	to	provide	staff	with	access	
to	face-to-face	or	peer-to-peer	education	sessions	run	at	the	hospital	(James	et	al.,	
2015).		
5.5	Chapter	summary	
In	this	chapter,	the	results	relating	to	the	current	clinical	governance	structure	
and	activities	at	the	study	hospital	are	presented.	In	addition	the	perceived	strengths	
and	weakness	of	the	current	clinical	governance	structures	among	key	stakeholders,	
ICNs	and	clinical	nurses	are	explored.	
	The	major	findings	showed	that	although	there	is	executive	level	
endorsement	of	AMS	projects	at	the	study	hospital	and	there	is	a	recognised	clinical	
champion	who	provides	strong	leadership	for	AMS	activities	across	the	organisation,	
that	the	AMS	program	has	not	yet	matured	to	the	stage	where	it	is	fully	integrated	
into	the	clinical	governance	structure	of	the	organisation.	The	findings	also	
highlighted	that	the	AMS	program	had	not	reached	clinicians	from	different	disciples	
to	the	extent	necessary	for	their	engagement	and	consistent	implementation	in	
clinical	practice.		
The	organisational	leaders	identified	a	range	of	AMS	initiatives	and	projects	
that	demonstrate	AMS	activities	related	to	each	of	the	core	elements	recommended	
in	the	CDC	framework.	This	range	of	activities	provides	evidence	of	willingness	on	the	
part	of	both	the	organisational	leaders	and	the	executive	to	take	steps	to	address	the	
problem	of	AMR.	It	is	noteworthy	that	the	majority	of	AMS	activities	involved	staff	
awareness	raising	and	provision	of	access	to	resources	to	support	and	inform	better	
prescribing	choices.	These	initiatives	can	be	considered	to	be	‘facilitating’	
interventions	designed	to	reinforce	and	improve	prescribing	practice,	rather	than	
‘restrictive’	interventions.	Although	the	organisational	leaders	identified	that	there	
were	some	restrictions	on	the	use	of	specific	classes	of	antibiotics	(such	as	the	
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carbapenems)	and	potentially	moved	to	extend	this	approach,	that	prescribers	at	the	
study	hospital	were	not	yet	sufficiently	supportive	of	AMS	to	accept	extensive	
restrictions	on	their	prescribing	choices.		
The	study	participants	identified	a	range	of	important	barriers	that	need	to	be	
addressed	before	a	sustainable,	organisation-wide,	comprehensive	AMS	program	is	
established	at	the	study	hospital.	Key	issues	that	were	identified	included:	the	need	
to	develop	formal	AMS	policies	and	to	embed	these	into	the	clinical	governance	
structure;	the	need	for	organisational	investment	in	personnel,	information	
management	systems,	and	staff	education;	and	the	need	to	establish	a	
multidisciplinary	approach	to	AMS	with	identifiable	roles	and	responsibilities	for	each	
member	of	the	team.	
In	the	following	chapter	the	results	of	patient	participation	in	AMS	is	
presented.	
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Chapter	6	
Patient	Participation	in	Antimicrobial	Stewardship	
In	this	chapter,	the	findings	pertaining	to	the	third	aim	of	this	research	are	
presented	and	discussed.	Patient	participation	is	defined	as	“….the	involvement	of	
patients	in	the	decision-making	process	regarding	health	issues”	(Longtin	et	al.,	2010,	
p.	54).	The	findings	of	the	patient	survey	are	presented	first,	followed	by	the	analysis	
of	the	data	derived	from	organisational	leader	interviews	and	nurse	focus	groups.	
The	chapter	concludes	with	a	discussion	of	the	current	and	potential	status	of	
patient	participation	in	AMS	in	acute	healthcare	in	Thailand.		
	
Aim	and	objectives	
The	third	aim	of	this	research	program	was	to	explore	current	and	potential	
patient	participation	in	AMS	in	Thailand.	The	specific	objectives	of	this	phase	of	the	
study	were	to:	
I. Explore	patients’	perceived	behaviours,	attitudes	and	knowledge	relating	
to	antibiotic	use	in	the	community	using	a	patient	survey.	
II. Determine	how	patients	participate	in	AMS	in	the	community	and	during	
hospital	admission	from	patients’	and	nurses’	perspectives.	
	
6.1	Patient	survey	results		
	 6.1.1	Methods	
The	methodological	approach	for	this	research	program	is	described	in	detail	
in	Chapter	3.	A	paper-based	survey	was	distributed	to	patients	from	selected	
medical	and	surgical	wards	at	the	case	hospital	between	January	and	March	2016.	
Patients	were	invited	to	participate	in	this	survey	if	they	had	been	prescribed	
antibiotics,	had	been	in	the	hospital	for	at	least	two	days	and	were	able	to	
communicate	verbally	in	Thai	with	the	researcher.	Consecutive	sampling	was	used	to	
recruit	patients	to	this	study.	The	survey	was	self-administered	however,	patients	
who	had	a	limited	ability	to	complete	the	survey	themselves	either	due	to	literacy	or	
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physical	issues	were	assisted	by	the	researcher.	The	average	time	to	complete	the	
survey	was	15	minutes.	
	 6.1.2	Patient	characteristics	
In	2016,	there	were	47,058	patients	admitted	to	the	case	hospital,	and	a	total	
of	22,628	patients	were	admitted	to	the	medical	and	surgical	wards.	Between	
January	and	March	2016,	205	inpatients	completed	this	survey.	Participant	
characteristics	are	presented	in	Table	6.1.	Overall,	53.7	%	(n=110)	of	the	participants	
were	female	and	the	median	age	was	56	(IQR=46-65)	years.	The	youngest	participant	
was	17	years	of	age	and	the	oldest	was	89	years	of	age.	Almost	half	the	participants	
(42.4%,	n=87)	had	completed	primary	school	and	33.7%	(n=	69)	university	level	
education.	Fifty-one	percent	of	the	participants	reported	having	one	or	more	chronic	
diseases	(n=111).	The	most	common	chronic	disease	was	hypertension	(20.5%,	
n=42).		
Table	6.1	Patient	characteristics	(n=205)	
	 n	 %	 Median	 Q1-Q3	
Demographics	 	 	 	 	
• Gender	 	 	 	 	
o Female	 110	 53.7	 	 	
o Male	 95	 46.3	 	 	
• Age	 	 	 56	 46-65	
• Education	level	 	 	 	 	
o None	 3	 1.5	 	 	
o Primary	school	 87	 42.4	 	 	
o High	school	 46	 22.4	 	 	
o Bachelor	degree	 60	 29.3	 	 	
o Post	graduate		 9	 4.4	 	 	
• One	or	more	chronic	
diseases		
111	 54.1	 	 	
	
	 6.1.3	Patients’	perceived	behaviors,	attitudes	and	knowledge	regarding	
antibiotic	use	in	the	community	
Patients’	self-reported	use	of	antibiotics	in	the	community	is	presented	in	
Table	6.2.	Almost	half	of	the	participants	(47.3%,	n=97)	reported	that	they	took	
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antibiotics	once	in	the	past	year.	The	three	most	common	reasons	reported	for	
taking	antibiotics	were	colds	(n=82,	40%),	wound	infection	(n=63,	30.7%)	and	
respiratory	tract	infections	(n=51,	24.9%).		
Table	6.2	Patients’	reported	antibiotic	use	in	the	community	(n=205)	
	 n	 %	
• How	many	times	did	you	take	antibiotics	in	the	past	
year	
	 	
o None	 62	 30.2	
o 1	 97	 47.3	
o 2	 22	 10.7	
o 3	 11	 5.4	
o 4	 3	 1.5	
o 5	 6	 2.9	
o 10	 4	 2.0	
• Why	did	you	take	antibiotics?	*	 	 	
o Cold	 82	 40.0	
o Wound	infection	 63	 30.7	
o Respiratory	tract	infections	 51	 24.9	
o Gastroenteritis	 19	 9.3	
o Mouth	ulcer	 7	 3.4	
*	Note:	participants	could	choose	≥	1	response	
	
Patients’	behaviors	regarding	acquisition	of	antibiotics	in	the	community	are	
presented	in	Table	6.3.	About	70	%	of	participants	reported	that	they	purchased	
antibiotics	from	a	drugstore	when	they	had	a	cold	(70.2%,	n=144)	and	73.7	%	(n=	
151)	went	to	see	a	doctor	when	they	had	a	cold.	Two	thirds	of	participants	(62.4	%	
n=128)	reported	that	they	stopped	taking	antibiotics	when	feeling	better.	The	
majority	of	participants	reported	that	they	never	shared	antibiotics	with	others	
(82.0%,	n=168),	nor	did	they	keep	antibiotics	for	subsequent	illnesses	(76.6%,	
n=157).	Furthermore,	84.9%	(n=174)	of	participants	reported	that	they	had	never	
bought	extra	antibiotics	after	completing	a	course	of	antibiotics,	despite	continuing	
to	feel	unwell.	
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Table	6.3	Patients’	reported	acquisition	of	antibiotics	in	the	community	(n=205)	
Attitudes	and	behaviors	 Never	 Sometimes	 Frequently	 Every	time	
3.	I	buy	antibiotics	from	a	
drugstore	when	I	get	a	cold.	
61	(29.8%)	
	
108	(52.7%)	
	
35	(17.1%)	
	
1	(0.5%)	
	
4.	I	go	to	see	a	doctor	when	I	get	a	
cold.	
54	(26.3%)	 105	(51.2%)	 39	(19.0%)	 7	(3.4%)	
5.	I	stop	taking	antibiotics	when	I	
feel	better.	
77	(37.6%)	 65	(31.7%)	 39	(19.0%)	 24	(11.7%)	
6.	I	share	antibiotics	with	others.	 168	(82.0%)	 31	(15.1%)	 6	(2.9%)	 0	
7.	I	keep	antibiotics	at	home	for	
next	time.	
157	(76.6%)	
	
39	(19.0%)	
	
7	(3.4%)	
	
2	(1.0%)	
	
8.	If	I	complete	antibiotics	but	I	am	
still	not	feeling	well,	I	will	buy	extra	
antibiotics	from	a	drug	store.	
174	(84.9%)	
	
30	(14.6%)	
	
1	(0.5%)	
	
0	
	
	
Patients’	beliefs	and	attitudes	regarding	antibiotic	use	in	the	community	are	
presented	in	Table	6.4.	About	half	of	participants	(54.1%,	n=111)	believed	that	
patients	should	not	be	able	to	buy	antibiotics	over	the	counter.	More	than	one-third	
of	participants	were	unsure	if	antibiotics	can	reduce	symptoms	of	a	cold	(41.5%,	
n=85)	and/or	prevent	complications	of	a	cold	(43.4%,	n=89).	Approximately	half	of	
participants	did	not	have	a	preference	whether	they	received	antibiotics	from	a	
doctor	(50.7%,	n=104)	or	a	drug	store	(49.8%,	n=102).	
Table	6.4	Patients’	beliefs	and	attitudes	regarding	antibiotic	use	in	the	community	
(n=205)	
Attitudes	and	perceptions	 Disagree	or	
Strongly	disagree	
Neutral/Unsure	
	
Agree	or	
Strongly	agree	
9.	I	believe	that	patients	should	be	
able	to	buy	antibiotics		
111	(54.1%)	
	
21	(10.2%)	
	
73	(35.6%)	
	
10.	I	believe	that	antibiotics	can	
reduce	symptoms	of	a	cold.	
61	(29.8%)	 85	(41.5%)	 59	(28.8%)	
11.	I	believe	that	antibiotics	can	
prevent	complications	of	a	cold.	
54	(26.3%)	 89	(43.4%)	 62	(30.2)	
12.	I	expect	to	be	prescribed	
antibiotics	by	a	doctor	when	I	get	a	
cold.		
64	(31.2%)	 104	(50.7%)	 37	(18.0%)	
13.	I	expect	to	receive	antibiotics	
from	a	drug	store	when	I	get	a	cold.	
62	(30.2%)	 102	(49.8%)	 41	(20.0%)	
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Patients’	knowledge	of	antibiotic	use	in	the	community	is	presented	in	Table	
6.5.	More	than	half	of	participants	knew	that	an	incomplete	course	of	antibiotics	
could	reduce	antibiotic	effectiveness	(58.5%,	n=120)	and	contribute	to	AMR	(60.0%,	
n=123).	Nearly	60%	of	participants	agreed	that	antibiotics	may	cause	a	drug	allergy	
(59.0%,	n=121).	However,	97.1%	(n=199)	of	participants	indicated	that	they	would	
like	more	information	about	the	best	way	to	use	antibiotics.	
Table	6.5	Patients’	knowledge	about	antibiotic	use	in	the	community	(n=205)		
Attitudes	and	perceptions	 Disagree	or	
Strongly	disagree	
Neutral/Unsure	
	
Agree	or	
Strongly	agree	
15.	I	believe	that	an	incomplete	
course	of	antibiotics	can	reduce	its	
effectiveness.	
7(3.4%)	
	
78	(38.0%)	
	
120	(58.5%)	
	
16.	I	believe	that	an	incomplete	
course	of	antibiotics	can	contribute	
to	antibiotic	resistance.	
1	(0.5%)	
	
81	(39.5%)	
	
123	(60.0%)	
	
17.	I	believe	that	antibiotics	may	
cause	a	drug	allergy.		
0	(0.00%)	 84	(41.0%)	 121(59.0%)	
18.	I	want	to	have	more	information	
regarding	the	best	way	to	use	
antibiotics.		
1	(0.5%)	
	
5	(2.4%)	
	
199	(97.1%)	
	
	
	 6.1.4	Sources	of	information	regarding	antibiotic	use	in	the	community	
The	sources	of	information	patients	used	regarding	antibiotic	use	in	the	
community	are	shown	in	Figure	6.1.	Participants	reported	that	they	normally	
received	information	about	antibiotic	use	from	doctors	(n=139,	67.8%),	drug	store	
staff	(n=60,	29.2%)	and	nurses	(n=35,	17.1%).		
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Figure	0.1	Sources	of	information	regarding	antibiotic	use	in	the	community	
	 6.1.5	Patient	participation	in	AMS	during	hospital	admission	 	
Patients’	responses	to	questions	regarding	participation	in	AMS	during	
hospital	admission	are	presented	in	Table	6.6.	More	than	half	the	participants	did	
not	expect	to	receive	antibiotics	while	in	hospital	(61.0%,	n=	125)	or	were	
ambivalent	regarding	receiving	intravenous	antibiotics	(55.1%,	n=113)	during	their	
hospital	care.	The	majority	of	participants	believed	intravenous	antibiotics	were	
stronger	than	oral	antibiotics	(84.9%,	n=	174).	During	hospital	admission,	97.6%	
(n=200)	of	participants	reported	that	they	would	not	ask	relatives	to	buy	antibiotics	
from	outside	the	hospital	and	the	majority	(74.6%,	n=153)	were	afraid	of	getting	an	
infection	from	multidrug-resistant	organisms.	
The	majority	of	participants	wanted	to	tell	doctors	or	nurses	about	antibiotics	
that	they	have	taken	previously	(96.1%,	n=197)	and	wanted	to	know	if	they	were	
receiving	antibiotics	during	their	hospital	admission	(91.2%,	n=187).		Further,	the	
majority	of	participants	also	wanted	information	about	the	reason	for	(91.7%,	
n=188),	the	duration	(92.2%,	n=189)	and	possible	side	effects	of	antibiotics	(95.6%,	
n=196).		
	
	
Doctors,	139
Drug	stores	
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Pharmacists,	
30
Internet,	20
Friends/	
Neighbors	,	19
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Table	0.6	Patient	participation	in	antibiotic	use	and	AMS	during	hospital	admission	
(n=205)	
Attitudes	and	perceptions	 Disagree	or	
Strongly	disagree	
Neutral/Unsure	
	
Agree	or	
Strongly	agree	
19.	I	expect	to	receive	antibiotics.	 18	(8.8%)	 125	(61.0%)	
	
62	(30.2%)	
20.	I	expect	to	receive	intravenous	
antibiotics.	
	
22	(10.7%)	
	
113	(55.1%)	 70	(34.1%)	
21.	I	believe	that	intravenous	
antibiotics	are	stronger	than	tablets.	
	
11	(5.4%)	 20	(9.8%)	
	
174	(84.9%)	
22.	I	would	ask	my	relatives	to	buy	
an	antibiotic	from	outside	if	doctor	
does	not	prescribe	it	for	me.	
	
200	(97.6%)	
	
3	(1.5%)	
	
2	(1.0%)	
	
23.	I	expect	to	be	asked	by	doctors	
and/or	nurses	about	antibiotics	that	
I’ve	taken	in	the	past	year.	
3	(1.5%)	
	
5	(2.4%)	
	
197	(96.1%)	
	
	 	 	 	
24.	I	would	tell	the	doctor/nurse	if	
my	relatives	bring	antibiotics	from	
outside	to	me.	
	
7	(3.4%)	
	
4	(2.0%)	
	
	
194	(94.6%)	
	
25.	I	want	to	tell	the	doctor/nurse	
about	antibiotics	that	I	have	taken	
recently.	
	
3	(1.5%)	
	
	
5	(2.4%)	
	
197	(96.1%)	
	
26.	I	want	to	know	whether	I’m	
receiving	antibiotics.	
	
4	(2.0%)	 14	(6.8%)	
	
187	(91.2%)	
27.	I	want	to	know	the	reason	why	I	
have	to	take	antibiotics.	
4	(2.0%)	
	
13	(6.3%)	 188	(91.7%)	
	
28.	I	want	to	know	how	long	I	have	
to	take	antibiotics.	
	
	
3	(1.5%)	
	
	
13	(6.3%)	
	
189	(92.2%)	
29.	I	am	afraid	of	getting	multi-drug	
resistant	infections	that	may	be	
difficult	to	treat.			
	
18	(8.8%)	
	
34	(16.6%)	
	
153	(74.6%)	
	
30.	I	want	to	know	the	side	effects	
of	antibiotics	that	I	am	taking.	
2	(1.0%)	 7	(3.4%)	 196	(95.6%)	
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6.2	Nurses’	perspectives	on	patient	participation	in	AMS	
Nurses’	perspectives	of	patient	participation	in	AMS	were	drawn	from	the	
nurse	participants	in	the	organisational	leader	interviews	and	focus	groups	with	
clinical	nurses	and	infection	control	nurses	(described	in	detail	in	Chapter	4).		
6.2.1.	Nurse	participant	characteristics		
The	total	number	of	nurse	participants	in	the	interviews	and	the	focus	groups	
was	24	(Table	6.7).	There	were	six	nurse	participants	in	the	organisational	leader	
group	and	18	nurses	in	the	three	focus	groups.	The	interviewed	participants	
consisted	of	the	Director	of	Nursing,	nurse	manager	of	the	IPC	department,	infection	
control	specialists	(2),	nurse	manager	in	operating	room	(1)	and	nurse	manager	in	
ICU	(1).		
The	three	different	groups	of	nurses	who	participated	in	the	focus	group	
discussions	were:	seven	infection	control	nurses;	five	senior	nurses	and	six	junior	
nurses.	The	participants	in	the	senior	and	junior	nurse	group	were	working	in	either	
the	medical	or	surgical	wards	at	the	hospital.	Senior	nurses	had	more	than	10years’	
experience	in	nursing	and	junior	nurses	less	than	three	years.	
Table	0.7	Participant	Categories:	Individual	interviews	and	focus	group	(N=24)	
Categories	 Number	of	interviews/	Focus	groups	 Number	of	participants	
Individual	interviews		 6	 6	
Focus	group		 3	 18	
Total	interviews		 9	 24	
	
	 The	analysis	of	interview	and	focus	group	data	identified	nurses’	perspectives	
in	relation	to	patients’	understanding	of	antibiotic	use	in	the	community	and	in	
hospital.			
6.2.1.1	Patient	participation	in	AMS	in	the	community		
Nurse	participants	perceived	patient	participation	in	antibiotic	decision	
making	in	the	community	as	having	a	negative	impact	on	antibiotic	use	because	of	
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the	interrelated	problems	of	antibiotic	availability	without	prescription	and	their	
perceptions	that	patients	had	very	little	understanding	of	appropriate	antibiotic	use.		
Because	antibiotics	are	available	over	the	counter	in	Thailand,	Thai	people	
can	access	antibiotics	without	a	formal	prescription.	Over	the	counter	availability	of	
antibiotics	raised	concerns	about	inappropriate	community	antibiotic	use	by	
patients.	One	nurse	stated	that	
	
“In	our	country	we	can	buy	drugs	at	the	drugstores.	A	seller	does	not	give	a	
proper	recommendation.	If	patients	want	antibiotics,	they	would	sell	them	
without	asking	about	the	condition	or	indication	for	use,	so	this	causes	
excessive	and	irrational	antibiotic	use	[by	consumers	in	the	community].	
(JRN2)	
	
Nurse	participants	perceived	that	patients’	knowledge	regarding	antibiotics	
and	antibiotic	use	was	poor	and	that	lack	of	knowledge	was	a	major	factor	
influencing	patients’	behaviours	related	to	antibiotic	use.	Perceived	poor	knowledge	
included	misconceptions	about	the	indications	for	antibiotic	use,	patient	
expectations	of	the	effect	of	antibiotics	and	poor	adherence	to	antibiotic	treatments.	
These	knowledge	deficits	were	expected	to	affect	the	quality	of	patient	decision	
making	related	to	antibiotics	and	hinder	effective	patient	participation	in	AMS	in	the	
Thai	community.		
	
“When	they	[consumers	in	the	community]	have	flu,	they	buy	medicines	
themselves	without	knowing	whether	they	are	infected	with	a	virus	or	
bacteria.”	(ICN4)	
	
	“[A]	friend	of	mine	told	me	that	when	she	had	flu,	[she]	went	to	see	a	doctor	
at	a	clinic	because	she	wanted	antibiotics.”	(ICN5)	
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“I’ve	had	an	experience	with	a	high-class	patient	and	his/her	relatives.	The	
patient	asked	for	strong	or	imported	antibiotics	because	he/she	could	afford	
the	medical	fee	and	wanted	to	fully	use	his/her	right	[to	the	most	advanced	
treatments]	(SRN2)	
	
“And	when	they	[patients]	feel	better,	they	instantly	stop	taking	medicines	
	 without	taking	it	for	the	full	course.”	(ICN4)	
	 	
6.2.1.2	Patient	participation	in	AMS	during	hospitalisation	
Patient	participation	in	antibiotic	use	during	hospitalisation	was	considered	
an	important	element	of	AMS.	Nurses	described	patients’	involvement	in	ensuring	
the	safe	administration	of	antibiotics	and	in	the	appropriate	use	of	antibiotics	once	
patients	are	discharged	from	hospital.		
Nurse	participants	perceived	that	patients	did	participate	in	AMS	while	in	
hospital,	both	during	the	hospital	admission	period	and	also	at	the	point	of	
discharge.	During	hospitalisation,	patient	participation	was	seen	as	one	element	in	
the	safe	use	of	antibiotics	use	by	providing	a	history	of	drug	allergies	on	first	
admission,		
	
	“Nurses	always	ask	patients	about	their	history	of	drug	allergy	when	they		are	
admitted	to	a	ward.	We	don’t	know	if	patients	have	a	history	of	drug	
allergies.	So	our	role	is	to	ask	both	patients	and	their	relatives.”	(SRN3)	
	
and	by	reporting	any	side-effects	of	antibiotic	use.	Nurses	described	the	importance	
of	informing	patients	having	antibiotics	about	the	possible	side	effects	and	
hypersensitivities	of	antibiotics	and	that	this	information	would	enable	patients	to	
participate	in	AMS	by	self-monitoring	for	signs	and	symptoms	of	adverse	drug	
reactions	and	notifying	nurses	if	these	occur,		
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“In	surgical	wards,	most	of	the	antibiotics	we	use	are	known	to	us..	We	know	
the	side	effects	of	those	antibiotics.	So,	every	time	we	administer	them	to	
patients,	we	inform	them	about	the	possible	side	effects	that	may	occur.	So	
patients	can	tell	us	early	if	they	experience	these	symptoms.”	(SRN1)	
	
	“For	some	antibiotics,	such	as,	Amphotericin	B,	we	inform	patients	about	any	
side	effects,	like,	fever	and	chills.	We	confirm	with	the	doctor	first	if	a	patient	
is	hypersensitive	to	that	antibiotic.	….	Nurses	must	know	patients’	histories	
and	cooperate	with	pharmacists	and	doctors	at	all	times.”	(JRN6)	
	
Patient	participation	in	the	use	of	antibiotics	was	also	considered	an	element	
in	discharge	planning.	Nurses	described	their	role	in	educating	patients	in	
appropriate	infection	prevention	and	control	practices	and	appropriate	antibiotic	
use	in	the	community.	Nurses	provide	education	to	patients	and	their	carers	about	
how	they	can	prevent	AMR	in	the	community	through	strategies	such	as	hand	
hygiene.			
	
“Before	discharge,	if	patients	have	an	antimicrobial	resistant	infection,	we	
[nurses]	educate	them	about	how	to	prevent	the	spread	of	antibiotic	
resistance	in	the	hospital.	Before	they	go	home,	nurses	educate	patients	and	
their	carers	again	about	basic	infection	prevention	control	such	as,	washing	
hands	and	wearing	gowns.”	(JRN4)	
	
Nurses	also	noted	the	importance	of	ensuring	that	patients	have	a	good	
understanding	about	antibiotic	use	at	discharge	from	acute	care.		Nurse	participants	
reported	educating	patients	to	complete	their	antibiotic	course	once	at	home,	avoid	
buying	antibiotics	at	drug	stores	and	to	see	a	doctor	at	the	hospital	if	they	were	
feeling	unwell.	In	addition	nurses	perceived	that	patients	could	participate	in	AMS	if	
they	understood	their	antibiotic	treatment	regimen.	
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	“In	terms	of	educating	patients	at	discharge,	we	[nurses]	always	educate	
	patients	to	complete	antibiotics	that	they	are	prescribed	from	the	hospital	
and	inform	patients	not	to	buy	antibiotics	themselves.	Some	patients	have	the	
misunderstanding	that	they	have	to	take	antibiotics	until	the	appointment	
date	so	they	buy	antibiotics	from	drug	stores	to	continue	taking	antibiotics.”	
(SRN2)	
	
	“When	give	advice	to	patients	about	taking	antibiotics	at	home,	we	insist	that	
	they	must	complete	the	course	of	antibiotics.	They	cannot	decide	to	stop	
taking	it	[the	antibiotic	course]	themselves	because	it	may	result	in	
antimicrobial	resistance.”	(JRN1)	
	
“We	remind	patients	before	they	are	discharged	that	if	they	feel	sick,	they	
have	to	see	a	doctor	and	not	buy	antibiotics	or	other	medications	
themselves.”		 (JRN3)	
	
6.3	Discussion		
Patients’	beliefs,	attitudes	and	expectations	about	the	utility	of	antibiotics	
during	episodic	illness	are	known	factors	in	influencing	antibiotic	prescribing.	In	
Thailand,	availability	of	antibiotics	for	consumers	without	health	professional	
involvement	is	an	additional	potential	influence	that	underscores	the	importance	of	
involving	patients	in	antibiotic	decision-making	and	providing	education	for	patients	
and	families	in	optimal	antibiotic	use.	This	phase	of	the	research	provides	another	
dimension	to	our	understanding	of	the	contextual	influences	on	antibiotic	use	in	
Thailand	and	informs	AMS	activities	when	patients	are	admitted	to	hospital.	
The	patient	survey	findings	confirmed	the	high	use	of	antibiotics	in	the	Thai	
community,	misconceptions	about	the	utility	of	antibiotics	in	viral	illness,	and	the	
frequency	of	patients	acquiring	antibiotics	without	health	professional	involvement.	
The	majority	of	patients	however,	did	want	to	know	more	about	safe	use	of	
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antibiotics	and	did	fear	acquiring	antimicrobial	resistant	organisms,	indicating	a	
readiness	to	be	better	informed	about	safe	use	of	antibiotics.		
Nurses	were	aware	of	the	risks	associated	with	the	availability	of	antibiotics	
in	the	community	and	patients’	access	to	antibiotics	without	health	professional	
involvement.	Nurse	were	also	supportive	of	patient	participation	in	the	safe	use	of	
antibiotics	during	treatment	in	hospital	and	recognized	their	role	in	ensuring	that	
patients	had	a	sound	understanding	of	the	principles	of	safe	continuation	of	
antibiotic	treatment	once	patients	are	discharged	from	hospital	care.		
	
6.3.1	Patients’	attitudes	and	behaviors	towards	antibiotic	use	in	the	
community	
Reported	previous	antibiotic	use	was	high	with	69.8	%	of	patients	reporting	
that	they	had	used	antibiotics	at	least	once	in	the	past	year.	In	leader	interviews	and	
focus	groups,	nurses	identified	the	easy	access	to	antibiotics	for	Thai	people	without	
the	need	for	a	formal	prescription	and	that	this	contributes	to	excessive	and	
inappropriate	antibiotic	use.	Antibiotics	are	the	most	commonly	used	medication	
worldwide	(Grosso,	Marventano,	Ferranti,	&	Mistretta,	2012).	Previous	studies	
conducted	in	community	settings	such	as	Qatar,	Syrian	Arab	Republic,	Mongolia	and	
India	have	also	reported	the	widespread	use	of	antibiotics	(Barah	&	Gonçalves,	2010;	
Kotwani	&	Holloway,	2011;	Moienzadeh,	Massoud,	&	Black,	2017;	Togoobaatar	et	
al.,	2010).	Indeed,	antibiotics	are	the	most	sold	medications	in	developing	countries	
(Cagri	Buke,	Ermertcan,	Hosgor-Limoncu,	Ciceklioglu,	&	Eren,	2003).	There	are	many	
countries	including	Thailand	that	allow	the	purchase	of	antibiotics	over	the	counter	
without	prescription	(Apisarnthanarak	et	al.,	2008;	Kagashe	et	al.,	2011;	Morgan	et	
al.,	2011a).	In	this	study,	70.2%	of	patients	reported	that	they	had	purchased	
antibiotics	from	drugstores	when	they	had	a	cold.	The	reasons	that	people	buy	
antibiotics	from	drugstores	needs	further	investigation,	but	it	is	likely	that	decisions	
to	buy	antibiotics	without	prescription	are	related	to	convenience,	cost	and	rapid	
service	delivery	(Smith,	2009).		
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The	misconception	that	antibiotics	are	useful	for	treating	viral	infections	is	a	
problem	because	it	is	a	leading	cause	of	AMR.	In	our	study,	patients	reported	that	
the	most	common	reasons	to	take	antibiotics	were	for	viral	infections	(40.0	%	for	
cold,	24.9%	for	respiratory	tract	infections	and	9.3%	for	gastroenteritis).	This	was	
recognised	by	the	nurse	participants	who	discussed	patients’	misunderstandings	
about	the	use	of	antibiotics	to	treat	colds	and	lower	respiratory	tract	infections.	
Misconceptions	that	antibiotics	are	needed	for	viral	illnesses	have	also	been	
reported	in	previous	studies.	For	example,	the	European	Commission	(EC)	found	that	
colds	and	flu	were	among	the	top	five	leading	reasons	for	taking	antibiotics	(EC,	
2013).	A	public	survey	related	to	beliefs	about	antibiotics	and	respiratory	tract	
infections	in	the	Netherlands,	found	that	almost	half	of	all	responders	(47.8%)	
believed	that	antibiotics	can	treat	viral	infections	(Cals	et	al.,	2007).	Also,	a	public	
survey	by	WHO	regarding	widespread	public	misunderstanding	about	antibiotic	
resistance	across	12	countries	reported	that	65%	of	respondents	incorrectly	believed	
that	colds	and	flu	can	be	treated	with	antibiotics	(WHO,	2015a).		
Patients’	level	of	knowledge	and	perceptions	about	antibiotic	therapy	have	
been	linked	to	the	unnecessary	use	of	antibiotics	particularly	in	primary	care	(Edgar	
et	al.,	2009b).	Promoting	awareness	of	antibiotic	use	and	antibiotic	resistance	
amongst	health	professionals	and	the	public	is	one	strategy	to	decrease	
inappropriate	antibiotic	use	(Sabuncu	et	al.,	2009;	Sumpradit	et	al.,	2012a).	Public	
campaigns	about	antibiotic	use	create	social	norms	and	increase	public	
understanding	of	the	consequences	of	inappropriate	antibiotic	use	(Pinder,	Sallis,	
Berry,	&	Chadborn,	2015).	There	are	several	campaigns	promoting	appropriate	
antibiotic	use	in	both	hospitals	and	the	community	across	the	world	(Earnshaw	et	al.,	
2009;	Sumpradit	et	al.,	2012a).	For	example,	in	the	USA,	‘The	Get	Smart	program’	
was	initiated	in	response	to	the	problem	of	AMR	and	promotes	appropriate	
antibiotic	prescribing	and	decreased	use	of	antibiotics	for	conditions	commonly	
treated	in	the	community	or	ambulatory	care	settings	(CDC,	2017a).		
A	public	campaign	for	'appropriate	antibiotic	use'	in	Korea	was	launched	
using	posters,	e-learning	programs	and	mass	media	campaigns	(Chung	&	Song,	
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2012).	The	European	Antibiotic	Awareness	Day	in	Europe	takes	place	annually	on	the	
18th	of	November	to	increase	public	awareness	of	AMR	and	responsible	antibiotic	
use	(ECDC,	2017).	The	‘Antibiotic	Guardian	Campaign’	was	developed	in	the	United	
Kingdom	to	increase	people’s	commitment	to	reducing	AMR	by	providing	knowledge	
through	an	online	pledge	system	(Kesten,	Bhattacharya,	Ashiru-Oredope,	Gobin,	&	
Audrey,	2017).	Public	campaigns	for	improving	the	use	of	antibiotics	in	outpatients	in	
high-income	countries	have	been	associated	with	positive	outcomes,	namely	
reduced	antibiotic	use	(Huttner,	Goossens,	Verheij,	&	Harbarth,	2010).	
In	Thailand,	Antibiotics	Smart	Use	(ASU)	was	a	major	public	campaign,	
introduced	in	2007.	The	ASU	program	was	initiated	to	promote	rational	antibiotic	
use	in	district	hospitals	and	primary	health	centres	in	Thailand.	After	demonstrating	
initial	effectiveness	in	one	province,	the	ASU	project	has	since	been	expanding	
across	the	country	(Sumpradit	et	al.,	2012a).	As	a	consequence,	the	ASU	project	has	
been	approved	as	a	practical	project	to	decrease	antibiotic	use	in	a	series	of	pilot	
communities	in	Thailand.	However,	misconceptions	about	antibiotic	use	are	still	
reported	in	the	Thailand	(Saengcharoen	et	al.,	2012)	and	in	this	study.	To	improve	
the	public’s	knowledge	of	appropriate	antibiotic	use,	multisectorial	collaboration	
between	bodies	such	as	Ministry	of	Public	Health	and	Ministry	of	Agriculture	for	
national	action	plans	on	the	AMR	issue	is	needed.	Additionally,	further	monitoring	
and	sustainability	of	the	AMS	campaign	along	with	intermittent	evaluation	of	
antibiotic	awareness	in	Thai	people	needs	to	be	continued.	
In	our	survey,	patients’	knowledge	about	antibiotics	in	general	was	
moderate.	Patients	knew	that	antibiotics	might	cause	a	drug	allergy	(59.0%)	and	that	
an	incomplete	course	of	antibiotics	could	reduce	antibiotic	effectiveness	(58.5%)	and	
contribute	to	AMR	(60.0%).	Nurses’	perceptions	were	that	patients’	knowledge	
regarding	antibiotic	use	was	suboptimal	and	that	poor	adherence	to	antibiotic	
treatments	was	a	major	contributor	to	the	development	of	AMR	in	Thailand.	These	
findings	are	similar	to	a	previous	study	in	Thailand	that	reported	66%	of	participants	
knew	that	unnecessary	use	of	antibiotics	causes	AMR	(Saengcharoen	et	al.,	2012).	
However,	97.1	%	of	patients	in	this	Phase	3	study,	wanted	more	information	
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regarding	the	best	way	to	use	antibiotics.	Patients	also	reported	that	in	the	
community,	they	relied	on	doctors,	drugstores,	nurses	and	pharmacists	for	antibiotic	
information.	Patients’	desire	for	information	about	optimal	antibiotic	use	in	this	
study	suggests	that	although	patients	are	talking	to	health	professionals,	they	may	
not	be	receiving	adequate	information.	
Patient’s	reported	antibiotic	use	in	the	community	showed	that	their	
management	of	antibiotic	use	was	reasonable.	Most	patients	reported	that	they	did	
not	share	antibiotics	(82.0%)	and	did	not	stockpile	antibiotics	(76.6%).	These	specific	
findings	were	similar	to	those	in	a	previous	Thai	study	where	64.2	%	and	69.2%	of	
participants	reported	that	they	did	not	share	and	stockpile	antibiotics	respectively	
(Porisutiwutiporn	&	Hemchayat,	2014a).	One	possible	explanation	is	that	antibiotics	
are	cheap	and	easy	to	get	in	Thailand	and	therefore	stockpiling	is	not	necessary.	
Findings	of	previous	studies	have	shown	that	in	low	and	middle-income	countries	
(LMIC),	pharmacy	practices	is	suboptimal	because	of	limitations	in	professional	
practices	regarding	advice-giving	and	the	supply	of	medicines	along	with	the	lack	of	
availability	of	trained	staff	(Smith,	2009).	In	Thailand,	although	pharmacists	typically	
own	the	drugstores,	relatives	or	employees	who	are	not	formally	qualified,	work	in	
the	business	and	provide	consumers	with	advice	and	information.	There	is	also	the	
problem	of	a	potential	conflict	of	interest,	where	high	sales	rather	than	provision	of	
information	about	the	appropriate	care	of	different	conditions	may	be	a	priority.		
	
6.3.2	Patient	participation	in	AMS	during	hospital	admission	from	patients’	
and	nurses’	perspectives	
During	hospitalisation,	patients	were	unsure	whether	they	wanted	
antibiotics.	However,	patients	reported	that	if	they	do	have	antibiotics,	they	would	
prefer	intravenous	antibiotics	with	84.0%	of	participants	believing	that	intravenous	
antibiotics	are	stronger	than	oral	antibiotics.	Evidence	shows	that	the	oral	and	
injection	forms	of	some	antibiotics	such	as	amoxicillin	have	equal	effectiveness	
(Addo-Yobo	et	al.,	2004;	Lodha,	Randev,	&	Kabra,	2016)	and	empowering	patients	in	
shared	decision-making	about	treatments	has	positive	outcomes	(Davey	et	al.,	
Page	188	
	
	
2002).	For	example,	informing	parents	about	how	to	choose	intravenous	or	oral	
therapy	for	their	children	promoted	higher	satisfaction,	and	oral	therapy	was	more	
likely	if	parents	were	involved	in	shared	decision	making	(Rosati	et	al.,	2014).	
Promoting	shared	decision-making	by	training	family	physicians	has	also	been	shown	
to	decrease	antibiotic	use	(Legare	et	al.,	2013;	Legare	et	al.,	2011b).	Therefore,	
informing	patients	about	the	relative	effectiveness	of	oral	and	intravenous	antibiotic	
treatment	accompanied	by	encouraging	shared	decision-making	between	clinicians	
and	patients	is	suggested	as	a	strategy	to	increase	patients’	knowledge	of	antibiotic	
use	and	promote	patient	satisfaction.		
During	hospital	admission,	patients	expected	healthcare	professionals	to	
control	antibiotic	use.	One	possible	explanation	is	that	Thai	patients	have	a	high	level	
of	trust	in	health	professionals	and	believe	that	they	should	not	question	their	
treatment	plan.	Other	studies	have	found	that	patients	have	a	high	degree	of	trust	
and	confidence	in	physicians	to	prescribe	appropriate	antibiotics	(Heid	et	al.,	2016).	
Further,	patients	have	not	been	found	to	be	concerned	about	potential	adverse	
effects	(such	as	developing	a	resistant	infection	or	experiencing	side-effects	of	
treatment)	as	a	result	of	inappropriate	use	of	antibiotics	(Heid	et	al.,	2016).	
However,	blind	trust	in	healthcare	professionals	might	result	in	patients	not	
questioning	the	prescribed	treatment	plan	or	being	fully	aware	of	potential	adverse	
effects	associated	with	antibiotic	treatment	(Kraetschmer,	Sharpe,	Urowitz,	&	Deber,	
2004).	If	patients	rely	on	health	professionals	to	control	and	monitor	their	antibiotic	
use	some	side	effects	of	treatment	may	go	unreported	and	patients	cannot	
participate	in	monitoring	their	own	safety	if	they	are	not	aware	of	their	treatment	
program.		
In	this	study,	patients	wanted	more	information	during	their	hospital	
admission,	about	antibiotic	use	including	the	reason	and	duration	of	treatment,	and	
potential	side	effects.	Previous	studies	have	shown	similar	findings.	For	example,	
patients	have	indicated	wanting	to	review	their	hospital	medication	list	for	accuracy	
because	this	could	potentially	reduce	medication	errors	(Cumbler,	Wald,	&	Kutner,	
2010).	Patients	who	are	informed	about	the	pros	and	cons	of	each	medication	and	
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have	a	high	degree	of	involvement	in	decision	making	are	still	likely	to	agree	with	
their	doctor’s	decision	(Heid	et	al.,	2016).	There	is	emerging	evidence	that	
empowering	patients	to	share	decision-making	can	lead	to	positive	outcomes	
including	attitude	change	and	behaviours	conducive	to	appropriate	antimicrobial	
therapy,	and	reduction	in	the	development	of	AMR	(Davey	et	al.,	2002).		
Nurse	participants	in	this	study	perceived	that	patient	participation	in	AMS	
was	about	patient	safety	in	antibiotic	administration	rather	than	shared	decision-
making	in	antibiotic	use.	Nurses	stated	that	informing	patients	about	possible	
hypersensitivities	during	antibiotic	administration	along	with	educating	patients	
about	IPC	and	appropriate	antibiotic	use	in	the	community	was	major	element	of	
patient	participation	in	AMS.	Patient	participation	is	the	involvement	of	patients	in	
decision-making	processes	in	relation	to	health	concerns	in	order	to	promote	patient	
safety	(Longtin	et	al.,	2010,	p.	54;	Rathert	et	al.,	2011).	Our	results	show	that	nurses	
were	playing	an	active	role	in	educating	patients	however	there	was	no	evidence	
that	nurses	actively	engaged	patients	in	shared-	decision	making	about	their	
treatment	choices.	Previous	studies	have	also	identified	that	nurses	fail	to	enable	
true	patient	participation	in	health	care	by	eliciting	patient	preferences	for	
participation.	In	Sweden,	a	study	of	patient	participation	in	clinical	decision-making	
showed	that	nurses	perceived	that	patients	preferred	to	be	more	active	in	clinical	
decision-making	about	nursing	care	whereas	patients	preferred	to	have	a	passive	
role	in	nursing	care.	Misinterpreting	patient	preferences	by	nurses	in	this	Swedish	
study	was	seen	as	a	barrier	in	engaging	patients	and	meeting	their	needs	regarding	
communication	and	pain	management	(Florin,	Ehrenberg,	&	Ehnfors,	2006).	
Similarly,	an	Australian	study	of	patient	participation	in	medication	management	
found	that	nurses	provided	insufficient	opportunities	to	engage	patients	in	
medication	management	during	hospital	admission	(McTier,	Botti,	&	Duke,	2015).	
The	authors	concluded	that	during	an	acute	care	admission,	providing	opportunities	
for	patients	to	engage	in	medication	management	by	nurses	is	needed	to	support	
quality	and	patient	safety	care.	
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A	systematic	review	on	the	barriers	and	facilitators	to	implementing	shared	
decision-making	in	clinical	practice	as	perceived	by	health	professionals,	concluded	
that	lack	of	time	was	the	major	barrier	to	patient	participation	in	shared	decision-
making	(Legare,	Ratte,	Gravel,	&	Graham,	2008).	However,	provider	motivation	and	
promotion	of	the	positive	impacts	of	shared	decision-making	on	clinical	care	and	
patient	outcomes	have	been	suggested	as	strategies	to	overcome	the	problem	of	
time	constraints	to	shared	decision-making	(Legare	et	al.,	2008).	Therefore,	
educating	clinicians	about	potential	positive	patient	outcomes	of	participation	may	
be	a	useful	strategy	to	increase	patient	participation	and	nurses’	role	in	patient	
participation	in	AMS.	
6.4	Chapter	summary	
The	findings	presented	in	this	chapter	detail	patients’	attitudes	and	reported	
behaviours	towards	antimicrobial	use	in	the	community	and	patient	participation	in	
AMS	from	patients’	and	nurses’	perspectives.	In	the	Thai	community,	patients	and	
nurses	confirmed	the	common	use	of	antibiotics	and	the	misconceptions	associated	
with	their	use.	Patients	appeared	to	rely	on	health	professionals	for	information	
about	antibiotic	use	in	the	community	and	wanted	more	information	about	the	best	
way	to	use	antibiotics.	When	in	hospital,	patients	expected	health	professionals	to	
control	antibiotic	use	although	patients	did	want	to	participate	in	AMS-related	
activities.	Nurses	perceived	that	encouraging	patients	to	monitor	their	safety	during	
antibiotic	use	and	educating	patients	about	antibiotic	use	and	side	effects	were	
strategies	to	support	patient	participation	in	AMS.	Further	work	is	required	to	
develop	strategies	for	more	active	patient	participation	and	shared	decision-making	
regarding	antibiotic	use	involving	clinicians,	patients	and	families.		
Page	191	
	
	
Chapter	7	
Nurses’	Role	in	Antimicrobial	Stewardship	
In	this	chapter,	the	analyses	of	the	interviews	and	focus	group	data	related	to	
the	role	of	nurses	in	AMS	are	presented	in	three	major	sections	in	line	with	the	
objectives	of	this	component	of	the	research.		
	
Aim	and	objectives	
The	fourth	specific	aim	of	this	research	program	was	to	explore	how	key	
stakeholders	and	nurses	perceive	potential	future	roles	for	nurses	in	AMS	in	Thailand	
within	the	current	governance,	educational	and	practice	context.	The	specific	
objectives	were	to:		
I. Describe	the	current	roles	of	nurses	in	AMS.	
II. Identify	perceived	barriers	and	facilitators	to	nurses	taking	a	broader	
role	in	AMS.		
III. Explore	the	potential	roles	of	nurses	in	AMS.		
7.1	Methods	
The	methodological	approach	used	in	this	research	program	is	described	in	
detail	in	Chapter	3.	Organisational	executive	and	clinical	leaders	involved	in	AMS	
programs	(referred	to	as	organisational	leaders,	or	leaders),	ICNs	and	clinical	nurses	
were	invited	to	participate	and	a	combination	of	semi-structured	interviews	(key	
stakeholders)	and	focus	groups	(ICNs	and	clinical	nurses)	were	used	to	explore	
concepts	related	to	the	roles	of	nurses	in	AMS.	The	full	interview	guide	is	available	in	
Appendix	A	and	B.		
7.2	Findings	
The	findings	are	presented	in	the	following	sections:	i)	the	current	role	of	
nurses	in	AMS,	ii)	the	perceived	barriers	and	facilitators	to	nurses	taking	a	larger	role	
in	AMS	and	iii)	the	potential	role	of	nurses	in	AMS.			
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	 7.2.1	Participant	characteristics	
The	combined	number	of	participants	in	the	interviews	and	the	focus	groups	
was	33	(Table	7.1).	There	were	15	individual	leader	interviews	and	three	focus	
groups	conducted.	The	interviewed	participants	consisted	of	the	Director	of	the	
hospital,	the	Director	of	Nursing,	the	Director	of	Pharmacy,	the	Chair	of	the	IPC	
committee,	the	nurse	manager	of	the	IPC	department,	infection	control	specialists	
(n=2),	surgeons	(n=2),	an	ID	specialist,	the	nurse	manager	of	the	operating	room,	the	
nurse	manager	of	the	ICU,	AMS	and	clinical	pharmacists	(n=2)	and	the	Head	of	the	
Virology	Department.	
The	three	different	groups	of	nurses	who	participated	in	the	focus	group	
discussions	were:	seven	participants	from	the	infection	control	nurse	group,	five	
participants	in	the	senior	nurse	group	and	six	participants	in	the	junior	nurse	group.	
The	participants	in	the	senior	and	junior	nurse	groups	were	working	in	either	the	
medical	or	surgical	wards	in	the	hospital.	The	senior	nurses	had	over	10	years’	
experience	in	nursing	and	the	junior	nurses	less	than	three	years.	
Table	7.1	Data	collection:	Individual	interviews	and	focus	groups	(N=33)	
Data	Collection	 Method	(n)	 Participants	(n)	
Individual	interviews		 15	 15	
Focus	group		 3	 18	
Total		 18	 33	
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	 7.2.2	Current	roles	of	nurses	in	antimicrobial	stewardship		
Thematic	analysis	of	the	interview	and	focus	group	data	identified	five	themes	
reflecting	areas	of	activity	in	which	nurses	currently	participate	in	AMS:	i)	supporting	
system	processes,	ii)	monitoring	for	safety,	iii)	monitoring	for	optimal	antibiotic	use,	
iv)	patient	education	and	v)	AMS	leadership	by	specialty	nurses.	The	data	are	
presented	in	Summary	Table	7.2	according	to	stakeholder	or	focus	group	
respondents.	
Theme	1.	Supporting	system	processes	
The	majority	of	participating	clinical	nurses	identified	the	role	of	nurses	in	
supporting	system	processes	in	AMS.	Related	activities	included	identification	and	
documentation	of	patient	allergies,	monitoring	for	signs	of	infection,	alerting	doctors	
to	microbiology	results	to	prompt	treatment,	and	promoting	timely	review	of	
antibiotic	sensitivity	reports.	Clinical	nurses	reported	that	one	of	their	roles	in	AMS	
was	to	ensure	that	patients’	allergies	to	antibiotics	were	recorded	on	the	hospital	
database	when	patients	were	admitted	to	the	hospital.	When	a	patient’s	drug	allergy	
history	was	identified	for	the	first	time,	nurses	not	only	reported	this	to	the	patients’	
treating	doctors	but	also	liaised	with	the	ward	pharmacists	to	investigate	the	type	of	
allergic	reaction	and	record	this	on	the	hospital	database	(Table	7.2,	Q1).		
During	hospital	admission,	nurse	participants	in	the	clinical	nurse	and	leader	
groups	identified	nurses’	role	in	further	supporting	system	processes	by	monitoring	
patients	for	signs	of	infection,	along	with	reviewing	culture	results	and	antimicrobial	
sensitivities.	For	example,	for	postoperative	patients,	if	patients	exhibited	signs	of	
infection	nurses	would	alert	the	treating	doctor	so	that	a	septic	work	up	could	be	
performed	(Table	7.2,	Q2).	In	terms	of	timely	review	of	cultures,	in	the	hospital	ICU	
and	high	dependency	wards,	nurses	described	a	proactive	process	in	which	they	
established	a	schedule	to	systematically	track	what	specimens	had	been	collected	
and	when	the	culture	results	became	available	for	review	(Table	7.2,	Q3).	Both	
senior	and	junior	nurses	described	processes	nurses	used	to	expedite	review	of	
microbiological	data	by	printing	out	patients’	microbiology	results	as	a	hard	copy	and	
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putting	these	in	the	patients’	charts	to	remind	doctors	to	consider	or	review	the	
current	antibiotic	treatment	regimen	or	by	contacting	the	Microbiology	Unit	directly	
if	reports	of	results	were	delayed	(Table	7.2,	Q5).	Nurses	described	strategies	to	
prompt	review	of	prescribed	antimicrobials	and	reported	microorganism	sensitivities	
by	printing	out	results	and	highlighting	if	the	current	microorganism	was	not	
sensitive	to	the	prescribed	antibiotic.	(Table	7.2,	Q4).		
Theme	2.	Monitoring	for	safety	
The	majority	of	clinical	nurses	identified	that	nurses	have	current	roles	in	
monitoring	for	safety	in	antibiotic	use.	Ensuring	patients’	drug	allergies	are	
documented	when	patients	are	admitted	to	the	ward,	monitoring	for	side	effects	
and	hypersensitivity	reactions	to	antibiotics	during	administration,	and	identifying	
antibiotic	side	effects	in	specific	populations	were	current	roles	of	nurses	in	AMS.		
Monitoring	patients	for	hypersensitivity	reactions	during	IV	antimicrobial	
administration	was	also	a	current	nurses’	role	in	AMS.	The	junior	nurse	participants	
were	the	major	group	to	identify	the	AMS	role	of	monitoring	patient	safety	during	
antibiotic	administration.	These	activities	involved	ensuring	that	when	patients	were	
admitted	to	the	ward,	their	drug	allergies	were	recorded	and,	during	antibiotic	
administration,	nurses	monitored	patients	for	any	effects	associated	with	antibiotic	
therapy.	Junior	nurses	reported	that	asking	a	patient	about	their	medical	history,	
previous	drug	allergies	or	adverse	drug	reactions	was	one	of	the	most	critical	pieces	
of	information	in	nursing	care	planning	for	individual	patients.	Clinical	nurses	would	
review	patients’	past	history	of	drug	allergies	on	admission	and	notified	doctors	
immediately	if	patients	informed	them	of	previous	allergies	or	sensitivity	reactions	
to	antibiotic	therapy	(Table	7.2,	Q6).	Monitoring	of	routine	antibiotic	orders	was	
considered	important	because	if	information	about	patients’	allergies	was	missed	
this	could	lead	to	patient	harm.	For	example,	some	doctors	may	routinely	prescribe	
prophylactic	antibiotics	and	could	miss	patients’	history	of	allergic	reactions	to	the	
prescribed	antibiotics	(Table	7.2,	Q7).		
Nurse	participants	also	identified	the	importance	of	educating	and	informing	
patients	about	their	antibiotic	treatment	as	a	nurses’	role	in	AMS.	Informing	patients	
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about	possible	side	effects	of	antibiotics	was	identified	as	an	important	process	to	
prevent	unintended	events	and	support	patient	engagement	in	AMS	(Table	7.2,	Q8).	
One	junior	nurse	participant	gave	an	example	of	concerns	raised	by	nurses	related	to	
specific	antibiotic	side-effects	and	the	policy	and	practice	changes	that	occurred	to	
ensure	safer	administration	of	antibiotics	(Table	7.2,	Q9).		
In	addition,	junior	nurse	participants	reported	that	nurses	play	an	active	role	in	
monitoring	for	antibiotic	side	effects	in	specific	patient	populations	or	for	some	
specific	antibiotics.	Nurses	coordinate	with	other	professionals	such	as	doctors	and	
pharmacists	to	ensure	the	safe	administration	of	antibiotics	(Table	7.2,	Q10-Q11).	A	
pharmacist	also	confirmed	that	nurses	play	an	active	role	in	safety	monitoring	for	
adverse	effects	when	administering	antibiotics	(Table	7.2,	Q12).		
Theme	3.	Monitoring	for	optimal	antibiotic	use	
Participants	in	both	key	stakeholder	and	clinical	nurse	groups	identified	nurses’	
roles	in	monitoring	antibiotic	prophylaxis,	antibiotic	timeout	and	switching	from	IV	
to	oral	therapy	to	support	optimal	antibiotic	use.	Nurse	participants	highlighted	their	
role	in	evaluating	patients’	need	for	ongoing	treatment	after	antibiotic	initiation.	
Monitoring	patients’	antibiotic	use	by	checking	doctors’	progress	notes	in	patient	
charts	was	identified	as	a	routine	nurses’	role	in	AMS	to	ensure	that	doctors’	
treatment	plans	were	being	followed	(Table	7.2,	Q13).	For	some	specific	antibiotics	
commonly	used	for	surgical	prophylaxis,	clinical	nurses	would	question	if	antibiotics	
had	been	used	for	more	than	24	hours	and	whether	the	treatment	should	be	ceased	
(Table	7.2,	Q14).		
In	terms	of	participating	in	antibiotic	timeout,	clinical	nurses	monitor	current	
antibiotic	therapy	and	remind	prescribers	to	review	treatment	for	the	therapeutic	
duration	(Table	7.2,	Q15).	A	doctor	stakeholder	also	recognised	that	nurses	play	a	
vital	role	in	antibiotic	timeout	because	nurses	work	consistently	with	patients	and	
are	aware	of	their	patients’	longer-term	treatment	plan	and	the	therapy	they	have	
already	received	(Table	7.2,	Q16).	Moreover,	participants	from	key	stakeholder	and	
clinical	nurse	groups	perceived	that	a	number	of	nurses,	particularly	senior	staff,	
played	a	role	in	ensuring	that	the	switch	from	the	IV	to	oral	route	of	antibiotic	
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administration	occurred	at	the	appropriate	time.	For	example,	on	the	surgical	wards,	
nurses	would	ask	doctors	to	switch	from	the	intravenous	(IV)	to	oral	route	once	
patients	were	able	to	tolerate	oral	intake	postoperatively	(Table	7.2,	Q17).	Clinical	
nurses’	awareness	of	the	importance	of	switching	antibiotic	therapy	from	IV	to	oral	
was	also	acknowledged	by	the	clinical	pharmacists.	One	pharmacist	participant	
recognised	the	importance	of	this	role	and	that	nurses	were	taking	the	lead	in	
ensuring	that	this	principle	was	implemented	in	practice	(Table	7.2,	Q18).		
Theme	4.	Patient	education	
Participants	in	the	clinical	nurse	group,	particularity	junior	nurses,	identified	
that	patient	education	was	an	important	role	nurses	play	in	AMS.	During	
hospitalisation,	nurses	inform	patients	about	the	reason	antibiotics	are	prescribed	
along	with	the	possible	side	effects	of	their	treatment	(Table	7.2,	Q19).	In	terms	of	
IPC	practice,	doctor	and	nurse	participants	recognised	nurses’	role	in	educating	and	
modeling	IPC	practices	to	ensure	that	patients	and	family	members	were	aware	of	
processes	to	prevent	infection	appropriately	in	the	hospital	and	on	their	discharge	
home	(Table	7.2,	Q20-Q21).		
Educating	patients	and	their	caregivers	about	appropriate	use	of	prescribed	
antibiotics	once	patients	are	discharged	from	hospital	was	also	recognised	as	a	
nurses’	role.	This	education	includes	the	need	to	complete	an	antibiotic	course,	
when	that	course	is	complete,	the	side	effects	of	antibiotics	(Table	7.2,	Q22-Q24),	
and	the	importance	of	reporting	the	symptoms	of	adverse	effects	to	their	treating	
doctor	(Table	7.2,	Q25).	
Theme	5.	AMS	leadership	by	specialty	nurses	
This	theme	relates	to	the	expanded	and	advanced	roles	of	specialty	nurses	
related	to	the	supportive	and	monitoring	roles	identified	in	the	previous	themes.	The	
activities	of	nurses	described	in	this	theme	build	on	the	recognised	current	roles	of	
nurses	described	above,	however	specialty	nurses	act	as	clinical	leaders,	their	
activities	are	supported	by	a	greater	knowledge	base	and	they	are	seen	to	actively	
(or	explicitly)	contribute	to	the	AMS	team.	
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Leaders	and	clinical	nurse	groups	discussed	the	leadership	and	team	roles	of	
nurses	within	some	specialty	areas	such	as	ICU	and	those	of	Infection	Control	Nurses	
and	senior	nurses	in	remote	or	provincial	areas.	Because	ICU	wards	provide	care	to	
patients	with	high	acuity	and	the	standard	nurse-patient	ratio	is	1:1,	nurses	were	
seen	to	have	an	important	role	in	AMS.	The	ICU	medical	team	in	being	based	within	
the	unit,	spent	less	time	outside	the	unit	compared	to	other	medical	teams	who	
review	patients	on	wards	throughout	the	hospital.	Nurses	and	doctors	therefore	
work	closely	together	and	there	is	a	stronger	sense	of	teamwork	within	the	ICUs;	a	
doctor	participant	stated	that	“	The	relationship	between	doctors	and	ICU	nurses	is	
quite	good,	we	work	like	colleagues”	(D3).	Doctor	participants	further	identified	ICU	
nurses’	contribution	to	the	AMS	program	in	developing	the	infection	surveillance	
protocol	and	as	having	a	key	role	in	monitoring	patients	with	severe	infections	along	
with	supporting	appropriate	antibiotic	use	within	the	ICU	(Table	7.2,	Q26).	
Additionally,	senior	nurses	in	ICU	wards	who	have	many	years	of	experience	were	
recognised	as	providing	prescribing	advice	when	clinical	pharmacists	were	not	
available	(Table	7.2,	Q27).		
Infection	Control	Nurses’	advanced	practice	roles	in	AMS	were	addressed	by	
both	doctor	and	ICN	participants	in	terms	of	ongoing	surveillance,	support	and	
education.	ICNs	were	recognised	by	doctor	participants	as	the	central	repository	of	
knowledge	regarding	AMR	across	the	hospital	(Table	7.2,	Q28)	who	regularly	discuss	
issues	related	to	optimal	antibiotic	use	with	doctors,	in	particular,	congruity	between	
sensitivity	results	and	antibiotics	prescribed	(Table	7.2,	Q32-Q33).	ICNs	reported	that	
their	expertise	was	demonstrated	by	such	activities	involved	in	consulting	with	
doctors	and	nurses,	as	knowledge	providers	and	as	role	models	for	ward	nurses	in	
AMS	whereby	nurses	can	develop	their	communication	skills	related	to	AMS	by	using	
the	ICNs	as	role	models	(Table	7.2,	Q34-Q35).	Further,	ICN	participants	reported	that	
when	ward	nurses	have	an	issue	or	concerns	about	AMR	or	AMS,	they	would	often	
consult	ICNs	first,	before	discussing	their	concerns	with	the	doctors	(Table	7.2,	Q29-
Q30).	ICNs	provide	training	courses	relating	to	IPC	and	AMR	for	nurses	across	the	
hospital	(Table	7.2,	Q31).		
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A	small	number	of	participants	in	the	key	stakeholder	group	spoke	about	the	
substantial	role	that	nurses	in	provincial	hospitals	played	in	AMS.	One	doctor	
participant	noted	that	because	the	provincial	hospitals	have	fewer	ID	specialists,	
ICNs	or	senior	nurses	played	an	important	role	in	encouraging	rational	use	of	
antibiotics	in	their	hospitals	(Table	7.2,	Q36).	Another	leader	participant	also	
confirmed	that	nurses	in	provincial	hospitals	perform	a	vital	extended	role	in	
antiviral	medication	management.	It	is	important	to	note	that	these	nurses	were	
recognised	as	having	high-level	competence	and,	because	the	turnover	rate	of	
doctors	in	these	provincial	centers	is	high,	nurses	manage	antiviral	medications	as	
prescribers	(Table	7.2,	Q37).		
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Table	7.2	Current	roles	of	nurses	in	antimicrobial	stewardship	in	acute	healthcare	in	Thailand	–	themes,	subthemes	and	exemplar	quotes	
Themes	 Subthemes	
Representative	quotes	from	professional	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(1)	Supporting	
system	processes	
Ensuring	patient	
allergies	are	
recorded	on	the	
hospital	database	
	 Q1	“When	asking	about	medical	history	of	patients,	if	patients	have	a	history	
of	drug	allergy,	we	ask	for	a	drug	allergy	card	and	if	they	don’t	have	it,	we	put	
a	record	in	the	database	and	request	the	pharmacist	to	do	an	assessment	
and	also	handover	this	information	to	nurses	in	the	next	shift.”	(JRN6)		
Monitoring	signs	of	
infection	and	
timely	review	of	
cultures		
	
Q3	“	Some	units	have	developed	a	list	that	includes	
information	about	what	is	the	infection,	and	when	it	
was	discovered.	They	have	a	form	to	collect	
information	about	the	culture	results	and	the	date	
that	antibiotics	were	started.	If	the	antibiotic	is	
insensitive,	nurses	notify	this	finding	to	the	
doctors.”	(N2)	
Q2	“If	a	patient	has	a	fever	after	the	operation,	we	[nurses]	report	to	a	
doctor	to	see	whether	a	doctor	wants	to	do	a	septic	work	up	and	reconsider	
antibiotic	use.”	(JRN4)	
Printing	out	
microbiology	
results	to	prompt	
doctors	
	 Q4	“When	we	[nurses]	receive	sensitivity	results,	we	[nurses]	print	them	out	
and	put	them	on	the	charts	for	doctors	to	easily	see.	Sometimes	if	we	
[nurses]	find	that	the	antibiotic	is	not	sensitive	to	the	bacteria,	we	would	
mark	it	with	a	magic	pen	to	make	it	obvious	to	doctors	or	we	discuss	it	with	
the	doctors	straight	away.”	(JRN2)	
Timely	review	of	
antibiotic	
sensitivity	
	 Q5	“We	[nurses]	make	a	tracking	list	for	each	patient	on	what	date	we	have	
obtained	microbial	cultures	and	what	date	the	results	should	be	reported.	
We	will	make	a	call	to	the	microbiology	unit	if	the	results	are	not	reported	on	
time.”	(SRN3)	
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Themes	 Subthemes	
Representative	quotes	from	professional	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(2)	Monitoring		
for	safety	
Identifying	patient	
drug	allergies	when	
patients	admitted	to	
the	ward	
	 Q6	“Nurses	always	ask	patients	about	their	history	of	drug	allergy	when	they	
are	admitted	in	a	ward.	We	don’t	know	if	patients	have	a	drug	allergy	history	
from	outside	the	hospital	or	not.	So	our	role	is	to	ask	both	patients	and	their	
relatives.	We	will	caution	the	doctors	right	away	if	they	prescribe	antibiotics	
that	patients	are	allergic	to.”	(SRN3)	
Q7	“We	ask	patients’	their	history	of	drug	allergy	when	patients	are	admitted	
in	the	ward.	Sometimes	a	doctor	prescribes	antibiotic	prophylaxis	as	a	routine	
but	that	antibiotic	is	what	the	patient	is	allergic	to.	Nurses	have	to	ask	and	
remind	doctors	again.	It	happens	quite	often	that	doctors	do	not	ask	patients	
about	past	drug	allergies.”	(JRN5)	
	 Monitoring	for	drug	
allergies	and	
hypersensitivities	to	
antibiotics	during	
antibiotic	
administration	
	 Q8	“In	a	surgical	ward,	most	antibiotics	are	the	regular	ones	we	use.	We	know	
the	side	effects	of	those	antibiotics.	So,	every	time	we	administer	them	to	
patients,	we	inform	them	about	the	possible	side	effects	that	may	occur.	So	
patients	can	tell	us	early	if	they	experience	these	symptoms.”	(SRN1).	
Q9“We	[nurses]	monitor	if	patients	have	any	adverse	events	during	antibiotic	
administration.	The	concern	about	adverse	effects	has	been	increasing	
because	of	a	previous	incident	where	a	patient	had	a	severe	allergic	reaction	
to	Ceftriaxone	via	IV	push	in	the	Emergency	Department.	Since	this	occurred	
we	now	give	Ceftriaxone	via	IV	drip	in	0.9%	NSS	over	90	minutes.	In	the	
medical	wards,	we	have	a	regulation	that	IV	antibiotic	therapy	must	take	at	
least	an	hour	and	that	nurses	must	keep	monitoring	[the	patients]	closely	for	
adverse	effects.”	(SRN3)	
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Themes	 Subthemes	
Representative	quotes	from	professional	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(2)	Monitoring		
for	safety	(cont)	
	
Monitoring	for	side	
effects	of	antibiotics	in	
special	populations	
Q12	“In	cases	of	patients	who	are	taking	Vancomycin,	
sometimes	ward	nurses	ring	me	[clinical	pharmacist]	to	
ask	whether	I	want	to	adjust	the	Vancomycin	level”	(P2)	
	
	
Q10	“For	patients	who	receive	particular	antibiotics	such	as	patients	
with	kidney	disease	and	are	prescribed	Vancomycin...	We	specifically	
monitor	the	side	effects	and	coordinate	with	pharmacists	and	
doctors.	If	we	[nurses]	find	that	the	Creatinine	blood	levels	are	getting	
high,	we	confirm	the	drug	dose	with	doctors	right	away.”	(JRN4)	
Q11	“Some	antibiotics,	such	as,	Amphotericin	B,	we	inform	patients	
about	any	side	effects,	like,	having	fever	and	chills.	We	confirm	with	
the	doctor	first	if	a	patient	is	hypersensitive	to	that	antibiotic.	Doctors	
will	adjust	administration	times	according	to	the	information	we	give.	
Nurses	must	know	patients’	information	and	cooperate	with	
pharmacists	and	doctors	all	the	time.”	(JRN6)	
(3)	Monitoring	
for	optimal	
antibiotic	use	
Monitoring	antibiotic	
prophylaxis	
	 Q13	“We	always	read	the	doctors’	progress	notes	to	see	the	
treatment	plans,	so	that	we	can	monitor	how	many	days	doctors	
prescribe	antibiotics	or	when	to	stop.”	(JRN2)	
Q14	“When	doctors	keep	prescribing	antibiotic	prophylaxis	more	than	
24	hours	for	patients	who	have	undergone	a	surgical	procedure,	we	
[nurses]	would	ask	in	as	polite	a	way	as	possible,	do	you	want	to	give	
it	more	than	24	hours	for	this	case?	Or	were	there	any	complications	
in	the	operating	room?”	(SRN1)	
	 Participate	in	
antibiotic	timeout	
Q16	“In	our	hospital	residents	rotate	to	new	departments	
frequently,	we	found	a	number	of	antibiotics	were	not	
stopped	appropriately	during	this	transitional	period.	I	think	
no	one	knows	better	than	the	nurses	[on	the	ward]	about	
patients’	medications.	Nurses	know	best	anyway.”	(D5)	
Q15	“We	remind	doctors	such	as	by	asking,	this	antibiotic	will	be	due	
for	re-prescription	soon	after	15	days	[of	therapy],	do	you	want	to	
discontinue?”	(JRN1)	
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Themes	 Subthemes	
Representative	quotes	from	professional	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(3)	Monitoring	
for	optimal	
antibiotic	use	
(cont)	
Facilitate	switching	
therapy	from	IV	to	
oral	
Q18	“I	noticed	that	when	patients	are	being	cared	for	by	
student	nurses,	the	clinical	nurse	educator	emphasises	the	
importance	of	switching	antibiotic	to	oral	therapy”	(P2)	
Q17	“In	changing	antibiotics	from	injection	to	oral	route…we	
experience	this	a	lot	in	surgical	wards.	We	always	ask	the	doctors,	
this	patient	has	now	started	eating,	do	you	want	to	change	from	IV	
into	oral	antibiotic?”	(SRN1)	
(4)	Patient	
education	
Educating	patients	
and	caregivers	
about	IPC	during	
hospitalisation	
Q20	“At	the	moment	I	think,	nurses	perform	the	role	of	IPC	
practices	very	well.	And	that	could	be	a	role	model	for	the	
patients.”	(D1)	
Q19	“During	antibiotic	administration	to	patients,	we	inform	
patients	about	names	and	purposes	of	antibiotics,	and	what	
bacterial	infections	we	found.	Also	when	changing	antibiotics	we	
also	have	to	tell	them.	Some	drugs,	such	as,	Amphotericin	B,	we	tell	
the	patients	about	any	side	effects	such	as	fever	and	chills.”	(JRN	6)	
Q21	“Before	discharge,	If	patients	have	got	antimicrobial	resistant	
infections,	we	[nurses]	educate	them	on	how	to	prevent	the	spread	
of	antibiotic	resistance	in	the	hospital.	Before	they	are	going	home,	
nurses	educate	patients	and	their	carers	again	about	basic	infection	
prevention	control	such	as	washing	hands	and	wearing	gowns.”	
(JRN4)	
Educating	patients	
about	appropriate	
antibiotic	use	post	
discharge	
	 Q22	“About	educating	patients	at	discharge,	we	always	educate	
patients	to	complete	antibiotics	that	they	are	prescribed	from	the	
hospital	and	inform	patients	not	to	buy	antibiotics	themselves.	
Some	patients	misunderstand	and	think	that	they	have	to	take	
antibiotics	until	the	next	appointment	date	so	they	buy	antibiotic	
from	the	drug	store	to	continue	taking	antibiotics.”	(SRN2)	
Q23	“When	giving	advice	to	patients	about	taking	antibiotics	at	
home,	we	insist	that	they	must	complete	the	antibiotics	prescribed.	
They	cannot	stop	taking	them	because	it	may	cause	antimicrobial	
resistance.”	(JRN1)	
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Themes	 Subthemes	
Representative	quotes	from	professional	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(4)	Patient	
education	(cont)	
	
Educating	patients	
about	appropriate	
antibiotic	use	post	
discharge	(cont)	
	 Q24	“Before	patients	are	discharged	from	the	hospital,	we	
work	with	the	pharmacist	in	giving	information	about	taking	
antibiotics	correctly	and	reminding	them	about	their	history	of	
drug	allergy.”	(JRN4)	
Q25	“We	remind	patients	before	they	are	discharged	that	if	
they	feel	sick,	they	have	to	see	a	doctor	and	not	to	buy	
antibiotics	or	other	medications	themselves.”	(JRN3)	
(5)	AMS	
leadership	by	
specialty	nurses	
Nurses	in	ICU:	
teamwork	between	
doctors	and	nurses	
strengthen	nurses’	
role	in	AMS	
Q26	“In	heart	surgery	in	the	ICU,	now	we	do	surveillance	surveys	
and	cultures	every	three	days	or	72	hours	and	follow-up	patients	
in	the	ICU.	The	ICU	nurses	worked	with	me	to	design	the	
protocol.	They	introduced	it	into	routine	nursing	care	and	set	up	
the	program	to	follow-up	white	blood	cell	(WBC)	count	every	
day.	When	nurses	notice	that	WBCs	of	patients’	blood	test	are	
abnormal,	they	notify	me	then	take	blood	for	cultures	right	
away”.	(D3)	
Q27	“I	understand	that,	at	the	moment,	we	do	not	have	a	
clinical	pharmacist	working	on	the	pediatric	ICU	wards,	so	the	
nurses	play	a	big	role	in	this	context.	Particularly,	by	providing	
surveillance	of	culture	results,	and	reminding	the	clinical	team	
about	how	many	days	we	have	been	giving	the	antibiotics.	
Especially	the	senior	nurses	who	know	and	are	familiar	with	the	
drug	dose,	they	sometimes	ask	me	“Are	you	sure?”	which	is	
reminding	me.	I	think	nurses	in	the	ICU,	have	a	high	level	of	
capacity	because	we	have	been	working	together	for	many	
years.	(D3)	
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Themes	 Subthemes	
Representative	quotes	from	professional	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(5)	AMS	
leadership	by	
specialty	nurses	
(cont)	
Infection	control	
nurses	(ICNs):	role	
in	surveillance,	
support	and	
education	
Q28	“Infection	control	nurses	are	a	source	of	
knowledge	about	antimicrobial	resistance.”	(D1)	
Q29	“Ward	nurses	would	ring	us	[ICNs]	when	their	patients	are	infected	by	
multidrug	resistant	organisms.	They	want	to	determine	whether	their	
patients	should	be	referred	to	the	ID	doctor	or	not.”	(ICN5)	
Q30	“In	ICU,	when	we	[ICNs]	see	sensitivity	results	[for	organisms]	that	are	
getting	close	to	becoming	multidrug	resistant	organisms,	we	would	talk	to	
nurses	to	be	cautionary.”	(ICN6)		
Q31	“We	[ICNs]	provide	knowledge	about	AMS	to	ward	nurses	individually.	
We	[ICNs]	also	have	a	training	program	about	basic	knowledge	in	IPC	and	
AMR	for	nurses	throughout	the	hospital.”	(ICN4)	
	 	 	 Q32	“Sometimes	we	talk	to	doctors	directly	if	the	microbiology	results	and	
antibiotics	are	not	matching	such	as	by	asking,	“Did	you	see	the	Lab	result?”	
as	a	reminder.”	(ICN2)	
Q33“In	the	morning,	we	all	have	to	look	at	the	Lab	results	to	see	whether	the	
patients	have	multidrug	resistant	organism	infections.	Especially	in	the	ICU	
ward,	we	do	check	whether	antibiotics	that	doctors	prescribe	are	
appropriate	with	the	microbiology	results	or	not.	If	not,	we	would	let	a	
primary	nurse	know	so	that	ward	nurses	can	inform	and	discuss	this	with	the	
doctors.”	(ICN4)	
Q34“When	we	[ICNs]	are	playing	the	role	of	monitoring	and	reminding	
doctors	about	antibiotic	use	in	the	ward,	I	think,	ward	nurses	could	learn	the	
AMS	role	from	us.”	(ICN1)	
Q35	“When	see	microbiology	results	that	are	of	concern,	sometimes	we	will	
call	the	primary	nurse	first	to	tell	him/her	to	call	the	doctor	to	look	at	the	
patient	or	ask	“Is	this	case	where	there	is	a	plan	to	consult	with	the	ID?”	In	
order	to	motivate	a	primary	nurse	to	tell	case	doctors.”	(ICN2)	
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Themes	 Subthemes	
Representative	quotes	from	professional	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
5)	AMS	
leadership	by	
specialty	nurses	
(cont)	
Provincial	nurses:	
advanced	and	
extended	roles	
Q36	“They	[Provincial	nurses]	often	email	me	and	
ask	me	questions	about	why	doctors	use	particular	
antibiotics.	Even	in	patients	with	sepsis,	the	ICNs	
[in	provincial	hospitals]	have	a	major	role	in	
setting	up	protocols	to	facilitate	antibiotics	being	
administered	on	time.”	(D1)	
Q37	“In	hospitals	outside	of	Bangkok,	anti-HIV	
drugs	are	prescribed	by	non-physicians.	I	have	this	
impression	when	I	attend	meetings	in	those	
hospitals.	Nurse’s	role	is	more	like	a	doctor’s	role.	
However,	they	consult	doctors	sometimes	when	
they	are	not	sure	about	the	treatments.”	(L1)	
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	 7.2.3	The	barriers	and	facilitators	to	nurses	taking	a	broader	role	in	
antimicrobial	stewardship	
Throughout	the	interviews	and	focus	group	discussions	it	was	clear	that	
although	participants	were	supportive	of	nurses’	current	roles	in	AMS	and	in	taking	a	
greater	role	in	AMS	in	the	future,	they	perceived	that	there	were	many	barriers	to	be	
overcome	before	this	could	be	fully	realised	in	practice.	The	specific	barriers	
identified	by	participants	emerged	as	two	major	themes:	(i)	nurses’	role	in	AMS	is	
not	well	articulated;	and	(ii)	engagement	in	AMS-related	activities	by	nurses	is	
inconsistent	(Table	7.3).	
Theme	1.	Nurses’	role	in	AMS	is	not	well	articulated		
The	majority	of	the	organisational	leader	participants	identified	that	an	
important	barrier	to	further	developing	nurse	participation	in	AMS	was	the	lack	of	
recognition	and	formal	delineation	of	nurses’	roles	in	formal	AMS	policies	at	the	
hospital.	In	addition,	traditional	professional	hierarchies	limited	active	participation	
of	nurses	in	AMS.		
At	the	time	of	interview,	according	to	participants,	there	were	no	formal	
policies	for	AMS	much	less	policies	regarding	nurses’	participation	in	AMS	programs.	
Current	policies	did	not	include	formal	performance	descriptions	for	nurses	outlining	
their	roles	and	responsibilities	in	AMS	and	participants	stated	that	this	impacted	on	
the	willingness	of	frontline	nurses	to	engage	in	AMS	activities	(Table	7.3,	Q1,	Table	
7.3,	Q3).		
Leader	participants	stated	that	in	order	to	support	and	develop	nurses’	role	in	
AMS	there	was	needed	a	formal	AMS	committee	that	included	nursing	
representation.	It	was	noted	that	although	the	hospital	currently	had	an	Antibiotics	
and	Vaccines	Working	Group	whose	primary	purpose	was	the	selection	of	which	
antimicrobials	would	be	available	for	prescription	within	the	hospital,	this	team	did	
not	currently	include	a	nurse	representative.	Therefore	the	perception	was	that	the	
role	of	nurses	in	AMS	was	not	formally	recognised	within	the	organisation	(Table	7.3,	
Q2).		
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A	perception	held	by	doctor	participants	and	a	pharmacist	was	that	written	
policy	and	nursing	leadership	endorsement	of	nurses’	participation	in	AMS	would	
influence	nurses’	willingness	to	participate	in	AMS	programs	and	increase	their	
understanding	of	the	importance	of	AMS-related	initiatives	in	the	hospital.	One	
doctor	participant	stated	that	currently	the	nursing	leadership	at	the	hospital	did	not	
recognise	that	taking	a	role	in	AMS	was	an	important	aspect	of	nurses’	
responsibilities	(Table	7.3,	Q4).		
Traditional	hierarchies	and	lack	of	recognition	by	other	health	professionals	of	
the	potential	role	nurses	could	play	in	AMS	was	a	common	thread	in	discussions	by	
senior	executive	and	nurses,	particularly	the	junior	nurses’	group.	One	doctor	
participant	discussed	doctors’	power	position	in	the	Thai	health	service	context	and	
that	challenging	traditional	roles	for	nurses	(such	as	becoming	more	involved	in	
AMS)	would	be	a	major	undertaking	within	this	context	(Table	7.3,	Q5).	Similarly,	
nurse	participants	also	talked	about	their	concerns	about	crossing	boundaries,	for	
example	encroaching	on	pharmacists’	roles,	and	being	respectful	to	doctors	when	
challenging	prescriptions	(Table	7.3,	Q6).	Nurse	participants	talked	about	their	
experiences	in	clinical	units	where	they	had	failed	to	develop	their	role	in	AMS	
because	there	was	a	lack	of	recognition	of	nurses’	contribution	to	AMS	initiatives	
(Table	7.3,	Q7-Q8).	Nurse	leaders	also	emphasised	the	importance	of	doctors’	
acceptance	of	nurses’	involvement	in	AMS	programs	(Table	7.3,	Q9-Q10).	If	nurses	
were	recognised	by	other	healthcare	professionals,	nurses	would	be	more	active	and	
willing	to	participate	in	AMS	programs	and	this	would	influence	antibiotic	use	in	the	
hospital	(Table	7.3,	Q10).	One	senior	doctor	participant	supported	the	idea	of	
providing	nurses	with	opportunities	to	engage	in	AMS	programs	in	the	future,“	
Actually,	I	think	we	should	work	together	and	further	discuss	this	issue	[nurses’	role	in	
AMS].”	(D1).		
The	junior	nurse	participants	suggested	that	a	facilitating	strategy	to	support	
nurses	to	engage	in	AMS	activities	would	be	written	protocols	regarding	antibiotic	
use,	for	example,	switching	from	IV	to	oral	antibiotic	therapy	in	postoperative	care.	
These	protocols	would	support	all	nurses	but	in	particular,	junior	nurses	to	feel	more	
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comfortable	raising	questions	and	prompting	treatment	with	doctors.	As	one	junior	
nurse	stated,	
“I	work	in	the	cardiovascular	ward,	sometimes	we	advise	doctors	against	
[prescribing	antibiotics].	We	have	a	protocol	(in	this	unit),	such	as,	after	removal	of	
an	ICC	[Intercostal	Catheters]….	we	also	have	a	protocol	for	changing	antibiotics	
from	injection	to	oral	administration.	That	makes	me	brave	enough	to	remind	
doctors	[that	it	is	time	to	switch]”	(JRN4)	
Theme	2.	Inconsistent	engagement	in	AMS	by	nurses	
Although	study	participants	identified	that	nurses	currently	played	an	
important	role	in	AMS	as	described	in	Section	7.2.2,	engagement	in	AMS-related	
activities	by	nurses	was	seen	to	be	inconsistent.	There	were	perceptions	that	AMS-
related	activities	were	not	a	priority	in	the	context	of	a	high	workload;	existing	IT	
systems	were	not	conducive	to	engagement,	and	that	inadequate	knowledge	of	the	
principles	of	antibiotic	use	inhibited	day-to-day	engagement	and	that	nurses	were	
not	educationally	prepared	to	engage	fully	in	AMS.		
The	majority	of	leader	participants	asserted	that	AMS	was	not	a	priority	for	
nurses	in	a	high	workload	environment.	There	appeared	to	be	a	consensus	within	
nurse,	doctor	and	pharmacist	participants	that	AMS	was	not	a	primary	responsibility	
associated	with	direct	patient	care	and	there	were	concerns	about	the	effect	of	
expanding	responsibilities	on	nurses’	workloads	(Table	7.3,	Q11-Q14).	Also	given	
that	nurses	were	not	prescribing	antibiotics,	AMS	was	not	their	priority	or	
responsibility	in	a	high	workload	environment	(Table	7.3,	Q15-Q17).	Some	doctors	
interpreted	the	focus	on	patient	care	as	nurses	lacking	interest	in	taking	on	
additional	responsibilities	related	to	AMS	activities	[Table	7.3,	Q18-Q19].	One	doctor	
participants	contrasted	this	with	his/her	perception	of	doctors	being	more	willing	to	
take	risks	and	provide	interventions	even	when	this	was	not	their	primary	area	of	
expertise	[Table	7.3,	Q20].	One	doctor	participant	discussed	the	consequences	of	
nurses’	focus	on	direct	patient	care	as	impacting	on	the	implementation	of	AMS-
related	initiatives	within	the	hospital	(Table	7.3,	Q21).		
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In	addition	to	workload,	well-developed	IT	systems	have	been	recognised	as	
pivotal	to	the	development	of	sustainable	AMS	programs.	At	the	time	of	interview,	
participants	perceived	that	the	IT	system	at	RH	was	inadequate	to	support	AMS	
programs.	The	current	IT	systems	did	not	have	mechanisms	to	track	antibiotic	
prescribing	or	duration	of	treatment	and	was	not	linked	to	the	hospital	pathology	
services.	All	microbial	sensitivities	therefore	needed	to	be	reviewed	individually.	The	
introduction	of	audit	and	feedback	systems	would	require	manual	chart	audits	and	
would	therefore	be	labour	intensive.	If	nurses	were	asked	to	take	on	the	role	of	
monitoring	antibiotic	use	in	their	clinical	area	using	the	current	IT	systems	this	would	
have	a	significant	impact	on	their	workload.	If	nurses	took	on	more	responsibilities	in	
monitoring	antibiotic	use,	it	was	highly	unlikely	that	this	role	would	be	sustainable	
without	IT	systems	to	support	these	activities	(Table	7.3,	Q22-Q23).		
Most	study	participants	both	within	the	leader	and	clinical	nurse	groups	were	
concerned	about	the	adequacy	of	nurses’	knowledge	about	antibiotic	use	and	this	
was	one	of	the	most	commonly	cited	barriers	to	engaging	nurses	in	AMS	activities.	A	
nurse	leader	participant	perceived	that	nurses	were	more	likely	to	have	knowledge	
about	IPC	than	other	health	professionals,	but	they	did	not	know	enough	about	
antibiotic	use	(Table	7.3,	Q24-Q25).	Clinical	nurses	also	discussed	having	superficial	
or	lack	of	uptodate	knowledge	of	antimicrobial	therapy	(Table	7.3,	Q26-Q27).		
Many	of	the	participants,	again	in	both	leader	and	clinical	nurse	groups	
asserted	that	because	nurses	are	not	educationally	prepared	to	engage	fully	in	AMS,	
education	and	training	programs	relating	to	AMR	and	AMS	to	address	knowledge	
gaps	for	nurses	as	well	as	a	stronger	focus	on	microbiology	and	pharmacology	in	
nursing	undergraduate	curricula	are	needed	(Table	7.3,	Q28-	Q32).	A	nursing	
academic	participant	also	suggested	that	if	AMR	and	AMS	were	to	be	considered	as	
important	by	Thai	nursing	professionals,	the	problems	of	AMR	and	the	principles	of	
antibiotic	prescribing	should	be	compulsory	topics	in	nursing	educational	curricula	
(Table	7.3,	Q33].	One	doctor	participant	stated	that	given	nurses’	role	in	caring	for	
patients	with	multi-drug	resistant	organisms,	all	nurses	in	the	hospital	should	have	
fundamental	knowledge	of	appropriate	antibiotic	use	and	matching	antibiotics	to	
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bacterial	sensitivities	(Table	7.3,	Q34).	This	view	was	supported	by	a	nurse	leader	
participant	who	stated	that	greater	knowledge	of	AMS	would	enable	nurses	to	take	
a	stronger	role	in	monitoring	the	appropriate	use	of	antibiotics	and	patients’	
response	to	treatment.	(Table	7.3,	Q35).	
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Table	7.3	The	barriers	and	facilitators	to	nurses	taking	a	larger	role	in	AMS	
Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(1)	Nurses’	
role	in	AMS	is	
not	well	
articulated	
Nurses’	role	in	
formal	AMS	
policies	not	
evident	
	
Q1	“So	far	the	hospital	does	not	have	a	written	policy	for	[nurses]	to	
be	involved	in	AMS.	So	it	is	difficult	for	all	nurses	to	participate.”(N4)	
	Q2	“Even	though	we	have	the	Antibiotics	and	Vaccines	working	
group,	nurses	and	ICNs	are	not	members	[of	the	working	group]	at	the	
moment”	(N1)	
Q3	“From	my	experience	when	working	with	nurses,	I	have	learned	
that	nurses	work	very	well	if	there	is	a	clear	formal	policy.”	(P2)	
Q4	“Nurse	leaders	should	not	be	too	conservative	[in	their	
perceptions	of	nurses’	role]	but	creative”	(D2)	
	
	 Traditional	roles	
exclude	nurses	
Q5	“Most	importantly,	in	our	country,	doctors	have	too	much	power,	
so	there	is	no	accepting	of	other	professionals	if	it	[the	extension	of	
their	role]	will	interfere	with	doctors’	[professional]	boundaries”	(D1)	
Q8	“I	suggested	a	protocol	for	antibiotic	prescribing	on	the	ward.	One	
doctor	suddenly	threw	back	at	me	[this	challenge]	‘How	do	you	know	
more	than	I	do?”	(N4)		
Q9	“That	would	be	great	if	the	hospital	recognised	and	respected	
nurses	as	being	members	of	the	AMS	team.	(N4)	
Q10	“I	think	that	the	hospital	[leadership]	might	think	nurses	are	not	
supposed	to	be	AMS	team	members.	So	they	do	not	give	nurses	a	
chance	at	the	moment	[to	get	involved].	If	they	really	want	nurses	to	
participate	in	the	AMS	team,	then	nurses	could	learn	a	lot	about	AMS.	
Finally,	it	would	impact	by	improving	antibiotic	use	in	the	hospital.	
(N3)	
Q6	“We	remind	doctors	such	as	by	asking,	this	antibiotic	
will	be	due	for	re-prescription	soon	after	15	days	[of	
therapy],	do	you	want	to	discontinue?	Just	remember	
that	we	should	tell	them	[doctors]	in	a	way	that	is	
providing	information	only,	don’t	make	them	feel	like	
they	are	being	dominated.	(JRN1)	
Q7	“I	think	it’s	about	the	power	to	make	a	decision,	like	
[for	example],	when	we	[nurses]	noticed	that	doctors	
had	prescribed	an	antibiotic	at	a	high	dose,	we	[nurses]	
and	the	pharmacist	tried	to	remind	the	doctor	but	
he/she	insisted	on	the	same	order.	Some	doctors	have	
huge	egos.	They	think	they	have	more	power.	They	feel	
they	will	lose	authority	if	we	question	them.	Especially	
junior	nurses,	doctors	would	not	listen	to	them.	But	for	
senior	nurses,	they	may	be	able	to	speak	up.”	(JRN4)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(2)	
Inconsistent	
engagement	
in	AMS	by	
nurses	
AMS	not	a	
priority	in	a	high	
workload	
environment	
Q15	“Nurses	focus	on	nursing	care	but	do	not	have	a	direct	role	in	
prescribing	antibiotics.	So	taking	a	role	in	AMS	is	quite	difficult.”	(N1)		
Q16	“The	thing	is	nurses	do	not	have	authority	to	prescribe	so	they	
(nurses)	feel	they	are	not	involved	in	AMS.”	(N3)	
Q17	“The	decision	making	related	to	use	of	antibiotics	is	the	doctors’	
role,	it’s	not	the	nurses’	role.”	(N6)	
Q18	“I	think	because	nurses	have	to	focus	on	patient	care	they	do	not	
focus	on	medications.”	(D1)	
Q19	I	think	at	the	moment	nurses	do	not	want	to	be	proactive	to	take	
a	role	in	AMS	because	they	are	concerned	about	the	workload.	(D5)	
Q20	“Nurses	in	general	are	not	concerned	about	this	[AMS]	issue	and	
think	it	is	not	their	role.	Doctors	are	the	opposite,	they	will	try	to	
extend	their	practice	as	much	as	possible	even	though	[these	
activities]	sometimes	overlap	[with	other	medical	specialties’]	jobs	or	
area	of	expertise”	(D2)	
Q21	“We	had	asked	nurses	when	they	are	dressing	infected	wounds	
to	do	a	wound	swab	for	culture	but	the	nurses	[continued	to]	just	
dress	the	wounds	without	doing	the	culture.	Then	how	do	we	know	
that	the	antibiotic	we	used	is	appropriate	to	the	infection?	I	think	
nurses	should	take	[wound]	swabs	for	culture	if	they	find	patients	
with	suspected	surgical	site	infections.	But	they	do	not	want	to	and	
this	throws	a	burden	on	to	the	doctors.	We	had	a	campaign	for	six	
months,	but	it	was	not	as	successful	as	we	wanted…….	“(D3)	
Q12	“I’m	afraid	that	if	we	take	on	this	AMS	role,	we	are	taking	over	
the	pharmacists’	role.	Nurses’	main	role	is	taking	care	of	patients.	If	
we	take	on	a	major	role	in	AMS,	it	may	be	too	much.”	(SRN5)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(2)	
Inconsistent	
engagement	
in	AMS	by	
nurses	(cont)	
IT	systems	are	not	
conducive	to	
engagement		
Q22	“Currently	we	have	to	track	laboratory	results	manually;	that	
would	be	much	easier	for	nurses	if	the	IT	system	could	pop	up	the	
results	automatically	especially	in	cases	of	patients	with	serious	
infection.	“	(N5)	
Q23	“When	the	culture	result	shows	a	particular	bacteria,	if	we	had	
a	system	that	could	identify	that	particular	bacteria	and	could	
indicate	what	antibiotics	we	could	give	to	the	patient	it	would	be	
possible.	At	the	moment,	we	do	not	have	anything	like	that.”	(JRN4)	
	 Inadequate	
knowledge	of	the	
principles	of	
antibiotic	use	
inhibit	day	to	day	
engagement		
Q24	“Nurses	have	good	knowledge	about	how	to	isolate	patients	who	
have	infectious	diseases.	Probably	they	[nurses]	have	more	knowledge	
than	doctors	in	isolation	precautions.	But	nurses	do	not	have	much	
knowledge	about	antibiotic	use.”	(N3)	
	
Q25“I	don’t	think	nurses	have	much	knowledge	about	antibiotic	use.	If	
I	had	not	taken	the	nursing	course	in	infection	prevention	and	control,	
I	would	not	have	much	knowledge	in	this	area.	(N4)	
	
		
Q26	“For	me	to	be	honest,	I	have	superficial	knowledge	about	
antibiotic	use.	We	only	know	the	principles	of	how	to	take	care	of	
patients	with	antimicrobial	resistance	but	we	do	not	know	how	to	
use	each	antibiotic,	what	risk	it	may	cause	with	what	bacterial	
infections.	We	don’t	know	even	the	basics	of	antibiotic	use	for	
example,	what	type	of	bacteria	that	are	able	to	treat	by	
Ceftriaxone?”	(SRN1)	
Q27	“There	was	a	situation	that	a	doctor	prescribed	two	antibiotics	
at	the	same	time	and	nurses	did	not	know	and	gave	them	to	a	
patient	for	2	days.	When	the	ID	specialist	came	and	asked	why	the	
patient	was	given	two	antibiotics,	we	realised	that	nurses	did	not	
know,	even	the	senior	nurses,	so	there	was	no	alert.”	(SRN2)	
	 Nurses	are	not	
educationally	
prepared	to	
engage	fully	in	
AMS	
	
Q28“We	[nurse	educators]	realise	that	we	do	not	have	subjects	or	
courses	regarding	antibiotics	in	the	undergraduate	nursing	curriculum.	
The	nursing	curriculum	at	our	university	provides	a	basic	
pharmacology	subject	in	the	second	year	in	which	there	is	only	
superficial	knowledge	about	antibiotics	use.”	(N3)	
	
Q29	“Even	though	we	[nurses]	have	studied	microbiology	in	the	
Bachelor’s	degree	we	have	already	forgotten	[the	material].”	(SRN1)	
Q30	“When	I	was	a	2nd	year	nursing	student,	we	studied	
Pharmacology,	bacteria	and	antibiotics	but	in	a	big	picture.	When	
working	as	an	RN,	we	cannot	use	that	knowledge	much.”	(JRN4)	
we	can	learn	and	be	aware	of	it	[AMR	problems	and	antibiotic	use].”	
(SRN3)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(2)	
Inconsistent	
engagement	
in	AMS	by	
nurses	(cont)	
Nurses	are	not	
educationally	
prepared	to	
engage	fully	in	
AMS	(cont)	
	
Q33	“In	fact,	if	we	want	this	issue	(of	AMR	and	AMS)	to	impact	on	
nursing	practice	across	the	whole	country,	then	nurses	are	one	of	the	
healthcare	professions	who	should	be	educated	about	this	when	they	
study	undergraduate	nursing.	Then	nurses	would	have	the	knowledge	
to	educate	other	people.”	(N3)	
Q34	“I	think	nurses	should	have	as	much	knowledge	as	doctors	or	at	
least	basic	knowledge	of	bacteria	and	how	many	antibiotic	groups	or	
which	group	can	treat	particular	bacteria.”	(D3)	
Q35	“If	you	want	nurses	to	be	engaged	in	AMS,	you	have	to	provide	
them	with	the	knowledge	to	support	this.	To	engage	in	AMS	is	not	just	
meant	to	be	prescribing	antibiotics	but	also	to	question	whether	the	
antibiotic	is	appropriate	or	not.	Particularity	when	patients	are	
prescribed	broad-spectrum	antibiotics,	if	nurses	had	sufficient	
knowledge	we	would	be	able	to	monitor	and	discuss	with	doctors	
whether	the	antibiotic	choice	was	appropriate	or	not.	Nowadays	
nurses	just	administer	antibiotics	according	to	doctors’	orders.”	(N4)	
Q31	“It	would	be	good	if	we	were	taught	about	this	topic	[AMR	and	
antibiotic	use]	in	the	4th	year	because	we	had	a	leadership	course	in	
which	we	learned	about	working	in	a	ward.	When	receiving	orders,	
we	can	learn	and	be	aware	of	it	[AMR	problems	and	antibiotic	use].”	
(SRN3)	
Q32	“We	should	have	knowledge	about	antimicrobial	resistance	and	
antibiotic	use	from	the	first	day	when	we	start	working	as	RNs.	And	
then	nurses	should	regularly	update	this	[knowledge	about	
antimicrobial	resistance	and	antibiotic	use].”	(SRN2)	
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	 7.2.4	The	potential	role	of	nurses	in	antimicrobial	stewardship			
When	participants	were	asked	about	potential	roles	for	nurses	in	AMS,	many	
discussed	furthering	or	supporting	the	current	role	of	nurses	so	that	this	could	be	
implemented	consistently	across	the	organisation.	The	potential	roles	for	nurses	that	
were	identified	emerged	in	two	major	themes:	(i)	Strengthening	existing	roles	by	
integrating	nurses	in	multidisciplinary	teams	and	(ii)	Advancing	existing	roles	(Table	
7.4).	
Theme	1.	Strengthening	existing	roles	by	integrating	nurses	in	the	
multidisciplinary	team	
Participants	in	all	groups	discussed	the	idea	that	the	AMS	team	round	should	
be	multidisciplinary	including	doctors,	nurses	and	pharmacists	in	the	future.	The	
purpose	of	the	AMS	team	round	is	to	monitor	and	support	AMS	by,	for	example,	
authorising	the	use	of	restricted	antibiotics,	reviewing	patients	to	switch	from	IV	to	
oral	use	and	reviewing	patients	on	selected	broad	spectrum	antibiotics	(SARI,	2009).	
Participants	in	both	leader	and	clinical	groups	acknowledged	that	if	the	AMS	team	
round	was	set	up	formally	in	the	hospital,	then	clinical	nurses	could	play	on	the	AMS	
team	round.	Nurse	participants	asserted	that	nurses’	could	explicitly	participate	in	
AMS	in	the	AMS	team	round	by	contributing	to	the	patient	care	plan	including	
antibiotic	use	as	members	of	the	multidisciplinary	team	(Table	7.4,	Q1).	A	clinical	
nurse	participant	felt	that	the	potential	benefit	of	nurses	being	made	part	of	the	
AMS	team	round	would	be	the	recognition,	by	other	health	professionals,	of	nurses’	
knowledge	of	their	patients’	condition	and	response	to	treatment	(Table	7.4,	Q2).	
For	another	nurse	participant,	including	nurses	in	a	multidisciplinary	AMS	round	
would	increase	patients’	and	families’	satisfaction	(Table	7.4,	Q3).		
One	junior	nurse	participant	who	supported	the	idea	of	nurses	being	part	of	
the	AMS	team	round,	believed	this	would	enable	nurses	to	play	a	larger	role	in	
ensuring	that	patients	received	safe	and	high-quality	care	by	monitoring	and	
preventing	medication	errors	(Table	7.4,	Q4).	Pharmacist	participants	also	supported	
the	potential	role	of	nurses	in	AMS	team	rounds	because	it	would	be	a	vehicle	for	
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nurses	to	provide	supportive	information	about	patients’	antibiotic	use	that	would	
be	valuable	to	the	team’s	decision	making.	(Table	7.4,	Q	5).	A	pharmacist	participant	
noted	that	if	nurses	were	recognised	as	part	of	the	AMS	team	round	this	would	
impact	on	overall	antibiotic	use	in	the	hospital	stating	that,	“If	that	role	[nurses’	role	
in	the	AMS	team	round]	happened,	my	department	[pharmacy	department]	would	
buy	less	medicines	particularly	antibiotics.	Currently	we	spend	approximately	$114	
million	USD	in	buying	all	medicines,	and	antibiotics	are	at	the	top	of	the	list.”	(P1).	
	 Although	the	theme	of	monitoring	for	optimal	antibiotic	use	was	identified	in	
the	current	role	of	nurses,	a	greater	more	consistent	role	in	monitoring	antibiotic	
use	along	with	questioning	the	use	of	certain	antibiotics	was	seen	as	an	essential	
future	role	for	clinical	nurses	in	AMS.	Most	of	the	participants	in	all	groups	thought	
that	nurses	should	have	a	basic	understanding	of	appropriate	antibiotic	use	and	be	
able	to	monitor	whether	the	antibiotic	choice	was	appropriate	given	the	culture	
results.	Doctor	and	ICN	participants	asserted	that	nurses	should	play	an	active	role	in	
monitoring	and	questioning	antibiotic	orders	and	the	need	for	continuing	treatment	
(Table	7.4,	Q6)	because	they	work	closely	with	doctors	(Table	7.4,	Q7-Q8).		
Although	the	potential	for	clinical	nurses	to	take	a	greater	role	in	AMS	was	
recognised,	the	need	to	provide	them	with	clinical	decision	support	tools	to	support	
this	role	was	also	identified.	Availability	of	an	AMS	decision	support	software	
program	at	the	bedside	was	seen	by	a	junior	nurse	participant	as	an	important	
device	to	support	nurses	and	give	them	the	confidence	in	taking	a	greater	role	in	
AMS	in	monitoring	antibiotic	prescribing,	“	I	want	a	[software]	program	to	confirm	
whether	the	antibiotic	prescription	by	the	doctors	is	appropriate	or	not.”	(JRN4)	
Theme	2.	Advanced	and	extended	existing	roles	
Participants	in	all	groups	identified	that	the	future	role	for	nurses	in	AMS	could	
be	developed	from	existing	roles.	Organisational	leaders	spoke	about	developing	
AMS	ward	nurse	specialist	roles,	increasing	ICN’s	roles	as	consultants	in	antibiotic	
use,	and	the	potential	development	of	health	promotion	roles	of	nurses	in	primary	
health	in	Thailand.		
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Participants	noted	that	currently,	most	inpatient	wards	in	the	hospital	have	a	
nurse	within	the	nursing	team	who	has	a	portfolio	related	to	issues	associated	with	
IPC.	While	these	nurses	are	recognised	as	taking	a	proactive	role	in	IPC,	the	scope	
and	responsibilities	of	the	role	are	still	unclear	(Table	7.4,	Q9).	Doctor	participants	
agreed	with	the	idea	of	developing	these	positions	for	infection	control	ward	nurses	
stating	that	if	these	nurses	were	more	involved	with	the	AMS	team,	this	would	
impact	on	prescribers’	behaviours	(Table	7.4,Q10)	and	that	patients	would	ultimately	
benefit.	One	doctor	stated	that	nurses	were	the	most	appropriate	healthcare	
professionals	to	take	the	lead	in	AMS	activities	as	they	were	the	professionals	who	
were	more	intimately	involved	in	patient	care,	“I	think	that	even	pharmacists	could	
not	do	this	role	as	appropriately	as	nurses	because	they	[pharmacists]	spend	less	
time	working	in	the	clinical	[environment]	(D5)”.	One	pharmacist	participant	who	
agreed	with	the	concept	of	developing	ward	nurse	specialists	in	AMS,	acknowledged	
that	there	were	not	enough	pharmacists	to	oversee	antimicrobial	use	across	the	
organisation	(Table	7.4,	Q11)	
Nurse	participants	in	all	groups	discussed	the	potential	role	of	ICNs	as	AMS	
consultants	in	the	Thai	context.	A	nurse	leader	participant	noted	that	although	the	
ICNs	do	not	provide	direct	nursing	care	to	patients,	they	have	a	sounder	knowledge	
base	related	to	the	principles	of	AMS	than	ward	nurses.	ICNs	could	therefore	take	on	
advanced	practice	roles	in	providing	expert	consultation	about	AMS	to	ward	staff	
(Table	7.4,	Q12).	In	addition,	another	senior	nurse	felt	that	ICNs	should	play	a	
greater	role	in	AMS	consultations	because	ICNs	are	already	involved	in	practice	
relating	to	the	management	of	AMR	and	AMS	across	the	organisation	(Table	7.4,	
Q13).	An	ICN	participant	stated	that	ICNs	should	not	only	provide	consultations	for	
ward	nurses	as	is	presently	the	case,	but	could	also	provide	consultations	and	expert	
advice	to	junior	doctors	about	appropriate	antibiotic	use.	As	a	nurse	leader	
participant	reflected,	ICNs	could	consult	with	junior	doctors	because	doctors	often	
feel	uncomfortable	consulting	with	ID	specialists	about	their	treatment	decisions	and	
would	feel	more	comfortable	consulting	ICNs	before	prescribing	antibiotics	(Table	
7.4,	Q14).	ICN	participants	also	identified	that	they	would	like	to	have	more	
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authority	to	provide	feedback	on	patients’	charts	to	prescribers	about	the	
appropriateness	of	antibiotic	therapy	(Table	7.4,	Q15).	One	ICN	discussed	a	potential	
advanced	role	in	AMS	where	ICNs	could	be	authorised	to	stop	antibiotic	treatment	
when	there	is	evidence	of	unnecessary	antibiotic	prescribing	(Table	7.4,	Q16).	A	
small	number	of	stakeholder	participants	discussed	the	potential	role	of	nurses	in	
AMS	as	educators	in	primary	health	to	promote	better	use	of	antibiotics	in	the	
community	overall.	(Table	7.4,	Q17,	Q18).
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Table	7.4	The	potential	role	of	nurses	in	antimicrobial	stewardship		
Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(1)	
Strengthening	
existing	roles	by	
integrating	
nurses	in	the	
multidisciplinary	
team.	
Attend	and	
contribute	to	the	
AMS	team	round	
Q1	“For	example,	on	the	AMS	ward	round,	we	could	
contribute	not	just	to	information	about	patient	care	
(administering	proper	antibiotics)	but	we	could	also	[be	
involved	in]	the	discussion	of	the	patients’	treatment	and	
care	plan,	because	nurses	know	the	patients’	condition	
the	most.”	(N3)	
Q5	“I	would	like	to	see	nurses	as	one	of	the	members	of	a	
multidisciplinary	AMS	team,	such	as	when	we	have	the	
AMS	grand	round.	This	activity	would	support	nurses	and	
give	then	the	opportunity	to	understand	the	antibiotic	
treatment	plan	along	with	providing	feedback...”	(P3)	
	
	
Q2	“I	think	it	would	be	good	if	we	could	be	members	of	the	AMS	
team…because	Dr.	K	used	to	discuss	patients	that	I	was	responsible	
for	with	me,	he	listened	to	my	information	and	respected	my	
opinion,	because	I	know	these	patients	the	best.”	(SRN1)	
Q3	“I	strongly	agree	that	we	should	join	the	AMS	team	round.	That	
would	be	good	in	terms	of	knowing	the	treatment	plans	in	detail.	
[this	would	mean	that]…when	patients’	relatives	ask	for	information,	
we	would	not	have	to	wait	for	the	doctors	but	could	give	
information	to	patients	and	their	relatives	straightaway.”	(SRN2)	
Q4	“I	would	like	to	see	nurses	as	part	of	a	patient	team	round	about	
antibiotic	use.	From	my	experience,	there	was	a	doctor	who	came	
on	a	ward	round	and	changed	the	antibiotics	to	one	that	a	patient	
was	allergic	to	without	knowing,	so	I	told	them	that	the	patient	is	
allergic	to	that	antibiotic.	The	doctor	said	“Really?	I	didn’t	know”.	
Then	he	changed	[the	prescription]	to	another	antibiotic.	I	think	
nurses	know	patients’	information	thoroughly.	If	we	are	in	the	team,	
it	could	reduce	errors	and	the	time	taken	in	getting	information	and	
confirmation	of	treatment	plans.”	(JRN6)	
	 Monitoring	and	
questioning	
appropriateness	
of	antibiotic	
prescriptions.	
Q6	“Nurses	should	be	a	part	of	the	team	monitoring	what	
doctors	do,	whether	they	prescribe	any	inappropriate	
medicines,…	more	or	less,	why	or	why	not	are	antibiotics	
needed?”	(D1)	
Q7	“Ward	nurses	work	closely	with	doctors,	so	they	should	be	able	
to	have	a	discussion	about	antibiotic	use.	If	any	patients	are	
prescribed	antibiotics,	nurses	should	question	the	use	of	antibiotics	
as	well.”	(ICN	2)	
Q8	“Nurse	work	closely	with	doctors	on	the	wards.	They	[nurses]	
could	be	both	monitoring	and	giving	feedback	to	doctors	when	they	
[nurses]	find	inappropriate	antibiotic	orders.	(ICN1)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(2)	Advanced	
and	
extended	
existing	roles	
Allocated	AMS	
role	for	ward	
nurse	specialists	
Q9	“We	have	wound	care	nurses,	IV	nurses	and	IPC	nurses.	I	would	
like	the	infection	[prevention]	and	control	ward	nurses	to	have	a	
clearer	role	and	act	as	a	central	resource	in	regards	to	this	topic	[AMS	
issue]”	(N2)	
Q10	“It	would	be	good	if	every	ward	had	a	position	for	nurses	who	are	
interested	in	AMS.	The	nurse	who	is	working	in	this	position	would	
collect	and	provide	data	regarding	antibiotic	use	and	AMR	in	their	
ward.	If	that	happened	then	this	would	impact	on	doctors’	antibiotic	
prescribing	behavior”(D5)	
Q11	“In	term	of	AMS	consultations	that	should	be	a	direct	role	of	
pharmacists,	pharmacists	would	play	this	role	properly.	But	the	
problem	is	the	hospital	does	not	have	enough	pharmacists	to	play	this	
role	systematically,	it	would	be	good	if	nurses	wanted	to	participate	in	
this	role	[AMS	role]	because	patients	would	be	advantaged.”	(P2)	
	
	 Advanced	AMS	
roles	for	ICNs	to	
consult	on	
appropriate	
antibiotic	use.	
Q12	“Actually,	infection	control	nurses	get	involved	in	AMS	more	than	
ward	nurses,	we	[ICNs]	are	the	key	people	to	be	consultants	in	AMS	
for	the	ward	nurses”	(N3)	
	
Q13	“About	being	a	consultant	in	AMS,	I	think	infection	
control	nurses	should	take	part	in	that	as	their	[current]	role	
in	infection	prevention	and	control	involves	[components	of]	
AMS.	We	normally	consult	them	[the	ICN	nurses]	if	we	have	
any	questions	in	terms	of	IPC	issues.	If	they	played	a	greater	
role	in	AMS	activities,	that	would	be	helpful	to	us	[ward	
nursing	staff]	and	the	patients.”	(SRN1)	
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Themes	 Subthemes	
Representative	quotes	from	different	profession	groups	
Organisational	leaders	 ICNs/	Clinical	nurses	
(2)	Advanced	
and	extended	
existing	roles	
(cont)	
Advanced	AMS	
roles	for	ICNs	to	
consult	on	
appropriate	
antibiotic	use	
(cont)	
Q14	“For	infection	control	nurses,	[I]	think	a	role	of	being	a	consultant	
in	choosing	antibiotics	ought	to	be	something	they	do,	for	example,	
some	doctors	feel	awkward	about	consulting	with	ID	doctors.	They	may	
call	infection	control	nurses	to	consult	before	prescribing.	“From	[my]	
experience,	some	doctors	order	antibiotics	inappropriately.	
Sometimes,	we	[ICNS]	know	that	this	antibiotic	should	be	used	to	treat	
UTI	[urinary	tract	infection]	but	it	is	prescribed	to	a	patient	with	an	
URTI	[upper	respiratory	tract	infection].	This	makes	us	want	to	give	
them	[the	doctors]	prescribing	advice.”	(N1)	
Q15	“It	would	be	great	if	infection	control	nurses	were	
able	to	write	feedback	about	the	appropriateness	of	
antibiotic	therapy	in	the	patients’	progress	notes.	For	
example,	we	could	write	in	the	notes	when	we	find	they	
[doctors]	had	inappropriately	prescribed	antibiotics	or	
patients	have	a	high	chance	of	developing	an	AMR	
infection	if	they	continue	using	those	antibiotics.”	(ICN6)	
Q16	“I	would	like	to	be	able	to	discontinue	an	antibiotic	in	
cases	where	they	have	been	used	longer	than	necessary.”	
(ICN4)	
	 Health	promotion	
–	providing	
consumer	
education	about	
appropriate	
antibiotic	use	
Q17	“When	I	was	studying	my	master	degree	in	public	health	nursing,	
people	in	the	community	were	educated	to	prevent	diseases	such	as	
diabetes	and	hypertension.	I	would	like	to	see	nurses	in	primary	health	
settings	educate	people	about	appropriate	antibiotic	use	too.”	(N4)	
Q18	“Certain	speciality	nurses	could	develop	their	role	to	be	
consultants	about	antibiotic	use	for	example	nurses	who	work	in	
primary	care	settings.”	(D2)	
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7.3	Discussion	
Analysis	of	the	data	collected	via	semi-structured	interview	of	key	
stakeholders,	ICNs	and	clinical	nurses	revealed	that	nurses	currently	play	a	role	in	
AMS	in	acute	healthcare	by	supporting	AMS	system	processes,	monitoring	for	
patient	safety,	monitoring	for	optimal	antibiotic	use	and	patient	education.	Further,	
specific	advanced	and	extended	roles	in	AMS	are	performed	by	specialty	nurses	in	
both	acute	and	primary	health	care	settings.	However,	the	lack	of	existing	policies	
that	formally	describe	nurses’	scope	of	practice	and	responsibilities	related	to	AMS,	
professional	hierarchies	that	limit	nurses’	role	within	the	context	of	a	poorly	defined	
role	for	nurses,	and	inconsistent	engagement	of	nurses	in	AMS	were	perceived	
barriers	to	full	involvement	of	nurses	and	the	attainment	of	potential	benefits	of	
their	involvement	in	managing	AMR.		
Potential	future	roles	for	nurses	discussed	were	to	strengthen	existing	roles	by	
integrating	nurses	into	the	multidisciplinary	team	and	further	development	of	
advanced	and	extended	existing	roles.	In	the	discussion	to	follow,	study	findings	are	
explored	in	relation	to	the	international	literature	relating	to	nurses’	role	in	AMS.	
7.3.1	Current	nursing	roles	in	AMS	in	Thailand	
Clinical	nurses	are	actively	involved	in	AMS	by	supporting	system	processes,	
monitoring	for	patient	safety,	monitoring	for	optimal	antibiotic	use	and	through	
patient	education,	however	these	activities	are	informal	and	not	well-defined,	nor	
articulated	in	hospital	policy	and	procedures.	Key	stakeholders	and	clinical	nurse	
participants	agreed	that	there	was	the	potential	to	develop	an	explicit	and	
recognised	role	for	nurses	as	part	of	a	multidisciplinary	AMS	team.	These	findings	
are	in	line	with	the	international	literature	in	which	recommendations	have	been	
made	to	develop	the	nursing	workforce	and	roles	in	AMS	(ANA	&	CDC,	2017;	
Edwards	et	al.,	2011c;	Manning	et	al.,	2016;	Olans,	Olans,	&	Witt,	2017b;	Olans	et	al.,	
2016).	
Both	stakeholders	and	clinical	nurses	identified	that	nurses	played	a	key	role	in	
supporting	AMS	system	processes	needed	for	effective	implementation	of	the	
Page	223	
	
	
principles	of	AMS	at	the	bedside,	such	as	ensuring	patient	allergies	were	identified,	
recorded	and	communicated,	monitoring	for	signs	of	infection,	timely	review	of	
antibiotic	cultures	and	sensitivities,	and	the	use	of	strategies	to	prompt	doctors	to	
review	treatment	orders.	System	and	process	support	is	a	recognised	fundamental	
role	of	nurses	in	AMS.	Nurses	play	an	essential	role	in	monitoring	for	signs	and	
symptoms	of	infection	(Gallagher	&	Storr,	2012b;	McGoldrick,	2014),	reviewing	
antibiotic	histories	of	patients	on	admission	and	during	clinical	handover	(Aziz,	
2013),	and	ensuring	that	antibiotic	treatment	is	in	line	with	microbiology	results	
(Edwards	et	al.,	2011c;	Lim,	2010;	Manning	&	Giannuzzi,	2015).	Olans	et	al.	(2016)	
identified	the	importance	of	nurse	participation	in	AMS	through	ensuring	that	
allergies	and	potential	drug	reactions	are	identified.		
Monitoring	for	safety	is	a	fundamental	AMS	activity	that	has	implications	for	
patient	safety	outcomes	(ANA	&	CDC,	2017;	Ladenheim	et	al.,	2013a;	Turkoski,	
2005).	In	this	Thai	study,	nurses	monitored	for	safety	in	AMS	by	ensuring	patient	
drug	allergies,	hypersensitivities	and	side	effects	of	antibiotics	were	recorded	and	
communicated.	Previous	research	has	confirmed	nurses’	roles	in	monitoring	for	
safety;	for	example,	in	a	study	of	the	awareness	of	patients’	adverse	drug	reactions	
related	to	penicillin,	nurses	were	the	professionals	most	aware	of	patients’	previous	
history	compared	with	doctors	and	pharmacists	(Fehily	et	al.,	2015).	According	to	the	
American	Nurses’	Association/Centers	for	Disease	Control	and	Prevention,	nurses	
have	always	taken	a	role	in	stewardship	activities	to	ensure	patient	safety	by	
monitoring	histories	of	allergies	and	performing	and	communicating	medication	
reconciliations,	but	these	roles	are	under-recognised	in	AMS	in	comparison	to	the	
roles	of	pharmacists	in	monitoring	prescription	therapy	(ANA	&	CDC,	2017).		
Appropriate	use	of	antibiotics	is	another	recognised	area	of	influence	by	
nurses	in	AMS	(Dyar	et	al.,	2016).	In	this	Thai	study,	nurses	currently	played	a	role	in	
monitoring	optimal	antibiotic	use	by	reviewing	antibiotic	prophylaxis,	participating	in	
antibiotic	time	out	and	facilitating	the	switching	of	therapy	from	intravenous	(IV)	to	
oral	use.	The	majority	of	clinical	nurses	in	this	study	reported	that	they	monitored	
doctors’	treatment	by	reading	the	doctors’	progress	notes	to	see	the	treatment	
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plans	and	then	respectfully	asking	doctors	to	review	treatment	once	the	original	plan	
was	completed.	This	contribution	to	AMS	principles	was	also	recognised	by	doctor	
and	pharmacist	participants.	Nurses		highlighted	the	importance	of	communication	
style	and	the	need	to	demonstrate	respect	for	the	medical	team.	Nurses	described	
indirect	strategies	to	communicate	the	need	to	review	existing	medical	orders	by	
placing	them	in	a	way	that	would	be	obvious	to	the	medical	team	or	highlighting	
results	of	interest.	These	described		interpersonal	and	indirect	communications	are	
in	line	with	the	findings	of	Burnard	and	Naiyapatana	(2004)	who	investigated	
communication	in	nursing.	Communication	is	more	likely	to	be	‘roundabout’	than	
direct	in	order	to	avoid	conflict.	Respect	for	hierarchies	and	showing	respect	is	a	
strong	cultural	expectation	of	nurses	in	Thailand	and	this	was	evident	in	the	nurses’	
data.	
One	of	the	most	important	elements	of	the	WHO	strategy	to	fight	AMR	is	to	
actively	educate	patients	about	appropriate	antibiotic	use.	Nurses,	through	provision	
of	24-hour	care	to	hospitalised	patients,	have	the	most	direct	patient	contact	and	
hence,	are	considered	to	be	in	an	optimal	position	to	provide	health	promotion	
education.	Nurses	can	play	an	important	role	in	educating	patients	and	their	family	
members	about	infection	and	prevention	control	practices	and	optimal	antibiotic	
use,	along	with	raising	awareness	about	patient	self-management	of	common	
infections	(Amalia,	2014;	Clark,	2000;	Crombie,	2012b;	Curry	et	al.,	2014;	Edwards,	
Loveday,	Drumright,	&	Holmes,	2011f;	Fry,	2012;	Gallagher	&	Storr,	2012b;	Glover,	
2000b;	Turkoski,	2005).	In	this	Thai	study,	nurses	were	recognised	as	having	a	role	in	
educating	patients	and	caregivers	about	the	appropriate	use	of	antibiotics	both	
during	their	hospitalisation	and	following	discharge	from	acute	care.	However,	the	
focus	of	activities	described	was	on	the	immediate	use	of	antibiotics	following	
discharge	from	hospital,	very	few	nurses	identified	a	broader	health	promotion	role	
in	the	appropriate	use	of	antibiotics	within	the	context	of	their	easy	availability	in	
the	community	in	Thailand.	One	nurse	leader	saw	this	expanded	health	promotion	
activity	as	an	important	potential	role	for	nurses.		
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Nurses	in	specialty	areas	such	as	intensive	care	units	(ICU),	infection	control	
nurses	(ICNs)	and	provincial	nurses	described	current	activities	that	suggested	
leadership	in	AMS.	Examples	of	these	activities	were	the	initiation	of	a	surveillance	
protocol	for	monitoring	signs	of	infection	and	timely	review	of	cultures	and	providing	
suggestions	about	antibiotic	dosing.	This	activity	occurred	in	the	ICU	where	
participants	described	collegial	relationships	between	nurses	and	doctors.	ICNs	
provided	information	about	AMR	and	AMS	to	ward	nursing	staff	across	the	hospital,	
and	were	proactive	in	questioning	doctors	about	antibiotic	treatment.	For	nurses	
working	in	provincial	areas,	setting	up	protocols	to	facilitate	timely	antibiotic	
administration,	and	acting	as	a	nurse	prescriber	for	anti-viral	medication	(under	
supervision	of	doctors)	were	identified	as	some	of	these	leadership	activities.	The	
findings	suggest	that	nurses	who	have	particular	expertise	or	more	specific	
knowledge	of	AMR	and	AMS	or	work	in	environments	where	there	are	collegial	
relationships	between	disciplines	were	more	confident	to	extend	their	scope	of	
practice	to	included	AMS	activities.	These	findings	highlight	that	nurse	participation	
in	AMS	activities	needs	to	be	facilitated	by	promoting	a	strong	multidisciplinary	team	
culture,	advancing	nurses’	knowledge	base,	and	explicit	recognition	of	nurses’	roles.		
There	was	widespread	support	for	nurses	in	both	acute	healthcare	and	
community	settings	to	initiate	and	lead	AMS	activities	in	their	own	areas	that	would	
improve	the	quality	of	patient	care.	This	was	particularly	evident	in	the	
organisational	leaders’	discussions.	Previous	similar	studies	have	shown	that	nurses	
in	specialty	areas	have	established	a	greater	AMS	role.	For	example,	nurses	in	an	
emergency	department	in	the	Netherlands	implemented	a	sepsis	care	bundle	
protocol	followed	by	staff	training	and	feedback	about	their	performance.	Similarly,	
emergency	nurses	in	a	hospital	in	the	USA	also	implemented	a	sepsis	protocol	to	
improve	compliance	with	serum	lactate	level	collection	in	emergency	departments	
(Bruce	et	al.,	2015).	In	residential	aged	care	facilities	(RACF),	in	Australia,	infection	
control	clinical	nurse	consultants	(CNC)	demonstrated	that	they	could	drive	the	
management	of	a	urinary	sepsis	program	for	residents	(Stuart	et	al.,	2015).		
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7.3.2	Current	governance,	educational	and	practice	barriers	
Participants	in	this	study	identified	gaps	in	current	governance,	education	and	
the	practice	context	that	were	perceived	as	barriers	to	developing	both	the	current	
and	future	roles	of	nurses	in	AMS.		
In	terms	of	clinical	governance,	professional	hierarchies	were	perceived	by	
nurses	to	limit	their	participation	in	AMS.	The	majority	of	nurse	participants	in	both	
clinical	and	leader	groups	identified	this	issue	as	a	main	barrier	for	nurses	in	
participating	in	AMS,	while	only	one	doctor	recognised	that	traditional	roles	could	
exclude	nurses	from	AMS	participation.	Less	experienced	nurses	in	particular,	
identified	the	lack	of	recognition	by	doctors	that	questioning	whether	antibiotic	
treatment	orders	were	in-line	with	best	practice	recommendations	could	be	part	of	
clinical	nurses’	role.	As	this	role	implicit	rather	thanspecified	in	any	protocols	or	
practice	guidelines,	clinical	nurses	felt	that	they	could	not	refer	to	hospital	policies	to	
give	them	the	authority	to	voice	their	opinions	or	concerns.	This	combined	with	a	
strong	sense	of	Thai	cultural	expectations	in	regards	to	respecting	seniority	and	
avoiding	conflict	meant	that	many	of	the	clinical	nurses	interviewed	in	this	study	
expressed	reticence	about	greater	involvement	in	AMS.	This	appeared	to	be	
reinforced	by	the	senior	nurses	interviewed	for	this	study	who	also	expressed	the	
importance	of	respecting	professional	hierarchies	in	healthcare.	Concerns	about	
scope	of	nursing	practice	and	respect	for	the	medical	profession	may	in	part	explain	
why	nurses’	contribution	to	AMS	activities	was	not	visible	in	the	AMS	governance	
structure.	These	findings	highlight	the	importance	of	developing	a	clear	governance	
framework	that	acknowledges	clinical	nurses’	role	in	AMS	and	also	developing	ward-
based	AMS	projects	that	are	sensitive	to	the	Thai	Cultural	context	and	address	some	
of	the	challenges	less	experienced	nurses	face	in	contributing	to	multidisciplinary	
team	discussions.		
Concerns	about	the	impact	of	professional	hierarchies	in	healthcare	on	
practice	change	have	been	reported	in	previous	studies	and	are	not	unique	to	
Thailand.	For	example,	hospital	hierarchical	structures	were	found	to	influence	
nurses’	engagement	in	an	AMS	program	to	change	antibiotic	use	in	patients	
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hospitalised	with	respiratory	hospital	pulmonary	infections	in	Australia	(Broom,	
Broom,	Kirby,	Gibson,	&	Post,	2017).		
The	issue	of	hierarchy	and	clinical	autonomy	affect	all	members	of	the	
healthcare	team	not	only	nurses.		Active	consultation	between	doctors	and	
Infectious	Diseases’	specialists	and	with	clinical	microbiology	was	found	to	be	limited	
by	perceived	autonomy	in	a	UK	hospital	(Broom,	Broom,	Plage,	Adams,	&	Post,	
2016).	The	results	of	the	study:	Understanding	the	determinants	of	antimicrobial	
prescribing	within	hospitals:	the	role	of	"prescribing	etiquette"	showed	that	junior	
doctors	were	influenced	by	the	antimicrobial	prescribing	behaviours	of	senior	
doctors	(Charani	et	al.,	2013).		
In	this	Thai	study,	junior	nurse	participants	felt	more	comfortable	participating	
in	AMS	activities	when	there	were	formal	protocols	that	outlined	best	practice	and	
therefore	they	could	use	the	protocols	to	support	and	validate	their	concerns	or	
requests.	Similarly,	the	study	of	a	nurse-	initiated	sepsis	protocol	in	an	emergency	
department	showed	that	providing	a	formal	structured	and	agreed	role	for	nurses	
reduced	the	time	to	start	antibiotic	administration	and	improved	compliance	with	all	
components	of	a	sepsis	care	bundle	(Bruce	et	al.,	2015)	suggesting	that	nurses,	when	
supported	by	protocol	were	more	likely	to	engage	in	active	communication	with	
medical	team	members.	To	overcome	hierarchical	barriers	to	AMS	implementation,	
support	is	needed	from	hospital	executives,	such	as	through	the	development	of	
institutional	AMS	policies	and	guidelines	and	the	development	of	antibiotic	care	
bundles,	as	a	part	of	patient	safety	initiatives.	In	addition	mechanisms	to	encourage	
and	foster	appropriate	interdisciplinary	communication	and	teamwork	between	
different	healthcare	professionals	is	suggested	as	fundamental	to	supporting	and	
embedding	the	principles	of	AMS	into	care	(Bal	&	Gould,	2011;	Lim	et	al.,	2014b;	Loh	
et	al.,	2015b;	Pakyz	et	al.,	2014a).	
A	further	barrier	to	greater	participation	in	AMS	by	Thai	nurses	was	their	
perceived	lack	of	knowledge	in	regards	to	best	practice	guidelines	for	antibiotic	use.	
Clinical	nurses	and	nurse	leaders	did	not	perceive	that	they	had	the	knowledge	base	
or	specialist	training	to	contribute	substantially	to	clinical	decision-making	about	
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appropriate	antibiotic	use.	Importantly	however,	this	perception	was	not	shared	by	
ICN	nurses	who	were	clear	that	in	specific	clinical	areas	they	did	have	the	skills	and	
knowledge	to	provide	expert	advice	about	antibiotic	prescribing	and	to	identify	
when	prescriptions	were	not	in	accordance	with	best	practice.	This	difference	in	
perspectives	between	the	ICN	nurses	and	other	nurses	interviewed	demonstrates	
with	the	potential	value	of	providing	more	extensive	academic	training	and	
preparation	for	practice	in	breaking	down	hierarchical	boundaries	and	giving	nurses	
more	confidence	in	their	own	skills	to	participate	in	AMS	activities.	Previous	studies	
have	also	shown	that	nurses	may	not	be	adequately	prepared	educationally	to	
engage	in	AMS	(ANA	&	CDC,	2017;	Lim	et	al.,	2014b).	Findings	of	studies	evaluating	
knowledge,	beliefs,	and	confidence	regarding	infection	and	AMS	have	shown	that	
healthcare	professionals	with	higher	knowledge	scores	of	infection	and	AMS	were	
more	confident	to	narrow	or	stop	antimicrobial	treatment	than	healthcare	
professionals	with	lower	knowledge	scores	(Jump	et	al.,	2015).	Therefore,	the	
outcomes	of	this	Thai	study	would	support	initiatives	by	the	hospital	leadership	team	
to	provide	more	in-service	educational	programs	about	AMS	and	rational	antibiotic	
use	as	these	educational	programs	have	the	potential	to	empower	nurses	to	take	a	
greater	role	in	AMS	that	could	impact	on	both	patient	outcomes	and	costs	
associated	with	antimicrobial	therapy.	
The	inadequacy	of	baseline	education	in	microbiology	and	AMS	in	the	nursing	
undergraduate	curriculum	was	also	identified	as	a	gap	in	the	Thai	study	that	
impacted	on	consistent	engagement	in	AMS	by	nurses.	It	has	been	noted	previously	
that	nurses	are	taught	subjects	covering	microbiology	and	pharmacology	as	pure	
rather	than	applied	sciences	(ANA	&	CDC,	2017;	Olans	et	al.,	2016;	Schellack	et	al.,	
2016)	and	this	makes	it	difficult	for	nurses	to	apply	this	knowledge	in	practice.	
Similarly,	in	this	Thai	study	the	nurse	participants	reported	that	in	the	second	year	of	
the	nursing	undergraduate	curriculum,	there	learning	of	microbiology	and	
pharmacology	was	superficial,	and	that	it	was	difficult	for	them	to	recall	this	
knowledge	and	apply	the	theoretical	principles	in	practice.	It	was	particularly	noted	
that	the	concepts	of	AMR	and	AMS	were	not	provided	in	the	current	undergraduate	
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nursing	curriculum.	Provision	of	training	and	education	regarding	AMS	in	both	
undergraduate	nursing	curricula	and	in-service	training	would	help	nurses	perform	
their	role	in	AMS	(Monsees,	Goldman,	&	Popejoy,	2017).	In	2014,	The	Royal	College	
of	Nursing	in	the	UK	recommended	that	AMR	and	its	associated	impact	should	be	
taught	as	part	of	pre-registration	nursing	programs	(Peate,	2015).	In	2017,	the	
American	Nurses	Association	(ANA)	in	collaboration	with	the	Centers	for	Disease	
Control	and	Prevention	(CDC)	released	a	white	paper	redefining	‘the	Role	of	
Registered	Nurses	in	Hospital	Antibiotic	Stewardship	Practices’	and	suggested	that	
nursing	schools	should	reconsider	the	content	of	their	current	microbiology	and	
pharmacology	courses,	so	that	principles	taught	were	more	applied	and	would	
provide	greater	practical	support	for	nurses	to	improve	patient	care	(ANA	&	CDC,	
2017).	Suggested	topics	included	the	principles	of	applied	microbiology	such	as:	how	
to	both	obtain	cultures	and	interpret	the	results,	the	differences	between	infection	
versus	colonisation,	assertiveness	and	communication	training	to	engage	in	
discussions	with	the	health	care	team,	information	on	intravenous	to	the	oral	switch	
criteria,	and	training	on	taking	an	allergy	history	(ANA	&	CDC,	2017).	Additionally,	in	
the	USA,	practical	topics	relating	to	empiric	guideline-based	antibiotic	prescribing	
versus	individualised	patient	therapy	and	the	role	of	clinical	practice	guidelines	in	
antibiotic	selection	were	suggested	as	crucial	topics	to	support	staff	nurses	in	playing	
their	role	in	AMS	(Olans	et	al.,	2016).	Updating	the	Thai	nursing	curriculum	along	
with	professional	training	and	education	regarding	AMR,	AMS	and	antibiotic	use	in	
Thai	hospitals	is	required	to	prepare	Thai	nurses	for	their	their	role	AMS.	
Another	influencing	factor	in	the	inconsistent	engagement	in	AMS	by	nurses	
was	the	shared	perception	by	organisational	leaders	and	nurses	in	particular,	that	
since	they	did	not	prescribe	antibiotics,	AMS	in	terms	of	appropriate	antibiotic	usage	
was	not	their	priority	or	responsibility	in	the	context	of	a	high	workload	
environment.	This	was	recognised	by	all	participants	as	a	significant	barrier	to	
greater	nurse	participation	in	AMS.	Similarly,	previous	studies	have	found	that	
although	nurses	contribute	to	AMS	activities,	nurses	do	not	perceive	themselves	as	
key	AMS	stakeholders	because	they	are	not	typically	prescribers	(ANA	&	CDC,	2017;	
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Hart,	2006;	Olans,	Nicholas,	Hanley,	&	DeMaria,	2015).	However,	nursing	
participation	is	recognised	as	important	in	improving	patient	safety	(Monsees	et	al.,	
2017).	The	nursing	executive	can	play	a	dominant	role	in	leading	nursing	
engagement	in	healthcare	organisations	(Manning	&	Giannuzzi,	2015).	What	is	
needed	in	order	to	engage	and	empower	nurses	in	AMS,	is	that	the	nurse	executive	
of	an	organisation	provides	greater	leadership	support	by	co-developing	a	clear	AMS	
structure	and	policy,	and	ensuring	that	sufficient	nurses	across	an	organisation	are	
provided	with	appropriate	AMS	education	and	training	to	become	active	participants	
in	and	leaders	of	AMS	activities.	
7.3.3	Future	potential	roles	
Strengthening	existing	roles	by	integrating	nurses	within	multidisciplinary	
teams	and	advancing	and	extending	practice	roles	in	both	acute	health	care	settings	
and	the	community	were	identified	as	future	potential	roles	of	nurses	in	AMS	in	
Thailand.		
Overcoming	perceived	governance	barriers	by	integrating	nurses	into	the	
multidisciplinary	team	was	seen	as	an	important	strategy	to	strengthen	nurses’	
existing	roles.	Consensus	in	support	of	clinical	nurses’	participation	in	the	AMS	team	
round	was	evident	in	all	participant	responses.	However,	there	was	a	noticeable	
difference	in	perspectives	between	nurse	participants	and	non-nursing	
professionals.	Nurses	supported	their	engagement	in	the	AMS	team	because	they	
perceived	that	they	would	impact	on	patient	safety	and	patient	satisfaction	because	
of	their	comprehensive	knowledge	of	their	patients’	histories	and	responses	to	
treatment,	whereas	doctors	and	pharmacists	supported	their	engagement	as	an	
opportunity	for	nurses	to	learn	more	about	antibiotic	treatments.	These	different	
perspectives	raise	questions	about	whether	doctors	and	pharmacists	recognise	the	
unique	contribution	that	nurses	can	make	to	the	AMS	multidisciplinary	team	and	this	
contribution	may	need	to	be	more	explicit.		
The	concept	of	a	multidisciplinary	approach	is	recommended	so	that	AMS	
programs	can	achieve	optimal	outcomes	(Lin	et	al.,	2013a).	Internationally,	the	
findings	of	several	studies	have	shown	that	the	success	of	AMS	activities	is	increased	
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by	including	nurses	in	the	AMS	team.	For	example,	the	presence	of	multidisciplinary	
rounds	including	nurses,	a	pharmacist	and	respiratory	therapists	was	considered	an	
important	facilitator	in	managing	ventilator-associated	pneumonia	in	intensive	care	
units	in	the	USA	(Safdar	et	al.,	2016).	An	evaluation	of	an	infection	team	review	
including	doctors,	nurses	and	antibiotic	pharmacists	in	UK	hospitals	reported	
positive	results	in	terms	of	improved	antimicrobial	use,	IV	to	oral	switching	and	a	
probable	impact	on	decreasing	the	potential	of	healthcare	associated	infections	
(Dryden	et	al.,	2012).	In	Ireland,	a	multidisciplinary	AMS	team	round	including	nurses	
was	established	to	guide	antibiotic	use	in	terms	of	the	duration	of	therapy,	
alternative	agents,	switching	from	IV	to	oral,	dose	recommendations	and	therapeutic	
drug	monitoring	(Galvin	&	Fennell,	2012).	In	Hong	Kong,	infection	control	nurses	and	
doctors	initiated	an	immediate	concurrent	feedback	model	that	resulted	in	
improvements	in	the	cost-effectiveness	of	treatments	(Cheng	et	al.,	2009).		
Participants	in	this	Thai	study	identified	the	potential	for	clinical	nurses	
(particularly	those	within	specialty	areas)	to	actively	lead	AMS	initiatives	and	that	
these	nurse-led	initiatives	could	improve	adherence	to	best	practice	and	patient	
outcomes.	For	clinical	nurses	in	general	wards,	doctor,	nurse	and	pharmacist	
participants	in	the	leader	group	supported	the	development	of	AMS	ward	nurse	
specialist	roles	that	may	impact	on	doctors’	antibiotic	prescribing	behaviours	and	
provide	patient	benefits	by	supporting	the	use	of	appropriate	antibiotics	across	a	
range	of	clinical	areas	in	the	hospital.	It	was	noted	however	that	pharmacists	saw	
this	initiative	as	a	way	of	filling	a	gap	in	the	availability	of	pharmacists	across	all	
clinical	areas.	The	pharmacist	participant	views	were	that	clinical	pharmacists	should	
be	taking	a	lead	in	AMS	activities	on	the	wards	by	reviewing	the	appropriateness	of	
antibiotic	prescribing.	Nurses	should	be	encouraged	contribute	to	this	process	
largely	because	there	were	insufficient	clinical	(ward-based)	pharmacists	in	the	
hospital.	The	perspectives	expressed	by	the	pharmacists	interviewed	appear	to	
reflect	the	belief	that	nurses	can	be	trained	up	to	fulfill	the	responsibilities	of	other	
professional	groups	when	there	is	an	identifiable	skill	or	personnel	shortage.	By	
implication	the	expertise	and	body	of	knowledge	informing	AMS	would	remain	the	
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domain	of	infectious	diseases	specialists,	doctors	and	pharmacists,	but	that	nurses	
would	ensure	that	the	principles	of	AMS	were	translated	into	practice.		
In	this	study,	ICNs	appeared	to	be	recognised	by	clinical	nurses	as	potentially	
playing	a	more	advanced	role	in	AMS	by	extending	their	focus	on	the	management	
of	IPC	to	include	AMS	related	activities.	Whereas	ICN	participants	were	ready	to	take	
a	greater	role	in	AMS	by	acting	as	consultants	in	antibiotic	decision-making	for	junior	
doctors	and	having	the	authority	to	stop	antibiotic	treatment	if	required.		
The	potential	role	of	nurses	in	AMS	as	educators	in	primary	health	to	promote	
better	use	of	antibiotics	in	the	community	was	identified	as	a	future	role	
development	for	nurses	in	this	study.	Approximately	80	percent	of	antibiotics	are	
prescribed	in	community	settings	(Olans	et	al.,	2016)	and,	in	Thailand,	the	availability	
of	antibiotics	over-the-counter	without	prescription	underscores	the	importance	of	
the	health	promotion	role	in	the	community.		The	conclusions	of	a	recent	narrative	
review	of	antibiotic	stewardship	in	primary	care	in	high	and	high-middle	income	
countries	were	that	nurses	should	take	a	leading	role	in	AMS	in	primary	care	through	
for	example,	educating	patients	on	judicious	use	of	antibiotics	and	IPC	practice	(Dyar	
et	al.,	2016).	In	South	Africa	and	Latin	American	countries,	primary	care	nurses	play	
an	important	role	in	the	management	of	antiretroviral	and	anti-tuberculosis	
medications	(Fairall	et	al.,	2012;	Giyose	&	Tshotsho,	2015;	Lekhuleni,	Kgole,	&	
Mbombi,	2015;	Musayón	Oblitas	et	al.,	2010).	Similarly,	public	health	nurses	in	Japan	
have	a	key	position	in	supporting	patients	with	tuberculosis	in	treatment	adherence	
(Shimamura	et	al.,	2013).	Therefore	there	are	opportunities	to	broaden	nurses’	role	
in	AMS	by	formally	developing	their	role	in	health	promotion	in	communities	to	
provide	patients	and	family	members	with	high	quality	information	about	
appropriate	antibiotic	use	(Gallagher,	2014).	Support	from	government,	hospital	and	
nursing	executives	is	required	to	develop	nurses’	current	role	in	health	promotion	to	
include	key	messages	related	to	AMS	so	that	nurses	in	Thailand	are	formally	
recognised	as	providing	evidence-based	information	relating	to	appropriate	
antibiotic	use	and	IPC	practice	for	the	general	public	and	patients	once	they	are	
discharged	into	the	community.	
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7.4	Chapter	summary	
The	findings	of	this	study	are	that	nurses	do	engage	in	AMS	but	that	
engagement	has	significant	governance,	hierarchical	and	educational	impediments.	
Further,	there	are	opportunities	to	extend	and	advance	practice	roles	for	clinical	and	
specialist	nurses	in	the	hospital	and	in	primary	care.	Strategies	are	needed	to	make	
explicit	and	consistent,	clinical	nurses’	support	for	AMS	activities	through	system	
processes,	monitoring	for	patient	safety,	monitoring	for	optimal	antibiotic	use	and	
patient	education.	These	functions	could	be	extended	so	that	members	of	the	
clinical	nursing	team	develop	experience	and	contribute	to	AMS	leadership	by	
becoming	members	of	AMS	clinical	teams,	and	by	participating	in	committees	that	
oversee	the	clinical	governance	of	antibiotic	use	within	the	hospital.	In	addition,	the	
study	findings	demonstrated	the	potential	to	further	develop	advanced	practice	
roles	for	nurses	in	AMS.	In	this	study,	the	descriptions	of	the	current	roles	of	ICNs	
and	provincial	nurse	leaders	provided	exemplars	of	how	leadership	roles	and	
consultant	roles	for	advanced	practice	nurses	could	be	developed	to	provide	AMS	
expertise	both	in	acute	care	settings	and	regional	and	remote	settings	in	Thailand.		
Gaps	in	the	current	governance,	educational	and	practice	context	need	to	be	
addressed	before	clearly	defined	roles	for	nurses	in	AMS	can	be	developed	and	
embedded	into	clinical	practice.	The	conclusion	and	integration	of	research	findings	
are	presented	in	Chapter	Eight
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Chapter	8		
Integrated	discussion	and	conclusions	
This	research	program	was	designed	to	explore	the	current	and	potential	
roles	of	nurses	in	AMS	in	acute	healthcare	in	Thailand	within	the	broader	context	of	
clinical	governance,	and	attitudes	and	perceptions	to	AMR	and	AMS.	A	participant	
triangulated	survey	and	interview	approach	was	used	in	a	case	study	at	a	1,000-	bed	
university	hospital	in	Bangkok,	Thailand	to	explore	four	different	perspectives	to	aid	
in	understanding	and	provide	a	more	comprehensive	view	of	the	current	and	
potential	roles	of	nurses	in	AMS	in	acute	healthcare	in	Thailand.	Methodological	
triangulation	was	used	to	address	the	specific	aims	of	the	research.	
A	review	of	the	literature	identified	that	AMR	is	a	global	healthcare	problem	
with	significant	consequences,	particularly	in	Thailand	where	antibiotics	are	sold	
without	prescription.	Antimicrobial	stewardship	programs	have	been	initiated	to	
respond	to	the	growing	problem	of	AMR	and	ensure	optimal	antimicrobial	use	with	
the	goal	of	minimising	AMR	(MacDougall	&	Polk,	2005).	A	multidisciplinary	approach	
is	considered	best	practice	in	AMS	(CDC,	2014;	Duguid	&	Cruickshank,	2011;	Lin	et	
al.,	2013a),	however	not	all	AMS	programs	include	nurses	(Edwards	et	al.,	2011c)	
who	are	the	largest	group	of	healthcare	professionals	and	the	only	healthcare	
professionals	with	patients	24	hours	a	day	in	acute	care	environments.	In	addition,	
the	role	of	nurses	in	AMS	has	not	been	fully	described	or	evaluated	in	the	
international	research	literature.	Therefore,	to	develop	an	understanding	of	nurses’	
contribution	to	AMS	in	the	unique	context	of	Thailand	it	was	essential	to	obtain	
views	from	organisational	leaders,	doctors,	pharmacists	and	clinical	nurses,	and	
patients.	The	study	was	conducted	within	a	single	institution	in	central	Bangkok.		
The	findings	of	this	study	identified	gaps	in	current	governance	and	policies	
to	support	nurses	in	developing	their	role	in	AMS,	and	the	challenges	in	the	
educational	and	practice	context	that	will	need	to	be	addressed	before	clearly	
defined	roles	for	nurses	in	AMS	can	be	developed	and	fully	embedded	into	clinical	
practice	in	Thailand.	Barriers	and	impediments	to	nurses’	consistent	engagement	in	
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AMS	activities	included	a	lack	of	AMS	policies	and	procedures	in	the	organisation	
that	clearly	articulated	a	role	for	nurses;	a	need	for	greater	executive	support	for	
AMS,	the	need	to	develop	decision	support	tools	that	are	specific	to	the	Thai	
context;	and	the	need	for	additional	IT	infrastructure	to	support	AMS.	In	addition,	an	
educational	program	to	provide	nurses	with	the	knowledge,	skills	and	confidence	to	
contribute	to	AMS	activities	is	needed.	To	realise	the	potential	contribution	of	
nurses,	the	outcomes	of	this	study	can	be	used	to	inform	nursing	education	and	
professional	development,	and	health	service	governance	related	to	AMS.		
The	patient	survey	of	perceived	behaviours,	attitudes	and	knowledge	of	
antimicrobial	treatments	added	another	dimension	to	our	understanding	of	the	
context	in	which	AMS	is	developing	in	Thailand	and	potential	roles	for	nurses.	The	
findings	revealed	the	potential	for	greater	patient	participation	in	AMS.	Enhanced	
roles	for	nurses	in	facilitating	participation	through	the	provision	of	information,	
education	and	health	promotional	messaging	about	appropriate	antibiotic	use	were	
identified.		
In	this	chapter,	the	findings	related	to	the	aims	and	objectives	are	
summarised	and	integrated	in	Section	8.1.	The	potential	to	develop	the	role	for	
nurses	in	AMS	is	discussed	in	relation	to	the	current	international	literature	in	
Section	8.2.	The	implications	of	the	research	findings	for	governance,	practice,	
education	and	professional	development	and	significance	of	the	findings	are	
integrated	in	Sections	8.3	to	8.5.	The	strengths	and	limitations	of	the	research	and	
recommendations	for	future	research	are	detailed	in	Sections	8.6	and	8.7.		
8.1	Summary	of	findings	
The	first	aim	of	the	study	was	to	explore	clinicians’	perceptions	and	attitudes	
towards	AMR	and	AMS	in	Thailand	among	clinicians.	A	clinician	survey,	semi-
structured	interviews	with	organisational	leaders	(executives	and	clinical	leaders)	
and	focus	groups	with	clinical	nurses	were	used	to	explore	clinicians’	perceptions	
and	attitudes	towards	AMR	and	AMS	in	Thailand.	There	were	total	of	1,087	
multidisciplinary	clinicians	who	completed	the	survey	and	33	participants	in	
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organisational	leadership	roles	and	clinical	ward	and	infection	control	nurses	were	
interviewed	individually	or	participated	in	focus	group	discussions.	The	major	
findings	were	that	all	participants	surveyed,	interviewed	or	in	focus	groups	perceived	
AMR	as	a	major	problem	and	that	improved	prescribing	and	use	of	antibiotics	was	
important.	There	was	variability	between	professions	regarding	their	perceptions	of	
AMR	and	AMS.	Nurses	were	less	likely	to	agree	that	community	antibiotic	use	
(p<0.001)	or	patient	pressure	for	antibiotics	contributes	to	AMR	and	fewer	nurses	
had	heard	of	AMS	terminology	in	English	than	doctors	and	pharmacists	(10.9%	vs.	
20.4%	vs.	48.8%,	p<0.001).	The	findings	highlighted	the	potential	barriers	and	
facilitators	to	effective	implementation	of	AMS	programs	in	Thai	hospitals	that	are	
based	on	health	professionals	understanding	of	the	problems	of	AMR	and	variability	
in	exposure	to	the	concept	of	antimicrobial	stewardship.	
In	the	second	aim	of	the	study,	the	current	AMS	clinical	governance	structure	
and	activities	within	the	institutional	case	study	were	described	using	organisational	
leaders	as	key	informants.	The	CDC	recommendations	for	core	elements	of	hospital	
AMS	programs	were	used	as	a	framework	for	the	analysis	(CDC,	2014).	In	addition,	
the	perceived	strengths	and	weaknesses	of	the	current	clinical	governance	
structures	among	organisational	leaders,	ICNs	and	clinical	nurses	were	explored.	The	
major	findings	were	that	although	there	is	strong	leadership	endorsement	of	the	
organisation-wide	implementation	of	the	principles	of	AMS,	these	initiatives	are	
hampered	by	suboptimal	information	management	systems	and	a	lack	of	tangible	
support	from	the	hospital	executive	in	terms	of	staff	and	resources.	The	findings	also	
highlighted	that	current	clinical	AMS	activities	had	not	reached	multidisciplinary	
clinicians	to	the	extent	necessary	for	their	engagement	and	consistent	
implementation	of	AMS	principles	into	clinical	practice.	Nurses	were	not	part	of	the	
membership	of	the	two	main	teams	responsible	for	AMS	polices	and	activities	in	the	
study	hospital.		
The	third	aim	of	the	research	was	to	explore	the	current	and	potential	for	
patient	participation	in	AMS	in	Thailand.	A	total	of	205	patients	completed	the	
patient	survey.	Relevant	data	of	the	nurse	interviews	and	focus	groups	were	
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analysed	to	provide	an	understanding	of	patients’	perceived	behaviours,	attitudes	
and	knowledge	of	antibiotic	use	and	utility	and	how	nurses	address	patients’	needs	
in	relation	to	safety	and	information.	Both	patients	and	nurses	perceived	that	
antibiotics	were	a	commonly	used	medication	and	the	acquisition	of	antibiotics	
without	health	professional	involvement	in	Thailand	confirmed.	Misconceptions	of	
the	utility	of	antibiotics	in	treating	viral	infections	were	evident	in	patients’	
responses	and	nurses	were	aware	of	these	misconceptions.	Patients	also	reported	
that	they	relied	on	health	professionals	for	information	about	antibiotic	use	in	the	
community	and	wanted	more	information	about	the	best	way	to	use	antibiotics.	
When	in	hospital,	patients	were	unsure	if	they	needed	antibiotics,	expected	health	
professionals	to	control	antibiotic	use	and	were	unlikely	to	seek	antibiotics.	Patients	
wanted	to	participate	in	AMS	during	hospitalisation.		
Nurse	participants	perceived	that	their	role	was	focused	on	monitoring	
patient	safety	during	antibiotic	administration,	and	to	a	lesser	extent	they	identified	
that	nurses	had	a	role	in	educating	patients	about	antibiotic	use	following	discharge	
from	hospital.	There	was	limited	expressed	recognition	by	clinical	nurses	of	the	
potential	to	engage	patients	to	take	an	active	role	in	AMS	or	to	facilitate	more	active	
participation	and	shared	decision-making	regarding	antibiotic	use.	It	is	noteworthy,	
that	the	results	of	the	Phase	1	clinician	survey	indicated	that	clinical	nurses	were	less	
concerned	than	other	professionals	about	the	community	use	of	antibiotics	in	
Thailand,	suggesting	the	need	for	greater	educational	preparation	for	nurses	so	they	
can	take	the	lead	in	promoting	appropriate	use	of	antibiotics	to	consumers.	
In	the	final	phase	of	the	research,	organisational	leaders’	and	clinical	nurses’	
perspectives	of	the	current	and	potential	role	of	nurses	in	AMS	in	Thailand	within	
the	current	governance,	educational	and	practice	context	were	explored.	The	
findings	revealed	that	nurses	currently	play	a	role	in	AMS	in	acute	healthcare	by	
supporting	AMS	system	processes,	monitoring	for	patient	safety,	monitoring	for	
optimal	antibiotic	use	and	patient	education.	Clinicians	identified	that	in	specific	
acute	care	contexts	(such	as	the	intensive	care	unit),	nurses	had	a	more	extended	
role	in	AMS	activities	and	in	rural	and	remote	areas	of	Thailand	and	that	ICNs	and	
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senior	nurses	undertook	advanced	practice	roles.	The	lack	of	existing	policies	that	
formally	describe	nurses’	scope	of	practice	and	responsibilities	related	to	AMS,	and	
professional	hierarchies	that	do	not	facilitate	active	engagement	of	nurses	were	
identified	as	barriers	to	greater	nurse	involvement	in	AMS	activities.	In	addition,	the	
current	lack	of	educational	preparation	limited	the	potential	for	nurses	to	develop	
and	extend	their	current	role.	Importantly	the	current	contribution	of	nurses	to	AMS	
was	perceived	to	be	largely	unseen	and	not	acknowledged	and	this	appears	to	
contribute	to	inconsistent	engagement	of	nurses	in	AMS	activities.		
Study	participants	identified	that	there	was	the	potential	to	develop	roles	for	
nurses	in	AMS	by	strengthening	and	consolidating	existing	roles	and	by	integrating	
nurses	into	the	multidisciplinary	AMS	team.	The	potential	to	develop	nurses	to	fulfil	
advanced	practice	and	or	AMS	leadership	roles	was	acknowledged	with	participants	
perceiving	the	greatest	potential	for	advanced	practice	roles	for	ICN	nurses.	The	
potential	for	ICNs	and	other	advanced	practice	nurses	working	in	more	remote	
settings	in	Thailand	to	act	as	advisers	for	sound	use	of	antibiotics	was	identified	as	
one	context	in	which	nurses	with	expertise	in	AMS	were	currently	needed.	
8.2	Integration	and	discussion	of	the	key	study	findings	
	 8.2.1	Professional	identities	and	crossing	boundaries	
The	findings	identified	that	professional	identities	and	professional	
boundaries	are	major	factors	that	influences	nurses’	engagement	in	AMS	activities	in	
Thailand.	
The	influence	of	professional	identity	on	participants’	perceptions	of	nurses’	
current	and	potential	role	in	AMS	was	a	key	finding.	The	multidisciplinary	survey,	
organisational	leader	interviews	and	focus	group	discussions	revealed	cross-
disciplinary	agreement	about	the	importance	of	the	AMR	problem	in	Thailand	with	
the	majority	of	clinicians	agreeing	that	it	is	necessary	to	implement	an	AMS	program	
to	address	this	issue	in	the	hospital.		
There	were	however,	differences	between	professional	groups	in	their	
preferences	for	how	AMS	activities	should	be	operationalised	at	the	study	site.	
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Doctors	wanted	to	maintain	their	professional	autonomy	and	did	not	want	
limitations	placed	on	their	prescribing,	and	pharmacists	understood	the	importance	
of	their	role	in	AMS	and	had	a	clear	sense	of	their	professional	responsibilities.	It	is	
noteworthy	that	the	pharmacist	participants	were	willing	to	support	nurses’	
engagement	in	AMS	as	long	as	their	activities	were	under	their	supervision	and	
control.	In	contrast,	the	nurse	participants	(with	the	exception	of	the	ICNs)	
expressed	a	lack	of	clarity	about	their	role	in	AMS	and	some	hesitation	about	
extending	their	responsibilities	to	include	AMS	activities.	In	contrast	to	nurses,	
doctors	were	more	likely	to	take	risks	and	to	cross	professional	boundaries	even	in	
areas	of	practice	that	were	not	their	primary	area	of	expertise.	
Nurses	had	a	limited	perception	of	their	current	role	in	AMS	that	focused	on	
medication	safety	and	antibiotic	administration.	Nurses	focused	their	attention	on	
provision	of	direct	patient	care	and	because	they	were	not	antibiotic	prescribers,	felt	
that	AMS	was	not	a	priority	in	their	busy	workload.	Nurses	also	recognised	that	they	
were	not	educationally	well	prepared	to	comment	on	antibiotic	prescribing	and	this	
perceived	lack	of	knowledge	may	also	have	contributed	to	their	hesitation	about	
taking	responsibility	for	AMS	activities	at	the	study	site.		
It	appears	from	the	study	findings	although	not	explicit,	that	cultural	norms	
and	social	expectations	about	the	appropriate	role	and	behaviour	of	women	in	Thai	
culture	may	have	also	been	influencing	the	professional	identity	boundaries	
expressed	by	the	participants.	Previous	researchers	have	explored	how	the	role	of	
nurses	in	Thai	hospitals	closely	reflects	traditional	expectations	of	women	in	Thai	
culture.	The	importance	of	facilitating	social	harmony,	avoiding	conflict,	and	respect	
for	social	and	professional	hierarchies	are	important	expectations	of	nurses	within	
Thai	society	and	hospital	culture	(Burnard	&	Naiyapatana,	2004).	These	cultural	
norms	may	create	barriers	to	greater	nurse	participation	in	AMS	activities,	
particularly	for	less	experienced	nurses,	where	the	role	expectations	involve	the	
need	to	act	assertively	and	question	antibiotic	prescribing	choices.	
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	 8.2.2	Nurses’	willingness	to	take	leadership	roles	was	heterogeneous	
	Another	significant	finding	of	this	study	was	that	there	were	also	
professional	differences	within	the	nurses’	as	a	professional	group	that	impacted	on	
their	acceptance	of	leadership	roles	in	AMS.	Important	differences	between	nurses	
(junior	nurses,	senior	nurses	or	ICNs)	emerged	in	this	study,	whereas	the	attitudes	of	
other	professional	groups,	namely	doctors	and	pharmacists,	were	relatively	
homogeneous.	The	differences	found	between	nurses	are	substantial	and	were	
dependent	on	their	level	of	clinical	experience,	sub-specialty	training	and	
organisational	role.	This	phenomenon	may	be	explained	by	the	social	context	in	
which	nurses	work.	When	nurses	do	not	have	organisational	authority,	they	use	
social	influence	and	relationships	to	achieve	their	desired	outcomes.	More	senior	
nurses	may	have	greater	confidence	in	their	capacity	to	influence	prescribers’	
behaviour	without	creating	inter	professional	conflicts	than	less	experienced	nurses	
which	may	in	part	explain	why	junior	nurses	were	more	hesitant	about	developing	a	
role	in	AMS.	In	contrast	senior	clinical	nurses	were	prepared	to	be	involved	in	the	
AMS	team	and	the	ICNs	expressed	an	interest	in	developing	advanced	practice	or	
consultative	roles	in	AMS.		
Another	potential	contributing	factor	to	junior	nurses	perceived	hesitancy	in	
participating	in	AMS	programs	is	that	clinical	nurses	have	so	many	delegated	roles	
within	their	practice.	In	acute	care	areas	where	the	workload	is	high,	more	junior	
nurses	appeared	to	feel	the	most	comfortable	focusing	on	their	own	direct	nursing	
care	role.	It	is	noteworthy	that	in	a	large	portion	of	clinical	nurses’	work,	for	example	
medication	administration,	nurses	have	a	delegated	role,	they	are	not	prescribers	
but	are	responsible	for	safe	medication	administration	and	monitoring	of	effects	and	
side-effects.	In	these	delegated	roles	they	do	not	have	direct	autonomy	over	their	
work.	Therefore,	if	nurses	want	to	have	a	role	in	AMS,	they	have	to	deal	with	
navigating	these	professional	and	organisational	boundaries.	Furthermore,	the	need	
to	fulfil	duties	for	which	they	have	a	high	level	of	responsibility	and	accountability	(to	
deliver	safe	patient	care)	but	low	authority	may	create	tensions	for	nurses.	Previous	
studies	in	a	range	of	occupational	areas	have	found	that	roles	in	which	responsibility	
Page	241	
	
	
is	high	but	authority	is	low	are	associated	with	substantial	occupational	stress	
(Marmot,	2006;	Marmot	et	al.,	1991).	
The	ICNs	interviewed	in	this	study	demonstrated	greater	professional	
confidence	that	was	underpinned	by	greater	educational	preparation	and	clinical	
experience.	The	ICNs	were	already	able	to	distinguish	a	clear	role	for	themselves	in	
AMS	and	were	willing	to	extend	their	role	and	take	on	increased	levels	of	
responsibility.	ICNs	demonstrated	that	they	were	interested	in	taking	on	leadership	
roles	in	AMS	and	saw	themselves	as	role	models	for	junior	nursing	and	medical	staff.	
Their	confidence	in	their	professional	ability	appeared	to	be	supported	by	both	a	
high	level	of	training	and	well-developed	skills	in	inter-professional	communication	
and	relationship	building.	Although	junior	nurses	have	experience	working	in	a	
multidisciplinary	clinical	environment	they	have	less	experience	in	building	effective	
team	communication	and	relationships,	as	a	consequence	they	appeared	to	be	less	
willing	and	less	likely	to	voice	their	concerns	or	challenge	prescribers’	decision-
making.		Importantly	ICNs	expressed	a	willingness	to	be	role	models	for	more	junior	
nurses,	by	contributing	to	multidisciplinary	team	discussions	around	AMS	and	
modelling	effective	communication	skills.	
It	is	evident	from	these	findings,	that	if	clinical	nurses	are	to	contribute	to	
AMS	activities	then	role	modelling	(by	senior	nurses)	of	affective	approaches	to	team	
communication	is	necessary.	Based	on	these	study	findings,	one	recommendation	to	
increase	clinical	nurses’	participation	in	AMS,	is	to	develop	team	models	of	care	that	
include	junior,	senior	and	ICNs	working	closely	together	so	that	junior	staff	have	
regular,	direct	exposure	to	professional	role	models	(Cioffi	&	Ferguson,	2009).		
	 8.2.3	Imbalance	between	expectations	and	the	available	resources	to	
support	nurses’	role	in	AMS	
Another	key	finding	was	that	nurses’	current	contributions	to	AMS	activities	
are	invisible	and	have	been	driven	by	the	needs	of	other	disciplines	not	by	their	level	
of	knowledge	or	expertise.	It	appears	that	there	is	a	huge	gap	in	current	AMS	
governance,	particularly	related	to	the	role	of	nurses.	There	is	an	imbalance	between	
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the	expectations	of	nurses	to	contribute	to	AMS	compared	to	the	resources	available	
to	support	them	and	the	recognition	of	their	role	in	the	organisational	governance	
structure.	In	this	study,	participants	reported	that	nurses	worked	to	support	AMS	
activities	despite	a	perceived	lack	of	role	clarity	and	policies	detailing	nurses’	scope	
of	practice	relating	to	AMS.	It	appears	that	despite	all	the	support	provided	by	
nurses	to	facilitate	AMS	implementation	at	a	ward	level,	these	activities	are	not	seen	
or	acknowledged	at	an	organisational	level	and	remain	largely	invisible.	Nurses	were	
also	working	in	a	space	that	they	do	not	feel	educationally	or	organisationally	
supported	to	perform.	The	perspectives	of	other	professional	groups	were	that	
nurses	are	gap	filling	rather	than	providing	a	skilled	professional	contribution.		
Nursing	expertise	includes	coordination	of	care,	maintaining	multidisciplinary	
communication,	and	engaging	patients	and	consumers	in	their	care.	If	nurses	were	
formal	members	of	the	AMS	clinical	team,	they	could	develop	their	knowledge	and	
support	consistent	implementation	of	AMS	in	clinical	care	and	this	was	
acknowledged	by	a	leader	participant.	In	the	future	nurses	could	become	key	players	
in	AMS	teams	and	their	role	could	include:	coordination	of	AMS	activities,	facilitating	
multidisciplinary	team	communication,	and	ensuring	consistent	implementation	of	
AMS	principles	in	clinical	practice.	However,	to	achieve	this	level	of	nursing	
participation	in	AMS,	nurses	would	need	a	greater	level	of	organisational	support.	
The	potential	strengths	of	the	discipline	of	nursing	and	its	contribution	to	knowledge	
translation	needs	to	be	acknowledged	at	an	organisational	level.	As	nurses	are	
present	in	the	hospital	24	hours	per	day	and	have	contact	with	all	members	of	the	
team,	they	are	in	a	key	position	to	influence	care,	build	relationships	and	raise	the	
importance	of	systematic	implementation	of	AMS	at	the	bedside.		
	 8.2.4	Patient	participation	in	AMS	
The	findings	suggested	that	nurse	participants’	conceptualisation	of	patient	
engagement	in	AMS	was	narrow	and	only	two	participants	discussed	the	importance	
of	broader	health	promotion.	One	explanation	for	this	finding	is	that	nurses	in	this	
case	study	work	in	a	university	tertiary	referral	hospital	and	the	focus	of	their	
activities	is	on	providing	advanced	care	for	complex	patients.	In	this	context	nurses	
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may	perceive	that	they	have	limited	opportunities	for	health	promotion	and	limited	
exposure	to	the	community	setting.	The	results	of	the	patient	survey	identified	that	
patients’	use	of	antibiotics	in	the	community	setting	is	commonplace.	The	
organisational	leaders	recognised	that	a	lack	of	regulatory	control	and	over-the-
counter	availability	of	antibiotics	contributed	to	high	rates	of	antibiotic	consumption	
in	the	community.	Consumer	access	to	antibiotics	without	prescription	places	
patients	in	a	more	powerful	position	when	it	comes	to	making	choices	about	
antibiotic	use.	The	nurse	participants	did	not	however	focus	on	providing	patients	
with	the	knowledge	and	skills	to	be	informed	consumers	once	they	were	discharged	
from	acute	care,	despite	repeated	comments	that	patient	antibiotic	use	outside	of	
the	hospital	was	a	key	influence	on	AMR.	The	focus	of	education	was	on	the	
immediate	use	of	discharge	medications.	It	was	not	explicitly	acknowledged	by	
nurses	that	once	discharged	into	the	community,	patients	have	responsibility	for	
making	complex	decisions	about	their	ongoing	care.	Of	note	patient	participants	
indicated	that	they	would	like	more	information	about	their	antibiotics	treatment.	
This	is	an	important	area	that	needs	to	be	explored	in	future	research.	
Importantly	the	nurse	participants	expressed	willingness	to	develop	this	
aspect	of	their	role	in	AMS.	Nurse	participants	were	willing	to	undertake	a	role	in	
patient	education	about	antibiotic	use	in	hospital	and	recognising	side	effects	of	
treatment,	and	identified	this	as	part	of	their	scope	of	practice.	This	implies	that	
nurses	believed	they	could	develop	a	more	autonomous	role	in	patient	education.		
8.3	Developing	nurses’	role	in	antimicrobial	stewardship	in	Thailand	
The	study	findings	indicate	that	there	was	a	willingness	on	the	part	of	both	
the	organisational	leaders	and	clinical	nurses	to	develop	the	role	and	contribution	of	
nurses	to	AMS	activities	at	the	study	hospital,	however	there	was	some	hesitation	by	
study	participants	as	they	identified	a	number	of	barriers	that	needed	to	be	
overcome	before	this	could	be	achieved.	Two	important	barriers	identified	by	
participants	were:	defining	the	role	and	responsibilities	of	nurses	and	making	these	
parts	of	hospital	policy	and;	secondly	providing	nurses	with	adequate	educational	
preparation	so	they	had	the	knowledge	and	confidence	to	perform	these	roles.		
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One	of	the	concerns	raised	by	clinical	nurses	in	the	general	ward	area	was	
that	traditional	professional	hierarchies	meant	that	it	was	difficult	for	them	to	
comment	on	prescribers’	decision-making.	The	challenge	of	nurses	and	junior	
doctors	commenting	on	senior	prescribers’	decisions	has	been	previously	reported	
as	a	barrier	to	AMS	implementation	(Charani	et	al.,	2013;	Livorsi,	Comer,	Matthias,	
Bair,	&	Perencevich,	2015;	Rawson	et	al.,	2016).	In	contrast,	some	of	the	
organisational	leaders	interviewed	commented	on	the	strong	team	culture	in	
specialty	units	such	as	ICU	and	how	nurses	working	in	these	areas	were	prepared	to	
take	a	more	proactive	role	in	AMS	(Henkin	et	al.,	2016).	These	findings	highlight	a	
common	issue	in	healthcare	settings	in	developing	more	advanced	roles	for	nurses	
and	asking	nurses	to	think	critically	and	to	communicate	proactively	when	they	
identify	activities	that	may	not	be	best	practice	(Boyle	&	Kochinda,	2004).	A	number	
of	studies	have	identified	that	nurses	find	it	difficult	to	voice	concerns	about	clinical	
practices	that	are	perceived	to	be	the	domain	of	other	clinicians,	doctors,	
physiotherapists,	pharmacists	etc.	(Churchman	&	Doherty,	2010;	Krogstad,	Hofoss,	&	
Hjortdahl,	2004;	Lim	et	al.,	2014a).	This	was	less	of	a	barrier	in	clinical	areas	where	
there	was	a	close	working	relationship	between	all	members	of	the	team	(Boyle	&	
Kochinda,	2004;	Pronovost	et	al.,	2008).	A	number	of	international	studies	have	also	
identified	problematic	inter-professional	communication	as	a	common	barrier	to	
both	practice	change	and	the	development	of	a	safety	focused	healthcare	culture	
(Huang	et	al.,	2007;	Pronovost	et	al.,	2008).	
The	nursing	responsibilities	to	ensure	safe	administration	of	all	prescribed	
medication	are	well	recognised	(NSQHS,	2012;	Supachutikul,	2008)	confirming	that	
clinical	nurses	have	a	high	level	of	awareness	of	their	role	in	patient	safety.	To	
promote	greater	nurse	participation	in	specific	AMS	related	activities,	such	as	
monitoring	for	optimal	antibiotic	use,	it	is	suggested	that	setting	up	a	formal	policy	
that	specifically	outlines	nurses’	responsibilities	and	the	specific	AMS	activities	that	
they	should	be	in	engaged	in	would	facilitate	more	consistent	engagement	of	clinical	
nurses	in	AMS	activities	at	the	bedside.	It	is	recognised	however	that	there	is	limited	
literature	evaluating	whether,	if	nurses	take	a	more	proactive	role	in	activities	such	
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as	‘antibiotic	time-out’,	this	results	in	improved	uptake	of	AMS	activities	and/	
improved	patient	outcomes.	Further	research	evaluating	whether	greater	
participation	by	nurses	in	supporting	AMS	system	processes	should	be	undertaken,	
to	determine	the	most	effective	approach	of	integrating	nurses	into	the	
multidisciplinary	AMS	team.	
In	Australia,	national	standards	for	safety	and	quality	in	health	care	have	
been	in	place	since	2006	(Australian	Commission	on	Safety	and	Quality	in	Health	
Care,	2014).	The	experiences	in	Australia	of	introducing	the	national	quality	and	
safety	framework,	integrating	this	into	healthcare	policies,	governance	and	
establishing	health	service	key	performance	indicators	may	provide	useful	insights	
into	how	the	role	of	nurses	in	AMS	could	be	developed	and	supported	(Duguid	&	
Cruickshank,	2011).	It	is	noteworthy	that	a	number	of	undergraduate	and	post	
graduate	nursing	education	programs	have	also	been	developed	to	provide	nurses	
with	the	skills	to	contribute	to	the	quality	and	safety	agenda	(Durham	&	Alden,	2008;	
Jang	&	Lee,	2017;	Mansour,	2015).	If	nurses	are	to	be	involved	in	quality	and	safety	
there	is	a	need	to	change	the	focus	of	their	undergraduate	programs	with	a	greater	
emphasis	on	quality	and	safety	processes	(Cronenwett	et	al.;	Hession-Laband	&	
Mantell,	2011).		
Cultural	expectations	about	the	role	of	nurses	and	their	contribution	to	AMS	
need	to	be	addressed	at	a	local	level	so	that	strategies	to	engage	nurses	are	
appropriate	to	the	Thai	context	(Burnard	&	Naiyapatana,	2004).	As	the	clinical	nurses	
in	this	study	identified	their	role	in	AMS	as	focusing	on	safe	medication	
administration,	it	is	possible	that	approaching	their	role	using	a	quality	and	safety	
lens	rather	than	a	prescribers’	perspective	may	be	one	way	to	facilitate	greater	nurse	
engagement	in	AMS.	If	clinical	nurses	understood	their	contribution	to	AMS	activities	
as	an	extension	of	their	responsibility	for	safe	medication	administration	and	that	
the	primary	purpose	of	AMS	is	to	achieve	optimal	patient	outcomes	with	minimal	
intervention	and	to	prevent	the	development	of	AMR,	then	perceptions	that	nurses	
are	crossing	professional	boundaries	when	questioning	antibiotic	use	might	be	
decreased	(Currey,	White,	Rolley,	Oldland,	&	Driscoll,	2015;	Durham	&	Alden,	2008;	
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Jang	&	Lee,	2017).This	approach	can	contribute	to	creating	a	clinical	culture	in	which	
nurses	are	expected	to	contribute	to	discussions	around	choice,	duration	and	
appropriateness	of	antimicrobial	use.		
Although	not	all	nurses	interviewed	in	this	study	were	willing	to	be	involved	
in	AMS	activities	related	to	antibiotic	use	in	acute	care,	their	potential	role	in	health	
promotion	and	patient	education	was	clearer	(Brink	et	al.,	2016;	Dyar	et	al.,	2016).	If	
nurses	are	to	develop	a	broader	role	in	health	promotion,	a	stronger	educational	
foundation	and	better	understanding	of	appropriate	antibiotic	use	in	ambulatory	
care,	community	and	primary	care	settings	is	needed	(Olans	et	al.,	2015;	Wilson	et	
al.,	2017).	In	Australia	for	example,	the	not-for-profit	and	evidence-based	
organisation	called	‘NPS	MedicineWise’	was	initiated	to	promote	quality	use	of	
medicines	and	support	prescribers	in	primary	care	settings	(MedicineWise,	2017).	
This	organisation	also	provides	guidance	and	direction	on	the	safe	and	wise	use	of	
medicines	and	health	technologies.		
The	finding	that	clinical	nurses	were	less	concerned	about	community	use	of	
antibiotics	and	AMR	in	the	Thai	community	and	that	the	education	they	provide	to	
patients	focuses	on	the	processes	of	care	directly	related	to	discharge	planning	such	
as	finishing	a	post-hospital	antibiotic	course	or	when	to	see	the	doctor,	suggested	a	
narrow	focus	when	they	were	talking	about	health	promotion.	To	undertake	a	more	
expanded	role	in	patient	education	and	health	promotion	in	the	community,	there	
would	need	to	be	a	structured	education	program	that	provided	nurses	with	
knowledge	of	appropriate	antibiotic	use,	effective	communication	skills	and	
resources	to	support	the	engagement	of	patients	in	their	care	(ANA	&	CDC,	2017;	
Hanucharurnkul,	2007;	Monsees	et	al.,	2017;	Olans	et	al.,	2017b;	Schellack	et	al.,	
2016).		
The	organisational	leaders	interviewed	for	this	study	identified	that	the	
widespread	availability	of	antibiotics	throughout	Thailand	and	inadequate	regulatory	
control	of	the	manufacture	and	distribution	of	antimicrobials	meant	that	there	was	
limited	data	available	on	current	antimicrobial	use	across	Thailand	(Sumpradit	et	al.,	
2017;	WHO,	2010b).	This	lack	of	effective	government	control	over	antimicrobial	
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distribution	and	a	lack	of	data	on	actual	antimicrobial	consumption	made	it	
extremely	difficult	to	implement	effective	nation-wide	AMS	strategies.	Over	the	last	
decade,	the	Thai	government	has	recognised	that	there	is	the	major	problem	with	
AMR	in	Thailand	and	is	taking	steps	to	both	regulate	antimicrobial	use	and	to	
persuade	prescribers	and	consumers	to	change	current	practices	(Sumpradit	et	al.,	
2017).	Although	these	changes	to	government	policy	are	positive,	it	is	clear	that	the	
clinical	leaders	of	AMS	programs	in	Thailand	do	not	have	access	to	the	well-
developed	policy	frameworks	and	decision-support	resources	for	AMS	that	are	now	
available	in	many	high-income	countries	(CDC,	2014;	Duguid	&	Cruickshank,	2011;	
Nathwani,	2006).	At	the	health	service	level	this	makes	development	and	
implementation	of	sustainable	AMS	programs	more	difficult	and	challenging	in	the	
Thai	context.		
It	is	striking	that	many	of	the	themes	that	emerged	related	to	the	role	of	
nurses	in	AMS	in	Thailand	resonated	with	what	has	been	reported	internationally	
(ANA	&	CDC,	2017;	Edwards	et	al.,	2011c;	Olans	et	al.,	2017b;	Olans	et	al.,	2016).	It	
appears	that	many	of	the	barriers	to	developing	a	role	for	nurses	in	AMS	in	Thailand	
are	similar	to	those	experienced	in	developed	countries.	The	Thai	context	does	
however	raise	some	unique	challenges.	Although	similar	to	many	low	and	middle	
income	countries,	Thailand	is	undergoing	a	demographic	transition	with	the	relative	
burden	of	chronic	disease	becoming	higher,	and	infectious	diseases	still	associated	
with	a	substantial	disease	burden	(WHO,	2017c,	2017d).	In	addition	there	are	
distinct	epidemiological	factors	of	infectious	diseases	that	make	Thailand	unique	
(CDC,	2017b).		
One	theme	that	has	emerged	from	this	and	previous	studies	was	that	ICNs	
are	the	most	willing	to	take	on	more	advanced	practice	roles	in	AMS	
(Hanucharurnkul,	2007;	Kruth,	2017;	Langkarpint,	2005;	Wongkpratoom,	Srisuphan,	
Senaratana,	Nantachaipan,	&	Sritanyarat,	2010).	In	order	for	ICNs	to	take	on	
advanced	practice	roles	in	AMS	in	the	Thai	context	education	and	training	programs	
are	needed	that	not	only	introduce	them	to	the	principles	of	AMS,	but	also	address	
the	specific	infectious	disease	problems	currently	being	faced	in	Thailand.	Education	
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and	training	programs	to	advance	ICN	practice	need	to	include	content	on	hospital-
acquired	infections,	multiple	drug	resistance	as	well	the	potential	for	new,	emerging	
infectious	diseases	(CDC,	2017b;	Sommanustweechai,	Iamsirithaworn,	
Patcharanarumol,	Kalpravidh,	&	Tangcharoensathien,	2017).		
8.4	Potential	benefits	of	consistent	sustained	engagement	of	nurses	in	AMS		
There	is	emerging	evidence	that	nurse	engagement	in	AMS	improves	patient	
safety	outcomes	and	decreases	healthcare	costs.	Studies	in	which	the	potential	
benefits	of	nurses’	taking	an	active	role	in	monitoring	antibiotic	use	have	shown	
beneficial	outcomes;	for	example,	when	surgical	nurses	ensured	compliance	with	
best	practice	for	antibiotic	prophylaxis	following	caesarean	section	there	was	an	
associated	decrease	in	wound	infections	(Shimoni	et	al.,	2009).	In	Australia,	an	
educational	intervention	to	promote	switching	from	intravenous	(IV)	to	the	oral	
route	for	antibiotics,	found	that	when	nurses	actively	questioned	patients’	need	for	
IV	antibiotics	this	resulted	in	reduced	duration	of	parenteral	antibiotic	therapy	and	a	
decreased	rate	of	bacteraemia	(Gillespie	et	al.,	2013).		
In	community	settings,	studies	in	South	Africa,	Latin	American	countries	and	
Japan	have	demonstrated	nurses’	crucial	role	in	AMS	in	managing	antimicrobials	
such	as	antiretroviral	and	anti-tuberculosis	medications	(Giyose	&	Tshotsho,	2015;	
Lekhuleni	et	al.,	2015;	Musayón	Oblitas	et	al.,	2010;	Shimamura	et	al.,	2013).	
Establishing	a	greater	AMS	role	of	nurses	in	specialty	areas	have	been	shown	
to	improve	AMS	system	processes	and	antibiotic	use.	For	example,	a	study	of	nurse-
initiated	the	sepsis	protocol	in	an	emergency	department	showed	reduced	time	to	
start	antibiotic	administration	and	improved	compliance	with	sepsis	bundles	in	the	
USA	(Bruce	et	al.,	2015).	In	residential	aged	care	facilities	(RACF)	in	Australia,	
infection	control	clinical	nurse	consultants	(CNCs)	demonstrated	that	they	could	
drive	the	management	of	urinary	sepsis	programs	in	residents	with	a	significant	
decrease	in	antibiotic	use	in	RACF	{Stuart,	2015	#220}.	
A	multidisciplinary	approach	is	vital	to	the	success	of	AMS	programs	(Lin	et	
al.,	2013).	Several	studies	have	shown	increased	success	of	AMS	activities	of	
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multidisciplinary	teams	that	included	nurses.	For	example,	the	presence	of	
multidisciplinary	rounds	including	nurses,	pharmacist	and	respiratory	therapists	was	
considered	an	important	facilitator	to	manage	ventilator-associated	pneumonia	in	
intensive	care	units	in	USA	(Safdar	et	al.,	2016).	An	audit	of	an	infection	control	team	
including	doctors,	nurses	and	antibiotic	pharmacists	in	UK	hospitals	was	reported	as	
having	positive	results	such	as	improving	antimicrobial	use,	IV	to	oral	antibiotic	
switching,	and	decreasing	the	risk	of	healthcare	associated	infections	(Dryden	et	al.,	
2012).	In	Ireland,	a	multidisciplinary	AMS	team	including	nurses	was	able	to	guide	
antibiotic	use	in	terms	of	the	course	length,	alternative	agents,	switching	from	IV	to	
oral	route,	dose	recommendations	and	therapeutic	drug	monitoring	(Galvin	&	
Fennell,	2012).	In	Hong	Kong,	ICNs	and	doctors	initiated	an	immediate	concurrent	
feedback	model	that	resulted	in	improvements	in	the	cost-effectiveness	of	care	
(Cheng	et	al.,	2009).	Including	nurses	and	increasing	nurses’	engagement	in	AMS	
teams	has	the	potential	to	improve	patient	safety	outcomes	and	healthcare	costs.		
8.5	Summary	of	the	implications	of	the	findings	
The	findings	of	this	study	have	implications	for	governance,	practice,	
education	and	professional	development	of	the	multidisciplinary	team.	
	 8.5.1	Implications	for	governance	
The	lack	of	a	clear	policy	that	supports	a	multidisciplinary	team	approach	to	
AMS	was	identified	as	a	gap	in	the	current	governance	structure	supporting	AMS	
programs	at	the	study	site.	In	order	to	support	the	multidisciplinary	team	in	
providing	consistent,	high	quality	stewardship,	a	clear	clinical	AMS	governance	
structure	is	needed.	To	support	nurses	involvement	in	AMS,	this	structure	need	to	
involve	nurses	and	the	policies	developed	need	to	provide	explicit	guidance	for	the	
responsibilities	of	the	multidisciplinary	team,	including	nurses.	To	facilitate	nurses’	
engagement	in	AMS	activities,	leadership	support	from	the	nurse	executive	is	
needed	to	provide	the	necessary	staffing	and	educational	resources	and	ensure	that	
policies	and	guidelines	developed	reflect	a	multidisciplinary	approach	to	AMS	that	
includes	both	engagement	of	and	accountabilities	for	the	nursing	workforce.	
Page	250	
	
	
Structured	education	and	skills	development	programs	are	required	for	clinical	
nurses	and	provision	should	be	made	to	ensure	that	nurses	can	participate	either	at	
induction	to	the	hospital	or	as	ongoing	professional	development.	Organisation-wide	
initiatives	and	strategies	are	needed	to	address	the	culture	of	clinical	interactions	
that	perpetuate	hierarchical	and	professional	boundaries	that	can	impact	on	patient	
safety	outcomes.		
	 8.5.2	Implications	for	practice	
Organisation-wide	initiatives	and	strategies	are	needed	to	address	the	shared	
perceptions	that	AMS-related	activities	were	not	a	priority	for	nurses	in	the	context	
of	a	high	clinical	workloads	and	concerns	about	the	effect	on	workload	of	expanding	
nurses’	responsibilities	to	include	AMS.	
These	strategies	could	include	open	multidisciplinary	and	uni-disciplinary	
forums	to	allow	concerns	to	be	voiced	and	to	achieve	greater	clarity	in	regards	to	
individual	and	multidisciplinary	roles	and	responsibilities	and	improve	inter-
professional	communication.	Anti-microbial	stewardship	should	be	incorporated	
within	nurses’	roles	and	responsibilities	related	to	maintaining	patient	safety	
through	safe	and	therapeutic	administration	of	all	medications.				
	 8.5.3	Implications	for	education	
There	is	a	need	for	reform	of	undergraduate	curricula	of	all	health	
professionals,	but	nurses	in	particular,	in	regards	to	the	teaching	of	microbiology	and	
pharmacology	in	Thailand.	Revisions	should	focus	on	the	acquisition	of	applied	
knowledge	rather	than	the	current	pure	science	approach	with	a	focus	on	AMR,	the	
principles	of	AMS	and	effective	multidisciplinary	communication	as	core	curriculum.		
Within	the	clinical	environment,	the	issues	related	to	AMR	and	the	principles	
and	role	expectations	of	AMS	should	be	integrated	in	induction	programs	for	new	
staff	in	the	hospital.	Continuing	professional	development	of	staff	should	be	
multidisciplinary	and	include	updates	in	the	status	of	AMR,	government	policy	and	
initiatives	in	Thailand,	governance	and	policy	for	AMS	at	the	organisational	level	and	
reinforcement	of	the	principles	of	AMS	and	the	rational	use	of	antibiotics.	Annual	
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local	updates	of	current	AMR	status	in	the	hospital,	performance	in	relation	to	AMS,	
along	with	information	about	the	impact	of	AMS	on	both	patient	outcomes	and	
costs	associated	with	antimicrobial	therapy	would	contribute	to	sustainability	of	
AMS.	It	is	suggested	that	these	updates	should	include	examples	of	both	high	
performing	areas	and	target	areas	for	further	improvements.	A	requirement	for	staff	
to	undertake	annual	educational	updates	of	their	knowledge	of	AMR	and	AMS	is	
suggested,	as	well	as	greater	access	to	resources	such	as:	eHealth	applications,	web-
based	educational	resources	and	peer-to-peer	education	sessions.	
	 8.5.4	Implications	for	professional	development		
Further	development	and	formalisation	of	leadership	roles	in	AMS	for	ICNs	in	
acute	care,	and	advanced	practice	roles	for	nurses	in	provincial,	regional	areas	of	
Thailand	could	provide	AMS	expertise	both	in	acute	care	settings	and	regional	and	
remote	settings	in	Thailand.		Expansion	of	Infection	Prevention	and	Control	nurses’	
roles	towards	leadership	through	consultancy	for	clinical	nurses	and	medical	staff	
would	require	professional	development	and	should	be	underpinned	by	a	formal	
policy	and	clear	career	pathway.		In	regional	and	remote	settings	in	Thailand,	ICNs	or	
primary	health	nurses	are	already	assuming	advanced	practice	roles	in	management	
of	infection	and	are	in	ideal	positions	to	initiative	AMS	programs	in	collaboration	
with	multidisciplinary	teams	or	university	hospitals	in	areas	with	limited	resources,	
or	in	remote	areas.		 	
8.6	Strengths	and	limitations	of	the	study	
	 8.6.1	Strengths	of	the	study	
This	research	program	is	the	first	comprehensive	investigation	of	nursing	
roles	in	AMS	in	Thailand.	The	concept	of	the	role	of	nurses	in	AMS	is	new	concept	in	
Thailand;	the	findings	of	this	study	provided	fundamental	analysis	of	the	current	role	
of	nurses	in	AMS	in	Thailand	that	can	inform	the	development	of:	nursing	education	
and	professional	development	materials	and	programs,	health	service	AMS	
governance,	and	strategies	to	engage	patients	in	AMS	in	hospitals.	
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The	research,	in	using	a	participant	triangulation	design,	elicited	a	range	of	
different	perspectives	that	covered	key	organisational	leaders	and	executive,	clinical	
nurses,	and	patients.	Those	different	perspectives	provided	a	more	comprehensive	
view	of	the	current	and	potential	roles	of	nursing	in	AMS	in	acute	healthcare	in	
Thailand	along	with	the	ability	to	propose	a	strategy	to	encourage	nurses’	
participation	in	AMS	governance	and	within	AMS	multidisciplinary	team.		
Clinicians’	perceptions	and	attitudes	towards	AMR	and	AMS	were	explored	
using	an	organisation-wide	clinician	survey,	there	was	a	high	response	rate	(62%),	
and	a	total	of	1,087	participants	who	completed	the	survey.	This	was	the	first	large-
scale	survey	of	doctors,	nurses	and	pharmacists	regarding	AMR	and	AMS	in	Thailand.	
It	is	anticipated	that	the	survey	results	will	raise	awareness	amongst	healthcare	
professions	in	the	study	hospital	and	in	Thailand	of	the	problem	of	AMR	and	the	
importance	of	AMS	in	Thailand.		
Third,	in	this	study,	participation	of	clinical	and	organisational	executive	
leaders	such	as	the	director	of	the	hospital,	director	of	nursing	and	director	of	
pharmacy	demonstrates	their	interest	in	and	commitment	to	developing	a	robust	
AMS	program	in	the	hospital	and	potentially	their	receptiveness	to	
recommendations	for	improvement	and	hence,	the	likelihood	that	the	findings	and	
recommendations	will	be	considered	for	future	implementation.	It	is	anticipated	that	
the	outcomes	of	this	study	will	be	used	to	inform	development	of	policies	related	to	
patient	safety	and	AMS	governance,	as	well	as	encouraging	leader	groups	to	support	
nurses	in	participating	in	AMS	governance	and	recognising	the	importance	role	that	
clinical,	and	ICN	nurses	can	play	in	AMS.			
	 8.6.2	Limitations	of	the	study	
The	research	program	had	limitations.		Data	collection	was	through	a	single	
engagement	with	key	informants	and	this	may	have	limited	the	richness	of	the	data	
for	several	reasons.	First,	participants,	during	the	interviews	and	focus	groups	may	
not	have	had	sufficient	time	to	engage	with	the	topic	under	investigation	and	to	fully	
consider	potential	roles	for	nurses.	Providing	participants	with	scenarios	or	
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exemplars	that	represented	the	range	of	potential	participation	of	nurses	may	have	
provided	richer	data.	There	was	evidence	that	nurse	and	non-nurse	respondents	had	
not	previously	considered	potential	nurses’	roles	in	any	depth	prior	to	the	
interviews.	Responses	therefore	were	limited	therefore	by	their	imagination	and	this	
was	evident	in	the	relatively	few	potential	roles	they	put	forward.		
Compounding	the	problem	discussed	above,	the	concept	of	AMS	is	a	
relatively	recent	in	Thailand,	particularly	the	use	of	the	term	‘antimicrobial	
stewardship’.	The	survey	results	showed	that	only	17.2%	of	clinicians	had	heard	of	
the	English	term	AMS	and	nurses	were	least	likely	to	have	heard	the	term	(10.9%).	
Although	the	meaning	was	explained,	there	were	limitations	to	the	depth	of	
explanation	that	could	be	given	without	contaminating	the	data	retrieved	through	
the	in-depth	interviews.	
This	research	was	conducted	within	a	single	institution.	Further	the	case	
study	site	was	a	well-resourced	university	hospital	in	Thailand.	This	raises	questions	
about	the	external	validity	and	transferability	of	the	data	derived	from	the	clinician	
surveys	and	interviews.	Whether	the	study	findings	can	be	generalised	to	other	Thai	
hospitals,	particularly	smaller	rural	hospitals	is	not	known	and	needs	further	
investigation.	In	addition,	although	participants	in	the	organisational	leader	groups	
were	purposively	selected	to	participate,	participants	in	clinician	survey	and	the	
nurse	focus	groups	generally	self-selected	and	it	is	not	known	how	much	selection	
bias	may	have	limited	how	representative	the	findings	were	to	those	who	did	not	
participate.		
8.7	Recommendations	for	future	research	
This	research	through	its	design,	has	provided	a	range	of	perspectives	from	
clinical	nurse	leaders,	clinical	nurses,	key	organisational	leaders	and	patients	on	the	
current	status	of	AMS	governance	and	activities,	current	nurses’	roles	and	potential	
future	roles	in	antimicrobial	stewardship	(AMS)	in	acute	healthcare	in	Thailand.		In	
doing	so,	the	findings	have	identified	the	need	for	advancement	in	terms	of	
governance,	education,	professional	practice	and	patient	engagement.	
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The	single	institution	design	provided	a	multidimensional	and	multi-lens	view	
of	the	role	within	the	governance,	practice	and	cultural	context	however	further	
research	is	needed	for	a	broader	perspective	by	exploring	the	current	and	potential	
role	of	nurses	in	different	acute	care	settings	in	different	level	hospitals	and	in	
remote	or	provincial	areas	in	Thailand.	Further,	the	descriptive	exploratory	design	
did	provide	an	understanding	of	AMS	from	the	perspectives	of	key	stakeholders	
however,	an	ethnographic	design	using	naturistic	observation	and	repeated	
engagement	with	clinicians	would	provide	a	deeper	and	wider	lens	for	
understanding	the	barriers	and	facilitators	to	nurses’	engagement	in	AMS.	
Future	interventional	research	would	include	the	investigation	of	the	effects	
of	specific	education,	professional	development	and	protocols	and	guidelines	on	
nurses’	engagement	in	AMS	and	in	facilitating	patient	participation	in	AMS.	Nurses	
support	AMS	activities	through	system	processes,	monitoring	for	patient	safety,	
monitoring	for	optimal	antibiotic	use	and	patient	education.	There	has	been	limited	
research	of	the	effects	of	nurses’	contribution	to	AMS	on	patient	safety	outcomes	
and	the	use	of	antibiotics	and	needs	further	exploration.				
8.6	Conclusions	
Nurses	play	a	fundamental	role	in	AMS	activities	in	acute	care	through	the	
24-hour	care	provided	to	patients	and	their	delegated	role	in	medication	
administration	and	management.	In	the	Thai	acute	healthcare	context,	there	are	
barriers	and	impediments	to	nurses’	full	involvement	in	AMS	that	are	related	to		
current	organisational	and	clinical	governance	and	the	absence	of	policy	and	
guidance	to	formally	describe	nurses’	scope	of	practice	and	responsibilities	related	
to	AMS,	inadequate	educational	preparation	to	fully	participate	in	review	of	
antibiotic	prescribing	and	use,	and	cultural	elements	of	the	practice	context	and	
professional	hierarchies	that	hinder	inter	professional	communication.	The	findings	
have	implications	for	organisational	and	clinical	governance,	the	culture	of	clinical	
practice,	undergraduate	and	continuing	education,	and	professional	career	
development	for	Thai	clinical	nurses	and	infection	control	and	prevention	nurses	in	
particular	who	were	ready	to	take	on	advanced	practice	roles	in	AMS	in	Thailand.	
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Further	research	is	needed	for	a	broader	perspective	by	exploring	the	current	and	
potential	role	of	nurses	in	different	acute	care	settings	in	different	level	hospitals	
and	in	remote	or	provincial	areas	in	Thailand.	
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Appendix	A:	Interview	Guides/Organisational	Leader	Interviews	
Topic	heading	 Question	 Prompts	
Opening	&	Icebreaking:	
• Thank	you	for	
participating	in	this	
study	
• Can	you	please	talk	a	little	about	your	position	and	
your	role	in	the	hospital	and	your	role	in	relation	to	
AMS?		
• How	long	have	you	been	in	role	in	AMS?	
	
1A:	Perceptions	of	the	
AMR	problem:	
	
• Antimicrobial	resistance	(AMR)	is	a	growing	
healthcare	problem	worldwide,	can	you	please	tell	
me	what	you	think	are	the	main	issue	regarding	
this	problem	in	Thailand?	
• In	this	hospital,	are	the	problems	you	described	in	
Thailand	similar	or	different?	
• Currently,	at	the	hospital,	do	you	believe	we	have	
substantial	problems/	challenges	managing	multi-
drug	resistant	bacteria?		
	
• Thai	animal/agricultural	sector,	Thai	
hospital,	patient	factors,	infection	control	
practices		
	
	
	
• What	are	the	main	issues	regarding	AMR	
in	the	hospital?	
• Such	as	A.	baumannii,	Multi	drug	resistant	
TB,	P.	aeruginosa,	Antimicrobial	resistant	
TB,	E.coli	(ESBL)	
• Are	you	concerned	about	emerging	
resistance	patterns	for	vanco,	
carbopenem,	cephalosporins	or	other	
antibiotics	at	the	hospital?	
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Topic	heading	 Question	 Prompts	
1B:	Establishing	a	common	
understanding	of	antimicrobial	
stewardship	(AMS):	
	
• Can	you	tell	me	the	aims	of	an	AMS	program	in	
Thailand?	(if	not	sure	-	AMS	is	about	optimising	
antimicrobial	use	in	order	to	improve	patient	
outcomes)		
• Can	you	tell	me,	what	you	think	are	the	main	issues	
• Staff	skill	and	knowledge,	training,	culture	of	
organisation,	ownership	of	AMS	activities,	
clinical		
2:	Current	AMS	governance	in	the	
hospital:		
• 2A:	Leadership	support	
	
• Let’s	talk	about	current	AMS	governance	in	the	
hospital.		
• In	terms	of	leadership	support,	can	you	tell	me	how	
the	senior	leadership	support	AMS	activities	in	the	
hospital?		
	
• Can	you	talk	about	the	challenges	of	providing	
leadership	support?	
	
• Staff,	money,	IT	support,	training		
• A	formal,	written	policy	to	improve	
antimicrobial	use		
• Committees	in	relation	to	improving	
antimicrobial	use	
	
• 2B:Accountability	and	drug	
expertise	
• In	terms	of	antimicrobial	committees,	in	your	opinion,	
which	key	health	professions	should	be	involved	in	
these	committees?	
• Do	you	think	nurses	should	be	involved	in	
these	committees?	why?	
• 2C:	Actions/interventions	
to	support	optimal	
antimicrobial	use	
• Let’s	talk	about	current	AMS	current	AMS	
interventions	in	the	hospital?		
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Topic	heading	 Question	 Prompts	
• 2C:	Action/intervention	to	
support	optimal	
antimicrobial	use	(Cont.)	
• What	current	policies	support	AMS	interventions?	
	
	
	
	
	
	
	
• What	are	current	system-wide	AMS	interventions	
in	the	hospital?		
	
	
	
	
	
	
• Do	nurses	have	a	role	in	these	interventions?	
• Can	you	talk	about	the	challenges	of	
implementing	those	interventions?	
• Requirements	for	prescribers	to	
document	dose,	duration,	and	
indication	of	antibiotics	
• Guidelines	to	assist	with	antibiotic	
selection	
• Development	and	implementation	
of	facility	specific	treatment	
recommendations	
• Formulary	restrictions	
• Pre	authorisation	
• Prospective	audit	and	feedback	
• Antibiotic	time	outs		
• A	parenteral	to	oral	conversion	
• Utilising	dose	optimisation	
• Time	sensitive	automatic	stop	order	
for	specified	antimicrobial	
prescriptions		
• local	antimicrobial	
guidelines/staff/money/time/clinical	
leadership/ownership	of	AMS	
activities,	culture	of	organisation	
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Topic	heading	 Question	 Prompts	
• 2D:	Tracking:	monitoring	
antimicrobial	prescribing,	
use,	and	resistance			
	 	
	
• Let’s	talk	about	current	AMS	current	
AMS	monitoring	and	tracking	in	the	
hospital?		
• How	do	we	monitor	and	track	
antimicrobial	use?	
• How	do	we	monitor	and	track	
antimicrobial	resistance?	
	
	
	
	
	
	
	
	
• Do	nurses	have	a	role	in	those	
activities?	
• Can	you	tell	me,	what	are	the	
barriers	to	monitoring	and	tracking	
antibiotic	use?	
	
	
• Adherence	to	a	documentation	policy	(dose,	
duration,	and	indication)	
• Adherence	to	facility-specific	treatment	
recommendations	
• C.	difficile	infection	rate	
• Antibiotic	use	by	counts	of	antibiotic(s)	
administered	to	patients	per	day	(Days	of	
Therapy;	DOT)	
• Antibiotic	use	by	number	of	grams	of	
antibiotics	used	(Defined	Daily	Dose;	DDD)	
• Direct	expenditure	for	antibiotics	
(purchasing	costs)	
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Topic	heading	 Question	 Prompts	
• 2E:	Reporting	information	to	
staff	on	improving	antimicrobial	
use	and	resistance	
• Let’s	talk	about	how	information	about	
AMS	is	communicated	to	staff	in	the	
hospital?			
• Do	we	report	the	outcomes	of	the	AMS	
program	to	staff?		
• What	kind	of	data	are	reported?	
• Do	prescribers	receive	reports	or	
feedback	of	their	antimicrobial	
prescribing?		
• What	are	some	of	the	challenges	related	
to	reporting	AMS	to	staff?			
	
	
• AMR	rate,	antimicrobial	consumption		
	
• 2F:	Education	
	
	
	
	
	
	
• Let’s	talk	about	staff	education	and	AMS	
in	the	hospital?		
• Do	you	think	our	healthcare	staff	have	
enough	knowledge	in	relation	to	AMS?	
• Does	our	stewardship	program	provide	
education	to	healthcare	staff?	
• Can	you	tell	me	who	should	be	
educated/trained	regarding	AMS?	
• What	educational	topics	do	you	think	
are	important	for	healthcare	staff	to	
receive	in	order	to	improve	
antimicrobial	use?	
	
	
	
	
• Doctors,	nurses,	pharmacists,	
epidemiologists		
• Basic	knowledge	of	infection	
management,	administration	and	
monitoring	of	antimicrobial	therapy	
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Topic	heading	 Question	 Prompts	
• 2F:	Education	(cont.)	
	
• Can	you	tell	me	what	barriers	there	
are	in	providing	AMS	education	and	
training?	
• Lack	of	financial	support,	clinical	leadership,	
resources	
3:	Current	role	of	nurses	in	AMS	in	the	
hospital	
	
	
	
• Let’s	talk	about	current	role	of	nurses	
in	AMS	in	the	hospital		
• 	
• Education,	challenging	prescribing	
decisions,	therapeutic	drug	monitoring,	
clinical	review	and	direct	prescriber	
feedback,	collaboration,	antimicrobial	
prescribing	surveillance	and	audit,	AMS	
hospital	service,	clinical	review	and	direct	
prescriber	feedback	
4:	Potential	role	of	nurses	in	AMS	
	
• What	do	you	think	may	be	
potential	roles	for	nurses	in	AMS?	
• Educator,	challenging	prescribing	decision,	
therapeutic	drug	monitoring,	clinical	review	
and	direct	prescriber	feedback,	
collaboration,	antimicrobial	prescribing	
surveillance	and	audit,	AMS	hospital	
service,	clinical	review	and	direct	prescriber	
feedback	
5:	Barriers/challenges	to	nurses’	
engaging	in	AMS	
• What	do	you	think	are	some	of	
the	barriers	to	nurses’	engaging	
in	AMS?	
• Knowledge/training/	leadership	
support/time/prescribing	authority,	
challenging	medical	staff	/Time	constraints/	
workload/staff	communication/	
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Appendix	B:	Interview	Guides/Focus	Groups		
	
Topic	heading	 Question	 Prompts	
Section	1	and	2	are	the	same	as	interview	guides	of	organisational	leader	interviews	
3:	Current	role	of	nurses	in	AMS	in	this	
hospital	
• 3A:	Ward	nurses	
	
	
	
	
	
	
	
• What	activities	are	you	currently	
doing	that	would	be	considered	
AMS?	
	
	
• Adjustment	of	timing	and	preparation	of	
medicines	
• Monitoring	for	side	effects	of	antimicrobial	
• Initiating	reviews	of	treatment	
• Obtaining	cultures	and	sensitivities	before	
beginning	antimicrobial	therapy	
• Providing	ongoing	for	treatment	safety	and	
effectiveness	
• Involvement	in	decision	to	change	the	route	
of	antimicrobial	medicines	from	IV	to	oral	
• Monitoring	the	duration	of	surgical	
prophylaxis	in	consultation	with	doctors	
and	pharmacists	
• Educating	patients	about	appropriate	
antimicrobial	use	
• Informing	patient	about	recognizing	and	
reporting	adverse	effects	and	complication	
• Infection	prevention	and	control	practices,	
strict	environmental	cleanliness	
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Topic	heading	 Question	 Prompts	
• 3B:	Infection	control	nurses	 • What	elements	of	your	everyday	
work	is	related	to	AMS?	
• Pre-authorization	of	restricted	
antimicrobials	
• Review	of	patients	on	intravenous				
antimicrobials,	for	potential	switch	
to	oral	therapy	
• Review	of	patients	receiving	
antimicrobials	with	duplicate	
spectra,	or	other	potentially	
inappropriate	drug	combinations	
• Review	of	patients	on	selected	
broad	spectrum	antimicrobials	
• Review	of	patients	with	documented	
sterile	site	infections	to	ensure	
appropriate	antimicrobial	therapy	is	
in	place	
• Review	of	patients	receiving	
antimicrobials	for	a	duration	that	
exceeds	recommendations	in	the	
hospital	antimicrobial	guidelines	
• Participation	in	the	infection	
prevention	and	control	program	
• Provision	of	education	on	prudent	
antimicrobial	use	to	consultant,	non-
consultant	and	nurse	prescribers	
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Topic	heading	 Question	 Prompts	
4:	Nurses’	interactions	with	patients	
regarding	AMS	on	admission,	during	
their	hospitalization	and	preparation	for	
discharge	from	hospital	
• 4A:	What	AMS	activities	do	you	
do	for	patients	on	admission	to	
the	ward?			
	
	
	
• 4B:		What	AMS	activities	do	you	
do	for	patients	during	their	
hospitalization?			
		
	
	
	
	
• 4C:		What	AMS	activities	do	you	
do	for	patients	in	preparation	
for	discharge?	
• Interview	patients	about	past	history	of	
antibiotic	taking	including	adverse	effects	
and	complication	
• Look	at	antibiotics	that	patients	bring	in	with	
them	
• Inform	patient	when	they	are	prescribed	
antibiotics	along	with	the	reason	why	they	
need	to	be	treated	by	that,	dose,	duration,	
possible	side	effects,	possible	adverse	effects	
and	complication	
• Monitoring	allergy	status	
• Clinical	specimen	and	drug	resistance	
• Ensuring	administration	and	continuation	of	
the	drug	
• Review	antibiotic	within	48	hours	after	order	
initiating	
• Educating	patients	and	their	carers	on	how	to	
take	antibiotics	and	hygienic	practices	
• Advising	patients	on	how	to	take	their	course	
when	they	are	at	home		
• Provide	guidance	about	possible	medication	
side	effects	
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Topic	heading	 Question	 Prompts	
5:	Potential	roles	for	
nurses/infection	control	nurses	in	
AMS	
	
	
	
	
• What	do	you	think	are	potential	
roles	for	nurses/infection	control	
nurses	in	AMS?		
• Prescribing	
• Collaboration;	participate	in	prevention	and	
infection	control	program,	review	of	hospital	
wide	infection	practices	of	clinicians	
• AMS	hospital	service	(with	AMS	team,	MD	
team)	
• Clinical	review	and	direct	prescriber	feedback	
• Antimicrobial	prescribing	surveillance	and	audit	
• Therapeutic	monitoring	
• Stop	antibiotics	
• Tracking	therapeutic	disease	
• Provision	of	education	on	prudent	antimicrobial	
use	
6:	Barriers/challenges	to	
nurses’/infection	control/	nurses’	
engagement	in	AMS	
	
• What	are	the	challenges	to	
nurses’/infection	control	nurses’	
engagement	in	AMS?			
• Education	
• A	lack	of	confidence	in	the	area	of	AMS	
• Time	constraints/	workload	
• Changing	practice/habits/	attitudes	
• Lack	of	knowledge/keeping	knowledge	up	to	
date	
• Patient/family	expectations	and	attitudes	
• Challenging	medical	staff/prescribing	decision	
• Staff	education/training	
• Staff	communication	
• Leadership	support	
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Appendix	C:	Clinician	Survey	
	
	
Clinician	questionnaire	 10Aug15		 	 	1	
Demographic information 
Profession   
☐ Physician                        ☐ Nurse                                          ☐ Pharmacist  
 
Department………………………………………………………………………….. 
Gender 
☐ Male                    ☐ Female                                         ☐Other 
 
Age………….. 
Number of years qualified 
☐ <1 year       ☐ 1 to 5 years       ☐ 6 to 10 years       ☐ 11 to 20 year        ☐ >20 year  
Please indicate how serious a problem you believe antimicrobial 
resistance is in the following places (scale of 1 to 7) 
1. Antimicrobial resistance is a worldwide problem.  
☐ 1 Not a         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6             ☐7     Very 
problem                                                                                                                 serious  
                                                                                                                            problem 
2. Antimicrobial resistance is problem in Thai Community.  
☐ 1 Not a         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6             ☐7     Very 
problem                                                                                                                 serious  
                                                                                                                            problem 
3. Antimicrobial resistance is problem in Thai Hospitals.  
☐ 1 Not a         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6             ☐7     Very 
problem                                                                                                                 serious  
                                                                                                                            problem 
4. Antimicrobial resistance is a problem in the study hospital 
☐ 1 Not a         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6             ☐7     Very 
problem                                                                                                                 serious  
                                                                                                                            problem 
Please indicate how strongly you believe the following contribute to 
antimicrobial resistance at the study hospital 
5. Use of antimicrobials in Thai animal/agricultural sectors 
☐ 1 Does         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6            ☐7 Strongly    
not contribute                                                                                                 contributes  
6. Use of antimicrobials in the Thai community 
☐ 1 Does         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6            ☐7 Strongly    
not contribute                                                                                                 contributes 
7. Use of antimicrobials in Thai Hospitals  
☐ 1 Does         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6            ☐7 Strongly    
not contribute                                                                                                 contributes 
8. Use of antimicrobials at the study hospital  
☐ 1 Does         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6            ☐7 Strongly    
not contribute                                                                                                 contributes                                                                                            
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	 Clinician	questionnaire	 10Aug15		 	 	2	
Please indicate how strongly you believe the following contribute to 
antimicrobial resistance at study hospital 
9. Patient pressure for antibiotics as part of treatment 
 1 Does          2               3               4               5               6            7 
Strongly    
not contribute                                                                                                 contributes 
10. Patients are able to buy antibiotics over the counter 
 1 Does          2               3               4               5               6            7 
Strongly    
not contribute                                                                                                 contributes 
Please indicate how strongly you agree or disagree with the following 
statements  
11. I previously involved in care of patients with an antibiotic resistant infection 
 Yes                               No               Unsure 
12. I have noticed increasing number of antimicrobial resistance infections over past 5 
years 
 Yes                               No               Unsure 
13. I would estimate that the percentage of inpatient antimicrobial orders that are 
inappropriate at the study hospital is: 
 <10% year                     10 to 25%                     26 to 50%                    
>50% 
14. In which patient groups do you believe that antimicrobial orders are inappropriate at 
study hospital in order of frequency (Please number the following in order of importance 
where 1 is most importance and 5 is least) 
 Patients with community acquired infection 
 Patients with immune suppressive condition  
 Surgical patients (exclude surgical prophylaxis) 
 Patients being treatment in critical care 
 Patients being treatment in general wards 
 Patients being treatment in VIP wards 
15. I would estimate that the percentage of surgical prophylaxis orders that are 
inappropriate at the study hospital is:  
 <10% year                     10 to 25%                     26 to 50%                    
>50% 
16. What do you consider is the most frequent problem associated with surgical 
prophylaxis at the study hospital (Please tick one only) 
 Timing of first dose of prophylaxis 
 Inappropriate antibiotic chosen 
 Prophylaxis is not stopped at the appropriate time 
 Other (please explain)…………………………………………………………………. 
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Please indicate how strongly you agree or disagree with the following 
statements 
17. Improving antimicrobial prescribing at the study hospital will help decrease 
antimicrobial resistance. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
18. Improving antimicrobial prescribing should be an organisational priority. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
19. A formal policy for the use of antimicrobials should be introduced at study hospital. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
20. A policy that limits the prescribing of selected antimicrobials to certain clinical 
indications via an approval process should be introduced at the study hospital. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
21. Local antimicrobial guidelines and protocols should be introduced at the study 
hospital. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
22. A computer application which gives advice on selection and duration of 
antimicrobial therapy for specific clinical conditions would be clinically useful 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
23. A team consisting of an ID specialist physician and Pharmacist providing 
individualized antimicrobial prescribing advice and feedback would assist with 
antimicrobial selection. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
24. I have heard of the term “Antimicrobial stewardship”. 
 Yes                               No               Unsure 
25. I worked in healthcare facilities with AMS programs 
 Yes                               No               Unsure 
26. I would rate the level of my knowledge about appropriate antibiotic is: 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
27. I would be interested in participating in education session about AMS 
Minimal               Limited               Average               Good            Very 
good 		
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Please indicate how strongly you agree or disagree with the following 
statements 
28. I would be willing to participate in any activities to improve the quality of 
antimicrobial use at the study hospital. 
☐ 1 Strongly        ☐ 2              ☐ 3            ☐ 4            ☐ 5            ☐ 6           ☐ 7 Strongly      
       disagree                                                                                                       agree 	
 
Page	300	
	
Appendix	D:	Patient	Survey	
	
	
	 Patient	questionnaire		 January	2016	 1	
Part	1:	Demographic	information	
Gender	
☐	Male		 	 										☐	Female																																													☐	Other	
	
Age……………………………	
Education	
☐None														☐Primary	school														☐High	school															☐Bachelor	degree														☐Post	graduate	
Long	term	health	problem		
☐None																																													☐Having	chronic	disease	(please	specify)	………..............................	
Part	2:	Attitudes	and	behaviors	regarding	antibiotic	use		
Please	write	in	the	space	provided	or	indicate	your	agreement	level	or	how	true	it	is	about	you	with	
the	following	statements	by	putting	a	tick	in	the	box.	
	
1.	How	many	times	did	you	take	antibiotics	in	the	past	year?................................................	
2.	Why	did	you	take	antibiotics?	
☐	Cold																																											☐	Respiratory	tract	infections										☐	Wound	infections			
☐	Gastroenteritis																								☐	Mouth	ulcer																																					☐Other	(please	specify)	………..	
3.	I	buy	antibiotics	from	a	drugstore	when	I	get	a	cold.		
	☐	Never		 	 											
	☐	Sometimes			
	☐	Frequently		 	 										
	☐	Every	time	
4.	I	go	to	see	a	doctor	when	I	get	a	cold.	
	☐	Never		 	 											
	☐	Sometimes			
	☐	Frequently		 	 										
	☐	Every	time	
5.	I	stop	taking	antibiotics	when	I	feel	better.		
	☐	Never		 	 											
	☐	Sometimes			
	☐	Frequently		 	 										
	☐	Every	time	
6.	I	share	antibiotics	with	others.		
	☐	Never		 	 											
	☐	Sometimes			
	☐	Frequently		 	 										
	☐	Every	time	
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Patient	questionnaire		 January	2016	 2	
7.	I	keep	antibiotics	at	home	for	next	time.		
	☐	Never		 	 											
	☐	Sometimes			
	☐	Frequently		 	 										
	☐	Every	time	
8.	If	I	complete	antibiotics	but	I	am	still	not	feeling	well,	I	will	buy	extra	antibiotics	from	a	drug	store.	
	☐	Never		 	 											
	☐	Sometimes			
	☐	Frequently		 	 										
	☐	Every	time	
Attitudes	towards	antibiotic	use	
9.	I	believe	that	patients	should	be	able	to	buy	antibiotics	
☐	1	Strongly	disagree																			
☐	2	Disagree																																			
☐	3	Unsure																				
☐	4	Agree													
☐	5	Strongly	agree		
10.	I	believe	that	antibiotics	can	reduce	symptoms	of	a	cold.	
☐	1	Strongly	disagree																			
☐	2	Disagree																																			
☐	3	Unsure																				
☐	4	Agree													
☐	5	Strongly	agree	
11.	I	believe	that	antibiotics	can	prevent	complications	of	a	cold.	
☐	1	Strongly	disagree																			
☐	2	Disagree																																			
☐	3	Unsure																				
☐	4	Agree													
☐	5	Strongly	agree	
12.	I	expect	to	be	prescribed	antibiotics	by	a	doctor	when	I	get	a	cold.	
☐	1	Strongly	disagree																			
☐	2	Disagree																																			
☐	3	Unsure																				
☐	4	Agree													
☐	5	Strongly	agree	
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Attitudes	towards	antibiotic	use	
13.	I	expect	to	receive	antibiotics	from	a	drug	store	when	I	get	a	cold.	
☐	1	Strongly	disagree																			
☐	2	Disagree																																			
☐	3	Unsure																				
☐	4	Agree													
☐	5	Strongly	agree	
Patient’s	knowledge	
14.	Where	do	you	get	information	regarding	antibiotic	use	in	the	community?		
☐	Doctor																					☐	Pharmacist	 																					☐Nurses																		☐Drug	stores				
☐Friends/Neighbors			☐Internet/Google	search				☐Hospital															☐Other	(please	specify)	………...	
15.	I	believe	that	an	incomplete	course	of	antibiotics	can	reduce	its	effectiveness.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Unsure																				
☐	4	Agree	
☐	5	Strongly	agree		
16.	I	believe	that	an	incomplete	course	of	antibiotics	can	contribute	to	antibiotic	resistance.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Unsure																				
☐	4	Agree	
☐	5	Strongly	agree	
17.	I	believe	that	antibiotics	may	a	cause	drug	allergy.		
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Unsure																				
☐	4	Agree	
☐	5	Strongly	agree	
18.	I	want	to	have	more	information	regarding	the	best	way	to	use	antibiotics.		
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Neither	expected	or	unexpected																															
☐	4	Agree	
☐	5	Strongly	agree		
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When	in	I	am	admitted	to	the	hospital,…………………..	
19.	I	expect	to	take	antibiotics.		
☐	1	Strongly	disagree																			
☐	2	Disagree																																			
☐	3	Unsure																				
☐	4	Agree													
☐	5	Strongly	agree	
20.	I	expect	to	receive	intravenous	antibiotics.	
☐	1	Strongly	disagree																			
☐	2	Disagree																																			
☐	3	Unsure																				
☐	4	Agree													
☐	5	Strongly	agree	
21.	I	believe	that	intravenous	antibiotics	are	stronger	than	tablets.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Unsure	
☐	4	Agree	
☐	5	Strongly	agree		
22.	I	would	ask	my	relatives	to	buy	an	antibiotic	from	outside	if	doctor	does	not	prescribe	it	for	me.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Unsure	
☐	4	Agree	
☐	5	Strongly	agree	
23.	I	expect	to	be	asked	by	doctors	and/or	nurses	about	antibiotics	that	I’ve	taken	in	the	past	year.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Unsure	
☐	4	Agree	
☐	5	Strongly	agree	
24.	I	would	tell	the	doctor/nurse	if	my	relatives	bring	antibiotics	from	outside	to	me.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Unsure	
☐	4	Agree	
☐	5	Strongly	agree	
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When	in	I	am	admitted	to	the	hospital,…………………..	
25.	I	want	to	tell	the	doctor/nurse	about	antibiotics	that	I	have	taken	recently.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Unsure	
☐	4	Agree	
☐	5	Strongly	agree	
26.	I	want	to	know	whether	I’m	receiving	antibiotics.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Neither	expected	or	unexpected																			
☐	4	Agree	
☐	5	Strongly	agree	
27.	I	want	to	know	the	reason	why	I	have	to	take	antibiotics.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Neither	expected	or	unexpected																			
☐	4	Agree	
☐	5	Strongly	agree	
28.	I	want	to	know	how	long	I	have	to	take	antibiotics.	
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Neither	expected	or	unexpected																			
☐	4	Agree	
☐	5	Strongly	agree	
29.	I	am	afraid	of	getting	multi-drug	resistant	infections	that	may	be	difficult	to	treat.			
☐	1	Strongly	disagree		
☐	2	Disagree		
☐	3	Neither	expected	or	unexpected																			
☐	4	Agree	
☐	5	Strongly	agree	
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TO: Healthcare administrators   
 
Plain Language Statement  
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Principal Researcher:  Professor Mari Botti 
Student Researcher:  Miss Nantanit Sutthiruk 
Associate Researchers:  Professor Julie Considine   
           Associate Professor Andrea Driscoll 
    Assistant Professor Kumthorn Malathum  
 
You are invited to participate in this research project because we would like to obtain your 
views in relation to clinical governance for antimicrobial stewardship (AMS) within the Thai 
context. 
1. Your Consent 
This Plain Language Statement contains detailed information about the research project. Its 
purpose is to explain to you as openly and clearly as possible all the procedures involved in 
this project so that you can make a fully informed decision whether you wish to participate. 
Once you understand what the project is about and if you agree to take part in it, you will be 
asked to sign the Consent Form. By signing the Consent Form, you indicate that you 
understand the information and that you give your consent to participate in the research 
project. You will be given a copy of the Plain Language Statement and Consent Form to keep 
as a record. 
2. Purpose and Background 
The overall aim of this project is to explore the current and potential role of nurses in AMS in 
acute healthcare in Thailand. The specific aim of this phase is to describe the current clinical 
governance structures in your hospital that relate to AMS and how nurses are involved in 
these structures. Detailed analysis of health service clinical governance for AMS is important 
to identify alignment with international best practice, gaps in best practice and where nurses 
could best contribute to AMS clinical governance. 
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3. Procedures 
You are invited to take part in a face-to-face interview. If you agree, the interview will be 
audiotaped and will take approximately 20-30 minutes using an interview guide. The 
interview will take place at a time and location that best suits you. The sorts of questions that 
will be asked include:  
• What is the current structure of antimicrobial stewardship governance at Ramathibodi 
hospital? 
• What is the main purpose of antimicrobial stewardship governance? 
• What are nurses’ current roles in antimicrobial stewardship governance at 
Ramathibodi hospital? 
• Are there roles that nurses could play in antimicrobial stewardship governance at 
Ramathibodi hospital but currently do not? Why not?  
4. Possible Benefits 
There may not be immediate benefits to you. However, your views will make a valuable 
contribution to the understanding of AMS governance in the Thai healthcare context.  
5. Possible Risks 
We do not anticipate there will be any risk to you in participating in this project.  
6. Privacy, Confidentiality and Disclosure of Information 
The information obtained in connection with the research project will be kept confidential and 
will only be used for the purpose of the research project. It will only be disclosed with your 
consent. In any publication, information will be provided in such a way that you cannot be 
identified. The data will be held in secure storage for five years after publication of the 
findings of the research project, after which it will be destroyed. 
7. Results of Project 
The results of this project will be reported as summary findings in publications and in a 
doctoral thesis.  In addition, a report of the findings will be submitted to the hospital 
executive. Should you wish to access this report, you can request it by contacting the research 
team or the Director of Ramathibodi hospital.  
8. Participation is Voluntary  
Participation in this study is voluntary. If you do not wish to take part in this study or change 
your mind after signing the consent form, you will be free to withdraw from the study without 
affecting your relationship with Ramathibodi Hospital or Deakin University. However, you 
will only be able to withdraw data within four weeks after the interview. After this time, your 
responses will have been integrated with those of others and it will not be possible to 
withdraw your data. 
9. Reimbursement for your costs 
You will not be paid for your participation in this study. 
10. Ethical Guidelines 
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This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. The ethical aspects of this research project have been 
approved by the Human Research Ethics Committees of Deakin University and Ramathibodi 
Hospital.  
11. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:   
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: +61 03 9251 7129, or email - research-ethics@deakin.edu.au 
Please quote project number 2015-131.  
Or, The Chair of the Ethics Committee, Ramathibodi Hospital, 270, Rama VI Rd. 
Payathai, Rachathewi, Bangkok, 10400, Telephone: +66 2201 1544 
12. Further information, Queries or Any Problems 
If you require further information, wish to withdraw your participation or if you have any 
questions concerning this project, please contact: 
Nantanit Sutthiruk (Student Researcher) International phone: +61 3 9244 6319, Thailand 
phone: +66 2441 4234, Email: nsutthir@deakin.edu.au or 
Professor Mari Botti (Principal Investigator) International phone: +61 3 9426 6565 Email: 
mari.botti@deakin.edu.au 
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TO:  Healthcare administrators   
 
Consent Form 
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Reference Number: 
 
 
I have read and understand the attached Plain Language Statement. I freely agree to 
participate in this project according to the conditions in the Plain Language Statement. I have 
been given a copy of the Plain Language Statement and Consent Form to keep.  
I understand that the interview will be audio-taped and transcribed. 
The researcher has agreed not to reveal my identity and personal details, including when 
information about this project is published, or presented in any public forum.   
 
 
Participant’s Name (printed) …………………………………………………………………… 
Signature ………………………………………………………Date  ………………………… 
 
Researcher’s Name (printed) …………………………………………………………………. 
Signature ………………………………………………………Date  ………………………… 
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TO:  Healthcare administrators   
 
 
Withdrawal of Consent Form 
(To be used for participants who wish to withdraw from the project) 
Date:  8 July, 2015 
Version: 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Reference Number: 
 
 
I hereby wish to WITHDRAW my consent to participate in the above research project and 
understand that such withdrawal WILL NOT affect my work or rights.  
 
 
 
Participant’s Name (printed)…………………………………………………………………. 
 
 
Signature ……………………………………………………………Date …………………… 
 
 
 
Please mail this form to: 
 
Nantanit Sutthiruk 
Ramathibodi School of Nursing, 999, Salaya, Puthamontol, Nakhonpathom, 73170, Thailand 
Phone: +66 2441 4234 
Email: nsutthir@deakin.edu.au 
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TO: Doctors, nurses and pharmacists   
 
Plain Language Statement  
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Principal Researcher:  Professor Mari Botti 
Student Researcher:  Miss Nantanit Sutthiruk 
Associate Researchers:  Professor Julie Considine   
           Associate Professor Andrea Driscoll 
    Assistant Professor Kumthorn Malathum  
 
You are invited to participate in this research project because we would like to obtain your 
perceptions and attitudes towards antimicrobial resistance, antimicrobial use and 
antimicrobial stewardship (AMS) interventions within the Thai context.  
1. Your Consent 
This Plain Language Statement contains detailed information about the research project. Its 
purpose is to explain to you as openly and clearly as possible all the procedures involved in 
this project so that you can make a fully informed decision whether you wish to participate. 
Once you understand what the project is about and if you agree to take part in it, you will be 
asked to complete a survey. By completing and returning the survey, you indicate that you 
understand the information and that you give your consent to participate in the research 
project. You may keep this copy of the Plain Language Statement as a record of your 
participation. 
2. Purpose and Background 
The overall aim of this project is to explore the current and potential role of nurses in AMS in 
acute healthcare in Thailand. The specific aim of this phase is to determine the perceptions 
and attitudes towards AMS among Thai clinicians. It is useful to understand the differences 
and similarities between professions along with barriers and facilitators to effective AMS in 
order to inform feasible and clinically useful AMS policy. 
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3. Procedures 
If you consent to participate, you are invited to take part in a survey by filling out a 
questionnaire. The questionnaire contains questions about you generally (profession, 
department, gender, age, for example) and perceptions and attitudes towards antimicrobial 
resistance, antimicrobial use and AMS interventions. The expected time to complete the 
survey is approximately 10-15 minutes. 
4. Possible Benefits 
There may not be immediate benefits to you. However, your views will make a valuable 
contribution to the understanding of AMS governance in the Thai healthcare context.  
5. Possible Risks 
We do not anticipate there will be any risk to you in participating in this project.  
6. Privacy, Confidentiality and Disclosure of Information 
The information obtained from you in connection with the research project will be kept 
confidential and will only be used for the purpose of the research project. In any publication, 
information will be provided in such a way that individual responses cannot identified. The 
data will be held in secure storage for five years after publication of the research project, after 
which it will be destroyed. 
7. Result of Project 
The results of this project will be reported as summary findings in publications and in a 
doctoral thesis.  In addition a report of the findings will be submitted to the hospital executive. 
Should you wish to access this report, you can request it by contacting the research team or 
the Director of Ramathibodi hospital.  
8.Paricipation is Voluntary  
Participation in this study is voluntary. If you do not wish to take part in this study you do not 
have to do so without affecting your relationship with Ramathibodi Hospital or Deakin 
University.  
9. Reimbursement for your costs 
You will not be paid for your participation in this study. 
10. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. The ethical aspects of this research project have been 
approved by the Human Research Ethics Committees of Deakin University and Ramathibodi 
Hospital.  
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11. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:   
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: +61 03 9251 7129, research-ethics@deakin.edu.au. Please quote 
project number 2015-131. 
Or, The Chair of the Ethics Committee, Ramathibodi Hospital, 270, Rama VI Rd. 
Payathai, Rachathewi, Bangkok, 10400, Telephone: +66 2201 1544 
12. Further information, Queries or Any Problems 
If you require further information, wish to withdraw your participation or if you have any 
questions concerning this project, please contact: 
Nantanit Sutthiruk (Student Researcher) International phone: +61 3 9244 6319, Thailand 
phone: +66 2441 4234, Email: nsutthir@deakin.edu.au or 
Professor Mari Botti (Principal Investigator) International phone: +61 3 9426 6565 Email: 
mari.botti@deakin.edu.au 
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TO: Nurses    
 
Plain Language Statement  
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Principal Researcher:  Professor Mari Botti 
Student Researcher:  Miss Nantanit Sutthiruk 
Associate Researchers:  Professor Julie Considine   
           Associate Professor Andrea Driscoll 
    Assistant Professor Kumthorn Malathum  
 
You are invited to participate in this research project because we would like to obtain your 
views in relation to nurses’ role in AMS within the Thai context.  
1. Your Consent 
This Plain Language Statement contains detailed information about the research project. Its 
purpose is to explain to you as openly and clearly as possible all the procedures involved in 
this project so that you can make a fully informed decision whether you wish to participate. 
Once you understand what the project is about and if you agree to take part in it, you will be 
asked to sign the Consent Form. By signing the Consent Form, you indicate that you 
understand the information and that you give your consent to participate in the research 
project. You will be given a copy of the Plain Language Statement and Consent Form to keep 
as a record. 
2. Purpose and Background 
The aim of this project is to explore the current and potential role of nurses in antimicrobial 
stewardship (AMS) from patient admission, during hospitalization, and after discharge in 
acute healthcare in Thailand. Understanding the current and potential role of nurses in AMS 
is important because it will inform nursing education and professional development in relation 
to AMS, health service AMS governance, and strategies to engage patients both within the 
hospital and the community. 
 
3. Procedures 
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You are invited to take part in a focus group. If you agree, you will be asked to complete this 
written consent form before starting the focus group. The researcher will conduct the focus 
groups while an observer documents interactions and non-verbal behaviors during the focus 
group. You will be provided with an opportunity to debrief and provide feedback. Two types 
of recording methods will be used including written notes and audio recording. The focus 
groups will be conducted over approximately 40-60 minutes using a question guide. The sorts 
of questions that will be asked include:  
• What do your understanding of antimicrobial stewardship? 
• What are the current roles for nurses/infection control nurses in antimicrobial 
stewardship? 
• What do you think potential roles for nurses/infection control nurses in antimicrobial 
stewardship may be in the future? 
• How do nurses interact with patients regarding to antimicrobial stewardship, from 
admission, during their hospitalized and in preparation for discharge? 
• What roles could nurses play to reduce antimicrobial resistance in relation to patient’s 
used of antibiotics? 
• What do you think are the barriers to nurses’ engagement in antimicrobial 
stewardship? 
4. Possible Benefits 
There may not be immediate benefits to you. However, your views will make a valuable 
contribution to nursing education and professional development in relation to AMS, health 
service AMS governance, and strategies to engage patients both within the hospital and the 
community. 
5. Possible Risks 
We do not anticipate there will be any risk to you in participating in this project.  
6. Privacy, Confidentiality and Disclosure of Information 
The information obtained in connection with the research project will be kept confidential and 
will only be used for the purpose of the research project. It will only be disclosed with your 
consent. In any publication, information will be provided in such a way that you cannot be 
identified. The data will be held in secure storage for five years after publication of the 
research project, after which it will be destroyed. 
7. Result of Project 
The results of this project will be reported as summary findings in publications and in a 
doctoral thesis.  In addition a report of the findings will be submitted to the hospital executive. 
Should you wish to access this report, you can request it by contacting the research team or 
the Director of Ramathibodi hospital.  
 
 
 
8. Participation is Voluntary  
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Participation in this study is voluntary. If you do not wish to take part, you do not have to. If 
you decided to take part and later change your mind, you are free to withdraw from this 
project at any stage before or during the focus group by informing the researcher. After the 
focus group, it will not be possible to remove information that you provided because your 
responses will have been integrated with those of others.  
9. Reimbursement for your costs 
You will not be paid for your participation in this study. 
10. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. The ethical aspects of this research project have been 
approved by the Human Research Ethics Committees of Deakin University and Ramathibodi 
Hospital.  
11. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:   
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: +61 03 9251 7129, research-ethics@deakin.edu.au. Please quote 
project number 2015-131. 
Or, The Chair of the Ethics Committee, Ramathibodi Hospital, 270, Rama VI Rd. 
Payathai, Rachathewi, Bangkok, 10400, Telephone: +66 2201 1544 
12. Further information, Queries or Any Problems 
If you require further information, wish to withdraw your participation or if you have any 
questions concerning this project, please contact: 
Nantanit Sutthiruk (Student Researcher) International phone: +61 3 9244 6319, Thailand 
phone: +66 2441 4234, Email: nsutthir@deakin.edu.au or 
Professor Mari Botti (Principal Investigator) International phone: +61 3 9426 6565 Email: 
mari.botti@deakin.edu.au 
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TO:  Nurses   
 
Consent Form 
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Reference Number: 
 
 
I have read and understand the attached Plain Language Statement. I freely agree to 
participate in this project according to the conditions in the Plain Language Statement. I have 
been given a copy of the Plain Language Statement and Consent Form to keep.  
I understand that the focus group will be audio-taped and transcribed. 
The researcher has agreed not to reveal my identity and personal details, including when 
information about this project is published, or presented in any public forum.   
 
 
Participant’s Name (printed) …………………………………………………………………… 
Signature ………………………………………………………Date  ………………………… 
 
Researcher’s Name (printed) ………………………………………………………………….. 
Signature ………………………………………………………Date  …………………………	
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TO:  Nurses 
 
 
Withdrawal of Consent Form 
(To be used for participants who wish to withdraw from the project) 
Date: 8 July, 2015 
Version: 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Reference Number: 
 
 
I hereby wish to WITHDRAW my consent to participate in the above research project and 
understand that such withdrawal WILL NOT affect my work or rights.  
 
 
 
Participant’s Name (printed)…………………………………………………………………. 
 
 
Signature ……………………………………………………………Date …………………… 
 
 
 
Please mail this form to: 
 
Nantanit Sutthiruk 
Ramathibodi School of Nursing, 999, Salaya, Puthamontol, Nakhonpathom, 73170, Thailand 
Phone: +66 2441 4234 
Email: nsutthir@deakin.edu.au 
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TO: Patients   
 
Plain Language Statement  
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Principal Researcher:  Professor Mari Botti 
Student Researcher:  Miss Nantanit Sutthiruk 
Associate Researchers:  Professor Julie Considine   
           Associate Professor Andrea Driscoll 
    Assistant Professor Kumthorn Malathum  
 
You are invited to participate in a research project that is being conducted by a research team 
from the School of Nursing and Midwifery, Deakin University, Australia and Ramathibodi 
Hospital. 
1. Your Consent 
This Plain Language Statement contains detailed information about the research project. Its 
purpose is to explain to you as openly and clearly as possible all the procedures involved in 
this project so that you can make a fully informed decision whether you wish to participate. 
Once you understand what the project is about you will be asked to complete a questionnaire.  
By completing and returning the questionnaire, you indicate that you understand the 
information and that you give your consent to participate in the research project. You may 
keep this Plain Language Statement as a record. 
2. Purpose and Background 
The overall aim of this project is to explore ways that nurses can participate in the safe use of 
antimicrobial medicines in acute healthcare in Thailand. Antimicrobial medicines are 
medicines used to treat or prevent infection. One of the ways that nurses can play a part in the 
safe use of antimicrobial medicines is through patient education. We wish to explore your 
attitudes and behaviors regarding your use of antimicrobial medicines (such as antibiotics) so 
that we can plan such education programs for patients and families including the development 
of information materials.   
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3. Procedures 
If you consent to participate, you will be invited to take part in a survey by filling out a 
questionnaire. The survey contains questions about you generally (gender, age, education 
background, for example) and your thoughts and behaviors related to antimicrobial use. You 
will complete the survey by yourself; the expected time to complete the survey is 
approximately 15 minutes. 
4. Possible Benefits 
There may not be immediate benefits to you. However, your views will make a valuable 
contribution to for the way doctors and nurses provide information to patients and families.  
5. Possible Risks 
We do not anticipate there will be any risk to you in participating in this project.  
6. Privacy, Confidentiality and Disclosure of Information 
The information obtained in connection with the research project will be kept confidential and 
will only be used for the purpose of the research project. In any publication, group 
information will be reported so that individual responses cannot be identified. The data will 
be held in secure storage for five years after publication of the research project, after which it 
will be destroyed. 
7. Result of Project 
The results of this project will be reported as summary findings in publications and in a 
doctoral thesis.  In addition a report of the findings will be submitted to the hospital executive. 
Should you wish to access this report, you can request it by contacting the research team or 
the Director of Ramathibodi hospital.  
8.Paricipation is Voluntary  
Participation in this study is voluntary. If you do not wish to take part in this study, you do not 
have to do so and this will not affect your treatment or your relationship with Ramathibodi 
hospital. 
9. Reimbursement for your costs 
You will not be paid for your participation in this study. 
10. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. The ethics aspects of this research project have been 
approved by the Human Research Ethics Committees of Deakin University and Ramathibodi 
Hospital.  
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11. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:   
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: +61 03 9251 7129, research-ethics@deakin.edu.au. Please quote 
project number 2015-131. 
Or, The Chair of the Ethics Committee, Ramathibodi Hospital, 270, Rama VI Rd. 
Payathai, Rachathewi, Bangkok, 10400, Telephone: +66 2201 1544 
12. Further information, Queries or Any Problems 
If you require further information, wish to withdraw your participation or if you have any 
questions concerning this project, please contact: 
Nantanit Sutthiruk (Student Researcher) International phone: +61 3 9244 6319, Thailand 
phone: +66 2441 4234, Email: nsutthir@deakin.edu.au or 
Professor Mari Botti (Principal Investigator) International phone: +61 3 9426 6565, Email: 
mari.botti@deakin.edu.au 
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Memorandum
To:
From:
Date:
Subject: 2015-131
The Role of Nurses in Antimicrobial Stewardship : A Thai Case Study
Prof Mari Botti
School of Nursing & Midwifery
B
Deakin University Human Research Ethics Committee (DUHREC)
30 July, 2015
Please quote this project number in all future communications
The application for this project was considered at the DU-HREC meeting held on 22/6/2015.
cc: Ms Nantanit Sutthiruk
Human Research Ethics
Deakin Research Integrity
Burwood Campus
Postal: 221 Burwood Highway
Burwood Victoria 3125 Australia
Telephone 03 9251 7123
  research-ethics@deakin.edu.au
Approval has been given for Ms Nantanit Sutthiruk, under the supervision of Prof Mari Botti, School of Nursing 
& Midwifery, to undertake this project from 30/07/2015 to 30/07/2019.
In addition you will be required to report on the progress of your project at least once every year and at the
conclusion of the project. Failure to report as required will result in suspension of your approval to proceed with
the project.
DUHREC may need to audit this project as part of the requirements for monitoring set out in the National
Statement on Ethical Conduct in Human Research (2007).
• Serious or unexpected adverse effects on the participants
• Any proposed changes in the protocol, including extensions of time.
• Any events which might affect the continuing ethical acceptability of the project.
• The project is discontinued before the expected date of completion.
• Modifications are requested by other HRECs.
The approval given by the Deakin University Human Research Ethics Committee is given only for the project and
for the period as stated in the approval. It is your responsibility to contact the Human Research Ethics Unit
immediately should any of the following occur:
Human Research Ethics Unit
research-ethics@deakin.edu.au
Telephone: 03 9251 7123

Page	323	
	
Appendix	K:	Publications	Arising	from	This	Thesis	
	
	
Major Article
Thai clinicians’ attitudes toward antimicrobial stewardship programs
Nantanit Sutthiruk RN, MNS a,*, Julie Considine RN, PhD a,b, Ana Hutchinson RN, PhD a,c,
Andrea Driscoll RN, PhD a,d, Kumthorn MalathumMD e, Mari Botti RN, PhD a,c
a School of Nursing and Midwifery, Deakin University, Geelong, VIC, Australia
b Centre for Quality and Patient Safety Research - Eastern Health Partnership, Box Hill, VIC, Australia
c Centre for Quality and Patient Safety Research - Epworth HealthCare Partnership, Richmond, VIC, Australia
d Austin Health, Heidelberg, VIC, Australia
e Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Key Words:
Attitudes
Perceptions
Antimicrobial stewardship
Antimicrobial resistance
Clinicians
Background: Effective hospital-wide antimicrobial stewardship (AMS) programs need multidisci-
plinary engagement; however, clinicians’ attitudes have not been investigated in Thailand where AMS is
in early development. The aim of this study was to explore Thai clinicians’ (doctors, nurses, and phar-
macists) perceptions and attitudes toward AMS.
Methods: A paper-based survey was distributed in a 1,000-bed university hospital in Bangkok, Thai-
land, between November 9, 2015, and December 21, 2015. A total of 1,087 clinicians participated:
392 doctors, 613 nurses, and 82 pharmacists.
Results: Most participants agreed that improving antimicrobial prescribing would decrease antimicro-
bial resistance (AMR) and should be a priority of hospital policy. Doctors were less likely to agree with
policies that limit antimicrobial prescribing (P < .001) than nurses or pharmacists, and were less likely
to be interested in participating in AMS education than other clinicians (P < .001). Pharmacists indicated
higher agreement with the statement, recommending that a specialist team provide individualized an-
timicrobial prescribing advice (P < .01) and that feedback improves antimicrobial selection (P < .001). Nurses
were less likely to agree that community antibiotic use (P < .001) or patient pressure for antibiotics con-
tribute to AMR (P < .001).
Conclusions: AMS programs are vital to improving antimicrobial use by clinicians. Understanding clini-
cians’ attitudes and perceptions related to AMS is important to ensure that AMS programs developed address
areas relevant to local clinical needs.
© 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier
Inc. All rights reserved.
BACKGROUND
Antimicrobial resistance (AMR) is a major health care problem
worldwide with significant consequences.1 Patients with
antimicrobial-resistant infections are at greater risk of worse clin-
ical outcomes, recurrent infection, and death than infected patients
without AMR.2 As many as 25,000 people in Europe die every year
because of antibiotic-resistant microorganisms,3 and it is estimated
that >2 million people are infected by antibiotic-resistant patho-
gens resulting in 23,000 deaths annually in the United States.4 It has
been estimated that >500,000 people worldwide die every year as
a result of AMR.4 In Thailand, as many as 90,000 patients are af-
fected by AMR annually and the cost of the therapeutic use of
antibiotic medications is >$200million per year. The increase in AMR
has resulted in approximately 3.24 million extra days of hospital
stay and accounted for 38,481 deaths annually in Thailand.5 It is es-
timated that an additional 19,000 deaths are caused by multidrug-
resistant (MDR) bacteria in Thailand each year. Mortality attributed
to MDR was highest for hospital-acquired MDR Acinetobacter bac-
teremia (41%).6
Inappropriate use of antimicrobial medications is a major cause
of AMR. In U.S. hospitals, as many as 50% of antibiotics prescribed
are unnecessary or inappropriate,4 and 47% of antibiotic use in Aus-
tralian hospitals was found to be inconsistent with antimicrobial
guidelines or patients’ microbiologic results.7 Antimicrobial
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stewardship (AMS) programs have been initiated to respond to the
growing problem of AMR. AMS is a process that aims to ensure
optimal antimicrobial medicine use and minimize AMR.8 For AMS
to be effective, hospital-wide AMS programs need the engage-
ment of multidisciplinary professionals who are involved in
antimicrobial prescribing and use.9 Clinicians need to be aware of
the causes and consequences of AMR and current evidence for ap-
propriate antimicrobial use.9,10 Differences and similarities between
professions will affect the implementation of AMS programs.9 Cli-
nician support for AMS programs has been identified in surveys
conducted in Europe,11 Australia,9 and the United States.12 However,
little is known about the attitudes and perceptions of clinicians
toward AMS in Thailand. The aim of this study was to explore the
perceptions and attitudes of clinicians. For the purpose of this study,
clinician refers to doctors, nurses, and pharmacists.
METHODS
This study was a cross-sectional survey of health professionals
at a 1,000-bed university hospital in Bangkok, Thailand. Data were
collected between November 9, 2015, and December 21, 2015. A
paper-based survey was distributed to 1,753 doctors, nurses, and
pharmacists in the following departments: surgery, pediatrics, med-
icine, operating room, pharmacy, obstetrics and gynecology,
orthopedics, ophthalmology, emergencymedicine, community health
nurses, family medicine, and anesthesiology. The overall response
rate was 62.0% (1,087/1,753). The specific response rates per pro-
fessional group were 41.4% (392/948) for doctors, 86.3% for nurses
(613/710), and 86.3% for pharmacists (82/95).
Survey instrument
The survey for this study was based on a survey used in an Aus-
tralian study.9 There were 26 items in the Australian survey of which
24 were retained: the 2 items deleted were related to Australian
guidelines and not relevant to the Thai context. Because antibiot-
ics can be purchased without prescription in Thailand and therefore
are widely used, 2 additional questions related to patient influ-
ences on antibiotic prescribing decisions and patients’ ability to buy
over-the-counter antibiotics were added by the researchers, because
these are important contextual issues for Thai health care.
To ensure content and face validity, the survey was reviewed by
the research team to determine that survey items were clear and
that survey content examined the correct concepts.13 The English
version was translated into Thai by 1 researcher. A nurse educator
from a Thai University who holds a PhD in Nursing (written in
English) performed a back translation from Thai to English. The con-
sistency of meaning between the Thai and the back-translated
English versions was determined by 1 researcher (N.S.). This com-
parison identified only minor differences that were corrected. The
content and face validity relevant to the Thai context and lan-
guage were established by a Thai panel consisting of specialists in
infection prevention and control. These specialists were infectious
disease physicians, an AMS specialist pharmacist, and a preven-
tion and control specialist nurse who evaluated the items for
relevance and accuracy. They independently rated the relevance of
each item to calculate a Content Validity Index. The Content Va-
lidity Index was 0.90. To ensure internal consistency, a pilot test of
the Thai version was conducted with 10 health care professionals
at the hospital before the study commenced, and coeﬃcient αwas
calculated as 0.89. Head nurses, senior doctors, and senior phar-
macists of each department and ward were asked to distribute the
survey to clinicians and remind them to complete the survey within
a 4-week period. The study was approved by the Human Research
Ethics Committees of Deakin University and the surveyed hospital.
Data analysis
Data were analyzed using SPSS version 23.0 for Windows (IBM,
Chicago, IL). Descriptive statistics (frequencies, percentages, means,
and SDs) were used to summarize the study data. Because the data
did not conform to the normal distribution, medians and first and
interquartile range are presented. For survey items that were cat-
egorical in nature, clinicians’ responses are presented as frequencies,
and comparisons were made using the χ2 test. For continuous data,
the Kruskal-Wallis test was used to compare the responses of dif-
ferent professional groups (doctors, nurses, and pharmacists).
RESULTS
A total of 1,087 clinicians completed the survey: 392 (36.1%) were
doctors, 613 (56.4%) were nurses, and 82 (7.5%) were pharmacists.
Overall, 80.9% (n = 879) of clinicians were women: 52.6% of doctors
(n = 206), 97.7% of nurses (n = 599), and 90.2% of pharmacists (n = 74).
Table 1 shows that clinicians were most commonly working in the
areas of surgery (20.8%), pediatrics (18%), and medicine (17.6%). The
median age was 29 years (interquartile range, 26-35), and ages
ranged from 22-70 years. Almost half the clinicians (42.3%) had
1-5 years of clinical experience (n = 460).
Clinician perceptions of AMR
Clinician perceptions in relation to AMR are presented in Table 2.
Comparedwith nurses, more doctors and pharmacists perceived that
patients’ ability to buy antibiotics over-the-counter was a signifi-
cant influence on AMR (P < .001). Clinicians, particularly doctors,
considered that AMRwas a serious problemworldwide, in Thai hos-
pitals, and at the surveyed hospital (P < .001). AMR in the Thai
community was considered less important, particularly by nurses
(P < .001). Clinicians, particularly doctors, believed that antimicro-
bial use in Thai hospitals contributed to AMR.
Clinicians’ responses toward AMS programs
Clinicians’ attitudes toward AMS programs are presented in
Table 3. Most clinicians from all professions agreed AMR would be
reduced by improving antimicrobial prescribing and it should be
a priority of the hospital and supported by a hospital-endorsed policy.
Clinicians perceived that local antimicrobial guidelines and proto-
cols, and a computer application to guide selection and duration
of antimicrobial therapy, would be clinically useful. However, doctors
were less likely than nurses and pharmacists to agree with a policy
that limits antimicrobial prescribing (P < .001). Doctors were also
less likely to be interested in participating in AMS education and
training than nurses and pharmacists (P < .001). Pharmacists were
more likely than doctors and nurses to agree that a team consist-
ing of an infectious disease specialist physician and pharmacist to
provide individualized antimicrobial prescribing advice and feed-
back would assist with antimicrobial selection (P < .001).
Previous involvement and experience with AMR and AMS
Clinicians’ responses to questions related to previous involve-
ment and experience with AMR and AMS are presented in Table 4.
Most clinicians had previously been involved in the care of pa-
tients with an antibiotic-resistant infection (88.1%). However, there
were less pharmacists involved in the care of patients with resis-
tant infections than doctors or nurses (59.8% vs 93.1% vs 88.7%,
respectively; P < .001). Most clinicians perceived increasing numbers
of antimicrobial-resistant infections over the last 5 years. Again, fewer
pharmacists perceived this change over time than doctors or nurses
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(P = .001). Overall, <1 in 5 clinicians (17.2%) had heard of AMS ter-
minology in English. Less than half the clinicians (37.6%) reported
that they had worked in health care facilities with AMS programs.
DISCUSSION
This study had 2 major findings. First, all clinicians surveyed per-
ceived AMR as a major problem, and that improved prescribing and
use of antibiotics was important. Second, there were differences
between professions regarding AMR and AMS that need to be con-
sidered when developing AMS programs for the Thai health care
system.
All clinicians surveyed perceived AMR as a major problem glob-
ally, in Thai hospitals, and at the surveyed hospital. The perception
that AMR is a major problem globally is reported in many other
studies.9-11,14-16 A few studies, including a study from Thailand, have
also found that clinicians perceived AMR as amajor problem for their
hospital.16,17 However, this is inconsistent, and several studies have
found that although clinicians may think AMR is a major problem,
they do not necessarily perceive AMR as a problem that affects
practice in their hospital.9-11,14-16 These findings are concerning
because AMR is an increasing and serious quality and safety issue.
Further, AMR is one of the biggest public health threats that re-
quires cooperation across government and public sectors globally
to prevent and control the spread of resistant infections.1,18 Resolv-
ing AMRwill be challenging if health care providers, oftenmistakenly,
do not perceive that AMR is an issue in their hospital so are not
willing to change their practice to address problems related to AMR.
The reason many health professionals are concerned about AMR
as a major issue in health care but not at their hospital is unclear.
One possible explanation may be the variation in availability of in-
fectious disease specialists in different hospitals. It may be proposed
that when infectious disease specialists are available for consulta-
tion, treating doctors may perceive less risk of AMR because they
are deferring decision-making to expert clinicians and expert judg-
ments about antibiotic use should limit the development of AMR.
Another possible reason for this finding is the different regulation
of purchasing and use of antibiotics in different countries. Antibi-
otics are purchased over-the-counter in many countries across the
world, including Thailand.10,19 Studies from Ethiopia and Peru where
Table 1
Clinicians’ employment characteristics
Demographic data All clinicians (N = 1,087) Doctors (n = 392) Nurses (n = 613) Pharmacists (n = 82)
Hospital departments
Surgery 226 (20.8) 76 (19.4) 150 (24.5) -
Pediatrics 196 (18.0) 51 (13.0) 145 (23.7) -
Medicine 191 (17.6) 115 (29.3) 76 (12.4) -
Operating room nurses 86 (7.9) - 86 (14.0) -
Pharmacy department 82 (7.5) - - 82 (100)
Obstetrics and gynecology 61 (5.6) 28 (7.1) 33 (5.4) -
Orthopedics 60 (5.5) 24 (6.1) 36 (5.9) -
Ophthalmology 51 (4.7) 24 (6.1) 27 (4.4) -
Emergency medicine 49 (4.5) 22 (5.6) 27 (4.4) -
Community health nurses 33 (3.0) - 33 (5.4) -
Family medicine 28 (2.6) 28 (7.1) - -
Anesthesiology 24 (2.2) 24 (6.1) - -
Years of experience since qualification
<1 94 (8.6) 2 (0.5) 76 (12.4) 16 (19.5)
1-5 460 (42.3) 171 (43.6) 252 (41.1) 37 (45.1)
6-10 247 (22.7) 122 (31.1) 107 (17.5) 18 (22)
11-20 204 (18.8) 61 (15.6) 135 (22) 8 (9.8)
>20 82 (7.5) 36 (9.2) 43 (7) 3 (3.7)
Age, y
Median 29 31 28 29
IQR 26-35 28-37 24-35 26-34
NOTE. Values are n (%) or as otherwise indicated.
IQR, interquartile range.
Table 2
Responses by profession to survey items related to antimicrobial resistance
Questions All clinicians (N = 1,087)
Doctors
(n = 392)
Nurses
(n = 613)
Pharmacists
(n = 82) χ2 df P value*
Indicate how serious a problem you believe antimicrobial resistance is in the following places†
Worldwide 7.0 (5.0-7.0) 7.0 (6.0-7.0) 6.0 (5.0-7.0) 6.0 (6.0-7.0) 61.53 2 <.001
Thai community 6.0 (4.0-7.0) 6.0 (5.0-7.0) 5.0 (4.0-6.0) 6.0 (5.0-7.0) 62.74 2 <.001
Thai hospitals 7.0 (6.0-7.0) 7.0 (6.0-7.0) 6.0 (5.0-7.0) 6.0 (6.0-7.0) 18.96 2 <.001
Surveyed hospital 7.0 (6.0-7.0) 7.0 (6.0-7.0) 6.0 (6.0-7.0) 6.0 (5.0-7.0) 38.34 2 <.001
Indicate how strongly you believe the following contribute to antimicrobial resistance at the surveyed hospital‡
Antimicrobial use in Thai animal and agricultural sectors 5.0 (4.0-5.0) 5.0 (4.0-6.0) 4.0 (3.0-5.0) 5.0 (4.0-6.0) 51.37 2 <.001
Antimicrobial use in Thai community 5.0 (4.0-6.0) 6.0 (5.0-7.0) 5.0 (4.0-6.0) 6.0 (5.0-6.0) 123.18 2 <.001
Antimicrobial use in Thai hospitals 6.0 (5.0-7.0) 6.0 (6.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-6.0) 85.01 2 <.001
Antimicrobial use at the surveyed hospital 6.0 (5.0-7.0) 6.0 (5.0-7.0) 5.0 (4.0-6.0) 5.0 (5.0-6.0) 52.48 2 <.001
Patient pressure for antibiotics as part of treatment 5.0 (4.0-6.0) 6.0 (5.0-7.0) 5.0 (3.0-6.0) 6.0 (5.0-6.0) 80.77 2 <.001
Patients are able to buy antibiotics over-the-counter 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-6.0) 25.72 2 <.001
NOTE. Values are median (interquartile range) or as otherwise indicated.
*Kruskal-Wallis test.
†Rated on a Likert scale from 1 (not a problem) to 7 (very serious problem).
‡Rated on a Likert scale from 1 (does not contribute) to 7 (strongly contributes).
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people can buy antibiotics without a prescription also showed that
most clinicians agreed AMR is a serious problemworldwide but less
so in their own practice.10,15 These studies from countries where pre-
scriptions are not required to buy antibiotics may explain clinicians’
perceptions that AMR is a problem originating from outside their
hospital and from the broader community.
In Thailand, antibiotics are easily bought over-the-counter at
grocery stores or drug stores. Thai people commonly seek basic
advice from the pharmacist at a drug store if they are feeling unwell.19
Clinicians in our study reported that antibiotic use and patients’ pur-
chase of over-the-counter antibiotics were major influences on the
AMR problem. Most clinicians (88%) in this Thai study also re-
ported that caring for patients with an antibiotic-resistant infection
was common, which may explain perceptions of Thai clinicians that
AMR is a major issue in the surveyed hospital. However, the rela-
tionship between perceptions of AMR as amajor problem in hospitals
and having cared for patients with antibiotic-resistant infection is
not the same in all studies. An Australian study showed that al-
though 84% of the clinicians reported they cared for patients with
antibiotic resistance, only 45% of them reported AMR as a major
problem in their hospital.9
Most clinicians in this study agreed that systems for improved
antibiotic prescribing were important to reduce the occurrence of
AMR and should be a hospital priority. Many other studies have also
reported that systems to improve antibiotic prescribing would be
clinically useful to ensure the optimal prescribing and use of
antibiotics9,11,14-16,20 and support the premise that AMS programs de-
crease inappropriate antibiotic use, reduce health care costs, and
decrease the occurrence of AMR and adverse drug events, all of which
improve patient care.21 Therefore, the strategies and systems that
promote appropriate antibiotic use or AMS programs have been set
as a worldwide agenda.1 In 2011, the World Health Organization
launched the WHO Global Strategy on Containment of Antimicro-
bial Resistance campaign to empower every country in the world
to respond to the AMR problem.22
In many countries, systems for improved antibiotic prescribing
have been initiated as a national agenda. For example, in Austra-
lia, a hospital AMS strategy is one of the compulsory criteria for
approval of hospital accreditation.23 In the United States, the Infec-
tious Diseases Society of America published guidelines for improving
the use of antimicrobial agents in the hospital as far back as 1988.
Recently, in 2016, the U.S. National Action Plan for Combating
Antibiotic-Resistant Bacteria has been approved.18 In England, the
National Health Service has launched activities to support AMS since
1999 with regular updates of their national guidelines. Antimicro-
bial Stewardship Toolkit for English Hospitals was the most recent
AMS guideline to be published in August 2015.24 All these strate-
gies demonstrate that many countries across the world have
responded to the emergence of AMR as a major issue. AMS is rec-
ognized as a key strategy to improve the appropriateness of
antimicrobial use.21
There were a number of differences between professions in per-
ceptions of AMR. Nurses were less likely than doctors and
pharmacists to agree that AMR was a serious problem in the Thai
community, and that antibiotic use in the community contributed
to AMR at the surveyed hospital. One possible explanation was that
nurses surveyed in this studywere hospital nurses and rarely worked
in community settings. Therefore, their knowledge of AMR issues
Table 3
Clinicians’ attitudes toward antimicrobial stewardship programs by profession
Questions
All clinicians
(N = 1,087)
Doctors
(n = 392)
Nurses
(n = 613)
Pharmacists
(n = 82) χ2 df P value*
Improving antimicrobial prescribing at the surveyed hospital
will help decrease antimicrobial resistance.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-6.25) 9.79 2 .008
Improving antimicrobial prescribing should be an
organizational priority.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-6.0) 1.17 2 .558
A formal policy for the use of antimicrobials should be
introduced at the surveyed hospital.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 1.38 2 .501
A policy that limits the prescribing of selected antimicrobials
to certain clinical indications via an approval process should
be introduced at the surveyed hospital.
6.0 (5.0-7.0) 5.0 (4.0-6.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 33.73 2 <.001
Local antimicrobial guidelines and protocols should be
introduced at the surveyed hospital.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 3.10 2 .212
A computer application which gives advice on selection and
duration of antimicrobial therapy for specific clinical
conditions would be clinically useful.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (6.0-7.0) 13.38 2 .001
A team consisting of an infectious disease specialist physician
and pharmacist providing individualized antimicrobial
prescribing advice and feedback would assist with
antimicrobial selection.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 7.0 (6.0-7.0) 18.05 2 <.001
I would be interested in participating in education sessions
about antimicrobial stewardship.
6.0 (5.0-7.0) 5.0 (4.0-6.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 22.45 2 <.001
I would be willing to participate in any activities to improve
the quality of antimicrobial use at the surveyed hospital.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (6.0-7.0) 16.08 2 <.001
NOTE. Values are median (interquartile range) or as otherwise indicated.
*Kruskal-Wallis test.
Table 4
Previous involvement and experience with antimicrobial resistance and antimicrobial stewardship by profession
Questions
All clinicians
(N = 1,087)
Doctors
(n = 392)
Nurses
(n = 613)
Pharmacists
(n = 82) χ2 df P value
Previously involved in care of patients with an antibiotic-resistant infection 958 (88.1) 365 (93.1) 554 (88.7) 49 (59.8) 79.52 4 <.001
Have noticed increasing number of antimicrobial-resistant infections over last 5 y 895 (82.3) 335 (85.5) 504 (82.2) 56 (68.3) 18.58 4 .001
Have heard of term antimicrobial stewardship (English term) 187 (17.2) 80 (20.4) 67 (10.9) 40 (48.8) 99.49 4 <.001
Worked in health care facilities with antimicrobial stewardship programs 409 (37.6) 154 (39.3) 217 (35.4) 38 (46.3) 42.16 4 <.001
NOTE. Values are n (%) or as otherwise indicated.
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in the community may be poor. Although both nurses and doctors
take a health history that includes antibiotic use in the communi-
ty, doctors have the major responsibility for prescribing so are more
likely than nurses to consider antibiotic use in the community in
their decision-making. Doctors also consult pharmacists for advice
regarding antibiotic prescriptions; therefore, pharmacists may also
have a deeper understanding than nurses of the consequences of
antibiotic use in the community. The finding that nurses were less
concerned than doctors and pharmacists about AMR in the com-
munity is similar to the results of an Australian study that showed
nurses, doctors, and pharmacists believed that antibiotic use in the
Australian community contributed to AMR at their hospital by 38%,
57%, and 70%, respectively.9
Nurses were more likely than pharmacists to report being in-
volved in the care of patients with antibiotic resistance and less likely
to report that patient pressure to prescribe antibiotics contributes
to AMR. AMR is an important consideration when providing edu-
cation to nurses about antibiotic use because nurses have a major
role in antibiotic management during a patient’s hospitalization.
Further, nurses have the most direct contact with patients and fami-
lies; therefore, it is vital that nurses provide patient and family
education about antibiotics throughout their hospital stay and prior
to discharge from hospital.25
Despite doctors agreeing that guidelines and protocols to support
antibiotic prescribing would be useful, doctors were significantly
less likely than nurses and pharmacists to agree with any inter-
ventions that limit prescribing decisions. The finding that doctors
do not favor interventions that limit prescribing has also been
reflected in other studies.9 Previous studies show that doctors are
one of the most trusted professions and have high levels of
decision-making about patient care.26 Therefore, doctors may
not see a need to change their practice or a need to be involved
in AMS programs. AMR is a worldwide problem that will require
multidisciplinary solutions. Involving doctors in the design
of AMS programs and engaging them to critically examine their
antibiotic prescribing may be needed along with audit and restric-
tive activities.
Pharmacists seemed to have a higher focus on system improve-
ments than doctors and nurses. Other studies from Australia also
show that pharmacists seemed to be more engaged with AMS
systems than doctors and nurses.9 One possible reason for this dif-
ference in perceptions of systems to improve AMS may be that
pharmacists have more of an overview of the whole hospital,
whereas doctors and nurses only know the patients and practices
on their ward or wards. In the surveyed hospital, it is general prac-
tice for pharmacists to work across the whole hospital, whereas
nurses typically only work in 1 ward and doctors may visit 2 or 3
wards. It is probable that these working circumstances of pharma-
cists, doctors, and nurses are similar in other countries.
There are a number of limitations that should be consideredwhen
interpreting the study findings. First, the study was conducted at
a single site that was a well-resourced university hospital in Thai-
land. Therefore, the study results may not be generalizable to other
Thai hospitals, particularly smaller rural hospitals. Second, partici-
pants were self-selecting and the characteristics of those who did
not participate in the survey are unknown. Further, purposive sam-
pling was used to target doctors, nurses, and pharmacists from
departments with high antibiotic use; therefore, there are depart-
ments such as psychiatry that are underrepresented. It is therefore
possible that the sampling approach and recruitment limit the
generalizability of the study results to other departments or hos-
pitals. Despite the sampling limitations, 1,087 clinicians participated
in the survey and the overall response rate was 62%; therefore, there
is confidence that the study results represent those groups tar-
geted for inclusion.
CONCLUSIONS
This study is the first large-scale survey of doctors, nurses, and
pharmacists regarding AMR and AMS in Thailand. The staff survey
was based on a survey used in an Australian study to understand
clinicians’ perceptions and attitudes toward AMR and AMS in the
Thai health care context. The major findings were that all partici-
pants surveyed perceived AMR as a major problem and that
improved prescribing and use of antibiotics was important. Further,
there were differences between professions regarding AMR and AMS.
The results of this study highlight the potential barriers and facili-
tators to effective implementation of AMS programs in Thai hospitals.
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